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ABSTRACT 
 
Harnessing the Power of Furfuryl Cations: 
The Aza-Piancatelli Rearrangement and Beyond 
by 
 
Gesine Kerstin Veits 
 
The ubiquity of amine functional groups in all of nature as well as a large majority of 
pharmaceutically active molecules makes methodologies capable of quickly constructing 
carbon–nitrogen bonds invaluable. Reactions capable of constructing these highly desirable 
bonds in addition to introducing molecular complexity are highly sought-after. Therefore we 
set out to develop a novel cascade rearrangement of furylcarbinols, a sustainable starting 
material, to 4-aminocyclopentenones, the aza-Piancatelli rearrangement.   
Inspired by Piancatelli’s rearrangement of furylcarbinols with water to form 4-
hydroxycyclopentenones for the synthesis of prostaglandins, we explored the rearrangement 
with amine nucleophiles to access valuable 4-aminocyclopentenones. The product-forming 
cascade is initiated by dysprosium trifluoromethanesulfonate, a relatively underdeveloped 
Lewis acid catalyst. Activation results in the formation of a furfuryl cation (oxocarbenium 
ion) that is intercepted by an amine nucleophile and terminates in a 4π conrotatory 
electrocyclization establishing the observed trans-stereochemistry. The chemistry was 
initially developed with aniline nucleophiles, and was later extended to substituted 
hydroxylamines. Mechanistic investigations of the aza-Piancatelli rearrangement have 
shown that an off-cycle binding of the dysprosium catalyst and the amine nucleophile 
controls the rate, as observed by a Hammett plot. However, the selectivity of the 
  ix 
rearrangement is determined by the ability of a nucleophile to efficiently capture the 
oxocarbenium ion upon its formation.  
The value of the aza-Piancatelli rearrangement has been highlighted by the synthesis of 
an hNK1 inhibitor and by efforts toward the total synthesis of homoharringtonine, a 
pharmaceutical drug approved for the treatment of chronic myeloid leukemia. Additionally, 
a Piancatelli rearrangement of macrocyclic furylcarbinols, to be applied to the total synthesis 
of coralloidolide F, has been explored.  
Finally, chiral phosphoric acids such as (R)-TRIP have been found to be catalysts for the 
aza-Piancatelli rearrangement capable of inducing enantioselectivity. This is the first 
example of asymmetric cascade rearrangements of its kind. 
  x 
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1. Introduction 
1.1 The Importance of Organic Chemistry 
Friedrich Wöhler’s synthesis of urea from cyanic acid and ammonia in 1828 marked the 
first recorded and recognized synthesis of an organic substance from inorganic starting 
materials, a discovery considered to be the starting point of organic chemistry and the end of 
vitalism (Scheme 1.1).1  




Scheme 1.1. Wöhler synthesis of urea. 
Since that discovery, organic chemistry has come a long way resulting in significant and 
important scientific advances. In 1902, Emil Fischer received the Nobel Prize in Chemistry 
for his work on the synthesis of sugars and purines. This recognition again marked the 
intrinsic link between biology and organic chemistry. By this point, organic chemistry had 
already come a long way from the accidental synthesis of small molecules to a concrete 
understanding of reactivity and the building of small molecules. The synthesis targets 
chosen by synthetic chemists are becoming more complex as our understanding of organic 
chemistry and our synthetic toolbox continues to expand. Modern organic synthesis greatly 
benefited from the game-changing contributions made by Robert Burns Woodward, who not 
only advanced the field from a synthetic standpoint, but also from a more fundamental 
physical organic standpoint. He was awarded the 1965 Nobel Prize in Chemistry “for his 
outstanding achievements in the art of organic synthesis”. His landmark synthetic 
achievements include the synthesis of cortisone (1),2 cholesterol (2)3 and strychnine (3),4 
among others (Figure 1.1). The immensity of his synthetic achievements can be put in 
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perspective when considering that since Woodward’s synthesis of strychnine, there have 
been seventeen successful approaches to the molecule, the latest one a 2011 synthesis by the 
Vanderwal group.5 It is absolutely amazing to think that a synthesis that took 28 steps to 




























Figure 1.1. Landmark total syntheses accomplished by Woodward. 
Following Woodward’s and others great contributions to organic chemistry, Elias James 
Corey’s concept of retrosynthetic analysis became perhaps the most valuable contribution to 
the field of natural product synthesis.6 Nowadays, total synthesis targets are routinely 
deconstructed into strategic building blocks using retrosynthetic analysts.  
Essential to these natural products and targets of synthetic efforts throughout time are 
compounds that have interesting biological activity. One commonality among many 
biologically active compounds is the presence of one or more carbon bound nitrogen atoms. 
In fact, the precise position of carbon-nitrogen bonds within a molecule are often 
responsible for the inherent biological activity.7 Perhaps the fact that the birth of organic 
chemistry involved the synthesis of a nitrogen-containing molecule – uric acid – was 
foreshadowing the importance of carbon-nitrogen bond formation in the field. Due to the 
ubiquity and necessity for strategically placed carbon nitrogen bonds in natural products and 
pharmaceutically active compounds, there has been great interest in the development of 
efficient and selective carbon-nitrogen bond-forming methodology. Our group’s interest in 
carbon-nitrogen bond forming methodology while introducing molecular complexity to 
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readily available starting materials forms the basis of this doctoral thesis. To achieve this in 
a rational and sustainable manner, we sought to develop a new cascade rearrangement that 
terminated with an electrocyclic reaction. The core concepts that are incorporated into our 
rational design are detailed below.  
1.1. Electrocyclic Reactions 
Electrocyclic reactions fall under the umbrella of pericyclic reactions that also includes 
cycloaddition reactions, such as the Diels–Alder reaction, sigmatropic rearrangements, such 
as the Claisen rearrangement, and ene reactions. By definition, a pericyclic reaction involves 
the making or breaking of bonds through a cyclic array of interacting orbitals. Pericyclic 
reactions proceed through a concerted mechanism that entails no observable intermediates 











Figure 1.2. Reaction coordinate diagram of a concerted pericyclic reaction. 
In their ground-breaking 1964 publication, Robert Burns Woodward and Roald 
Hoffmann described pericyclic reactions with the concept of conservation of orbital 
symmetry, a discovery that led to the bestowal of the 1981 Nobel Prize in Chemistry to 
Hoffmann (Woodward passed away in 1979).8 The collection of research in this area is 
widely known as the Woodward-Hoffmann rules. The conservation of orbital symmetry 
describes the formation of bonds during electrocyclic reactions in terms of the correlation 
between the Highest Occupied Molecular Orbital (HOMO) of the starting material and the 
product. This analysis accounts perfectly for the observed conrotation in electrocyclizations 
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of systems containing 4n π electrons as well as the disrotation observed in 4n+2 π systems 
(Figure 1.3). 
conrotatory motion disrotatory motion
 
Figure 1.3. Conrotatory and disrotatory motion in electrocyclizations. 
Kenichi Fukui, who shared the 1981 Nobel Prize with Hoffmann expanded on the 
original explanation of orbital symmetry with his Frontier Molecular Orbital (FMO) 
theory.9–12 
The concept is best explained pictorially with butadiene and 1,3,5-hexatriene serving as 
simple examples for the 4π and 6π electron systems, respectively. An analysis of the frontier 
molecular orbitals shows that in the case of a 4π system, conrotation along the C2 axis 
results in overlap of orbital nodes of the same sign, conserving symmetry and resulting in a 
process that is allowed (Figure 1.4). Disrotation of the 4π system leads to forbidden and 














Figure 1.4. 4π Conrotatory electrocyclization. 
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Analysis of the 6π system shows that conrotation along the C2 axis results in an 
interaction of orbitals of opposite signs and is therefore forbidden (Figure 1.5). However, 
disrotation results in overlap of orbitals of the same sign and is therefore allowed and 
favored in these systems. It should be noted that as a gross generalization, photochemical 
processes proceed in the exact opposite manner. Pathways that are thermally forbidden are 
photochemically allowed, while thermally allowed pathways are photochemically forbidden 
meaning that in a photochemical setting 4π systems undergo disrotation, while 6π systems 















Figure 1.5. 6π Disrotatory electrocyclization. 
Since this original description in terms of orbital symmetry and FMOs, a number of 
other methods have been used to explain electrocyclizations, including aromatic transition 
state (TS) theory and Möbius/Hückel analysis.13 
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The concerted nature of electrocyclization is the root of one of the magnificent features 
of this class of reactions: a conservation of stereochemistry. Bond formation in a single step 
with no intermediates results in an inability for pendant groups to scramble during the bond-
forming process. In fact, it was the observation of stereospecificity in these 
electrocyclizations that led Woodward and Hoffmann to their Nobel Prize winning 
discovery of conservation of orbital symmetry. In practical terms, this means that the 
arrangement of R groups around the π bonds of the system will directly translate to the 
stereochemistry of the observed product, and the same is true for the reverse ring-opening 
reaction. For example, cyclobutene 4 will ring-open to form diene 5, while cyclobutene 6 
will ring-open to form diene 7, in agreement with the prescribed conrotatory mode of 
rotation (Figure 1.6). Triene 8 undergoes disrotatory cyclization to form cis-substituted 














8 9  
Figure 1.6. Examples of conrotatory and disrotatory motion and their steric outcomes. 
In search of a better model and explanation for the observed stereoselectivity, Houk and 
co-workers examined a series of ring-opening reactions of cyclobutenes with various 
substituents.14 Remarkably, methyl-substituted cyclobutene 10 forms 11 exclusively, while 
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12 was not observed (Scheme 1.2). In the case of aldehyde-substituted cyclobutene 13 

















Scheme 1.2. Torquoselectivity in electrocyclizations. 
This observed directional conrotation is designated with the term torquoselectivity 
and is controlled by the electronics of the substitutents.15,16 Houk found that in general, a 
donor group will rotate outward, while an acceptor group rotates inward due to stabilization 
gained from orbital overlap during the ring-opening event (Figure 1.7). 
inward rotationoutward rotation
HOMO of bond
- FAVORABLE interaction for           
ACCEPTOR substituent
- UNFAVORABLE repulsion for        
DONOR
- empty for ACCEPTOR
- filled for DONOR
EDG EDG EWG
EWG
EDG  rotates outward EWG  rotates inward
 
Figure 1.7. Effects of donor and acceptor groups on torquoselectivity.  
To me, the beauty of pericyclic reactions lies in their relative simplicity, which is often 
translated into rather complex products.  
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1.2. The Nazarov Cyclization  
The rules governing the illustrative systems described above also apply to the 4π 
conrotatory process that governs the Nazarov cyclization. Although it was not correctly 
identified at the time, the first example of a Nazarov reaction in the literature was described 
by Vorländer in 1903 when he carried out the reaction of dibenzylidene acetone with 
concentrated sulfuric acid and acetic anhydride.17 Almost 40 years passed before Ivan 
Nazarov published his work on the formation of cyclopentenones 1941 which came to be 
associated with his name.18 The Nazarov cyclization generally describes the formation of a 
cyclopentenone from a divinyl ketone (16) under strongly acidic conditions and involves the 
generation of a pentadienyl cation (18) that undergoes a 4π conrotatory electrocyclization to 
form an oxyallyl cation (19) which, upon deprotonation, forms the desired cyclopentenone 
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Scheme 1.3. Mechanism of the Nazarov cyclization.  
Much progress has been made in the area of the Nazarov cyclization, and these 
developments have been beautifully summarized in reviews by Denmark,19 Tius,20 
Frontier,21 West,22 and Read de Alaniz.23 Within these reviews, publications addressing 
some of the problems associated with the classic Nazarov cyclization, such as the lack of 
stereoselectivity in the proton elimination step, and the need for stoichiometric acid are 
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detailed. Frontier’s study of the effect of substituents along the backbone of the divinyl 
ketone has greatly impacted the understanding of the transformation and requirements for 
successful control of stereochemistry.24 Positioning an electron donating group (EDG) at C2 
while an electron withdrawing group (EWG) is positioned at C4 of the divinyl ketone (24) 
creates a donor-acceptor system with complementary partial negative and partial positive 
charges at the C1 and C5 termini of the system, respectively (Scheme 1.4, 25). This 
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Scheme 1.4. Donor/acceptor Nazarov substrates. 
In addition to the formation of a partial positive charge at C5, the EWG at C4 also 
greatly influences the geometry of the substrate-catalyst binding as well as the catalyst 
turnover. Shown in Scheme 1.5 is the effect of the EWG on the E/Z isomerization of the C5 
substituent (29 to 31), which may be necessary for electrocyclization to occur. Additionally, 
the presence of the EWG may facilitate the reaction by adding a second binding point for the 
catalyst. With this knowledge in hand, specialized Nazarov substrates can be prepared for 
optimal results. 
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Scheme 1.5. E/Z Isomerization preceding electrocyclization in donor/acceptor Nazarov 
substrates. 
Since cyclopentenones are ubiquitous in nature, the Nazarov cyclization has been 
successfully applied to a number of natural product syntheses, including the synthesis of 
trichodiene (36) by Harding and Frontier’s synthesis of merrilactone A (40) (Scheme 
1.6).25,26 
One great feature of the Nazarov cyclization is the relative ease with which quaternary 
carbon centers can be formed via the electrocyclic bond-formation. Wenz and Read de 




















































Scheme 1.6. Total synthesis of trichodiene and merrilactone A via Nazarov cyclizations. 
  11 
1.3. Cascade Processes  
The process of forming and breaking bonds to carbon forms the basis of organic 
chemistry, where the goal is to do so in a well defined, controlled manner. Most often, a 
synthetic method is developed that allows for the formation of one new bond throughout the 
course of a reaction. However, in terms of ideal processes, it is much more desirable to 
develop reactions where multiple bonds form during a single reaction. Such transformations 
are classified as domino or cascade reactions. By definition, domino reactions are 
transformations during which two or more bonds (usually carbon–carbon) are formed.27 In 
analogy to dominos falling, a single activation step – pushing the first domino stone - is 
required that results in a cascade of bond-forming steps – domino stones falling – that are 
progressively lower in energy, until a resting state is reached – all of the dominos lie flat on 
the ground. The first domino reaction resulting in the formation of a natural product was 
Nobel Prize winner Robert Robinson’s one-pot synthesis of tropinone (44) in 1917.28 The 
synthesis was accomplished via a double Mannich reaction between succindialdehyde (41) 









4441 4342  
Scheme 1.7. Robinson's landmark cascade synthesis of tropinone.  
In the synthetic community, the development of cascade processes is highly desirable 
due to the speed and ease at which complexity can be built. However, despite these positive 
attributes, cascade processes can be difficult to see or predict, and are often serendipitously 
discovered during the synthesis of natural products. In some cases of excellent retrosynthetic 
analysis (possibly combined with a smidge of luck) however, cascade sequences yielding 
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complex products are not only predicted, but also executed. Illustrative examples include 
Heathcock’s pentacyclization to form dihydro-proto-daphniphylline (46) and Johnson’s 
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Scheme 1.8. Cascade processes in the synthesis of dihydro-proto-daphnyphylline and 
progesterone. 
 In addition to the aesthetically pleasing nature of cascade processes, these 
transformations also have great practical value in terms of their environmental impact. 
Performing multiple bond-forming events in a single pot and a single step increases atom 
economy of the reaction,31 decreases solvent waste and reactor time associated with the 
reaction, work-up and purification steps, greatly decreasing the environmental impact of 
such transformations.   
1.4. Sustainable Reaction Design 
 A relatively recent concept to be applied to organic chemistry is the idea of sustainable 
reaction design and green chemistry. Considering the birth of organic chemistry involved the 
use of highly toxic cyanide compounds, the invention of the fume hood is quite a comfort to 
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modern organic chemists. However, simply ensuring the safety of the chemist while 
synthesizing valuable chemicals is no longer the sole goal for academics or industry. With 
increasing awareness of the effects of industrialization and the cumulating carbon footprint 
on planet Earth, there has been a great shift toward developing new environmentally friendly 
chemical processes. Paul Anastas’ twelve principles of green chemistry are the bible of the 
green chemist and provide guidelines and rules to orient chemists toward developing 
reactions and processes that have less of a negative effect on nature.32 To this end, one of the 
merits cited for the choice of the 2005 Nobel Prize in chemistry awardees Yves Chauvin, 
Robert H. Grubbs, and Richard R. Schrock was the fact that for the metathesis methods in 
organic synthesis allow for short, efficient routes to desired products and contribute to green 
chemistry. In terms of sustainable reaction design, much work is being done in the area of 
using sustainable and renewable starting materials. With the undeniable environmental 
effects and depletion of petroleum sources, there is a great need for the development of 
reactions using renewable starting materials, such as biomass. To avoid interference with 
food supply, the ideal material would be a non-edible by-product of the food industry.  
1.5. Furfural 
The methodology described in this thesis revolves around reactions of furfural 
derivatives. Furfural is produced from hemicellulose present in agricultural waste, such as 
corncobs, oat hulls, almond husks, and bagasse. In fact, the Quaker Oats company 
developed the first industrial scale production of furfural in the 1920s to make use of their 
cereal waste.33 Today, annual production of furfural is approximately 300,000 tons per year, 
and can be purchased from Aldrich at a price of $95 for 3 kg. Since it is produced from a 
non-edible byproduct of the food industry and is very cheap, furfural is an excellent choice 
of sustainable starting material for applications in synthesis and materials chemistry. 
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In terms of its chemistry, furfural is very versatile. Compared to the 36 kcal/mol 
resonance energy of benzene, the aromatic stabilization of the furan ring is relatively low at 
only 16 kcal/mol, even compared to its closer cousins thiophene (29 kcal/mol) and pyrrole 
(22 kcal/mol). This allows for reactions under relatively mild conditions. The furan unit can 
serve as the source of a 1,4-dicarbonyl,34 an olefin, a diene35 or an enol ether.36,37 
The reactivity of furan has been exploited in synthetic methods developed by 
Achmatowicz,38 Piancatelli39 and Batey40, all of which rely on rearrangements of furfural or 
its derivatives to access synthetically valuable scaffolds (Figure 1.8). Additionally, a number 
of total syntheses of natural products including Henschke’s synthesis of prostaglandin 
analogues,41 Zakarian’s synthesis of (+)-brevisamide,42 and Wu’s synthesis of tonghaosu 
analogues originate from furfural and its derivatives (Figure 1.8).43 
In terms of other applications, furfural has been used to synthesize surfactants, ionic 
liquids, chiral ligands, as well as self-healing polymers.44–48 There are also ongoing 
investigations of its use as a biofuel,49 which would be more desirable than alternative fuels, 
such as starch based methods, which interfere with food production.  






























Figure 1.8. Select applications of furfural and its derivatives. 
1.6. The Piancatelli Rearrangement 
With the determination of the structure and of the importance of prostaglandins by Sune 
K. Bergström in the 1950s, a discovery that earned him and his student Bengt I. Samuelsson 
the 1982 Nobel Prize in Physiology or Medicine together with John R. Vane, there came an 
enormous interest in synthetic methods to quickly access the prostaglandin scaffold.50 Many 
of the methods required multiple steps to access the requisite cyclopentenone unit, often by 
way of a 1,4-diketone. Motivated by the lack of direct routes, Piancatelli developed the 
synthesis of 4-hydroxycyclopentenones (52) directly from furylcarbinols  (51) (Scheme 
1.9).39 Simple furylcarbinols (51) can be accessed in one step via a Grignard reaction 
between furfural and an aryl or alkyl halide. Exposure of these furylcarbinols to protic acid, 
such as formic acid, polyphosphoric acid (PPA) or para-toluenesulfonic acid (p-TSA), in 
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aqueous solvent initiates a cascade resulting in 5-substituted-4-hydroxycyclopentenones (52) 














Scheme 1.9. The Piancatelli rearrangement of furylcarbinols. 
The reaction proceeds in a stereospecific manner, exclusively furnishing the trans-
substituted product, which led Piancatelli to invoke a 4π conrotatory electrocyclization as 
the carbon–carbon bond forming and stereodetermining event. The mechanism is proposed 
to commence with activation of the alcohol followed by loss of water, generating the highly 
reactive oxocarbenium ion 54 (Scheme 1.10). Nucleophilic attack at the 5-position of the 
oxocarbenium ion initiates the productive cascade process that ultimately yields the desired 
cyclopentenones (52). Nucleophilic trapping of the oxocarbenium results in acetal 55, which 
can open up to form 56. Redrawn as a pentadienyl cation, 57 undergoes a 4π conrotatory 
electrocyclization forming the oxyallyl cation (58) that, upon loss of a proton, yields the 
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Scheme 1.10. Proposed mechanism of the Piancatelli rearrangement. 
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In a subsequent publication, Piancatelli demonstrated that a functional group (a t-butyl 
ester) incorporated into the side chain of the furylcarbinol did not interfere with the reaction 
conditions for the Piancatelli rearrangement (59 to 60, Scheme 1.11).51 Treatment with 
aluminum oxide facilitates rearrangement to the more stable cyclopentenone (61). 
Alternatively, reduction followed by elimination using aluminum oxide gives 































Scheme 1.11. Progress toward prostaglandin synthesis via the Piancatelli rearrangement. 
To further expand the utility and general understanding of the reaction, Piancatelli 
investigated substituents at the 5-position of the furan ring (63, Scheme 1.12). The presence 
of a methyl group required a switch to Lewis acidic reaction conditions due to the decreased 
stability of the starting materials because of the donating group – conditions which have 
passed the test of time. One equivalent of zinc chloride efficiently promoted the 
rearrangement to cyclopentenone 64 (Scheme 1.12).52 Interestingly, the reaction was 
stereospecific, resulting in exclusive formation of the product where the alcohol and R-
group are trans to one another, again pointing to a 4π electrocyclic process. When 
attempting the transformation with a 5-OMe group, Piancatelli and co-workers found that 
the Piancatelli rearrangement did not take place, and instead resulted in formation of the 4-
ylidenebutenolides 66 and 4-oxo-2-enoic acid methyl esters 67 (Scheme 1.12).53  
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Scheme 1.12. The Piancatelli rearrangement with 5-substituted furylcarbinols. 
Since its initial development, Piancatelli’s rearrangement conditions have been applied 
to a number of syntheses of prostaglandins, such as the synthesis of prostaglandin E1 (71) 
by Spur and co-workers (Scheme 1.13).54 Additional applications and developments can be 


































Scheme 1.13. Total synthesis of prostaglandin E1 via a Piancatelli rearrangement. 
More recently, Reiser and co-workers have developed methods that will likely improve 
the use of the Piancatelli rearrangement in an industrial setting through the development of a 
microwave-assisted rearrangement of furfuryl alcohol to 4-hydroxycyclopent-2-en-1-one.56 
The group then showed that a microreactor setup allows for rapid synthesis of large 
quantities of the desired cyclopentenones, with residence times of only 53 seconds. The 
Read de Alaniz group also developed a new method for the synthesis of 4-
hydroxycyclopentenones (52) using dysprosium triflate as the catalyst (Scheme 1.14).57  
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Scheme 1.14. Dysprosium triflate catalyzed Piancatelli rearrangement. 
These recent advances will greatly benefit the industrial scale production of 4-
hydroxycyclopentenones by decreasing the waste associated with the ZnCl2-catalyzed 
process, as exemplified by the use of 16 equivalents of ZnCl2 (65 kg ZnCl2 for 16 kg of 
starting material) in Henschke’s multi kilogram synthesis of 4-hydroxycyclopentenone.41  
The Piancatelli rearrangement is a beautiful transformation that takes a simple molecule 
derived from a sustainable natural resource – furfural – and converts it into a sterically and 
chemically complex molecule with great synthetic potential. Piancatelli’s proposed 
mechanism, shown in Scheme 1.10, proceeds via a conrotatory electrocyclic ring closure. 
There is much evidence that the Nazarov cyclization proceeds via this pathway, but an 
analysis of the Piancatelli rearrangement as a transformation in its own right was necessary. 
De Lera and co-workers completed a computational study of the Piancatelli rearrangement 
to determine the viability of a conrotatory electrocyclization pathway.58 They evaluated 
possible transition structures at the 6-311G* DFT level, considering energies of the varying 
conformers, aromaticity and magnetic criteria. Of the four possible isomers, out,out-72 was 
most stable by up to 7.50 kcal/mol (Figure 1.9). However, the cyclization energy of out,in-
78 is slightly lower at 5.29 kcal/mol compared to 5.95 kcal/mol. The high activation 
energies for bond formation from in,out-75 and in,in-81 make these isomers less likely 
participants in the reaction.  




















































Figure 1.9. Possible isomers in the Piancatelli rearrangement and their energies. 
The possibility of an aldol-type reaction was also considered, and was analyzed via the 
natural bond orbital (NBO) method. They found a significant charge separation at the 
termini of the system (84), which helps in lowering the energy of the electrocyclization 
(Figure 1.10). This facilitation of bond formation via charge separation is quite similar to the 
observed increase in reaction rates in Frontier’s study of donor-acceptor Nazarov substrates 
(24).24 The conclusion that the Piancatelli rearrangement proceeds via a 4π conrotatory 
electrocyclization via the out,out-isomer (72) is in complete agreement with the observed 









Figure 1.10. Charge separation in the Piancatelli rearrangement. 
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The simplicity and untapped potential of the Piancatelli rearrangement have served as 
the inspiration for the work presented within this thesis.  
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2. The Aza-Piancatelli Rearrangement 
2.1. The Importance of 4-Aminocyclopentenones 
 The simplicity with which a densely functionalized small molecule can be accessed 
from a sustainable starting material via the Piancatelli rearrangement inspired our group to 
elaborate on the methodology by developing an aza variant of the reaction. The importance 
of nitrogen-containing molecules was briefly discussed in the introduction, but this point 
cannot be emphasized enough. A large majority of the world’s top selling pharmaceuticals 
contain at least one carbon-nitrogen bond, and amine functional groups are widely 
represented in nature. However, nitrogen compounds are notoriously difficult to work with 
due to the basicity of the nitrogen, which is also the cause of many incompatibilities when 
metal catalysts are involved. Installing nitrogen functionalities is no easy task; doing so in a 
chemoselective, stereoselective or enantioselective manner can be a lengthy and downright 
daunting process.  
The aminocyclopentane scaffold (1) is well represented in natural products and 
pharmaceutically active compounds with homoharringtonine (3), stemonamine (4), 
pactamycin (2), (–)-agelastatin A (6) and an hNK1 inhibitor (7) serving as illustrative 
examples (Figure 2.1.). 





















































Figure 2.1. Natural products and biologically active cyclopentanes. 
Methods to access this scaffold directly are scarce, forcing chemists to embark on 
elaborate synthetic journeys to generate aminocyclopentanes. Miller and Happe have 
reported methods for the formation of 4-aminocyclopentanes via nitroso hetero-Diels–Alder 
(HDA) reactions with cyclopentadienes (Scheme 2.1).59–62 Cleavage of the N–O bond 
followed by oxidation provides access to 4-aminocyclopentenones (9). However, the 
synthesis of these products requires three forcing steps, is limited by the diene partner, and 






1) (Bu)4NIO4, CH2Cl2            79%
2) Na/Hg, Na2HPO4, EtOH   74%
3) TEMPO, H5IO5, CH2Cl2    97%
O
NH297 8  
Scheme 2.1. Happe's 4-aminocyclopentenone synthesis via the HDA. 
Davis and co-workers developed a method to access 4-aminocyclopentenones from 
Davis’ chiral sulfinimine via Grubbs metathesis.63 The group then applied their 
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methodology to the total synthesis of (–)-agelastatin A (14) (Scheme 2.2).64 Although the 
ring closing metathesis (RCM) reaction could be considered a step toward green chemistry 

































Scheme 2.2. Access to 4-aminocyclopentenones via Grubbs metathesis. 
Additional notable progress in the field has been accomplished by Johnson,65–67 
Miller61,62 and Batey40 and will be discussed in later parts of this thesis. 
 
2.2. Rearrangements of Furan Derivatives with Amines 
Examples of rearrangements of furfural and its derivatives to substituted 
aminocyclopentenones are scarce in the literature. Of course the limited but significant 
examples make this an exciting area of research.  
The path to the formation of 4,5-diaminocyclopentenones takes us all the way back to 
1850, where Dr. J. Stenhouse described the formation of highly colored salts (17) from a 2:1 
condensation of fufural (15) with amines (16) in the presence of Brønsted acids (Scheme 
2.3).68 The chemistry of these highly colored substances was further investigated by 
Schiff69,70 and Zincke.71 It wasn’t until almost a century later that the real value of these salts 
in terms of aminocyclopentanes was demonstrated by Lewis and co-workers who showed 
that 4,5-diaminocyclopentenones (18) could be generated in low yield from the reaction of 
furfural and anilines (Scheme 2.3).72,73  

































Scheme 2.3. Formation of Stenhouse salts and 4,5-diaminocyclopentenones from furfural. 
The low yields are likely due to the harsh conditions used for these transformations, as 
well as the formation of the 2,4-diaminocyclopentenone (19). Batey and Li set out to 
improve on Lewis’ efforts to develop a mild and efficient method for the synthesis of trans-
substituted diaminocyclopentenones (21) with hopes that this methodology would provide 
access to the trans-substituted-4,5-diaminocyclopentane unit in (–)-agelastatin A (6, Figure 
2.1.).40 A screen of Lewis acid catalysts led them to explore rare earth triflates (RE(OTf)3) 
for the rearrangement. Figure 2.2 summarizes their results when using either scandium 
trifluoromethansulfonate (Sc(OTf)3) or dysprosium trifluoromethansulfonate (Dy(OTf)3). 
Dysprosium and other RE(OTf)3 have many desirable properties compared to traditional 
Lewis acids. For one, they are both air and moisture stable and non-toxic, allowing for easy 
handling. Additionally, rare earth triflates are relatively oxophilic and can actively catalyze 
reactions in the presence of Lewis basic amines. The properties and merits of dysprosium 
and its use in synthesis are discussed in detail in Chapter 3 of this thesis.      
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Figure 2.2. Scope of Batey's 4,5-diaminocyclopentenone synthesis. 
The proposed mechanism for the reaction is thought to proceed via a 4π 
electrocyclization analogous to the Piancatelli rearrangement, accounting for the observed 
trans-selectivity. Six years after their initial development of the rearrangement, Batey and 
Duspara employed the rearrangement as the key transformation in their elegant six step total 
synthesis of (±)-agelastatin A (14) (Scheme 2.4).74 It is remarkable how quickly the desired 
trans-4,5-diaminocyclopentenone (23) can be accessed using Batey’s method compared to 
Davis’ elaborate effort to generate the requisite precursor (11) for the key RCM reaction 
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Scheme 2.4. Batey's synthesis of (±)-agelastatin A. 
Comparatively much less work has been completed in terms of the rearrangement of 
furylcarbinols. Throughout his extensive investigations of the rearrangements of furfuryl 
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alcohols, Piancatelli never strayed away from the hydroxyl group as the nucleophile. 
Denisov and co-workers reported the only example of a Piancatelli rearrangement with an 
amine in 1993. The conditions for the rearrangement were similar to those developed by 
Piancatelli, requiring stoichiometric amounts of acid, such as p-TSA or BF3!OEt2.75 Aside 
from the relatively forcing conditions, the range of nucleophiles for the transformation was 
limited to only three electron deficient para-substituted anilines (25) and specialized 
cobaltacene-protected alkynyl furylcarbinols (24) (Scheme 2.5). Reaction conditions for the 
rearrangement were adjusted from substrate to substrate, and yields for the reaction were 











R1 = Pr, Hex, Ph
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BF3•OEt2, Et2O, 20 °C
86%  
Scheme 2.5. Scope of Denisov's aza-Piancatelli rearrangement. 
 In addition to the report by Denisov and co-workers, we were intrigued by a 
publication by Safar and co-workers that described the rearrangement of furans containing a 
Meldrum’s acid unit (31) to cyclopentenones 33 when treated with HBr in the presence of 
cyclic amines, such as pyrrolidine (32) (Scheme 2.6).76 This scaffold has since been applied 
to the development of a new class of photoswitch from donor-acceptor Stenhouse adducts 
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(DASAs) for applications in polymer and materials chemistry in a collaboration between the 




















Scheme 2.6. Synthesis of 4-aminocyclopentenones from a Meldrum's acid furan derivative. 
The examples detailed above demonstrate the ability of amines to participate in 
rearrangements similar to the Piancatelli rearrangement with water. Entering this research 
area, it was our goal to develop a simple and general method for the formation of 
4-aminocyclopentenones directly from a cheap sustainable starting material under mild 
conditions.  
2.3. The Aza-Piancatelli Rearrangement 
Driven by the need for simple ways to access aminocyclopentenes, our group decided to 
focus on developing a Piancatelli rearrangement with amines. We hypothesized that 
judicious choice of a Lewis acid capable of activating the furylcarbinol (34) in the presence 
of the Lewis basic amine nucleophile would initiate the cascade reaction to form trans-




































34 35 36 37
38 39 40 41
 
Scheme 2.7. Proposed mechanism of the aza-Piancatelli rearrangement. 
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Initial studies were performed with phenyl furylcarbinol 43, prepared via a simple 
Grignard addition (Scheme 2.11, step 1), and commercially available p-iodoaniline in 
acetonitrile (MeCN). Based on Batey’s success with rare earth triflate catalysis in the 
presence of amines, we commenced our studies with these catalysts. Satisfyingly, we found 
that either Dy(OTf)3 or Sc(OTf)3 catalyzed the reaction to cleanly give the desired trans-
substituted 4-aminocyclopentenone 42 in excellent yield (entries 1-3, Table 2.1).78 Other 
solvents were explored, but reactions in tetrahydrofuran (THF), methylene chloride or 
toluene were slower and resulted in some undesired side reactions, and MeCN gave the best 
results overall. Coupling constants for the enone peaks were consistent with products 
exhibiting a trans relationship between the amine and R-group, a relationship that was later 
confirmed by single-crystal X-Ray crystallography (Figure 2.3), leading us to conclude that 
the reaction does indeed go through a 4π conrotatory electrocyclization as described in the 
proposed mechanism (Scheme 2.7).    
 
Figure 2.3. ORTEP drawing of the crystal structure of 4-aminocyclopentenone 42 with 50% 
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Entry Catalyst Temp (°C) Time Yield (%)[c] 
1 5 mol % Sc(OTf)3 40 3 h 83 
2 5 mol % Dy(OTf)3 40 2 h 79 
3 5 mol % Dy(OTf)3 80 30 min 92 
4 5 mol % HOTf 80 30 min 62 
5[b] 5 mol % HOTf 100 mol % K2CO3 
80 4 h 0 
6 5 mol % Dy(OTf)3 100 mol % K2CO3 
80 1 h 93 
[a] All reactions were performed in MeCN. [b] The starting material was recovered from the 
reaction. [c] Isolated yields.  
 
Because it is known that triflic acid (HOTf) can be released in reactions with rare earth 
triflates (RE(OTf)3),79 we performed a series of control experiments to determine if this was 
the case with our reaction. Although 5 mol % HOTf was an effective catalyst for the 
rearrangement (Table 2.1, entry 4), the reaction was much cleaner with Dy(OTf)3. Addition 
of one equivalent (equiv) of potassium carbonate (K2CO3) completely shut down the 
reaction with HOTf (Table 2.1, entry 5) resulting in complete recovery of starting materials, 
while addition of one equiv K2CO3 merely slowed down the reaction with Dy(OTf)3 without 
affecting the yield of the reaction (Table 2.1, entry 6).  
A screen of other protic acids revealed a clear effect of the pKa on the rearrangement. 
Hydrochloric acid and sulfuric acid catalyze the rearrangement, but the reactions are not 
very clean and the strong acids can result in loss of the trans stereochemistry (45) and 
further rearrangement to the more highly substituted cyclopentenone 46 (entries 1-3, Table 
2.2). Camphorsulfonic acid ((±)-CSA) and trifluoroacetic acid (TFA) are excellent catalysts 
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for the rearrangement, resulting in only the desired product in 84% and 90% yield, 
respectively (entries 4 and 5, Table 2.2). The pKa of acetic acid (4.75 compared to –0.25 for 
TFA) was determined to be too high to effectively activate the furylcarbinol, and only 
starting material was recovered from this reaction (entry 6, Table 2.2).  
























Entry Catalyst pKa Time Yield (42:45:46) (%) 
1 HCl –8 1 h 93:6:0 
2[a] HCl –8 2 weeks N/A 
3 H2SO4 –3 48 h 68:0:14 
4 (±)-CSA –1 8 h 84:0:0 
5 TFA –0.25 1 h 90:0:0 
6[b] AcOH 4.76 >72 h N/A 
                       [a] Reaction performed at rt. [b] The starting material was recovered from the reaction. 
 
Other rare earth triflates (Yb(OTf)3, La(OTf)3, Ce(OTf)3, Nd(OTf)3) have been tested 
and were shown to be effective catalysts, but we chose to focus our efforts on reactions with 
dysprosium. 
2.4. The Scope of the aza-Piancatelli rearrangement 
Having established effective reaction conditions for the rearrangement of phenyl 
furylcarbinol 43 with p-iodoaniline (5 mol % Dy(OTf)3, MeCN, 80 °C), we were ready to 
develop the scope of the aza-Piancatelli rearrangement. Initial explorations focused on the 
range of anilines able to participate in the cascade. The results of these investigations are 
summarized in Table 2.3. A variety of ortho-, meta-, and para-substituted anilines 
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participated in the rearrangement, including electron rich (51) and electron poor anilines 
(51). Even sterically hindered 2,4,6-trimethylaniline gave the desired products in excellent 
yield (55, 91%). As may be expected, when bulkier groups are placed next to nitrogen, the 
reactivity is eventually stunted, and thus extremely sterically hindered 2,4,6-tri-
tertbutylaniline (63) did not participate in the reaction, resulting in recovery of starting 
material. Disubstituted secondary anilines also generated the desired tertiary amino-
substituted cyclopentenones (58, 59, and 60). In general, we observed that reactions with 
electron rich anilines proceeded at a slower rate than electron poor anilines, presumably the 
increased basicity leads to competitive binding of the dysprosium catalyst.  
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[a] The reaction was performed with 20 mol % Dy(OTf)3. [b] The reaction was performed with 3 equiv amine. 
[c] Formed as a 1:1 ratio of diastereomers.  
 
The reactions were generally clean, and no rearrangement to the more highly substituted 
cyclopentenone was observed under Dy(OTf)3 catalyzed conditions. However, in the case of 
sterically hindered, electron rich 2,6-dimethylaniline, the desired product (62) was formed in 
only 33%, while two additional products were observed. The side products 65 and 66 were 
formed in 38% and 15%, respectively, and are results of Friedel–Crafts alkylation (Scheme 
2.8).  






























Scheme 2.8. Friedel–Crafts side reactions with electron rich hindered anilines. 
     Having determined that a wide range of anilines will participate in the rearrangement, 
we set out to evaluate the scope of furylcarbinols. Experiments with electron rich p-
methoxyphenyl furylcarbinol or electron poor p-trifluoromethylphenyl furylcarbinol 
proceeded cleanly to give the desired products with a variety of aniline partners (Table 2.4, 
69-74). Reactions with electron rich p-methoxyphenyl furylcarbinol were much faster 
compared to unactivated substrates, presumably because the alcohol was more prone to 
activation; however we also found that this furylcarbinol was much less stable than other 
furylcarbinols and had to be stored in the freezer. Additionally, extended exposure to light 
was avoided to limit decomposition of the starting material. Because of these factors, 
reactions with p-methoxyphenyl furylcarbinol were conducted at rt. Reactions with p-
trifluoromethylphenyl furylcarbinol were much slower compared to phenyl furylcarbinol, 
and in the case of hindered 2,4,6-trimethylaniline, this necessitated the use of 20 mol % 
Dy(OTf)3 to generate the 74 at a reasonable rate.   
We were pleased to find that furylcarbinols with methyl or isopropyl groups also 
rearrange to give cyclopentenones 75-80 (Table 2.4). The decrease in yields with alkyl 
furylcarbinols can be attributed to starting materials that are less stable compared to phenyl 
furylcarbinol. In the rearrangement of methyl furylcarbinol with m-chloroaniline (76), the 
exceptionally low yield was attributed to the formation of Friedel–Crafts side products.80–82 
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[a] The reaction was performed at rt. [b] The reaction was performed with 10 mol % Dy(OTf)3. [c] Friedel–
Crafts alkylation products were observed.  
  
We also examined the rearrangement with unsubstituted furylcarbinol 81, but found that 
the rearrangement did not take place (Scheme 2.9). We speculated that this was due to the 
lack of stabilization of the carbocation upon loss of water. The thiophene analog of 
phenylfurylcarbinol, 82, was also subjected to the reaction conditions, but did not rearrange, 
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81 82  
Scheme 2.9. Substrates that did not undergo the aza-Piancatelli rearrangement. 
During our studies on the rearrangement of isopropyl furylcarbinol to 83 we became 
intrigued by a transient product, which was observed by thin layer chromatography (TLC). 
We chose to isolate this product and found that it was the product of amine substitution at 
the 1-position of the furylcarbinol (84) (Scheme 2.10). Resubjecting the substitution product 
84 to the reaction conditions led to complete conversion to the desired cyclopentenone 78. 
Further investigations revealed that this substitution product forms during the first 3 to 5 
minutes of the reaction between phenyl furylcarbinol and p-iodoaniline (85), but is not 
observable after that point. Due to the short lifetime of this intermediate, it is most likely an 
off-cycle product that re-enters the productive pathway upon loss of the aniline and 
formation of the oxocarbenium (36, Scheme 2.7). It should be noted that formation of this 
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Scheme 2.10. Formation of a substitution product during the reaction. 
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Overall, we found that the rearrangement was general both in terms of the anilines and 
furylcarbinols that can be employed for the dysprosium triflate catalyzed aza-Piancatelli 
rearrangement.  
2.5. Synthesis of an hNK1 Inhibitor 
With robust reaction conditions and a solid reaction scope in hand, we were excited to 
apply the rearrangement to the synthesis of a small molecule with interesting biological 
activity. A 2006 structure-activity relationship (SAR) study by chemists at Merck 
investigated the 1,2-trans-2,3-trans-cyclopentane scaffold (86) as a human neurokinin 1 
(hNK1) antagonist (Figure 2.4).83,84 Their studies found that the hNK1 inhibition with these 
cyclopentanes was comparable to that of Aprepitant (87), an FDA approved drug for the 





















Figure 2.4. Structures of SAR study cylopentanes and Aprepitant. 
We commenced our synthetic efforts toward the synthesis of hNK1 inhibitor 5, confident 
that our trans-substituted aminocyclopentenone scaffold could serve as the key intermediate 
in the synthesis.78 Phenyl furylcarbinol was easily prepared on a 10 gram scale via a simple 
Grignard addition to furfural, and we were pleased to demonstrate that the aza-Piancatelli 
rearrangement with para-methoxyphenyl (PMP) aniline could be performed on a 1 gram 
scale to provide 51 (Scheme 2.11). Although the subsequent Luche reduction of the ketone 
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was only moderately selective (2:1 dr), the major product did display the desired 1,2-trans-
2,3-trans stereochemistry (88). Based on more recent results with Luche typed reductions, I 
am confident that this selectivity could be improved (vide infra). Alkene reduction to the 
cyclopentane (89) required rather forcing hydrogenation conditions. However, a more 
thorough investigation of hydrogenation catalysts may reveal that milder conditions would 
suffice.  The reduction was followed by chemoselective O-alkylation. Our alkylation studies 
showed that formation of the N-alkylated product could occur, but use of excess sodium 
hydride resulted in exclusive formation of the O-alkylation product 90. Oxidative removal of 
the PMP group proved to be quite challenging. Standard conditions using ceric ammonium 
nitrate (CAN) resulted in decomposition of the product or recovery of the starting 
material.85,86 After many trials and tribulations, we were delighted to discover that treatment 
of 90 with periodic acid (H5IO6) and H2SO4 generated the desired primary amine, 
completing the synthesis of the desired hNK1 inhibitor 5 in only 6 steps from furfural 
(Scheme 2.11).87 Comparing this short synthesis to the 20 steps it took to prepare the hNK1 
inhibitors described in the study by Merck truly highlights the value and potential of the aza-
Piancatelli for applications in medicinal chemistry and total synthesis.  





















































Scheme 2.11. Synthesis of an hNK1 inhibitor. 
2.6. Experimental Procedures 
Materials and Methods.  Unless stated otherwise, reactions were conducted in flame-
dried glassware under an atmosphere of air using reagent grade solvents.  All commercially 
obtained reagents were used as received.  Reaction temperatures were controlled using a 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC).  Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with anisaldehyde and potassium permanganate.  
Flash column chromatography was performed using normal phase silica gel (60 Å, 230-240 
mesh, Merck KGA).  1H NMR spectra were recorded on Varian spectrometers (at 400, 500 
or 600 MHz) and are reported relative to deuterated solvent signals.  Data for 1H NMR 
spectra are reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) 
and integration.  13C NMR spectra were recorded on Varian Spectrometers (125 MHz).  
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Data for 13C NMR spectra are reported as follows: shift (δ ppm), multiplicity and coupling 
constant (Hz).  IR spectra were recorded on a Jasco FT/IR 4100 and are reported in terms of 
frequency of absorption (cm-1). High resolution mass spectra and X-Ray analysis were 
obtained from the UC Santa Barbara Mass Spectrometry and X-Ray Facilities.  
Furylcarbinols 43, 92, 83, 105 were prepared according to literature precedent by 
reacting furfural with the corresponding Grignard reagent.88 Furylcarbinol 106 was used as 
received.  The crystal structure data for 4-((4-iodophenyl)amino)-5-phenylcyclopent-2-
enone 42 can be obtained free of charge from the Cambridge Crystallographic Data Centre 







Furan-2-yl(phenyl)methanol (43): Light yellow oil; 1H NMR (500 MHz, CDCl3) δ 
7.49 – 7.43 (m, 2H), 7.42 – 7.36 (m, 3H), 7.36 – 7.30 (m, 1H), 6.32 (dd, J = 3.2, 1.8 Hz, 
1H), 6.12 (d, J = 3.3 Hz, 1H), 5.83 (d, J = 4.0 Hz, 1H), 2.42 (d, J = 4.3 Hz, 1H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 156.1, 142.7, 140.9, 128.6, 128.2, 126.7, 110.4, 107.6, 70.3 
ppm; IR (thin film) 3362, 3063, 3031, 2897, 1957, 1888, 1810, 1602, 1492, 1452, 1141, 
1007 cm-1; MS (EI+) m/z 174.0685 (174.0681 calcd for C11H10O2+ [M]+). 
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Furan-2-yl(4-methoxyphenyl)methanol (92): Yellow oil. 1H NMR (600 MHz, CDCl3) 
δ 7.38 (d, J = 0.8 Hz, 1H), 7.34 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 8.7 Hz, 2H), 6.31 (dd, J = 
3.2, 1.8 Hz, 1H), 6.11 (d, J = 3.2 Hz, 1H), 5.76 (s, 1H), 3.80 (s, 3H) ppm; 13C NMR (150 
MHz, CDCl3) δ 159.5, 156.3, 142.5, 133.2, 128.1, 113.9, 110.3, 107.3, 69.9, 55.4 ppm; IR 
(thin film) 3402, 3001, 2957, 2935, 2910, 2837, 1610, 1586, 1510 cm-1; MS (EI) m/z 







1-(Furan-2-yl)-2-methylpropan-1-ol (83): Yellow oil; 1H NMR (600 MHz, CDCl3) δ 
7.37 (dd, J = 1.8, 0.9 Hz, 1H), 6.33 (dd, J = 3.2, 1.8 Hz, 1H), 6.23 (d, J = 3.2 Hz, 1H), 4.38 
(d, J = 7.0 Hz, 1H), 2.11 (h, J = 6.8 Hz, 1H), 1.84 (s, 1H), 1.02 (d, J = 6.7 Hz, 3H), 0.86 (d, 
J = 6.8 Hz, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 156.3, 141.8, 110.2, 106.6, 73.7, 33.5, 
18.9, 18.4 ppm; IR (thin film) 3392, 2961, 2933, 2873, 1665, 1505, 1468 cm-1; MS (EI) m/z 















4-((4-iodophenyl)amino)-5-phenylcyclopent-2-enone (42): According to the general 
procedure Dy(OTf)3 (23 mg, 0.038 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 43 (128 mg, 0.74 mmol, 1 equiv) and 4-iodoaniline 44 (162 mg, 0.74 
mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 80 ºC for 
30 minutes. The reaction was then quenched with 5 mL of saturated aqueous sodium 
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bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
by column chromatography to afford cyclopentenone 42 (255 mg, 92%) as an oil. 1H NMR 
(500 MHz, CDCl3) δ 7.72 (dd, J = 5.7, 2.4 Hz, 1H), 7.40 – 7.28 (m, 5H), 7.15 – 7.09 (m, 
2H), 6.40 (dd, J = 5.7, 1.7 Hz, 1H), 6.27 (dddd, J = 9.8, 2.0, 2.0, 2.0 Hz, 2H), 4.69 (dd, J = 
8.2, 1.7 Hz, 1H), 4.19 (d, J = 8.3 Hz, 1H), 3.35 (d, J = 2.6 Hz, 1H) ppm; 13C NMR (125 
MHz, CDCl3) δ 206.4, 161.5, 145.9, 138.0, 137.9, 135.0, 129.2, 128.0, 127.6, 116.0, 79.6, 
63.2, 60.1 ppm; IR (thin film) 3776, 3026, 1704, 1588, 1496, 1316 cm-1; HRMS (ESI) m/z 

























Methyl 4-((4-oxo-5-phenylcyclopent-2-en-1-yl)amino)benzoate (50): According to the 
general procedure Dy(OTf)3 (17 mg, 0.028 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 43 (97 mg, 0.56 mmol, 1 equiv) and methyl 4-aminobenzoate 93 (84 
mg, 0.56 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 
80 ºC for 1 h. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
by column chromatography to afford cyclopentenone 50 (148 mg, 86%) as a solid. 1H NMR 
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3H), 7.16 – 7.10 (m, 2H), 6.49 – 6.42 (m, 3H), 4.82 (dddd, J = 8.1, 2.2, 2.2, 2.2 Hz, 1H), 
4.63 (d, J = 8.3 Hz, 1H), 3.84 (s, 3H), 3.39 (d, J = 2.6 Hz, 1H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 206.2, 167.2, 161.0, 150.3, 137.8, 135.3, 131.7, 129.3, 128.1, 127.8, 119.8, 112.6, 
62.8, 60.3, 51.8 ppm; IR (thin film) 3359, 3023, 2950, 1705, 1604, 1280 cm-1; HRMS (ESI) 















4-((4-methoxyphenyl)amino)-5-phenylcyclopent-2-enone (51): According to the 
general procedure Dy(OTf)3 (69 mg, 0.114 mmol, 0.2 equiv) was added to furan-2-
yl(phenyl)methanol 43 (100 mg, 0.57 mmol, 1 equiv) and 4-methoxyaniline 94 (78 mg, 0.57 
mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 80 ºC for 
18 h. The reaction was then quenched with 5 mL of saturated aqueous sodium bicarbonate 
and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo.  The residue was purified by column 
chromatography to afford cyclopentenone 51 (99 mg, 62%) as an oil. 1H NMR (500 MHz, 
CDCl3) δ 7.78 (dd, J = 5.7, 2.3 Hz, 1H), 7.38 – 7.24 (m, 3H), 7.12 (d, J = 7.2 Hz, 2H), 6.72 
(d, J = 8.9 Hz, 2H), 6.51 (d, J = 8.9 Hz, 2H), 6.39 (dd, J = 5.7, 1.5 Hz, 1H), 4.67 (d, J = 1.7 
Hz, 1H), 3.73 (s, 3H), 3.38 (d, J = 2.5 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 206.9, 
162.3, 153.2, 140.2, 138.3, 134.8, 129.1, 128.2, 127.5, 115.8, 115.1, 64.6, 60.1, 55.8 ppm; 
IR (thin film) 3363, 3031, 2935, 2835, 1709, 1593, 1512, 1242 cm-1; HRMS (ESI) m/z 
302.1154 (302.1151 calcd for C18H17NO2Na+ [M + Na]+). 
 

















4-((3,5-dimethylphenyl)amino)-5-phenylcyclopent-2-enone (52): According to the 
general procedure Dy(OTf)3 (18 mg, 0.029 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 43 (100 mg, 0.58 mmol, 1 equiv) and 3,5-dimethylaniline 95 (70 mg, 
0.58 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 80 ºC 
for 3 h. The reaction was then quenched with 5 mL of saturated aqueous sodium bicarbonate 
and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo.  The residue was purified by column 
chromatography to afford cyclopentenone 52 (130 mg, 81%) as a solid. 1H NMR (500 MHz, 
CDCl3) δ 7.78 (dd, J = 5.7, 2.2 Hz, 1H), 7.43 – 7.29 (m, 3H), 7.17 (d, J = 7.2 Hz, 2H), 6.47 
– 6.39 (m, 2H), 6.16 (s, 2H), 4.75 (d, J = 1.6 Hz, 1H), 3.94 (bs, 1H), 3.40 (d, J = 2.5 Hz, 
1H), 2.17 (s, 6H) ppm; 13C NMR (125 MHz, CDCl3) δ 206.9, 162.1, 146.3, 139.3, 138.5, 
134.8, 129.1, 128.3, 127.5, 120.8, 112.1, 63.7, 60.5, 21.6 ppm; IR (thin film) 3375, 3028, 
2916, 2858, 1709, 1600, 1492, 1338 cm-1; HRMS (ESI) m/z 300.1359 (300.1359 calcd for 



















According to the general procedure Dy(OTf)3 (18 mg, 0.029 mmol, 0.05 equiv) was added to 
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furan-2-yl(phenyl)methanol 43 (103 mg, 0.592 mmol, 1 equiv) and 3,5-
bis(trifluoromethyl)aniline 96 (97 mg, 0.8 mmol, 1 equiv) in 6 mL of MeCN.  The resulting 
reaction mixture was heated to 80 ºC for 24 h. The reaction was then quenched with 5 mL of 
saturated aqueous sodium bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo.  
The residue was purified by column chromatography to afford cyclopentenone 53 (171 mg, 
75%) as a solid. 1H NMR (500 MHz, CDCl3) δ 7.71 (dd, J = 5.7, 2.4 Hz, 1H), 7.40 – 7.28 
(m, 3H), 7.17 (s, 1H), 7.14 – 7.08 (m, 2H), 6.80 (s, 2H), 6.49 (dd, J = 5.7, 1.8 Hz, 1H), 4.78 
(dddd, J = 8.2, 2.3, 2.3, 2.3 Hz, 1H), 4.60 (d, J = 8.2 Hz, 1H), 3.34 (d, J = 2.6 Hz, 1H) ppm; 
13C NMR (125 MHz, CDCl3) δ 206.0, 160.2, 147.1, 137.6, 135.9, 132.8 (q, J = 32.9 Hz), 
129.5, 128.1, 128.0, 123.4 (q, J = 272.8 Hz), 113.1 (d, J = 2.9 Hz), 111.7 (dddd, J = 3.8, 3.8, 
3.8, 3.8 Hz), 63.3, 60.8 ppm; IR (thin film) 3375, 3055, 2908, 1705, 1600, 1315 cm-1; 















4-((3-chlorophenyl)amino)-5-phenylcyclopent-2-enone (54): According to the general 
procedure Dy(OTf)3 (18 mg, 0.029 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 43 (100 mg, 0.58 mmol, 1 equiv) and 3-chloroaniline 97 (73 mg, 0.58 
mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 80 ºC for 
20 minutes. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
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by column chromatography to afford cyclopentenone 54 (134 mg, 82%) as an oil. 1H NMR 
(500 MHz, CDCl3) δ 7.74 (dd, J = 5.7, 2.3 Hz, 1H), 7.40 – 7.29 (m, 3H), 7.16 – 7.12 (m, 
2H), 7.03 (t, J = 8.1 Hz, 1H), 6.74 – 6.69 (m, 1H), 6.49 (t, J = 2.1 Hz, 1H), 6.44 (dd, J = 5.7, 
1.7 Hz, 1H), 6.38 (dd, J = 8.2, 2.3 Hz, 1H), 4.72 (dddd, J = 8.3, 2.1, 2.1, 2.1 Hz, 1H), 4.16 
(d, J = 8.5 Hz, 1H), 3.38 (d, J = 2.7 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 206.4, 
161.3, 147.5, 137.9, 135.3, 135.2, 130.6, 129.3, 128.1, 127.7, 118.7, 113.8, 112.1, 63.3, 60.3 
ppm; IR (thin film) 3376, 3062, 3029, 1704, 1596, 1327 cm-1; HRMS (ESI) m/z 306.0656 




















4-(mesitylamino)-5-phenylcyclopent-2-enone (55): According to the general procedure 
Dy(OTf)3 (20 mg, 0.033 mmol, 0.05 equiv) was added to furan-2-yl(phenyl)methanol 43 
(114 mg, 0.66 mmol, 1 equiv) and 2,4,6-trimethylaniline 98 (92µl, 0.66 mmol, 1 equiv) in 6 
mL of MeCN.  The resulting reaction mixture was heated to 80 ºC for 4 h. The reaction was 
then quenched with 5 mL of saturated aqueous sodium bicarbonate and extracted with ethyl 
acetate (3 × 10 mL).  The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo.  The residue was purified by column chromatography to afford 
cyclopentenone 55 (175 mg, 91%) as an oil. 1H NMR (500 MHz, CDCl3) δ 7.65 (dd, J = 5.7, 
2.2 Hz, 1H), 7.33 – 7.21 (m, 3H), 7.06 – 7.00 (m, 2H), 6.81 (bs, 2H), 6.34 (dd, J = 5.7, 1.4 
Hz, 1H), 4.43 (s, 1H), 3.40 (d, J = 2.9 Hz, 1H), 3.17 (bs, 1H), 2.23 (s, 3H), 2.10 (s, 6H) ppm; 
13C NMR (125 MHz, CDCl3) δ 207.1, 163.1, 140.9, 138.1, 133.7, 132.5, 130.0, 129.9, 
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128.9, 128.1, 127.3, 67.7, 60.6, 20.8, 18.8 ppm; IR (thin film) 3359, 2920, 1708, 1589, 1485, 






















5-phenyl-4-((2,4,6-trifluorophenyl)amino)cyclopent-2-enone (50): According to the 
general procedure Dy(OTf)3 (21 mg, 0.035 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 43 (120 mg, 0.69 mmol, 1 equiv) and 2,4,6-trifluoroaniline 99 (304 mg, 
2.1 mmol, 3 equiv) in 6 mL of MeCN.  The resulting reaction mixture was allowed to 
proceed at rt for 3 h. The reaction was then quenched with 5 mL of saturated aqueous 
sodium bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic 
layers were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was 
purified by column chromatography to afford cyclopentenone 56 (155 mg, 74%) as an oil. 
1H NMR (500 MHz, CDCl3) δ 7.72 (dd, J = 5.8, 2.2 Hz, 1H), 7.32 – 7.20 (m, 3H), 7.04 – 
6.93 (m, 2H), 6.64 – 6.56 (m, 2H), 6.37 (dd, J = 5.8, 1.7 Hz, 1H), 4.85 – 4.74 (m, 1H), 3.56 
(d, J = 10.0 Hz, 1H), 3.34 (d, J = 3.0 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 206.0, 
161.7, 156.3 (ddd, J = 243.9, 15.0, 15.0 Hz), 154.5 (ddd, J = 244.1, 14.5, 9.0 Hz), 137.3, 
134.6, 128.9, 128.0, 127.4, 120.4 (ddd, J = 15.1, 15.1, 4.7 Hz), 100.6 (dddd, J = 26.2, 26.2, 
20.5, 8.6 Hz), 66.1 (dd, J = 2.9, 2.9 Hz), 61.2 ppm; IR (thin film) 3344, 3070, 1712, 1612, 
1508, 1442 cm-1; HRMS (ESI) m/z 326.0782 (326.0763 calcd for C17H12F3NONa+ [M + 
Na]+). 
 













5-phenyl-4-(phenylamino)cyclopent-2-enone (57): According to the general procedure 
Dy(OTf)3 (18 mg, 0.029 mmol, 0.05 equiv) was added to furan-2-yl(phenyl)methanol 43 
(100 mg, 0.58 mmol, 1 equiv) and aniline 100 (54 mg, 0.58 mmol, 1 equiv) in 6 mL of 
MeCN.  The resulting reaction mixture was heated to 80 ºC for 1.5 h. The reaction was then 
quenched with 5 mL of saturated aqueous sodium bicarbonate and extracted with ethyl 
acetate (3 × 10 mL).  The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo.  The residue was purified by column chromatography to afford 
cyclopentenone 57 (124 mg, 86%) as an oil. 1H NMR (500 MHz, CDCl3) δ 7.76 (dd, J = 5.7, 
2.3 Hz, 1H), 7.41 – 7.30 (m, 3H), 7.20 – 7.12 (m, 4H), 6.78 (dd, J = 10.6, 4.1 Hz, 1H), 6.57 
– 6.51 (m, 2H), 6.41 (dd, J = 5.7, 1.6 Hz, 1H), 4.76 (bs, 1H), 4.11 (bs, 1H), 3.41 (d, J = 2.6 
Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 206.7, 162.0, 146.3, 138.1, 134.7, 129.5, 
129.1, 128.1, 127.5, 118.7, 113.9, 63.4, 60.1 ppm; IR (thin film) 3374, 3053, 3027, 1708, 
















4-(methyl(phenyl)amino)-5-phenylcyclopent-2-enone (58): According to the general 
procedure Dy(OTf)3 (18 mg, 0.029 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 43 (100 mg, 0.57 mmol, 1 equiv) and 2,6-dimethyl aniline 101 (61 mg, 
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0.57 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 80 ºC 
for 2.5 h. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
by column chromatography to afford cyclopentenone 58 (111 mg, 74%) as an oil. 1H NMR 
(500 MHz, CDCl3) δ 7.72 (dd, J = 5.8, 2.3 Hz, 1H), 7.35 – 7.24 (m, 3H), 7.13 (t, J = 8.0 Hz, 
2H), 7.09 (d, J = 7.2 Hz, 1H), 6.74 (t, J = 7.3 Hz, 1H), 6.64 (d, J = 8.3 Hz, 2H), 6.48 (dd, J = 
5.8, 2.0 Hz, 1H), 5.16 – 5.12 (m, 1H), 3.53 (d, J = 2.9 Hz, 1H), 2.86 (s, 3H) ppm; 13C NMR 
(125 MHz, CDCl3) δ 206.7, 163.5, 149.4, 138.5, 135.3, 129.4, 129.2, 128.3, 127.4, 118.6, 
114.6, 70.1, 56.3, 33.5 ppm; IR (thin film) 3059, 2916, 2812, 1709, 1597, 1500, 1377 cm-1; 

















4-((4-bromophenyl)(methyl)amino)-5-phenylcyclopent-2-enone (59): According to 
the general procedure Dy(OTf)3 (21 mg, 0.034 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 43 (119 mg, 0.68 mmol, 1 equiv) and 4-bromo-N-methylaniline 102 
(127 mg, 0.68 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated 
to 80 ºC for 45 minutes. The reaction was then quenched with 5 mL of saturated aqueous 
sodium bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic 
layers were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was 
purified by column chromatography to afford cyclopentenone 59 (205 mg, 88%) as an oil. 
1H NMR (500 MHz, CDCl3) δ 7.68 (dd, J = 5.8, 2.4 Hz, 1H), 7.37 – 7.24 (m, 3H), 7.24 – 
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7.15 (m, 2H), 7.10 – 7.04 (m, 2H), 6.51 – 6.43 (m, 3H), 5.13 – 5.04 (m, 1H), 3.48 (d, J = 3.0 
Hz, 1H), 2.82 (s, 3H) ppm; 13C NMR (126 MHz, CDCl3) δ 206.3, 162.8, 148.4, 138.2, 
135.5, 132.0, 129.3, 128.3, 127.5, 115.9, 110.4, 69.8, 56.4, 33.3 ppm; IR (thin film) 3062, 
2896, 2815, 1712, 1589, 1496, 1311 cm-1; HRMS (ESI) m/z 364.0306 (364.0307 calcd for 

















According to the general procedure Dy(OTf)3 (18 mg, 0.03 mmol, 0.05 equiv) was added to 
furan-2-yl(phenyl)methanol 43 (105 mg, 0.6 mmol, 1 equiv) and 6-methyl-1,2,3,4-
tetrahydroquinoline 103 (87 mg, 0.6 mmol, 1 equiv) in 6 mL of MeCN.  The resulting 
reaction mixture was heated to 80 ºC for 18 h. The reaction was then quenched with 5 mL of 
saturated aqueous sodium bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo.  
The residue was purified by column chromatography to afford cyclopentenone 60 (122 mg, 
67%) as an oil. 1H NMR (500 MHz, CDCl3) δ 7.65 (dd, J = 5.7, 2.2 Hz, 1H), 7.33 – 7.21 (m, 
3H), 7.06 – 7.00 (m, 2H), 6.81 (s, 2H), 6.34 (dd, J = 5.7, 1.4 Hz, 1H), 4.43 (s, 1H), 3.40 (d, J 
= 2.9 Hz, 1H), 3.17 (bs, 1H), 2.23 (s, 3H), 2.10 (s, 6H) ppm; 13C NMR (125 MHz, CDCl3) δ 
206.8, 164.2, 142.4, 138.8, 135.1, 130.3, 129.2, 128.2, 127.5, 127.3, 126.6, 123.9, 112.5, 
68.7, 55.9, 44.5, 28.1, 22.9, 20.3 ppm; IR (thin film) 3020, 2931, 2854, 1709, 1504, 1296 
cm-1; HRMS (ESI) m/z 326.1524 (326.1515 calcd for C21H21NONa+ [M + Na]+). 

















4-((4-(1-hydroxyethyl)phenyl)amino)-5-phenylcyclopent-2-enone (61): According to 
the general procedure Dy(OTf)3 (23 mg, 0.038 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 43 (130 mg, 0.75 mmol, 1 equiv) and 1-(4-aminophenyl)ethanol 104 
(103 mg, 0.75 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated 
to 80 ºC for 2 h. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
by column chromatography to afford cyclopentenone 61 (193 mg, 88%) as an oil. 1H NMR 
of 1:1 mixture of diastereomers (500 MHz, CDCl3) δ 7.75 (dd, J = 5.7, 2.3 Hz, 1H), 7.39 – 
7.28 (m, 3H), 7.17 – 7.06 (m, 3H), 6.71 (dd, J = 7.4, 3.5 Hz, 1H), 6.50 (d, J = 9.6 Hz, 1H), 
6.46 – 6.37 (m, 2H), 4.78 (s, 1H), 4.67 (dddd, J = 6.4, 6.4, 6.4, 1.9 Hz, 1H), 4.14 (bs, 1H), 
3.36 (d, J = 2.5 Hz, 1H), 1.94 (bs, 1H), 1.35 (dd, J = 6.3, 5.3 Hz, 3H) ppm; 13C NMR (125 
MHz, CDCl3) δ 206.8, 206.8, 162.0, 161.9, 147.5, 147.5, 146.5, 146.5, 138.3, 138.3, 134.8, 
134.8, 129.6, 129.62, 129.1, 129.1, 128.2, 128.2, 127.5, 115.9, 115.8, 113.1, 113.0, 110.9, 
110.8, 70.3, 63.5, 63.4, 60.6, 60.5, 25.1, 25.0 ppm; IR (thin film) 3375, 3032, 2970, 2920, 
1705, 1601, 1489, 1331 cm-1; HRMS (ESI) m/z 316.1309 (316.1308 calcd for 
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4-((2,6-dimethylphenyl)amino)-5-phenylcyclopent-2-enone (62): According to the 
general procedure Dy(OTf)3 (20 mg, 0.03 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 43 (115 mg, 0.66 mmol, 1 equiv) and 2,6-dimethylaniline 64 (82 µl, 
0.66 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 80 ºC 
for 3 h. The reaction was then quenched with 5 mL of saturated aqueous sodium bicarbonate 
and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo.  The residue was purified by column 
chromatography to afford cyclopentenone 62 (60 mg, 33%) as an oil. 1H NMR (500 MHz, 
CDCl3) δ 7.66 (dd, J = 5.7, 2.3 Hz, 1H), 7.31 – 7.22 (m, 4H), 7.02 – 6.95 (m, 4H), 6.90 – 
6.83 (m, 1H), 6.36 (dd, J = 5.7, 1.6 Hz, 1H), 4.50 – 4.47 (m, 1H), 3.39 (d, J = 2.9 Hz, 1H), 
2.13 (s, 6H) ppm; 13C NMR (125 MHz, CDCl3) δ 207.1, 163.0, 143.6, 138.1, 134.0, 129.9, 
129.3, 129.0, 128.1, 127.4, 123.2, 67.4, 60.7, 19.0 ppm; IR (thin film) 3359, 3032, 2927, 















4-(furan-2-yl(phenyl)methyl)-2,6-dimethylaniline (65): According to the general 
procedure Dy(OTf)3 (22 mg, 0.036 mmol, 0.05 equiv) was added to 1-(furan-2-yl)-2-
methylpropan-1-ol 43 (100 mg, 0.71 mmol, 1 equiv) and 2,6-dimethylaniline 64 (91 mg, 
0.71 mmol, 1 equiv) in 6 mL of MeCN. The resulting reaction mixture was heated to 80 ºC 
for 24 h. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
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by column chromatography to afford 65 (60 mg, 38%) as a solid. 1H NMR (500 MHz, 
CDCl3) δ 7.42 (d, J = 1.0 Hz, 1H), 7.35 (t, J = 7.4 Hz, 2H), 7.30 – 7.21 (m, 3H), 6.82 (s, 
2H), 6.35 (dd, J = 3.0, 1.9 Hz, 1H), 5.96 (d, J = 3.2 Hz, 1H), 5.37 (bs, 1H), 3.55 (s, 2H), 
2.18 (s, 6H) ppm; 13C NMR (126 MHz, CDCl3) δ 157.8, 142.7, 141.8, 141.6, 131.2, 128.8, 
128.7, 128.5, 126.6, 121.8, 110.1, 108.0, 50.4, 17.9 ppm; IR (thin film) 3473, 3114, 3025, 





























enone (66): According to the general procedure Dy(OTf)3 (22 mg, 0.036 mmol, 0.05 equiv) 
was added to 1-(furan-2-yl)-2-methylpropan-1-ol 43 (100 mg, 0.71 mmol, 1 equiv) and 2,6-
dimethylaniline 64 (91 mg, 0.71 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction 
mixture was heated to 80 ºC for 24 h. The reaction was then quenched with 5 mL of 
saturated aqueous sodium bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo.  
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15%) as a solid. 1H NMR (500 MHz, CDCl3) δ 7.69 (dd, J = 5.7, 1.8 Hz, 1H), 7.41 – 7.39 
(m, 1H), 7.35 – 7.31 (m, 2H), 7.28 – 7.23 (m, 4H), 7.20 – 7.16 (m, 2H), 6.98 – 6.92 (m, 2H), 
6.80 (s, 2H), 6.37 (dd, J = 5.7, 0.7 Hz, 1H), 6.34 – 6.32 (m, 1H), 5.90 (d, J = 2.5 Hz, 1H), 
5.34 (s, 1H), 4.49 (s, 1H), 3.38 (d, J = 2.7 Hz, 1H), 3.26 (bs, 1H), 2.10 (s, 6H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 207.1, 163.0, 157.2, 142.3, 142.0, 138.1, 136.3, 134.0, 123.0, 
129.6, 129.5, 128.9, 128.8, 128.6, 128.1, 127.3, 126.9, 110.3, 108.3, 67.4, 60.8, 50.5, 19.1 

















4-((4-iodophenyl)amino)-5-(4-methoxyphenyl)cyclopent-2-enone (69): According to 
the general procedure Dy(OTf)3 (15 mg, 0.025 mmol, 0.05 equiv) was added to furan-2-yl(4-
methoxyphenyl)methanol 92 (100 mg, 0.49 mmol, 1 equiv) and 4-iodoaniline 44 (107 mg, 
0.49 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was allowed to react 
at rt for 1.5 h. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
by column chromatography to afford cyclopentenone 69 (135 mg, 68%) as an oil. 1H NMR 
(500 MHz, CDCl3) δ 7.72 (dd, J = 5.7, 2.2 Hz, 1H), 7.37 (d, J = 8.8 Hz, 2H), 7.04 (d, J = 8.6 
Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 6.41 (dd, J = 5.7, 1.5 Hz, 1H), 6.29 (d, J = 8.7 Hz, 2H), 
4.66 (s, 1H), 4.10 (bs, 1H), 3.81 (s, 3H), 3.30 (d, J = 2.5 Hz, 1H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 206.7, 161.2, 159.1, 146.0, 138.1, 135.2, 130.0, 129.1, 116.1, 114.7, 79.7, 63.3, 
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59.5, 55.5 ppm; IR (thin film) 3374, 2931, 2839, 1709, 1589, 1504, 1300 cm-1; HRMS (ESI) 
















4-((3-chlorophenyl)amino)-5-(4-methoxyphenyl)cyclopent-2-enone (70): According 
to the general procedure Dy(OTf)3 (15 mg, 0.025 mmol, 0.05 equiv) was added to furan-2-
yl(4-methoxyphenyl)methanol 92 (100 mg, 0.49 mmol, 1 equiv) and 3-chloroaniline 57 (63 
mg, 0.49 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was allowed to 
react at rt for 6.5 h. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
by column chromatography to afford cyclopentenone 70 (126 mg, 82%) as an oil. 1H NMR 
(500 MHz, CDCl3) δ 7.74 (dd, J = 5.7, 2.3 Hz, 1H), 7.09 – 7.00 (m, 3H), 6.92 – 6.87 (m, 
2H), 6.73 – 6.69 (m, 1H), 6.51 (t, J = 2.0 Hz, 1H), 6.44 (dd, J = 5.8, 1.6 Hz, 1H), 6.40 (dd, J 
= 8.2, 1.8 Hz, 1H), 4.68 (dd, J = 8.4, 1.8 Hz, 1H), 4.06 (bs, 1H), 3.81 (s, 3H), 3.34 (d, J = 
2.7 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 206.6, 161.1, 159.2, 147.5, 135.4, 135.3, 
130.6, 129.9, 129.2, 118.8, 114.8, 113.9, 112.1, 63.5, 59.6, 55.5 ppm; IR (thin film) 3371, 
2927, 1708, 1597, 1512, 1250 cm-1; HRMS (ESI) m/z 336.0757 (336.0762 calcd for 
C18H16ClNO2Na+ [M + Na]+). 
 


















4-(mesitylamino)-5-(4-methoxyphenyl)cyclopent-2-enone (71): According to the 
general procedure Dy(OTf)3 (30 mg, 0.05 mmol, 0.1 equiv) was added to furan-2-yl(4-
methoxyphenyl)methanol 92 (100 mg, 0.49 mmol, 1 equiv) and 2,4,6-trimethylaniline 98 
(66 mg, 0.49 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was allowed 
to react at rt for 5 h. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
by column chromatography to afford cyclopentenone 71 (140 mg, 89%) as an oil. 1H NMR 
(500 MHz, CDCl3) δ 7.64 (ddd, J = 5.7, 2.0, 2.0 Hz, 1H), 6.98 – 6.92 (m, 2H), 6.89 – 6.79 
(m, 4H), 6.33 (ddd, J = 5.7, 1.5, 1.5 Hz, 1H), 4.39 (s, 1H), 3.80 (d, J = 1.8 Hz, 3H), 3.35 (d, 
J = 2.8 Hz, 1H), 3.16 (s, 1H), 2.24 (s, 3H), 2.12 (s, 6H) ppm; 13C NMR (125 MHz, CDCl3) δ 
207.5, 163.0, 158.8, 141.0, 133.7, 132.5, 130.1, 130.0, 129.9, 129.2, 114.4, 67.7, 59.9, 55.4, 
20.8, 18.9 ppm; IR (thin film) 3357, 2996, 2915, 2835, 1713, 1612, 1513, 1250 cm-1; HRMS 


















According to the general procedure Dy(OTf)3 (13 mg, 0.020 mmol, 0.05 equiv) was added to 
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furan-2-yl(4-(trifluoromethyl)phenyl)methanol 105 (100 mg, 0.41 mmol, 1 equiv) and 4-
iodoaniline 44 (90 mg, 0.41 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction 
mixture was heated to 80 ºC for 4.5 h. The reaction was then quenched with 5 mL of 
saturated aqueous sodium bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo.  
The residue was purified by column chromatography to afford cyclopentenone 72 (151 mg, 
83%) as an oil. 1H NMR (500 MHz, CDCl3) δ 7.78 (dd, J = 5.8, 2.4 Hz, 1H), 7.62 (d, J = 8.3 
Hz, 2H), 7.43 – 7.35 (m, 2H), 7.29 – 7.23 (m, 2H), 6.46 (dd, J = 5.8, 1.7 Hz, 1H), 6.33 – 
6.25 (m, 2H), 4.73 (bs, 1H), 4.08 (bs, 1H), 3.44 (d, J = 2.6 Hz, 1H) ppm; 13C NMR (125 
MHz, CDCl3) δ 205.2, 161.4, 145.6, 141.9, 138.3, 135.2, 130.0 (q, J = 32.6 Hz), 128.5, 
126.2 (q, J = 3.8 Hz), 124.2 (q, J = 272.2 Hz), 116.1, 80.2, 63.0, 59.9 ppm; IR (thin film) 
3379, 3062, 2924, 1712, 1589, 1496, 1327 cm-1; HRMS (ESI) m/z 444.0062 (444.0067 calcd 

















According to the general procedure Dy(OTf)3 (14 mg, 0.024 mmol, 0.05 equiv) was added to 
furan-2-yl(4-(trifluoromethyl)phenyl)methanol 105 (115 mg, 0.47 mmol, 1 equiv) and 3-
chloroaniline 57 (61 mg, 0.47 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction 
mixture was heated to 80 ºC for 2 h. The reaction was then quenched with 5 mL of saturated 
aqueous sodium bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo.  The residue 
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was purified by column chromatography to afford cyclopentenone 73 (144 mg, 87%) as an 
oil. 1H NMR (500 MHz, CDCl3) δ 7.79 (dd, J = 5.7, 2.3 Hz, 1H), 7.63 (d, J = 8.1 Hz, 2H), 
7.27 (d, J = 8.0 Hz, 2H), 7.05 (t, J = 8.1 Hz, 1H), 6.74 (ddd, J = 7.9, 1.9, 0.8 Hz, 1H), 6.50 – 
6.46 (m, 2H), 6.38 (ddd, J = 8.2, 2.3, 0.7 Hz, 1H), 4.75 (bs, 1H), 4.08 (bs, 1H), 3.47 (d, J = 
2.8 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 205.1, 161.3, 147.1, 141.9, 135.5, 135.3, 
130.7, 130.1 (d, J = 32.7 Hz), 128.6, 126.3 (q, J = 3.8 Hz), 119.2, 112.2, 63.2, 60.1 ppm; IR 
(thin film) 3375, 3070, 2924, 1712, 1597, 1508, 1327 cm-1; HRMS (ESI) m/z 374.0538 



















4-(mesitylamino)-5-(4-(trifluoromethyl)phenyl)cyclopent-2-enone (74): According to 
the general procedure Dy(OTf)3 (25 mg, 0.041 mmol, 0.1 equiv) was added to furan-2-yl(4-
(trifluoromethyl)phenyl)methanol 105 (100 mg, 0.41 mmol, 1 equiv) and 2,4,6-
trimethylaniline 98 (56 mg, 0.41 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction 
mixture was heated to 80 ºC for 8 h. The reaction was then quenched with 5 mL of saturated 
aqueous sodium bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo.  The residue 
was purified by column chromatography to afford cyclopentenone 74 (115 mg, 78%) as an 
oil. 1H NMR (500 MHz, CDCl3) δ 7.69 (dd, J = 5.6, 1.4 Hz, 1H), 7.55 (d, J = 8.0 Hz, 2H), 
7.13 (d, J = 8.0 Hz, 2H), 6.82 (s, 2H), 6.37 (d, J = 5.6 Hz, 1H), 4.44 (bs, 1H), 3.46 (d, J = 
2.6 Hz, 1H), 3.20 (bs, 1H), 2.24 (s, 3H), 2.11 (s, 6H) ppm; 13C NMR (125 MHz, CDCl3) δ δ 
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206.0, 163.1, 142.1, 140.6, 133.7, 132.9, 129.9, 129.6 (q, J = 32.5 Hz), 128.6, 125.9 (q, J = 
3.7 Hz), 124.3 (q, J = 272.0 Hz), 67.4, 60.4, 20.8, 18.8 ppm; IR (thin film) 3359, 2924, 
2858, 1712, 1616, 1481, 1326 cm-1; HRMS (ESI) m/z 382.1405 (382.1389 calcd for 
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4-((4-iodophenyl)amino)-5-methylcyclopent-2-enone (75): According to the general 
procedure Dy(OTf)3 (27 mg, 0.045 mmol, 0.05 equiv) was added to 1-(furan-2-yl)ethanol 
106 (100 mg, 0.89 mmol, 1 equiv) and 4-iodoaniline 44 (195 mg, 0.89 mmol, 1 equiv) in 6 
mL of MeCN.  The resulting reaction mixture was heated to 80 ºC for 2.5 h. The reaction 
was then quenched with 5 mL of saturated aqueous sodium bicarbonate and extracted with 
ethyl acetate (3 × 10 mL).  The combined organic layers were dried over MgSO4, filtered 
and then concentrated in vacuo.  The residue was purified by column chromatography to 
afford cyclopentenone 75 (190 mg, 68%) as an oil. 1H NMR (500 MHz, CDCl3) δ 7.59 (dd, 
J = 5.8, 2.2 Hz, 1H), 7.49 – 7.46 (m, 2H), 6.50 – 6.47 (m, 2H), 6.28 (dd, J = 5.8, 1.6 Hz, 
1H), 4.34 – 4.29 (m, 1H), 3.83 (d, J = 8.8 Hz, 1H), 2.22 (dddd, J = 7.4, 7.4, 7.4, 2.9 Hz, 1H), 
1.33 (d, J = 7.4 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 208.7, 160.4, 146.4, 138.3, 
134.4, 115.9, 79.6, 61.9, 49.1, 14.6 ppm; IR (thin film) 3367, 3062, 2970, 1709, 1589, 1496, 
1315 cm-1; HRMS (ESI) m/z 335.9860 (335.9856 calcd for C12H12INONa+ [M + Na]+). 
 

















4-((3-chlorophenyl)amino)-5-methylcyclopent-2-enone (76): According to the general 
procedure Dy(OTf)3 (60 mg, 0.1 mmol, 0.05 equiv) was added to 1-(furan-2-yl)ethanol 106 
(222 mg, 1.98 mmol, 1 equiv) and 3-chloroaniline 57 (253 mg, 1.98 mmol, 1 equiv) in 15 
mL of MeCN.  The resulting reaction mixture was heated to 80 ºC for 3 h. The reaction was 
then quenched with 10 mL of saturated aqueous sodium bicarbonate and extracted with ethyl 
acetate (3 × 20 mL).  The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo.  The residue was purified by column chromatography to afford 
cyclopentenone 76 (44 mg, 10%) as an oil. 1H NMR (500 MHz, CDCl3) 1H NMR (500 
MHz, CDCl3) δ 7.60 (dd, J = 5.7, 1.9 Hz, 1H), 7.13 (t, J = 8.0 Hz, 1H), 6.76 (d, J = 7.9 Hz, 
1H), 6.68 (s, 1H), 6.60 – 6.52 (m, 1H), 6.29 (d, J = 5.7 Hz, 1H), 4.33 (d, J = 8.0 Hz, 1H), 
3.86 (d, J = 8.8 Hz, 1H), 2.23 (dddd, J = 7.4, 7.4, 7.4, 2.8 Hz, 1H), 1.35 (d, J = 7.4 Hz, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 208.7, 160.4, 147.9, 135.5, 134.4, 130.8, 118.7, 113.4, 
112.0, 61.9, 49.1, 14.6 ppm; IR (thin film) 3367, 2968, 2930, 1709, 1598, 1483, 1324 cm-1. 



















4-(mesitylamino)-5-methylcyclopent-2-enone (77): According to the general procedure 
Dy(OTf)3 (27 mg, 0.45 mmol, 0.05 equiv) was added to 1-(furan-2-yl)ethanol 105 (100 mg, 
0.89 mmol, 1 equiv) and 2,4,6-trimethylaniline 98 (125 µl, 0.89 mmol, 1 equiv) in 6 mL of 
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MeCN.  The resulting reaction mixture was heated to 80 ºC for 3.5 h. The reaction was then 
quenched with 5 mL of saturated aqueous sodium bicarbonate and extracted with ethyl 
acetate (3 × 10 mL).  The combined organic layers were dried over MgSO4, filtered and then 
concentrated in vacuo.  The residue was purified by column chromatography to afford 
cyclopentenone 77 (151 mg, 74%) as a solid. 1H NMR (500 MHz, CDCl3) δ 7.48 (dd, J = 
5.7, 1.9 Hz, 1H), 6.88 (s, 2H), 6.19 (d, J = 5.7 Hz, 1H), 4.00 – 3.98 (m, 1H), 2.98 (bs, 1H), 
2.29 (s, 6H), 2.26 (s, 3H), 2.24 (dddd, J = 7.4, 7.4, 7.4, 2.9 Hz, 1H), 1.26 (d, J = 7.4 Hz, 3H) 
ppm; 13C NMR (125 MHz, CDC3) δ 209.3, 162.5, 141.2, 133.1, 132.4, 129.9, 129.9, 66.3, 
49.6, 20.8, 18.8, 13.9 ppm; IR (thin film) 3356, 2927, 1712, 1481, 1234 cm-1; HRMS (ESI) 


















4-((4-iodophenyl)amino)-5-isopropylcyclopent-2-enone (78): According to the general 
procedure Dy(OTf)3 (22 mg, 0.036 mmol, 0.05 equiv) was added to 1-(furan-2-yl)-2-
methylpropan-1-ol 83 (100 mg, 0.71 mmol, 1 equiv) and 4-iodoaniline 44 (156 mg, 0.71 
mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 80 ºC for 5 
h. The reaction was then quenched with 5 mL of saturated aqueous sodium bicarbonate and 
extracted with ethyl acetate (3 × 10 mL).  The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo.  The residue was purified by column 
chromatography to afford cyclopentenone 78 (176 mg, 73%) as an oil. 1H NMR (500 MHz, 
CDCl3) δ 7.61 (dd, J = 5.7, 2.1 Hz, 1H), 7.51 – 7.41 (m, 2H), 7.27 (s, 1H), 6.54 – 6.42 (m, 
2H), 6.20 (dd, J = 5.8, 1.4 Hz, 1H), 4.48 (d, J = 8.8 Hz, 1H), 3.84 (d, J = 8.6 Hz, 1H), 2.43 – 
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2.25 (m, 1H), 2.16 (dd, J = 4.1, 3.1 Hz, 1H), 1.03 (d, J = 7.0 Hz, 3H), 0.91 (d, J = 6.8 Hz, 
3H) ppm; 13C NMR (125 MHz, CDCl3) δ 208.3, 161.3, 146.2, 138.3, 134.9, 115.8, 79.3, 
59.1, 56.4, 28.1, 20.6, 18.6 ppm; IR (thin film) 3371, 3062, 2958, 2877, 1589, 1496, 1319 



















4-((3-chlorophenyl)amino)-5-isopropylcyclopent-2-enone (79): According to the 
general procedure Dy(OTf)3 (22 mg,0.036 mmol, 0.05 equiv) was added to 1-(furan-2-yl)-2-
methylpropan-1-ol 83 (100 mg, 0.71 mmol, 1 equiv) and 3-chloroaniline 57 (91 mg, 0.71 
mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 80 ºC for 6 
h. The reaction was then quenched with 5 mL of saturated aqueous sodium bicarbonate and 
extracted with ethyl acetate (3 × 10 mL).  The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo.  The residue was purified by column 
chromatography to afford cyclopentenone 79 (92 mg, 52%) as an oil. 1H NMR (500 MHz, 
CDCl3) δ 7.64 (dd, J = 5.8, 2.1 Hz, 1H), 7.13 (dd, J = 8.0 Hz, 1H), 6.79 – 6.73 (m, 1H), 6.69 
(dd, J = 2.0 Hz, 1H), 6.56 (dd, J = 8.2, 2.3 Hz, 1H), 6.24 (dd, J = 5.7, 1.3 Hz, 1H), 4.51 (d, J 
= 7.1 Hz, 1H), 3.77 (d, J = 7.8 Hz, 1H), 2.41 – 2.31 (m, 1H), 2.20 – 2.14 (m, 1H), 1.05 (d, J 
= 7.0 Hz, 3H), 0.94 (d, J = 6.8 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 208.2, 161.2, 
147.7, 135.6, 135.1, 130.8, 118.6, 113.3, 112.0, 59.2, 56.4, 28.2, 20.7, 18.6 ppm; IR (thin 
film) 3377, 2958, 2926, 1703, 1598, 1483, 1323 cm-1. HRMS (ESI) m/z 272.0824 (272.0818 
calcd for C14H16ClNONa+ [M + Na]+). 




















5-isopropyl-4-(mesitylamino)cyclopent-2-enone (80): According to the general 
procedure Dy(OTf)3 (22 mg, 0.036 mmol, 0.05 equiv) was added to 1-(furan-2-yl)-2-
methylpropan-1-ol 83 (100 mg, 0.71 mmol, 1 equiv) and 2,4,6-trimethylaniline 98 (91 mg, 
0.71 mmol, 1 equiv) in 6 mL of MeCN.  The resulting reaction mixture was heated to 80 ºC 
for 24 h. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 × 10 mL).  The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo.  The residue was purified 
by column chromatography to afford cyclopentenone 80 (163 mg, 89%) as an oil. 1H NMR 
(500 MHz, CDCl3) δ 7.48 (dd, J = 5.7, 2.2 Hz, 1H), 6.86 (s, 2H), 6.16 (dd, J = 5.7, 1.1 Hz, 
1H), 4.21 (d, J = 1.0 Hz, 1H), 2.91 (bs, 1H), 2.35 – 2.23 (m, 11H), 2.17 (dd, J = 3.6, 2.6 Hz, 
1H), 0.98 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 
209.7, 163.8, 141.2, 134.17, 132.3, 130.0, 129.9, 60.4, 59.9, 28.4, 20.8, 20.5, 19.1, 18.6 
ppm; IR (thin film) 3352, 2958, 1704, 1589, 1481, 1230 cm-1; HRMS (ESI) m/z 258.1863 








N-(1-(furan-2-yl)-2-methylpropyl)-4-iodoaniline (84): 1H NMR (500 MHz, CDCl3) δ 
7.37 (dd, J = 3.4, 1.9 Hz, 1H), 7.36 (dd, J = 3.0, 2.0 Hz, 1H), 7.33 – 7.31 (m, 1H), 6.38 (dd, 
J = 2.8, 1.9 Hz, 1H), 6.37 (dd, J = 2.8, 2.0 Hz, 1H), 6.27 (dd, J = 3.2, 1.8 Hz, 1H), 6.11 (d, J 
= 3.2 Hz, 1H), 4.18 (d, J = 6.0 Hz, 1H), 4.00 (s, 1H), 2.15 (dqq, J = 13.7, 6.9, 6.5 Hz, 1H), 
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1.00 (d, J = 6.8 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 









    MeOH, 0 °C
2) 10 mol % Pd/C, H2







methoxyphenyl)amino)-5-phenylcyclopent-2-enone 51 (399 mg, 1.43 mmol, 1 equiv) and 
CeCl3•7H2O (745 mg, 2.00 mmol, 1.4 equiv) were combined in 16 mL MeOH at 23 °C. 
After 20 min, the solution was cooled to 0 °C and NaBH4 (76 mg, 2.0 mmol, 1.4 equiv) was 
added in several portions. Upon completion, the reaction was quenched with saturated 
aqueous NH4Cl (20 mL) and extracted with EtOAc (3 × 20 mL). The combined organic 
layers were dried over MgSO4, filtered and concentrated in vacuo. The material was purified 
by flash column chromatography, eluted with 4:1 hexanes/EtOAc, to give the reduced 
product as a 2:1 mixture of diastereomers of the allylic alcohol that were not separated. This 
mixture of diastereomers (347 mg, 1.23 mmol, 1 equiv) was added to a suspension of Pd/C 
(10%) (131 mg, 1.23 mmol, 0.1 equiv) in 14 mL MeOH and placed under an atmosphere of 
H2 at 500 psi for 16 h. The solution was filtered through Celite®, washed with EtOAc (3 × 
15 mL) and the combined organic phases were reduced in vacuo. Purification by flash 
column chromatography, eluting with 4:1 hexanes/EtOAc, afforded cyclopentanol 89 (350 
mg, 76% 2:1 mixture; 227 mg, 49% 89) as a yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.37 
– 7.30 (m, 2H), 7.28 – 7.19 (m, 3H), 6.77 – 6.66 (m, 2H), 6.55 – 6.46 (m, 2H), 4.21 (ddd, J 
= 13.4, 6.7, 6.7 Hz, 1H), 3.81 (ddd, J = 13.5, 7.5, 7.5 Hz, 1H), 3.73 (s, 3H), 2.85 (dd, J = 
7.4, 7.4 Hz, 1H), 2.32 (dddd, J = 13.8, 7.4, 7.4, 7.4, Hz, 1H), 2.20 – 2.11 (m, 1H), 1.92 – 
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1.82 (m, 1H), 1.82 – 1.72 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 152.4, 141.9, 141.1, 
128.9, 127.8, 127.1, 115.4, 114.9, 78.9, 61.5, 60.4, 55.9, 32.5, 30.8 ppm; IR (thin film) 3377, 
3028, 2952, 1602, 1512, 1237 cm-1; MS (ESI) m/z 306.18 (306.15 calcd for C18H21NO2Na+ 






















89 90  
N-3-((3,5-bis(trifluoromethyl)benzyl)oxy)-2-phenylcyclopentyl)-4-methoxyaniline 
(90): Cyclopentanol 89 (111 mg, 0.39 mmol, 1 equiv) was added slowly to a suspension of  
NaH (168 mg, 7 mmol, 18 equiv) in 11 mL anhydrous THF under an atmosphere of N2 and 
stirred for 1 h. Subsequently, 3,5-bis-trifluoromethylbenzyl bromide was added to the 
solution and the reaction was stirred at 23 °C for 16 h. The reaction was quenched with H2O 
(15 mL) and extracted with EtOAc (3 × 15 mL). The combined organic phases were dried 
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eluting with 9:1 hexanes/EtOAc, to afford 90 (149 mg, 75%) as a yellow oil. 1H NMR (600 
MHz, CDCl3) δ 7.77 (s, 1H), 7.66 (s, 2H), 7.36 – 7.31 (m, 2H), 7.28 – 7.24 (m, 3H), 6.72 (d, 
J = 8.8 Hz, 2H), 6.48 (d, J = 8.8 Hz, 2H), 4.53 (dd, J = 31.5, 12.8 Hz, 2H), 4.06 (ddd, J = 
12.0, 6.1, 6.1 Hz, 1H), 3.80 (ddd, J = 14.3, 7.1, 7.1 Hz, 1H), 3.73 (s, 3H), 3.08 (ddd, J = 6.7, 
6.7 Hz, 1H), 2.36 (dddd, J = 13.3, 7.0, 7.0, 7.0 Hz, 1H), 2.18 (dddd, J = 14.8, 7.6, 7.6, 7.6 
Hz, 1H), 2.1 – 1.99 (m, 1H), 1.87 – 1.80 (dddd, J = 15.1, 7.5, 7.5, 7.5 Hz, 1H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 152.5, 141.9, 141.9, 141.4, 131.8 (q, J = 33.2 Hz), 129.0, 127.7, 
127.4 (m), 127.2, 123.5 (q, J = 272.2 Hz), 121.57 (ddd, J = 3.8, 3.8, 3.8 Hz),115.3, 115.0, 
86.7, 70.1, 61.4, 59.6, 56.0, 31.3, 30.3 ppm; IR (thin film) 3030, 2937, 2834, 1622, 1512, 



























3-((3,5-bis(trifluoromethyl)benzyl)oxy)-2-phenylcyclopentanamine (5): To a solution 
of cyclopentane 90 (103 mg, 0.203 mmol, 1 equiv) in 4.4 mL MeCN/H2O (1:1), H5IO6 (46.3 
mg, 0.203 mmol, 1 equiv) and 1 M H2SO4 (203 µL, 0.203 mmol, 1 equiv) were added 
sequentially. The reaction mixture was stirred for 6 h at 23 °C. Upon completion, the 
solution was extracted with CH2Cl2 (3 × 10 mL). The aqueous phase was then adjusted to 
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layers were acidified to pH 1 with HCl/EtOAc, dried over MgSO4, filtered and reduced in 
vacuo. The material was then purified by flash column chromatography, eluting with a 
gradient hexanes/EtOAc to 9:1 CH2Cl2/MeOH, to afford 3-((3,5-
bis(trifluoromethyl)benzyl)oxy)-2-phenylcyclopentanamine 5 (47.5 mg, 58%). 1H NMR 
(600 MHz, CDCl3) δ 7.73 (s, 1H), 7.59 (s, 2H), 7.36 – 7.31 (m, 2H), 7.29 – 7.21 (m, 3H), 
4.46 (dd, J = 26.9, 12.8 Hz, 2H), 4.04 (ddd, J = 12.3, 7.1, 7.1 Hz, 1H), 3.28 (ddd, J = 15.7, 
9.2, 9.2 Hz, 1H), 2.83 (dd, J = 7.5, 7.5 Hz, 1H), 2.54 – 2.19 (bs, 2H), 2.17 – 2.07 (m, 2H), 
2.00 – 1.92 (m, 1H), 1.85 – 1.73 (m, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 141.4, 141.2, 
131.8 (q, J = 33.3 Hz), 129.1, 127.8, 127.4 (m), 127.3, 123.5 (q, J = 272.4 Hz), 121.5 (dddd, 
J = 7.7, 3.7, 3.7, 3.7 Hz), 86.2, 69.9, 62.2, 59.1, 32.3, 29.8 ppm; IR (thin film) 3062, 3030, 
2933, 1624, 1510, 1376, 1280, 1173 cm-1; HRMS (ESI)  m/z 404.1434 (404.1449 calcd for 
C20H19F6NOH+ [M + H]+). 
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3. Dysprosium Trifluoromethanesulfonate Catalysis 
3.1. Rare Earth Lewis Acid Catalysis  
Following the development of a dysprosium catalyzed aza-Piancatelli rearrangement, we 
wanted to address the choice of catalyst in more detail and provide insight on the potential 
of dysprosium triflate, and rare earth triflates in general, as versatile catalysts.   
Within this chapter, the merits and potential of dysprosium will be highlighted based on 
a review and an e-EROS article we authored to create a knowledge base and generate 
interest in this catalyst in the synthetic community.89,90 
The chemistry of rare earth (lanthanide) Lewis acids has received increasing attention 
from the synthetic community since their initial use as shift reagents.91–95 Thanks to 
intensive studies by Kobayashi94–96 and others,97 lanthanides have since found widespread 
use as mild, stable Lewis acids that are known for their oxophilicity and stability in aqueous 
media, making them water-compatible Lewis acids. These qualities combined with 
recyclability, low toxicity and a moderate price makes lanthanide catalysis attractive, 
especially in terms of sustainability.  
The rare earth elements possess a gradual variation in physical properties that result in 
many examples where the efficacy varies only slightly from one reaction to another.95,98,99 
The similar reactivity patterns have caused synthetic chemist to focus predominantly on 
scandium and ytterbium, the two rare earth elements with the highest Lewis acidity.  As a 
result little is known about the possible advantages or disadvantages of the other members of 
the lanthanide family. An existing challenge in reaction development with lanthanide Lewis 
acid catalysts is predictability and a clear understanding of when or why particular rare 
earths promote a certain transformation. Exploring the reactivity of the other lanthanides 
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will undoubtedly lead to a better understanding of these catalysts and hopefully also result in 
new reaction development.   
3.2. About Dysprosium  
Our group became highly intrigued by difficult to pronounce dysprosium, after 
discovering Batey’s success with the metal in his synthesis of 4,5-
diaminocyclopentenones.40 The word dysprosium originates from the Greek dysprositos, 
meaning hard to get at, and element 66 holds true to its name. First discovered in 1886 by 
Lecoq de Boisbaudran, dysprosium was not isolated in its pure form until almost a century 
later, in 1950.5 The metal has not received much attention from the synthetic community 
even though, compared to other lanthanides, dysprosium exhibits similar stability to air and 
water, ease of handling, Lewis acidity and oxophilicity.  
The basic properties of dysprosium are outlined in Figure 3.1.91–95,98,99 Analogous to the 
other lanthanides, dysprosium (III) is the most stable oxidation state.  Dysprosium resides 
after the gadolinium break and has an extended Xe-core electronic configuration, [Xe]4f9.  
The ionic radius and therefore its intrinsic Lewis acidity (Lewis acidity = Z/r3; Z= charge 
and r = ionic radius) are just below scandium and ytterbium and very similar to the 
surrounding elements Tb, Ho, Er, Tm and Lu.  Dysprosium is the cheapest element in the 
Tb–Lu series but comparable in price to ytterbium.100 The number of ligands coordinated to 
dysprosium is often between 8 and 9.101 Unlike d-transition metals, however, ligand bonding 
such as σ-donor/π-acceptor interactions, the 18-electron rule, and the formation of double or 
triple bonds are not observed with dysprosium(III) or in other lanthanide(III) chemistry.  
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Sc Y La Ce Pr Nd Pm Sm Eu Gd Tb Dy Ho Er Tm Yb Lu
Ln3+ electron configurations [Ar] [Kr] [Xe] [Xe]4f1 [Xe]4f7 [Xe]4f8 [Xe]4f14









oxophilicity / kcal mol-1
(D0 ± 5 kcal mol-1)
165 190170 188 176 167   -   136 112 170 165 146 144 - 122 95 159
Sc Y La Ce Pr Nd Pm Sm Eu Gd Tb Dy Ho Er Tm Yb Lu
Sc Y La Ce Pr Nd Pm Sm Eu Gd Tb Dy Ho Er Tm Yb Lu
Sc Y La Ce Pr Nd Pm Sm Eu Gd Tb Dy Ho Er Tm Yb Lu
 
Figure 3.1. Characteristic features of lanthanide ions and elements. D0 = dissociation energy 
of the Ln–O bond. 
 
Due to its mild nature, dysprosium is an excellent catalyst for multicomponent reactions 
where both nitrogen and oxygen functionalities are present. Importantly, the metal retains its 
catalytic activity in the presence of Lewis basic nitrogen groups, allowing for its use in a 
variety of transformations with unprotected amines. Dysprosium triflate is commercially 
available, but may also be prepared by treatment of its oxide with aqueous triflic acid.102 
Many transformations with dysprosium can be achieved in protic media and ionic liquids 
and the catalyst can be recycled, making dysprosium a suitable catalyst for applications in 
green chemistry. The following section is a nearly extensive list of reports that focused on 
reaction development with dysprosium.  
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3.3. Organic Chemistry with Dysprosium 
3.3.1. Dysprosium Catalyzed Friedel–Crafts Alkylation 
Alkylation reactions are crucial for carbon-carbon bond formation, and the Friedel–
Crafts alkylation, initially reported in 1877, deservedly still receives attention from synthetic 
chemists as a means to establish essential carbon-carbon bonds.103 In 1986, Fujiwara and co-
workers reported the use of lanthanide chlorides (LnCl3) in the Friedel–Crafts alkylation of 
arenes.104 The heterogeneous reaction proceeded with the arene as the solvent using 37 mol 
% of the LnCl3 relative to the alkyl halide. Screening of all lanthanide chlorides, with the 
exception of radioactive promethium(III) chloride, revealed that the late lanthanides were 
more effective catalysts than the early rare earths. It is important to note that the hydrated 
LnCl3!xH2O (x = 6, or 7) was an ineffective catalyst, producing only trace amounts of 
product after 18 h compared to 74% after 1 h when the catalyst was dried by heating at 150 




37 mol % cat.
C6H6, 75 °C
X = Cl          DyCl3            1 h 74%
X = Br          DyCl3            2 h 57%
X = Cl    DyCl3•7H2O      18 h trace
1 2 3
 
Scheme 3.1. Dysprosium catalyzed Friedel–Crafts alkylation. 
The catalyst can easily be recovered and recycled, maintaining catalytic activity over 
three reaction cycles (Scheme 3.2). This method is one of the few examples of DyCl3 as a 
catalyst, as the rare earth chlorides often are not included in catalyst screening or show no 
catalytic activity. The scope of the reaction is limited, extending only to benzene and toluene 
arene partners. 
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Cl
+
37 mol % DyCl3
C6H6, 75 °C
trial 1:    1 h      74%  
trial 2:    2 h      40%
trial 3:    3 h      68%
31 4
 
Scheme 3.2. Recycling of the dysprosium catalyst. 
3.3.2. Dysprosium Catalyzed Mannich-Type Reactions 
Widely used as a valuable transformation in total synthesis, the Mannich reaction is an 
important target in method development and is particularly useful when stereocenters are set 
during the transformation under mild reaction conditions.105–107 
The unusual use of DyI3 as catalyst for a Mannich-type addition of imines to 
α,α-disubstituted enolates, generated from a cyclopropane ring opening, to access 
pyrrolidines containing all-carbon quaternary stereocenters was detailed by Matsunga and 
Shibasaki and co-workers.108 Use of 20 mol % DyI3 was the most effective Lewis acid 
catalyst loading and addition of 30 mol % Na2SO3 could enhance the yield from 66 to 79% 
without affecting the excellent >96:4 diastereomeric ratio (Scheme 3.3). This additive is 
speculated to generate a reducing medium in which the detrimental formation of I2 is 
suppressed. Use of the 4-bromo-3,5-dimethylpyrazole analogue allowed for an additional 
increase in yield to 84%. Conversion of the N-acyl pyrazole group of 8 to the methyl ester 
was achieved in high yield when using Er(OTf)3 in MeOH at 50 °C in 93% yield. 

























8  X = Br    84%  >96% dr
 
Scheme 3.3. DyI3 catalyzed Mannich reaction. 
In addition to a variety of substituted aryl imines, where electron-poor substrates 
performed better than their electron-rich counterparts, Matsunga and Shibasaki and co-
workers were also able to extend the methodology to alkyl imines (Scheme 3.4). The high 
diastereoselectivity is believed to stem from preferred formation of the cis-enolate depicted 





































Scheme 3.4. Scope of the DyI3 catalyzed Mannich reaction. 
A method for the synthesis of benzotriazole derivatives from N-(α-benzotriazolyl-
alkyl)amides was developed by Fan and co-workers.109 After screening a variety of Lewis 
  81 
acids, Dy(OTf)3 was identified as the Lewis acid capable of promoting transformation to the 
desired compound 14, reported to have fungicidal activity (Scheme 3.5). Using less than one 
equivalent of Dy(OTf)3 did not promote the reaction. However, the authors found that the 














13 14  
Scheme 3.5. Dysprosium catalyzed synthesis of benzotriazole derivatives. 
Regarding the substrate scope of the transformation, Fan and co-workers found that 
electron-poor substrates produced higher yields compared to electron-rich starting materials, 
and that use of aliphatic substrates was unsuccessful under the reaction conditions (Scheme 
3.6, 15–17). Varying the nucleophile, methyl- (18) or ethyl-3-oxobutanoate (not shown) also 
participated in the reaction in good yield, but ethyl-2-nitroacetate (19) or ethyl-2-











































Scheme 3.6. Scope of the benzotriazole synthesis. 
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In 2009, Wu and co-workers reported the use of a AgOTf/Dy(OTf)3 catalyst system to 
synthesize 1-(indol-3-yl)-2-aminoisoquinolinium triflates that relied on a Mannich-type 
reaction.110 This transformation allowed access to a range of substituted indoles. Present in a 
large number of natural products and biologically active molecules, the indole structural 







30 mol % Dy(OTf)3




























































32  R = 4-OMe    97%
33  R = 6-OMe    84%





Scheme 3.7. Proposed reaction mechanism and scope for Wu's Mannich type reaction. 
Use of AgOTf in 1,2-dichloroethane (DCE) at 70 °C gave the 6-endo cyclization product 
25 in 99% yield but the desired product, 28 was not observed (Scheme 7). Use of Dy(OTf)3 
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and other Lewis acids produced only small amounts of 25. Significantly, the authors found 
that reaction of 25 with indole catalyzed by Dy(OTf)3 in MeCN produced 23 in 28% yield 
(the initially proposed product 28 was not observed). Driven by these results, the 
investigation of a tandem catalytic reaction using AgOTf and Dy(OTf)3 led to the 
development of the multicatalytic methodology. The one-pot, three step reaction proceeded 
in good yield via a silver-catalyzed intramolecular cyclization followed by dysprosium-
catalyzed nucleophilic addition of indole, and finally elimination of the sulfonyl group, 
affording unexpected 1-(indol-3-yl)-2-aminoisoquinolinium triflates. A multicatalytic 
reaction that provides the possibility of accomplishing numerous transformations in one pot 
makes this transformation a powerful synthetic tool.112,113 
A fluorine substituent on the aryl ring (29) decreased the yield slightly to 93%, and 
exchange of phenyl for a p-methoxyphenyl group (30) on the acetylene reduced the yield to 
90% (Scheme 3.7). Even alkyl groups on the acetylene (31) and a variety of substituents on 
the indole portion were tolerated (32–34).  
3.3.3. Dysprosium Catalyzed Diels–Alder and Povarov Reaction 
The Diels–Alder reaction has long been recognized as a powerful reaction with a rich 
history in the synthesis of natural and unnatural carbocycles and heterocycles.114,115 The 
Povarov reaction, an imino variant of the Diels–Alder cycloaddition provides a direct route 
to different nitrogen heterocycles from readily available Schiff bases.116 There has been a 
renewed interest in the Povarov reaction since Kobayashi and co-workers demonstrated that 
lanthanide triflates, specifically Yb(OTf)3, catalyze the reaction of cyclopentadiene or 
dihydrofuran (DHF) with in situ formed imines.117  
In efforts toward the total synthesis of the alkaloids martinelline and martinellic acid 
(47), Batey and co-workers developed a three-component coupling of anilines, 
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benzaldehydes and N-substituted-2-pyrrolidine to access substituted hexahydropyrrolo[3,2-
c]-quinolines (Scheme 3.8).118 The favored catalyst for this reaction was Dy(OTf)3 in 







7 mol % Dy(OTf)3


















































Scheme 3.8. Scope of Batey's three-component coupling reaction. 
The proposed mechanism proceeds through the complexation of the imine, formed in 
situ via condensation of the aldehyde and aniline. Stepwise nucleophilic addition of the 
pyrrolidine and ring closure by electrophilic aromatic substitution then affords the product. 
In addition, Batey and co-workers found that a 2:1 coupling of enamine and aniline gave 45 
as mainly the endo diastereomer (Scheme 3.9).  Using water as the co-solvent, the endo-
product was favored, presumably due to the hydrophobic effect that would favor a more 
compact transition state. In the published total synthesis of martinelline 47, Batey and co-
workers resorted to the use of camphorsulfonic acid as they were unable to obtain the 
desired exo diastereomer using Lewis acids.119 













































Scheme 3.9. Selective formation of the endo isomer. 
In a subsequent report, Batey and co-workers described the 2:1 coupling of DHF with 
anilines catalyzed by Dy(OTf)3.120 The reaction of 4-chloroaniline with DHF proceeded well 
in MeCN giving approximately a 3:1 mixture of endo:exo diastereomers (Scheme 3.10). At a 
detriment to the yield, the endo:exo ratio could be greatly improved to 92:8 when performed 
in toluene. It is worth noting that DyCl3!6H2O (5 mol %) also catalyzed the reaction to 
afford a 64:36 ratio of endo:exo products in 78% yield; a rare example of a reaction with 
dysprosium(III) chloride. The trend of increased endo selectivity in toluene held true for a 
variety of anilines with the exception of p-methoxyanline 53 where no effect was noted. 
Interestingly, use of methyl-4-aminobenzoate led to product 54 in a >98:2 endo:exo ratio in 
MeCN.  


















MeCN         81%      endo:exo  76 : 24








MeCN         81%      endo:exo  66 : 34







MeCN         84%      endo:exo  58 : 42







MeCN         86%      endo:exo  76 : 24







MeCN         86%      endo:exo  >98:2  
Scheme 3.10. Batey's 2:1 coupling of DHF with anilines. 
In an attempt to increase the diastereomeric ratio, the effect of temperature was tested. 
At lower temperatures, oxepin 56 was formed. However, oxepin 56 rearranged to the exo-
diastereomer when resubjected to the reaction conditions at rt, such that, ultimately, the 




























Scheme 3.11. Effect of temperature on the reaction. 
The mechanism of the reaction could proceed via a concerted or stepwise process, and it 
could change depending on the solvent. Batey and co-workers propose that, due to the 
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formation of the oxepin at lower temperatures, at least a partially stepwise mechanism is 















Figure 3.2. Depiction of both concerted and stepwise mechanisms. 
Although a three-component coupling had successfully been developed for the Povarov 
reaction with aldehydes lacking α-protons, the use of aliphatic aldehydes with enolizable 
protons was limited to only a few examples.121,122 However, following the exploration of the 
2:1 coupling of DHF and anilines,120 Batey and co-workers developed a three-component 
coupling of aniline with cyclopentadiene and aliphatic aldehydes containing enolizable 
protons and their synthetic equivalent (Scheme 13–15).123 Reaction conditions had to be 
adjusted such that the competing Doebner-von Miller product would not be observed 
(Scheme 3.12). The competing 2:1 coupling with DHF was minimized by slow syringe-
pump addition of DHF to afford the desired product.  































































Use of 2-ethoxytetrahydrofuran allowed for further reduction of the undesired 2:1 
coupling and gave 68 in 63–67% yield and >95:5 diastereomeric ratio (Scheme 3.14). A 
variety of substituted anilines participate in the reaction with the exception of p-methoxy 
aniline (66, 69–71).  
NH2
O (3 equiv)










66  R  = 4-Cl            63%   >95:5
69  R  = 2-Cl            67%   >95:5
70  R  = 4-CO2Me    65%   >95:5
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Taking advantage of the mild reaction conditions and employing the slow-addition 
protocol, aliphatic aldehydes, such as ethyl and isopropyl aldehyde could be used with high 








5 mol % Dy(OTf)3





75  R  = Et                  58%   >95:5
76  R  = iPr                 64%   >95:5
77 R  = CH2CH2Ph    82%   >95:5






3.3.4. Enantioselective Dysprosium Catalyzed Alkylation 
A rare enantioselective alkylation of indoles with α,β-unsaturated trifluoromethyl 
ketones was developed by Higashiyama and co-workers who reported use of a 
Dy(OTf)3!PyBox catalyst system.124 Initial screening of Lewis acids indicated Sc(OTf)3 as a 
suitable catalyst with a follow-up screen of lanthanide trifluoromethanesulfonates 
identifying Dy(OTf)3 to be the optimal catalyst producing 82 in 95% yield and 84% ee 
(Scheme 3.16). Although N-alkylated indoles participated in the reaction in good yield, 
enantioselectivity was greatly affected, suggesting an interaction of the indole nitrogen with 
dysprosium during the stereodefining event (N-H, 84% ee, N-Me, 16% ee). In contrast to 
many other rare earth metal catalyzed reactions, ytterbium and lanthanum were ineffective 
catalysts for this alkylation reaction. 





7.5 mol % Dy(OTf)3
5 mol % 81








79 80 82  R  = H    95%   84% ee




Scheme 3.16. Dysprosium catalyzed enantioselective alkylation. 
Varying substitution at the C5-position of the indole established a trend of increased 
yield and selectivity for electron-donating substituents compared to electron-withdrawing 
substituents. The scope of α,β-substituted trifluoromethyl ketones included 
electron-withdrawing substituents with little effect on yield and selectivity, but greatly 







R1 7.5 mol % Dy(OTf)3














































Scheme 3.17. Scope of the enantioselective alkylation reaction. 
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3.3.5. Other Dysprosium Catalyzed Reactions 
Mei and co-workers investigated the synthesis of cyanohydrins from aldehydes and 
TMSCN catalyzed by a alkyldimethoxysilane dysprosium complex.125 The reaction of 
benzaldehyde with TMSCN using 4.5 mol % dysprosium catalyst afforded the cyanohydrin 
94 in 94% yield (Scheme 3.18). When substituted in the 2- and 4-position, 2-substituted aryl 




4.5 mol % cat.




cat. = ((CH3)2CH)2Si(OCH3)2, DyCl3
9392
 
Scheme 3.18. Dysprosium catalyzed cyanohydrin synthesis. 
In a comparative study of Dy(OTf)3 and InCl3, Yadav and co-workers studied the 
formation of 3-pyrrolyl-indolines and pyrrolyl-indeno[1,2-b] quinoxalines.126 A coupling of 
isatins with 4-hydroxyproline catalyzed by 10 mol % Dy(OTf)3 allowed for the synthesis of 
N-substituted pyrroles in good to excellent yields under neutral conditions (Scheme 3.19 and 








10 mol % 
cat.




cat. = Dy(OTf)3   20 min      94%
cat. = InCl3         30 min
95 96 97
90%  
Scheme 3.19. Comparative study with Dy(OTf)3 and InCl3. 
The reaction worked best in MeCN, but similar yields could be achieved in water at a 
sacrifice of reaction time. One limitation of this method is that simpler 1,2-diketones did not 
participate in the reaction due to the requisite stabilization provided by the zwitterionic 
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intermediate of the α-ketoamido functionality of the diketone. Interestingly, 11H-
indeno[1,2-b]quinoxalin-11-one derivatives also participated in the reaction to afford 11-
(1H-pyrrol-1-yl)-11H-indeno[1,2-b]quinoxalin-11-ones in good yield (Scheme 3.20, 102 
and 103).  
Other lanthanides, such as Y(OTf)3, Ce(OTf)3, Sm(OTf)3 and Gd(OTf)3, were tested but 
their performance was inferior to Dy(OTf)3. Indium trichloride was an effective catalyst for 
the transformation, but produced slightly lower yields and due to its lower cost, Dy(OTf)3 is 





Dy(OTf)3    90%
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Dy(OTf)3    84%





Scheme 3.20. Scope of the comparative study with Dy(OTf)3 and InCl3. 
3.3.6. Dysprosium in Protic Media 
A prominent feature of lanthanides is their stability and activity in protic media, making 
them ideal catalysts for green chemistry.96,127,128 Wang and co-workers made use of this 
feature, exploring the use of lanthanides as stable Lewis acids in water.129 They reported the 
use of Ln(OTf)3 catalysts for the reaction of indoles with both aldehydes and ketones in 
protic systems. A test of various lanthanides established Dy(OTf)3 as the optimal catalyst. 
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The reaction of indole with benzaldehyde in EtOH/H2O (3:1 v/v) proceeded in 93% yield at 
room temperature, using 10 mol % of Dy(OTf)3 catalyst (Scheme 3.21). 
Additionally, the catalyst is recyclable and control experiments using NaOTf and 
Mg(OTf)2 show that dysprosium is likely to be involved in the catalytic process and is 
necessary to promote the transformation. 
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Scheme 3.21. Dysprosium catalyzed reaction of indoles and aldehydes in protic media. 
Expanding on their publication, Wang and co-workers described the reaction of indole 
with imines in protic media.130 The reaction of N-benzylidene aniline with indole to afford 
3-(phenylamino benzylidene) indole was catalyzed by 10 mol % Dy(OTf)3 in EtOH/H2O 
(4:1) (Scheme 3.22). The range of Ln(OTf)3 catalysts tested showed Yb and Dy to be the 

















Scheme 3.22. Dysprosium catalyzed reaction of indole and an imine in aqueous medium. 
Interestingly, the reaction of indole with methylene aminoacetonitrile gave 108 and 109 
as the sole products (Scheme 3.23). Presumably, these products stem from the generation of 
formaldehyde from in situ hydrolysis to form an iminium ion. Subsequent Mannich reaction 
with the indole affords the observed products. Unfortunately, a three-component coupling 
reaction of indole, benzaldehyde and aniline proved unsuccessful, resulting only in the 
formation of phenyl bisindolylmethane. 
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Scheme 3.23. Dysprosium catalyzed reaction of indole with methylene amino-acetonitrile in 
aqueous medium. 
 
In 2002, Chen and Quian reported the Dy(OTf)3-catalyzed synthesis of 
tetrahydroquinoline derivatives in water through a one-pot condensation reaction of N-
methylaniline, formaldehyde and electron-rich alkenes (Scheme 3.24).131 The reaction was 
performed in commercially available aqueous formaldehyde solution, consisting of 
approximately 37% H2CO and 8-10% methanol. Compared to other lanthanide triflate 
catalysts as well as other Lewis acids, Dy(OTf)3 gave marginally better yields and was 
chosen for the development of the reaction. The authors were able to synthesize a variety of 
1,4-disubstituted-1,2,3,4-quinolines, utilizing acyclic precursors like styrene and 1-octene, in 
addition to DHF. 











































Scheme 3.24. Scope of the dysprosium catalyzed three-component reaction in water. 
3.3.7. Dysprosium in Ionic Liquids 
In the synthetic community, there is a growing interest in environmentally friendly, 
energy efficient reactions that will reduce the amount of waste and toxins introduced into the 
environment.132 Ionic liquids are salts with a melting point below room temperature that can 
be employed as a green alternative to traditional solvents.133,134 They allow for reactions to 
be run at room temperature in a non-volatile reaction medium that is simple to make, simple 
to handle and reusable.  
Yadav and co-workers investigated the use of Dy(OTf)3 in ionic liquids as a reusable 
catalyst for the synthesis of 2,3-unsaturated glycopyranosides.135 The 2,3-unsaturated 
glycopyranoside motif is an important building block for the synthesis of biologically active 
molecules.136 The glycosidation of glycals with alcohols was catalyzed by Dy(OTf)3 in the 
ionic liquid 1-butyl-3-methyl-imidazolium hexafluorophosphate ([bmim]PF6). The reaction 
proceeded with a variety of alcohols including 1°, 2°, phenols, allylic and propargylic 
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alcohols in high yields to give the α-anomer as the major glycosidation product (Scheme 
3.25). The nature of the ionic liquid used in the reaction greatly affected the catalytic activity 
of dysprosium, where hydrophobic ionic liquids produced the highest yields. The ionic 
liquid and catalyst could be recycled 2 to 3 times with no effect on the yield or reaction 
profile. 
It should be noted that at elevated temperatures and longer reaction times, the reaction 
proceeded without the Dy(OTf)3 catalyst. Among other catalysts screened for the reaction, 
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Scheme 3.25. Scope of the dysprosium catalyzed glycosidation of glycals in ionic liquid. 
In another report on the use of Dy(OTf)3 in ionic liquids, Cheng and co-workers detailed 
their development of the reaction of indoles with aldehydes and ketones.137 To achieve 
suitable reaction conditions, the group initially screened a number of solvents including 
ionic liquids and found that 2 mol % Dy(OTf)3 immobilized in [bmim]BF4 afforded the 
desired product 130 from the reaction of indole and hexanal in 95% yield in 1 h, compared 
to 84% after 24 h in EtOH/H2O (2:1 v/v) with 10 mol % Dy(OTf)3 (Scheme 3.26) .  
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22 129 130  
Scheme 3.26. Dysprosium catalyzed alkylation in ionic liquid. 
Unlike Yadav and co-workers’ glycosidation reaction,135 Cheng’s reaction of indole with 
aldehydes and ketones did not proceed in the absence of Dy(OTf)3. Applying the reaction 
conditions to ketones, they found that the reaction with acetone proceeded smoothly using 5 
mol % Dy(OTf)3 in [bmim]BF4 to afford the product 132 in 96% yield (Scheme 3.27). 
















Scheme 3.27. Dysprosium catalyzed alkylation of indole and acetone in ionic liquid. 
Extending their reaction scope to the use of imines, Cheng and co-workers found that the 
reaction of indole with N-benzylidene aniline proceeded using 5 mol % Dy(OTf)3 in 
[bmim]BF4, giving the desired product 106 and bis(indolyl) methane 104 as a side product 
in a 30:45 ratio (Scheme 3.28). Switching to [bupy]BF4, this ratio could be improved to 
47:45 (EtOH/H2O (4:1 v/v) gave a 57:12 ratio). Importantly, similar to other work with ionic 
liquids, the catalyst could be recycled up to six times with no loss in reactivity. These 
reaction profiles in ionic liquids mimic the Dy(OTf)3 catalyzed reactions in water (vide 
supra). 



























47 : 45  
Scheme 3.28. Dysprosium catalyzed reaction of indole and imine in various ionic liquids. 
3.4. Conclusions 
Dysprosium is an extremely mild and efficient Lewis acid catalyst for numerous types of 
carbon–carbon bond-forming reactions. The ability of dysprosium to catalyze reactions with 
unprotected amines makes it a valuable catalyst for transformations in total synthesis, 
voiding the need for protecting groups.  In addition to its mild nature, it also has a future in 
the development of green chemistry. Reactions can easily be performed in water and ionic 
liquids, and the catalyst can often be recycled without loss of activity or reactivity. The 
future of dysprosium chemistry will also see an increase in valuable asymmetric 
transformations under very mild conditions.  
Our group57,78,138–140 and Batey’s40,74 have now shown that Dy(OTf)3 also makes for a 
great catalyst for electrocyclization reactions in the presence of amines. With that 
knowledge and this extensive background information on other examples of dysprosium 
catalysis, we are eager to see what else our group and others can accomplish with this 
fascinating rare earth metal catalyst. 
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4. The Hydroxylamine Aza-Piancatelli Rearrangement 
4.1. The Value of Non-Aniline Amines 
The development of the aza-Piancatelli rearrangement with anilines was a great step in 
the direction of a general method for the synthesis of 4-aminocyclopentenones. When 
examining biologically and medically relevant aminocyclopentanes however, their variety of 
amine functional groups makes access to non-aniline products crucial. In Chapter 2.5 we 
presented one solution to this problem, which employed the oxidative removal of the PMP 
group with periodic acid to give access to an hNK1 inhibitor. However, these reaction 
conditions did not translate to aminocyclopentenones that are more susceptible to 
decomposition under strongly oxidizing conditions. At this point we set out to find 
alternative amine nucleophiles for use in the aza-Piancatelli rearrangement to enable access 
to a larger range of 4-aminocyclopentenones.  
4.2. Exploration of the Aza-Piancatelli Rearrangement with Non-Aniline Amines 
We commenced our exploration of an aza-Piancatelli rearrangement with alkyl amines at 
the same time as the reaction with anilines, but this task proved itself infinitely more 
difficult to accomplish. In his development of a dysprosium catalyzed synthesis of 4,5-
diamines, Batey found that the reaction worked best with secondary amines, such as 
morpholine, diallylamine, and N-methyl benzylamine (Chapter 2.2).40 Interestingly, the 
reaction did not proceed with primary benzylamine and required a switch to Sc(OTf)3 for the 
reaction with aniline.  
We expected that the aza-Piancatelli rearrangement would follow a similar trend, but 
surprisingly we found that anilines were the best nucleophiles for our rearrangement. 
Reactions of furylcarbinols with secondary amines, such as morpholine or benzylamine did 
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not result in product formation. Instead we observed the formation of a white precipitate and 
complete recovery of starting material (Scheme 4.1). Presumably, the amine binds 
irreversibly to dysprosium to form a dysprosium-amine complex (the white precipitate (4)) 
and keeps the catalyst from activating the furylcarbinol. Various reaction conditions 
including increased catalyst loading, other Lewis or Brønsted acid catalysts, or addition of 













Dy(OTf)x • x OHN
4
x5 mol % Dy(OTf)3MeCN, 80 °C
 
Scheme 4.1. Formation of a dysprosium-morpholine complex prevents rearrangement. 
Given Batey’s precedent these results were perplexing, but we surmised that the 
equilibrium in the aza-Piancatelli must lie too far to the left. In Batey’s reaction, on the other 
hand, formation of aminal (8) pushes the equilibrium toward the 4,5-diamine forming 
cascade (Figure 4.1). Batey and Li observed formation of aminal 8 during NMR studies, and 
although it was not observed, speculated that formation of imine 6 leads to the product-
forming cascade.141 Moreover, Batey reported that imine formation occurred in the absence 
of a catalyst, albeit much slower. Overall, we believe that aminal formation serves two 
important roles that enable the use of more basic secondary amines. First, it lowers the 
activation barrier for ring opening of the furan by going through iminium 6, which is the key 
step in the cascade rearrangement. Second, formation of the aminal (8) creates an off-cycle 
reservoir that reduces the concentration of Lewis basic nitrogen present in solution, 
liberating the catalyst for the desired cascade rearrangement. 










































10 mol % Dy(OTf)3











Figure 4.1. Batey's reaction proceeds from an off-cycle aminal reservoir. 
Despite initial setbacks, over the course of our studies we identified a privileged 
substrate, sterically hindered acylated triisopropyl furylcarbinol (10), that would rearrange 
with morpholine (2) when treated with 20 mol % Dy(OTf)3 to give the desired 4-
morpholino-cyclopentenone (11) in a respectable 47% yield (Scheme 4.2). We believe that 
the unusual reactivity of 10 can be attributed to both the increased activation from the acyl 
group, as well as steric hindrance from the isopropyl groups, which blocks products derived 












20 mol % Dy(OTf)3








Scheme 4.2. Aza-Piancatelli rearrangement with morpholine. 
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Unfortunately, we were unable to improve the reaction yield and the water product from 
a Piancatelli rearrangement (12) was a common side product. In fact, our investigations 
showed that increasing the catalyst loading led to increased formation of the Piancatelli 
product 12 (Table 4.1), suggesting water outcompetes the amine nucleophile. This is the first 
time that this competitive reactivity was observed.   












x mol % Dy(OTf)3















Entry  x 
Product ratio 
(11:12) 
1 30 1:0.4 
2 40 1:0.8 
3 50 0.7:1.0 
4 70 0.3:1.0 
5 90 0.1:1 
Although several other amines participated in the rearrangement with this privileged 
furylcarbinol (Table 4.2), these reactions proceeded extremely slowly, taking several days, 
and often did not go to completion.  









20 mol % Dy(OTf)3
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We eventually surmised that the electronic nature of the amine plays a more significant 
role in the success of the reaction than activating the furylcarbinol. Operating under the 
assumption that the pKa of the amine is key to a successful aza-Piancatelli rearrangement, 
we explored the reaction with a range of amines from basic morpholine (pKa = 8.4 to more 
acidic N-methylacetamide (pKa = –0.5). As a general rule, anilines and other amines with a 
pKa around 4.7 readily participate in the rearrangement, while amines with a higher pKa 
bind irreversibly to dysprosium and shut down the reaction. Amines with a lower pKa than 
anilines are neither basic enough to bind to dysprosium nor nucleophilic enough to attack at 



































Figure 4.2. Reaction outcome with varying amine pKa value. 
Exploring amines with pKa values similar to aniline, we were pleased to find that N-
methyl-O-methyl hydroxylamine (17) and bis(2-chloroethyl)amine (19) proved viable 
nucleophiles for the aza-Piancatelli rearrangement (Scheme 4.3).142  
































Scheme 4.3. Successful rearrangement with N-methyl-O-methyl hydroxylamine and bis(2-
chloroethyl)amine. 
 
Due to some concerns about the potential formation of nitrogen mustards143 from bis(2-
chloroethyl)amine and limited success with other electronically similar amines, we chose to 
focus on developing the reaction with hydroxylamines. We became particularly excited 
about hydroxylamines as a new class of nucleophiles for the aza-Piancatelli rearrangement 
because the intrinsically weak nitrogen–oxygen bond (55 kcal/mol) of hydroxylamines is 
easily cleaved to reveal the alkylamine.144–147  
Additionally, there is not much work in the area of substituted cyclopentanes with N–O 
bonds despite their potential synthetic utility. Miller’s work is limited to HDA reactions with 
cyclopentadiene and derivatives,62 while Johnson’s work enables access to NO2-substituted 
cyclopentanes (Scheme 4.4).66 

































Scheme 4.4. Synthesis of aminocyclopentanes by Miller and Johnson. 
4.3. Development of a Hydroxylamine Aza-Piancatelli Rearrangement 
With the encouraging result from the reaction of N-methyl-O-methyl hydroxylamine 
with phenyl furylcarbinol in hand (Scheme 4.3a), we set out to evaluate the scope of a 
hydroxylamine aza-Piancatelli rearrangement. Initial investigations with commercially 
available N-benzylhydroxylamine and O-benzylhydroxylamine disappointingly resulted in 







x5 mol % Dy(OTf)3MeCN, 80 °CO Ph
N26











Scheme 4.5. First attempts at a hydroxylamine aza-Piancatelli rearrangement. 
Speculating that the free hydroxyl group or amine might bind too strongly to dysprosium 
or compete as a nucleophile, we decided to evaluate N,O-disubstituted hydroxylamines. 
Importantly, these adducts can be accessed by simple condensation of the O-alkyl 
hydroxylamine with an aldehyde, followed by reduction with NaBH3CN affords the desired 
secondary amine nucleophile (Table 4.3).144,148–150 
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We were pleased to find that the reaction of phenyl furylcarbinol (1) and N-benzyl-O-
benzyl hydroxylamine (32) proceeded cleanly under the reaction conditions developed for 
the aza-Piancatelli rearrangement (5 mol % Dy(OTf)3, MeCN, 80 °C) to give trans-
substituted 4-hydroxyalmine-substituted cyclopentenone 38 in 87% yield (Scheme 4.6). A 
quick screen of reaction conditions revealed nitromethane (MeNO2) as a superior solvent, 










5 mol % Dy(OTf)3
solvent, 80 oC
MeCN    18  h      87% 







Scheme 4.6. Development of reaction conditions for the hydroxylamine aza-Piancatelli 
rearrangement. 
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[a] Isolated yields. [b] The reaction was performed with 10 mol % Dy(OTf)3. [c] Isolated as a 1:1 
mixture of trans diastereomers. [d] The reaction was performed with 30 mol % Dy(OTf)3. 
 
With the optimized reaction conditions in hand, we set out to develop the scope of the 
transformation. Gratifyingly, the rearrangement of furylcarbinols proceeded with a wide 
range of substituted hydroxylamines, as summarized in Table 4.4. A variety of alkyl 
substituents at the O-terminus were tolerated including benzyl, methyl, bulky t-butyl and 
allyl (Table 4.4, 38, 41, 42, 46, respectively).  
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The benzyl substituent at the N-terminus could be modified with electron donating or 
withdrawing groups with only a small effect on the yield of the reaction (Table 4.4, 44 and 
43). Cinnamaldehyde- and the bulky pivalaldehyde-derived hydroxylamines participated in 
the rearrangement to give the desired products 45 and 47 in good yield.  
Moving to an extended alkyl chain hydroxylamine, we found that an increase in catalyst 
loading to 10 mol % Dy(OTf)3 was required to generate the desired product at a sufficient 
rate (Table 4.4, 48). Pleasingly, a cyclic hydroxylamine and O-benzoyl hydroxylamine also 
participated in the rearrangement to give cyclopentenone 49 and 50 in acceptable 50% yield. 
Finally, we demonstrated that phenyl furylcarbinol with a pendent hydroxylamine readily 
rearranged in an intramolecular fashion to give spirocyclic 51 in 82% yield.  
To get a more complete picture of the hydroxylamine aza-Piancatelli rearrangement, we 
also explored the scope of furylcarbinols that will participate in the rearrangement, 
summarized in Table 4.5. Similar to the aza-Piancatelli rearrangement with anilines, the 
electron donating p-methoxy group increases the rate of the reaction (Table 4.5, 55), while 
an electron withdrawing p-nitrile group has the opposite effect on the rate of the reaction 
(Table 4.5, 54). Thiophene-substituted furylcarbinol rearranged cleanly to give 56 in 92% 
yield, again highlighting the difference between the ability of furan and thiophene to 
participate in dearomatizing reactions (vide supra). Privileged triisopropylphenyl 
furylcarbinol reacted with N-benzyl-O-benzyl hydroxylamine to give 57, and tertiary bis-
phenyl furylcarbinol reacted with N-benzyl-O-benzyl hydroxylamine or N-benzyl-O-
neopentyl hydroxylamine to give quaternary stereocenter-featuring 58 and 59, respectively 
(Table 4.5).140  
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[a] Isolated yields. [b] The reaction was performed with 10 mol % Dy(OTf)3.  
 
Exploring alkyl-substituted furylcarbinols proved to be more challenging with 
hydroxylamines (Table 4.5, 60-62). When reactions with these substrates were performed in 
MeCN, only decomposition was observed. Upon monitoring the reaction of isopropyl 
furylcarbinol with N-benzyl-O-benzyl hydroxylamine closely by TLC, we made two 
observations. For one, we observed the formation of a more non-polar species, 
corresponding to the substitution product, 64 (Scheme 4.7). It should be noted that 
substitution products were observed in almost all cases of the hydroxylamine aza-Piancatelli 
rearrangement, in contrast to the aniline reaction where they were only observable in certain 
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cases. The formation of the substitution product in mechanistically interesting but it does not 
affect the overall outcome of the reaction because it is an intermediate that can re-enter the 
catalytic cycle (Figure 4.3, 66 to 65). In addition to the formation of substitution product 64, 
the appearance of compound with the expected Rf of cyclopentenone 61 was observed, but 
this species quickly disappeared, and no desired product was isolated from the reaction. It 
was gratifying to find that when switching to MeNO2, 61 could be isolated in 50% yield 
when using 10 mol % Dy(OTf)3. Using these conditions, 5-alkyl substituted 







10 mol % Dy(OTf)3
















































Figure 4.3. Proposed mechanism showing the off-cycle substitution event in the 
hydroxylamine aza-Piancatelli rearrangement. 
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With the scope of the hydroxylamine aza-Piancatelli rearrangement fully developed, we 
were ready to explore the potential of these densely functionalized small molecules and the 
possibility of accessing alkylamines via N–O bond cleavage. 
4.4. Functionalization of Hydroxylamine-Substituted Cyclopentenones 
Close examination of the 4-aminocyclopentenones produced in the hydroxylamine aza-
Piancatelli rearrangement reveals the potential for structural modification at several points of 
the molecule (Figure 4.4). To rationally highlight this potential we investigated a range of 







Figure 4.4. Points of functionalization around the 4-aminocyclopentenone core. 
A Luche reduction of the enone facilitated access to the 1,2-trans-2,3-trans substituted 
cyclopentene core, reminiscent of our previously synthesized hNK1 inhibitor. Standard 
Luche reduction with cerium chloride at 0 °C resulted in 2.5:1 diastereomeric ratio (dr) of 
allylic alcohol 71:72, similar to our previous results (Scheme 4.8, conditions A). 
Interestingly, a simple switch to ytterbium chloride hexahydrate (YbCl3•6H2O) and lowering 
the reaction temperature to –78 °C resulted in up to 20:1 dr (Scheme 4.8, conditions B). This 
represents a huge improvement in selectivity, and I am confident that this improvement 
would apply to the hNK1 inhibitor synthesis. The stereochemistry of the major product (71) 
was confirmed to possess a 1,2-trans-2,3-trans relationship by single crystal X-Ray 
diffraction (Figure 4.5).  

















A: NaBH4, CeCl3•7H2O          
     MeOH, 0 °C
B:  NaBH4, YbCl3•6H2O
     MeOH/THF (8:1), -78 °C
A: 88%, 2.5:1 dr
B: 78%,  20:1 dr  
Scheme 4.8. Results of Luche-type reductions of the cyclopentenone. 
 
Figure 4.5. ORTEP drawing of the crystal structure of the major diastereomer of the Luche 
reduction with 50% thermal ellipsoids. CCDC 986010. 
 
Continuing modification of the ketone, we explored 1,2-addition at this position. 
Addition of n-butyllithium was unsuccessful, and Grignard reaction was not selective for the 
desired 1,2-addition. However, addition of methylmagnesium bromide using Knochel’s 
conditions provided 73 in 80% yield and 15:1 dr (Scheme 4.9).151 With this tertiary allylic 
alcohol in hand, we were excited to attempt an allylic transposition. To our delight, 
treatment with pyridinium chlorochromate (PCC) resulted in clean formation of 74 (Scheme 
4.9).152 This is an exciting prospect since the aza-Piancatelli coupled with this allylic 
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aminocyclopentenones (74). Additionally, the trans-relationship established during the 4π 























Scheme 4.9. Selective 1,2-Grignard addition followed by allylic transposition. 
Finally, as mentioned above, we were enthusiastic about the prospect of the 
hydroxylamine aza-Piancatelli rearrangement because cleavage of the weak N–O bond 
generates access to valuable alkylamines. Unfortunately, despite ample literature precedent 
for the cleavage of N–O bonds, this step proved much more difficult than anticipated. 
Treatment of cyclopentenone 38 with hydrogenation over palladium on carbon resulted in 
reduction of the alkene, providing cyclopentanone 75 in quantitative yield, but no N–O bond 
cleavage (Scheme 4.10). No reaction or decomposition was observed when using SmI2,144 













Scheme 4.10. Hydrogenation of a hydroxylamine cyclopentenone. 
Speculating that the acidic proton alpha to the carbonyl might be the source of our 
difficulties, we examined 58 and 59 with quaternary stereocenters. Gratifyingly, 
hydrogenation of these substrates proceeded cleanly to give primary amine 78 or secondary 
alkyl amine 77 in quantitative yield (Scheme 4.11).145  



























Scheme 4.11. Successful N–O bond cleavage of diphenyl-substituted cyclopentenones. 
With the knowledge that the N–O bond could in fact be clipped, and that the acidic alpha 
proton might be the source of our difficulties, we chose to examine bond cleavage from the 
allylic alcohol. Our speculations proved valid, and we found that treatment of a variety of 
allylic alcohols with Zn/HCl resulted in formation of the desired alkyl amines (Table 4.6). 
The reaction proceeded with either the major 1,2-trans or 1,2-cis isomer (71 or 72), and the 
nature of the R group can be either aryl (81) or alkyl (84). We were most excited about the 
result with aza-spirocyclic substrate 85, since this may enable entry to the total synthesis of 
homoharringtonine (87) and stemonamine (88) from the same spirocyclic precursor (86) 
(Figure 4.6).  








































[a] Isolated yields. [b] The starting material came from an 8:1 mixture of diastereomers. 
 























Figure 4.6. Potential intermediate for the synthesis of homoharringtonine and stemonamine. 
Finally, we were happy to find that pyridinium dichromate (PDC) in CH2Cl2 enabled the 
oxidation of 81 to the desired cyclopentenone 89 in 60% yield (Scheme 4.12). It should be 
noted that in this case, 10% of the rearranged cyclopentenone 90 was also isolated. The 
desired product may also rearrange upon extended time on the benchtop at rt, or if the 






















Scheme 4.12. Oxidation to the desired aminocyclopentenone. 
4.5. Summary  
In conclusion, we developed a new method to access hydroxylamine-substituted 
cyclopentenones in a single step from furfural derived precursors. We showed that this 
scaffold could further be manipulated with a variety of transformations. Most importantly, 
we were able to cleave the N–O bond to access alkylamines. Even though this 
transformation adds several steps to the synthesis, it marks great progress from the aniline 
aza-Piancatelli rearrangement. These studies are helping us to truly understand the 
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transformation from a synthetic standpoint, but a deeper mechanistic and fundamental 
understanding is still needed.  
4.6. Experimental Procedures 
Materials and Methods.  Unless stated otherwise, reactions were conducted in flame-
dried glassware under an atmosphere of air using reagent grade solvents. All commercially 
obtained reagents were used as received. Reaction temperatures were controlled using an 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates, (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with anisaldehyde and potassium permanganate. 
Flash column chromatography was performed using normal phase silica gel (60 Å, 0.040 – 
0.063 mm, Geduran). 1H NMR spectra were recorded on Varian spectrometers (at 500 or 
600 MHz) and are reported relative to deuterated solvent signals. Data for 1H NMR spectra 
are reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) and 
integration. 13C NMR spectra were recorded on Varian Spectrometers (125 or 150 MHz). 
Data for 13C NMR spectra are reported in terms of chemical shift (δ ppm), multiplicity, 
coupling constant (Hz). IR spectra were recorded on a Perkin Elmer Spectrum 100 FT/IR 
spectrometer and are reported in terms of frequency of absorption (cm-1). Mass spectra were 
obtained from the UC Santa Barbara Mass Spectrometry Facility on a (Waters Corp.) 
Micromass QTOF2 with an electrospray ionization source. X-ray data were obtained from 
the UC Santa Barbara X-ray Facility.  
 
Reactions with a privileged furylcarbinol 






Furan-2-yl(2,4,6-triisopropylphenyl)methyl acetate (10): Brown solid; 1H NMR (600 
MHz, CDCl3) δ 7.55 (s, 1H), 7.39 (dd, J = 1.0, 1.1 Hz, 1H), 7.05 (s, 2H), 6.29 (dd, J = 3.3, 
1.8 Hz, 1H), 5.98 (ddd, J = 3.3, 1.1, 1.1 Hz, 1H), 3.39 (dt, J = 6.8, 6.8 Hz, 2H), 2.89 (dt, J = 
7.0, 7.0 Hz, 1H), 2.13 (s, 3H), 1.26 (dd, J = 7.0, 1.4 Hz, 6H), 1.24 – 1.17 (m, 6H), 1.15 (d, J 









20 mol % Dy(OTf)3












4-Morpholino-5-(2,4,6-triisopropylphenyl)cyclopent-2-en-1-one (11): Brown oil; 1H 
NMR (600 MHz, CDCl3) δ 7.71 (dd, J = 6.0, 1.8 Hz, 1H), 6.99 (d, J = 1.9 Hz, 1H), 6.95 (d, 
J = 1.9 Hz, 1H), 6.45 (dd, J = 6.0, 1.8 Hz, 1H), 4.01 (d, J = 3.4 Hz, 1H), 3.98 (dd, J = 3.6, 
1.8 Hz, 1H), 3.69 (dd, J = 4.6, 4.6 Hz, 4H), 3.21 (hept, J = 6.7 Hz, 1H), 2.86 (hept, J = 6.8 
Hz, 1H), 2.69 (ddd, J = 11.3, 4.6, 4.6 Hz, 2H), 2.54 (ddd, J = 11.4, 4.6, 4.6 Hz, 2H), 2.09 – 
1.99 (m, 1H), 1.36 (d, J = 6.7 Hz, 3H), 1.24 (d, J = 7.0 Hz, 6H), 1.22 (d, J = 6.8 Hz, 3H), 

















20 mol % Dy(OTf)3
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4-(Benzyl(methyl)amino)-5-(2,4,6-triisopropylphenyl)cyclopent-2-en-1-one (15): 
Brown oil; 1H NMR (600 MHz, CDCl3) δ 7.71 (dd, J = 6.0, 1.8 Hz, 1H), 6.99 (d, J = 1.9 
Hz, 1H), 6.95 (d, J = 1.9 Hz, 1H), 6.45 (dd, J = 6.0, 1.8 Hz, 1H), 4.01 (d, J = 3.4 Hz, 1H), 
3.98 (dd, J = 3.6, 1.8 Hz, 1H), 3.69 (dd, J = 4.6, 4.6 Hz, 4H), 3.21 (dt, J = 6.9, 6.9 Hz, 1H), 
2.86 (dt, J = 6.9, 6.8 Hz, 1H), 2.69 (ddd, J = 11.4, 4.6, 4.6 Hz, 2H), 2.54 (ddd, J = 11.3, 4.6, 
4.6 Hz, 2H), 2.08 – 1.98 (m, 1H), 1.36 (d, J = 6.7 Hz, 3H), 1.24 (d, J = 6.9 Hz, 6H), 1.22 (d, 










5 mol % Dy(OTf)3
1 equiv K2CO3






4-(Methoxy(methyl)amino)-5-phenylcyclopent-2-en-1-one (18): Brown oil; 1H NMR 
(500 MHz, CDCl3) δ 7.80 (dd, J = 5.8, 2.3 Hz, 1H), 7.35 – 7.29 (m, 2H), 7.28 – 7.23 (m, 
1H), 7.16 – 7.11 (m, 2H), 6.40 (dd, J = 5.9, 1.8 Hz, 1H), 4.10 (dd, J = 2.3, 2.3 Hz, 1H), 3.64 
(s, 1H), 3.51 (s, 3H), 2.63 (s, 3H) ppm. 
 
General Procedure for the Synthesis of Hydroxylamines: Hydroxylamines were 






N,O-Dibenzylhydroxylamine (32): Colorless oil; 1H NMR (500 MHz, CDCl3) δ 7.38 – 
7.27 (m, 10H), 5.74 (s, 1H), 4.67 (s, 2H), 4.07 (s, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 
138.0, 137.7, 129.1, 128.6, 128.5, 128.5, 127.9, 127.6, 76.5, 56.7 ppm; IR (thin film) 3260, 
3087, 3019, 2912, 2858, 1895, 1877, 1810, 1604, 1495, 1453, 1275, 1260, 988 cm-1; MS 
(ESI) m/z 214.1219 (214.1232 calcd for C14H16NO+ [MH]+). 











N-Benzyl-O-methylhydroxylamine (33): Colorless oil; 1H NMR (600 MHz, CDCl3) δ 
7.38 – 7.32 (m, 4H), 7.31 – 7.27 (m, 1H), 5.73 (s, 1H), 4.06 (s, 2H), 3.52 (s, 3H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 137.7, 129.0, 128.6, 127.6, 62.0, 56.4 ppm; IR (thin film) 3259, 
3030, 2937, 2894, 2808, 1604, 1454, 1275, 1260, 992 cm-1; MS (ESI) m/z 160.0737 





N-Benzyl-O-(tert-butyl)hydroxylamine (92): Colorless oil. 1H NMR (500 MHz, 
CDCl3) δ 7.41 – 7.27 (m, 5H), 4.00 (s, 2H), 1.18 (s, 9H) ppm; 13C NMR (150 MHz, CDCl3) 
δ 129.4, 128.5, 127.6, 57.8, 26.9 ppm; IR (thin film) 3255, 2975, 2929, 2863, 1947, 1876, 








Methyl 4-(((benzyloxy)amino)methyl)benzoate (93): Colorless oil. 1H NMR (600 
MHz, CDCl3) δ 8.01 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 8.0 Hz, 2H), 7.38 – 7.27 (m, 5H), 4.63 
(s, 2H), 4.09 (s, 2H), 3.92 (s, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 167.1, 143.3, 137.8, 
129.8, 129.4, 128.9, 128.6, 128.5, 128.0, 76.6, 56.3, 52.2 ppm; IR (thin film) 3267, 3031, 
2951, 1937, 1721, 1612 cm-1; MS (ESI) m/z 294.1096 (294.1106 calcd for C16H17NNaO3+ 
[MNa]+). 







O-Benzyl-N-(4-methoxybenzyl)hydroxylamine (94): Colorless oil. 1H NMR (600 
MHz, CDCl3) δ 7.37 (d, J = 3.0 Hz, 4H), 7.35 – 7.32 (m, 1H), 7.30 (d, J = 8.5 Hz, 2H), 6.91 
(d, J = 8.6 Hz, 2H), 5.68 (bs, 1H) 4.70 (s, 2H), 4.03 (s, 2H), 3.83 (s, 3H) ppm; 13C NMR 
(150 MHz, CDCl3) δ 159.1, 138.0, 130.3, 129.7, 128.5, 128.4, 127.8, 113.9, 76.3, 56.0, 55.3 
ppm; IR (thin film) 3261, 3031, 2910, 2859, 2060, 1883, 1612, 1513 cm-1; MS (ESI) m/z 







O-Benzyl-N-cinnamylhydroxylamine (37): Colorless oil; 1H NMR (600 MHz, CDCl3) 
δ 7.41 – 7.29 (m, 9H), 7.27 – 7.21 (m, 1H), 6.58 (d, J = 16.0 Hz, 1H), 6.30 (dt, J = 15.9, 6.6 
Hz, 1H), 5.61 (s, 1H), 4.76 (s, 2H), 3.72 (dd, J = 6.6, 1.3 Hz, 2H) ppm; 13C NMR (125 
MHz, CDCl3) δ 138.0, 137.1, 133.3, 128.7, 128.6, 128.5, 128.0, 127.7, 126.5, 125.7, 76.5, 
54.6 ppm; IR (thin film) 3258, 3061, 3028, 2910, 2853, 1877, 1598, 1494, 1453, 1361, 






O-Allyl-N-benzylhydroxylamine (35): Colorless oil; 1H NMR (500 MHz, CDCl3) δ 
7.40 – 7.30 (m, 4H), 7.32 – 7.25 (m, 1H), 5.91 (ddt, J = 17.3, 10.4, 5.9 Hz, 1H), 5.72 (s, 1H), 
5.26 (ddt, J = 17.3, 1.6, 1.6 Hz, 1H), 5.18 (ddt, J = 10.4, 2.0, 1.2 Hz, 1H), 4.17 (ddd, J = 6.0, 
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1.3, 1.3 Hz, 2H), 4.07 (s, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 137.6, 134.6, 129.1, 
128.5, 127.6, 117.7, 75.2, 56.7 ppm; IR (thin film) 3254, 3065, 3030, 2907, 2858, 1807, 






O-Benzyl-N-neopentylhydroxylamine (34): Colorless oil; 1H NMR (600 MHz, CDCl3) 
δ 7.38 – 7.33 (m, 4H), 7.32 – 7.28 (m, 1H), 5.60 (s, 1H), 4.70 (s, 2H), 2.75 (s, 2H), 0.93 (s, 
9H) ppm; 13C NMR (125 MHz, CDCl3) δ 138.1, 128.6, 128.4, 127.8, 75.9, 63.6, 31.1, 28.3 
ppm; IR (thin film) 3276, 3031, 2953, 2906, 2865, 1476, 1454, 1363, 1275, 1259, 978 cm-1; 







O-Benzyl-N-pentylhydroxylamine (36): Colorless oil; 1H NMR (600 MHz, CDCl3) δ 
7.39 – 7.33 (m, 4H), 7.32 – 7.27 (m, 1H), 5.54 (s, 1H), 4.71 (s, 2H), 2.93 (dd, J = 7.3, 7.3 
Hz, 2H), 1.52 (dddd, J = 7.4, 7.4, 7.4, 7.4 Hz, 2H), 1.36 – 1.25 (m, 4H), 0.90 (dd, J = 6.8, 
6.8 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 138.2, 128.5, 128.5, 127.9, 76.3, 52.4, 
29.5, 27.2, 22.7, 14.2 ppm; IR (thin film) 3265, 3031, 2955, 2930, 1857, 1454, 1362, 1275, 
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Ethyl (trans)-5-phenylisoxazolidine-4-carboxylate (95): Prepared according to 
literature procedure.153 Colorless oil. 1H NMR (600 MHz, Chloroform-d) δ 7.39 – 7.32 (m, 
4H), 7.32 – 7.28 (m, 1H), 5.72 (s, 1H), 5.08 (d, J = 5.7 Hz, 1H), 4.27 – 4.12 (m, 2H), 3.57 
(dd, J = 11.8, 3.3 Hz, 1H), 3.47 (dd, J = 11.8, 8.4 Hz, 1H), 3.35 – 3.20 (m, 1H), 1.27 (t, J = 
7.2 Hz, 3H) ppm; 13C NMR (151 MHz, Chloroform-d) δ 173.2, 139.2, 128.7, 128.3, 126.2, 
86.8, 61.4, 56.6, 53.7, 14.2 ppm; IR (thin film) 3229, 3065, 3034, 2983, 2942, 2906, 1886, 









O-Benzoyl-N-propylhydroxylamine (96): Colorless oil. 1H NMR (600 MHz, CDCl3) δ 
8.03 (dd, J = 8.5, 1.4 Hz, 2H), 7.58 (t, J = 7.5 Hz, 1H), 7.46 (t, J = 7.8 Hz, 2H), 3.12 (t, J = 
7.1 Hz, 2H), 1.66 (h, J = 7.4 Hz, 2H), 1.01 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (150 MHz, 
CDCl3) δ 167.1, 133.4, 129.5, 128.7, 128.6, 54.5, 20.7, 11.7 ppm; IR (thin film) 3239, 2963, 
2936, 2876, 1765, 1716 cm-1; MS (ESI) m/z 180.0997 (180.1019 calcd for C10H14NO2+ 
[MH]+). 
 
General Procedure for the Synthesis of Furylcarbinols: Furylcarbinols were prepared 








(5-(3-((Benzyloxy)amino)propyl)furan-2-yl)(phenyl)methanol (97): Light yellow oil; 
1H NMR (500 MHz, CDCl3) δ 7.47 – 7.42 (m, 2H), 7.39 – 7.28 (m, 8H), 5.94 (d, J = 3.1 Hz, 
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1H), 5.90 (d, J = 3.1 Hz, 1H), 5.76 (s, 1H), 4.70 (s, 2H), 2.95 (t, J = 7.0 Hz, 2H), 2.65 (t, J = 
7.5 Hz, 2H), 1.85 (tt J = 7.3, 7.3 Hz, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 156.0, 154.5, 
141.1, 138.0, 128.5, 128.5, 128.5, 128.0, 127.9, 126.7, 108.4, 105.8, 76.4, 70.2, 51.5, 25.8 
ppm; IR (thin film) 3382, 3087, 3062, 3030, 2910, 2858, 1955, 1885, 1453, 1190, 1010, 961 







4-(Furan-2-yl(hydroxy)methyl)benzonitrile (98): Yellow solid; 1H NMR (500 MHz, 
CDCl3) δ 7.69 – 7.63 (m, 2H), 7.59 – 7.54 (m, 2H), 7.42 – 7.38 (m, 1H), 6.36 – 6.31 (m, 
1H), 6.15 (d, J = 3.3 Hz, 1H), 5.88 (s, 1H), 2.69 (s, 1H) ppm; 13C NMR (150 MHz, CDCl3) 
δ 154.7, 146.0, 143.2, 132.4, 127.3, 118.8, 111.8, 110.6, 108.1, 69.4 ppm; IR (thin film) 
3418, 3122, 2879, 2228, 1927, 1808, 1609, 1504, 1410, 1141, 1009 cm-1; MS (EI+) m/z 






Furan-2-yl(thiophen-2-yl)methanol (99): Yellow oil. 1H NMR (600 MHz, CDCl3) δ 
7.69 (d, J = 3.3 Hz, 1H), 7.38 (dd, J = 1.5, 0.7 Hz, 1H), 7.32 (d, J = 3.2 Hz, 1H), 6.35 – 6.30 
(m, 2H), 6.08 (s, 1H), 4.79 (s, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 171.7, 153.3, 143.1, 
142.3, 119.9, 110.6, 108.4, 67.6 ppm; IR (thin film) 3119, 2852, 1766, 1621, 1503, 1432 
cm-1; MS (EI) m/z 180.0247 (180.0245 calcd for C9H8O2S+ [M]+). 
 






Furan-2-yl(2,4,6-triisopropylphenyl)methanol (100): Brown solid; 1H NMR (500 
MHz, CDCl3) δ 7.39 (ddd, J = 1.8, 0.8, 0.8 Hz, 1H), 7.05 (s, 2H), 6.41 (d, J = 2.9 Hz, 1H), 
6.31 (dd, J = 3.3, 1.8 Hz, 1H), 6.00 (ddd, J = 3.3, 1.1, 1.1 Hz, 1H), 3.35 (hept, J = 6.8 Hz, 
2H), 2.89 (hept, J = 6.9 Hz, 1H), 2.32 (d, J = 3.5 Hz, 1H), 1.26 (d, J = 6.9 Hz, 6H), 1.20 (d, 
J = 6.8 Hz, 6H), 1.15 (d, J = 6.8 Hz, 6H) ppm; 13C NMR (150 MHz, CDCl3) δ 156.4, 148.8, 
142.0, 131.7, 122.2, 110.5, 106.6, 65.8, 34.3, 29.8, 25.1, 24.1, 24.1 ppm; IR (thin film) 3408, 
2959, 2928, 2868, 1768, 1607, 1460, 1362, 1142, 1004 cm-1; MS (EI+) m/z 300.2096 







Furan-2-yldiphenylmethanol (101): Yellow oil. 1H NMR (600 MHz, CDCl3) δ 7.46 (s, 
1H), 7.40 – 7.27 (m, 10H), 6.34 (d, J = 1.5 Hz, 1H), 5.94 (d, J = 3.2 Hz, 1H), 3.11 (s, 1H) 
ppm; 13C NMR (150 MHz, CDCl3) δ 158.0, 144.7, 142.8, 128.1, 127.8, 127.3, 110.2, 109.8, 
78.1 ppm; IR (thin film) 3410, 3061, 3028, 1957, 1888, 1813, 1725, 1675, 1598, 1554, 







1-(Furan-2-yl)pentan-1-ol (102): Colorless oil; 1H NMR (500 MHz, CDCl3) δ 7.37 (m, 
1H), 6.32 (dd, J = 3.3, 1.8 Hz, 1H), 6.22 (d, J = 3.2 Hz, 1H), 4.66 (td, J = 6.7, 3.8 Hz, 1H), 
1.91 (s, 1H), 1.88 – 1.80 (m, 2H), 1.47 – 1.23 (m, 4H), 0.90 (t, J = 7.1 Hz, 3H) ppm; 13C 
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NMR (125 MHz, CDCl3) δ 157.1, 142.0, 110.2, 105.9, 68.0, 35.4, 27.8, 22.6, 14.1 ppm; IR 
(thin film) 3360, 2956, 2932, 2861, 1597, 1505, 1466, 1149, 1007 cm-1; MS (EI+) m/z 
154.0998 (154.0994 calcd for C9H14O2+ [M]+). 
 
















4-(Benzyl(benzyloxy)amino)-5-phenylcyclopent-2-en-1-one (38): According to the 
general procedure, furan-2-yl(phenyl)methanol (38.2 mg, 0.220 mmol) and N,O-
dibenzylhydroxylamine (32) (46.8 mg, 0.220 mmol) were treated with Dy(OTf)3 (6.7 mg, 
0.011 mmol) in MeNO2 (2.2 mL). The resulting reaction mixture was heated to 80 ºC for 30 
min. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) and 
extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 38 (71.6 mg, 88%) as a light orange/yellow solid. 
1H NMR (600 MHz, CDCl3) δ 7.61 (s, 1H), 7.36 – 7.20 (m, 9H), 7.15 – 7.04 (m, 6H), 6.33 
(dd, J = 5.8, 1.9 Hz, 1H), 4.43 (d, J = 11.9 Hz, 1H), 4.41 (d, J = 10.2 Hz, 1H), 4.24 (ddd, J = 
2.3, 2.3, 2.3 Hz, 1H), 4.01 (d, J = 12.6 Hz, 1H), 3.93 (s, 1H), 3.80 (d, J = 12.6 Hz, 1H) ppm; 
13C NMR (125 MHz, CDCl3) δ 207.1, 162.4, 139.0, 136.7, 136.6, 134.9, 129.9, 129.2, 
129.1, 128.5, 128.4, 128.3, 128.3, 127.7, 127.2, 76.9, 73.9, 61.3, 52.7 ppm; IR (thin film) 
3063, 3031, 2919, 1709, 1595, 1454, 1265, 1029, 975 cm-1; MS (ESI) m/z 392.1636 
(392.1626 calcd for C25H23NNaO2+ [MNa]+). 
























4-(Benzyl(methoxy)amino)-5-phenylcyclopent-2-en-1-one (41): According to the 
general procedure, furan-2-yl(phenyl)methanol (30.0 mg, 0.172 mmol) and N-benzyl-O-
methylhydroxylamine (33) (23.6 mg, 0.172 mmol) were treated with Dy(OTf)3 (5.2 mg, 
0.0086 mmol) in MeNO2 (1.8 mL). The resulting reaction mixture was heated to 80 ºC for 
30 min. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) 
and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 41 (46.2 mg, 91%) as an orange/brown solid. 1H 
NMR (600 MHz, CDCl3) δ 7.76 (dd, J = 5.7, 2.3 Hz, 1H), 7.33 (dd, J = 7.4, 7.4 Hz, 2H), 
7.29 – 7.24 (m, 1H), 7.23 – 7.21 (m, 3H), 7.12 (d, J = 7.2 Hz, 2H), 7.08 (s, 2H), 6.36 (dd, J 
= 5.7, 1.9 Hz, 1H), 4.21 (ddd, J = 2.3, 2.3, 2.3 Hz, 1H), 3.99 (d, J = 12.7 Hz, 1H), 3.87 (s, 
1H), 3.74 (d, J = 12.7 Hz, 1H), 3.32 (s, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 207.1, 
162.1, 138.9, 136.7, 135.0, 129.7, 129.1, 128.5, 128.3, 127.6, 127.2, 73.9, 62.4, 60.9, 52.9 
ppm; IR (thin film) 3062, 3030, 2934, 2812, 1709, 1595, 1454, 1266, 1040, 978 cm-1; MS 

















4-(Benzyl(tert-butoxy)amino)-5-phenylcyclopent-2-en-1-one (42): According to the 
general procedure, furan-2-yl(phenyl)methanol (31.7 mg, 0.182 mmol) and N-benzyl-O-
(tert-butyl)hydroxylamine (92) (32.7 mg, 0.182 mmol) were treated with Dy(OTf)3 (5.54 
mg, 0.0091 mmol) in MeNO2 (1.8 mL). The resulting reaction mixture was heated to 80 ºC 
  129 
for 1 h. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) 
and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 42 (46.2 mg, 76%) as a colorless oil. 1H NMR 
(600 MHz, CDCl3) δ 7.68 – 7.63 (m, 1H), 7.35 – 7.25 (m, 3H), 7.19 – 7.03 (m, 5H), 6.79 (d, 
J = 7.5 Hz, 2H), 6.28 (d, J = 3.6 Hz, 1H), 4.19 – 4.08 (m, 3H), 3.80 (d, J = 12.7 Hz, 1H), 
1.22 (s, 9H) ppm; 13C NMR (150 MHz, CDCl3) δ 207.9, 164.9, 140.0, 136.9, 134.1, 129.4, 
129.1, 128.7, 128.3, 127.5, 127.1, 78.0, 72.0, 62.8, 51.1, 28.1 ppm; IR (thin film) 3062, 





















(43): According to the general procedure, furan-2-yl(phenyl)methanol (28.8 mg, 0.166 
mmol) and methyl 4-(((benzyloxy)amino)methyl)benzoate (93) (44.9 mg, 0.166 mmol) were 
treated with Dy(OTf)3 (5.1 mg, 0.0084 mmol) in MeNO2 (1.6 mL). The resulting reaction 
mixture was heated to 80 ºC for 1 h. The reaction was then quenched at 23 ºC with saturated 
aqueous NaHCO3 (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by flash column chromatography to afford cyclopentenone 43 (57.4 mg, 82%) 
as a white solid. 1H NMR (600 MHz, CDCl3) δ 7.92 (d, J = 7.8 Hz, 2H), 7.62 (s, 1H), 7.33 
(t, J = 7.3 Hz, 2H), 7.31 – 7.27 (m, 4H), 7.18 – 7.13 (m, 2H), 7.13 – 7.08 (m, 4H), 6.35 (dd, 
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J = 5.8, 1.9 Hz, 1H), 4.47 – 4.37 (m, 2H), 4.24 (d, J = 2.3 Hz, 1H), 4.04 (d, J = 12.8 Hz, 
1H), 3.94 (s, 1H), 3.91 (s, 3H), 3.84 (d, J = 12.8 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) 
δ 206.8, 167.0, 162.0, 141.9, 138.8, 136.5, 135.1, 129.8, 129.6, 129.6, 129.2, 129.2, 128.5, 
128.5, 128.4, 127.3, 77.0, 74.1, 61.0, 52.7, 52.2 ppm; IR (thin film) 3084, 3031, 2950, 2910, 






















According to the general procedure, furan-2-yl(phenyl)methanol (19.7 mg, 0.113 mmol) and 
O-benzyl-N-(4-methoxybenzyl)hydroxylamine (94) (27.6 mg, 0.113 mmol) were treated 
with Dy(OTf)3 (3.4 mg, 0.0057 mmol) in MeNO2 (1.1 mL). The resulting reaction mixture 
was heated to 80 ºC for 2h. The reaction was then quenched at 23 ºC with saturated aqueous 
NaHCO3 (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified 
by flash column chromatography to afford cyclopentenone 44 (34.4 mg, 76%) as a white 
solid. 1H NMR (600 MHz, CDCl3) δ 7.59 (s, 1H), 7.36 – 7.26 (m, 6H), 7.20 – 7.14 (m, 2H), 
7.11 (d, J = 7.5 Hz, 2H), 6.95 (s, 2H), 6.76 (d, J = 8.1 Hz, 2H), 6.33 (dd, J = 5.8, 2.1 Hz, 
1H), 4.44 (s, 2H), 4.24 (d, J = 2.5 Hz, 1H), 3.96 (d, J = 12.5 Hz, 1H), 3.94 (s, 1H), 3.78 (s, 
3H), 3.74 (d, J = 12.6 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 207.2, 162.6, 159.2, 
139.1, 136.8, 134.9, 131.1, 129.3, 129.1, 128.7, 128.6, 128.4, 128.3, 127.2, 113.7, 76.8, 
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73.6, 60.6, 55.4, 52.8 ppm; IR (thin film)  3030, 2930, 2837, 1884, 1712, 1611, 1513 cm-1; 
MS (ESI) m/z 422.1716 (422.1732 calcd for C26H25NNaO3+ [MNa]+). 
 
+













4-((Benzyloxy)(cinnamyl)amino)-5-phenylcyclopent-2-en-1-one (45): According to 
the general procedure, furan-2-yl(phenyl)methanol (15.0 mg, 0.086 mmol) and O-benzyl-N-
cinnamylhydroxylamine (37) (20.6 mg, 0.086 mmol) were treated with Dy(OTf)3 (5.2 mg, 
0.0086 mmol) in MeNO2 (1.8 mL). The resulting reaction mixture was heated to 80 ºC for 
1.5 h. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) and 
extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 45 (29.3 mg, 86%) as a light orange oil. 1H NMR 
(600 MHz, CDCl3) δ 7.63 (s, 1H), 7.35 – 7.19 (m, 11H), 7.16 (d, J = 7.4 Hz, 2H), 7.11 (d, J 
= 7.2 Hz, 2H), 6.33 (dd, J = 5.8, 2.0 Hz, 1H), 6.12 (ddd, J = 14.7, 6.6, 6.6 Hz, 1H), 5.90 (d, J 
= 15.9 Hz, 1H), 4.69 (d, J = 10.7 Hz, 1H), 4.63 (d, J = 10.8 Hz, 1H), 4.37 (s, 1H), 3.87 (s, 
1H), 3.69 (dd, J = 12.8, 6.1 Hz, 1H), 3.48 (dd, J = 13.0, 8.1 Hz, 1H) ppm; 13C NMR (125 
MHz, CDCl3) δ 207.1, 162.5, 139.0, 136.8, 136.7, 134.9, 134.9, 129.2, 129.1, 128.6, 128.6, 
128.5, 128.3, 127.9, 127.2, 126.5, 123.9, 76.8, 73.6, 59.3, 52.4 ppm; IR (thin film) 3061, 
3029, 2822, 2854, 1950, 1709, 1495, 1453, 1165, 1028, 968 cm-1; MS (ESI) m/z 418.1766 
(418.1783 calcd for  C27H25NNaO2+ [MNa]+). 
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4-((Allyloxy)(benzyl)amino)-5-phenylcyclopent-2-en-1-one (46): According to the 
general procedure, furan-2-yl(phenyl)methanol (100.0 mg, 0.57 mmol) and O-allyl-N-
benzylhydroxylamine (35) (93.8 mg, 0.57 mmol) were treated with Dy(OTf)3 (17.5 mg, 
0.029 mmol) in MeNO2 (5.7 mL). The resulting reaction mixture was heated to 80 ºC for 45 
min. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (10 mL) and 
extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 46 (173.5 mg, 95%) as an orange oil. 1H NMR 
(600 MHz, CDCl3) δ 7.75 (dd, J = 6.0, 2.5 Hz, 1H), 7.33 (t, J = 7.4 Hz, 2H), 7.29 – 7.24 (m, 
1H), 7.23 – 7.18 (m, 3H), 7.12 (d, J = 7.3 Hz, 2H), 7.07 (s, 2H), 6.36 (dd, J = 5.8, 2.0 Hz, 
1H), 5.70 (dddd, J = 16.8, 10.3, 6.2, 6.2 Hz, 1H), 5.15 – 5.07 (m, 2H), 4.25 – 4.19 (m, 1H), 
4.02 (d, J = 12.7 Hz, 1H), 4.00 – 3.89 (m, 3H), 3.78 (d, J = 12.7 Hz, 1H) ppm; 13C NMR 
(150 MHz, CDCl3) δ 207.1, 162.3, 138.9, 136.6, 135.0, 133.5, 129.8, 129.1, 128.5, 128.3, 
127.6, 127.2, 118.3, 75.9, 73.8, 61.4, 52.8 ppm; IR (thin film) 3063, 3029, 2916, 2858, 
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4-((Benzyloxy)(neopentyl)amino)-5-phenylcyclopent-2-en-1-one (47): According to 
the general procedure, furan-2-yl(phenyl)methanol (30.0 mg, 0.172 mmol) and O-benzyl-N-
neopentylhydroxylamine (34) (33.3 mg, 0.172 mmol) were treated with Dy(OTf)3 (5.2 mg, 
0.0085 mmol) in MeNO2 (1.8 mL). The resulting reaction mixture was heated to 80 ºC for 
45 min. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) 
and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 47 (52.6 mg, 81%) as an orange oil. 1H NMR 
(500 MHz, CDCl3) δ 7.80 (dd, J = 5.8, 2.3 Hz, 1H), 7.35 – 7.30 (m, 2H), 7.30 – 7.22 (m, 
4H), 7.17 – 7.09 (m, 4H), 6.40 (dd, J = 5.8, 1.9 Hz, 1H), 4.70 (d, J = 10.5 Hz, 1H), 4.62 (d, J 
= 10.5 Hz, 1H), 4.38 (ddd, J = 2.3, 2.3, 2.3 Hz, 1H), 3.72 (d, J = 2.8 Hz, 1H), 2.65 (d, J = 
14.1 Hz, 1H), 2.58 (d, J = 14.1 Hz, 1H), 0.94 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3) δ 
207.3, 162.2, 139.2, 136.6, 135.4, 129.0, 128.7, 128.5, 128.3, 128.1, 127.1, 76.5, 75.1, 67.8, 
53.5, 31.7, 28.5 ppm; IR (thin film)  3063, 3030, 2952, 2866, 1711, 1601, 1453, 1362, 1026, 
981 cm-1; MS (ESI) m/z 372.1932 (372.1939 calcd for C23H27NNaO2+ [MNa]+). 
 
+













4-((Benzyloxy)(pentyl)amino)-5-phenylcyclopent-2-en-1-one (48): According to the 
general procedure, furan-2-yl(phenyl)methanol (15.0 mg, 0.086 mmol) and O-benzyl-N-
pentylhydroxylamine (36) (16.7 mg, 0.086 mmol) were treated with Dy(OTf)3 (5.2 mg, 
0.0086 mmol) in MeNO2 (0.9 mL). The resulting reaction mixture was heated to 80 ºC for 1 
h. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) and 
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extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 48 (22.8 mg, 76%) as an orange oil. 1H NMR 
(500 MHz, CDCl3) δ 7.73 (dd, J = 5.8, 2.3 Hz, 1H), 7.32 (ddd, J = 7.7, 4.1 Hz, 5H), 7.27 – 
7.22 (m, 3H), 7.13 – 7.08 (m, 2H), 6.36 (dd, J = 5.8, 1.9 Hz, 1H), 4.69 (d, J = 10.6 Hz, 1H), 
4.64 (d, J = 10.7 Hz, 1H), 4.27 (ddd, J = 2.3, 2.3, 2.3 Hz, 1H), 3.77 (s, 1H), 2.87 (ddd, J = 
12.5, 8.9, 5.6 Hz, 1H), 2.67 (ddd, J = 12.5, 8.8, 5.9 Hz, 1H), 1.57 – 1.41 (m, 2H), 1.29 – 1.20 
(m, 4H), 0.89 – 0.81 (m, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 207.3, 162.2, 139.1, 
136.8, 135.0, 129.1, 128.9, 128.5, 128.3, 128.3, 127.1, 77.2, 75.1, 57.4, 52.8, 29.5, 27.1, 
22.6, 14.1 ppm; IR (thin film) 3062, 3029, 2954, 2982, 2858, 1711, 1496, 1453, 1165, 1029, 


























(49a,b): According to the general procedure, furan-2-yl(phenyl)methanol (33.7 mg, 0.194 
mmol) and ethyl 5-phenylisoxazolidine-4-carboxylate 95 (42.9 mg, 0.194 mmol) were 
treated with Dy(OTf)3 (5.9 mg, 0.0097 mmol) in MeNO2 (1.9 mL). The resulting reaction 
mixture was heated to 80 ºC for 1.25 h. The reaction was then quenched at 23 ºC with 
saturated aqueous NaHCO3 (5 mL) and extracted with ethyl acetate (3 × 5 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by flash column chromatography to afford cyclopentenone 49a,b 
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(46.0 mg, 63%, 1:1 mixture of diastereomers) as a brown oil. Higher RF diastereomer 1H 
NMR (500 MHz, Toluene-d8, 90 ºC) δ 7.45 – 7.30 (m, 3H), 7.21 – 6.94 (m, 8H), 6.02 (d, J = 
5.8 Hz, 1H), 5.33 (d, J = 5.9 Hz, 1H), 4.09 (s, 1H), 3.94 – 3.75 (m, 2H), 3.52 (s, 1H), 3.19 – 
3.08 (m, 2H), 3.08 – 3.00 (m, 1H), 3.04 (t, J = 8.1 Hz, 1H), 0.88 (t, J = 7.1 Hz, 3H) ppm; 
13C NMR (200 MHz, Toluene-d8, 70 ºC) 204.0, 171.6, 170.0, 159.8, 135.4, 129.2, 129.1, 
128.6, 127.5, 126.8, 125.7, 81.8, 74.3, 61.3, 60.2, 57.0, 56.8, 56.1, 14.3 ppm; IR (thin film) 
3063, 3030, 2981, 2927, 2852, 1714, 1597 cm-1; MS (ESI) m/z 400.1516 (400.1525 calcd 
for C23H23NNaO4+ [MNa]+). 
Lower RF diastereomer 1H NMR (500 MHz, Toluene-d8, 90 ºC) δ 7.32 (d, J = 7.1 Hz, 
3H), 7.19 – 7.10 (m, 2H), 7.10 – 6.95 (m, 6H), 6.02 (dd, J = 5.8, 1.6 Hz, 1H), 5.18 (d, J = 
6.5 Hz, 1H), 4.06 (q, J = 2.5 Hz, 1H), 3.90 (dddd, J = 17.9, 10.8, 7.1, 3.7 Hz, 2H), 3.58 (d, J 
= 3.1 Hz, 1H), 3.37 (dd, J = 9.4, 5.2 Hz, 1H), 3.06 (ddd, J = 8.7, 6.5, 5.1 Hz, 1H), 2.78 (t, J 
= 9.1 Hz, 1H), 0.92 (t, J = 7.1 Hz, 3H) ppm; 13C NMR (125 MHz, Toluene-d8, 90 ºC) 203.9, 
171.5, 159.5, 159.3, 141.2, 139.4, 135.6, 135.6, 127.4, 127.0, 100.8, 82.1, 74.9, 61.3, 57.0, 
56.5, 56.2, 24.5, 14.4 ppm; IR (thin film)  3063, 3030, 2981, 2925, 2852, 1714, 1597 cm-1; 




















4-((Benzoyloxy)(propyl)amino)-5-phenylcyclopent-2-en-1-one (50): According to the 
general procedure, furan-2-yl(phenyl)methanol (28.3 mg, 0.163 mmol) and O-benzoyl-N-
propylhydroxylamine (96) (29.1 mg, 0.163 mmol) were treated with 30 mol % Dy(OTf)3 
(29.8 mg, 0.0489 mmol) in MeCN (1.6 mL). The resulting reaction mixture was stirred at 
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room temperature for 58 h. The reaction was then quenched with saturated aqueous 
NaHCO3 (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified 
by flash column chromatography to afford cyclopentenone 50 (27.1 mg, 50%) as a yellow 
solid. 1H NMR (500 MHz, CDCl3) δ 7.90 (dd, J = 8.3, 1.4 Hz, 2H), 7.84 (dd, J = 5.8, 2.4 
Hz, 1H), 7.58 (dddd, J = 7.1, 7.1, 1.3, 1.3 Hz, 1H), 7.47 – 7.39 (m, 2H), 7.38 – 7.31 (m, 2H), 
7.31 – 7.25 (m, 1H), 7.20 – 7.14 (m, 2H), 6.36 (dd, J = 5.8, 1.9 Hz, 1H), 4.56 (dd, J = 4.6, 
2.3 Hz, 1H), 3.89 (d, J = 2.8 Hz, 1H), 3.16 – 3.09 (m, 1H), 2.91 (ddd, J = 12.7, 8.2, 6.8 Hz, 
1H), 1.61 – 1.48 (m, 2H), 0.89 (t, J = 7.4 Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 
206.2, 165.7, 160.9, 138.4, 135.7, 133.6, 129.6, 129.3, 128.7, 128.5, 128.2, 127.5, 76.0, 
59.6, 52.7, 20.6, 11.6 ppm; IR (thin film)  3063, 3030, 2964, 2935, 2876, 1743, 1712 cm-1; 














1-(Benzyloxy)-6-phenyl-1-azaspiro[4.4]non-8-en-7-one (51): According to the general 
procedure, (5-(3-((benzyloxy)amino)propyl)furan-2-yl)(phenyl)methanol (97) (240 mg, 0.71 
mmol) was treated with Dy(OTf)3 (21.6  mg, 0.036 mmol) in MeNO2 (7 mL). The resulting 
reaction mixture was heated to 80 ºC for 1 h. The reaction was then quenched at 23 ºC with 
saturated aqueous NaHCO3 (5 mL) and extracted with ethyl acetate (3 × 5 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by flash column chromatography to afford cyclopentenone 51 
(185.6 mg, 82%) as a yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 5.8 Hz, 1H), 
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7.38 – 7.21 (m, 8H), 7.06 – 7.00 (m, 2H), 6.34 (d, J = 5.8 Hz, 1H), 4.73 (d, J = 11.4 Hz, 
1H), 4.70 (d, J = 11.4 Hz, 1H), 4.00 (s, 1H), 3.28 – 3.20 (m, 1H), 3.10 (ddd, J = 10.2, 8.0, 
4.3 Hz, 1H), 1.71 – 1.59 (m, 2H), 1.60 – 1.50 (m, 1H), 1.28 – 1.13 (m, 1H) ppm; 13C NMR 
(125 MHz, CDCl3) δ 208.2, 165.5, 137.8, 137.6, 134.5, 130.2, 129.0, 128.6, 128.5, 128.2, 
127.1, 78.5, 76.8, 56.6, 53.5, 29.5, 18.9 ppm; IR (thin film) 3061, 3029, 2940, 2865, 1707, 
1594, 1496, 1453, 1342, 1208, 1032, 977, 918 cm-1; MS (ESI) m/z 342.1477 (342.1470 
calcd for C21H21NNaO2+ [MNa]+). 
 
 51 




5 mol % Dy(OTf)3














According to the general procedure, 4-(furan-2-yl(hydroxy)methyl)benzonitrile (34.4 mg, 
0.172 mmol) and N,O-dibenzylhydroxylamine (32) (36.8 mg, 0.172 mmol) were treated 
with Dy(OTf)3 (5.2 mg, 0.0086 mmol) in MeNO2 (1.8 mL). The resulting reaction mixture 
was heated to 80 ºC for 17 h. The reaction was then quenched at 23 ºC with saturated 
aqueous NaHCO3 (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
was purified by flash column chromatography to afford cyclopentenone 54 (57.0 mg, 84%) 
as an orange oil. 1H NMR (500 MHz, CDCl3) δ 7.63 – 7.56 (m, 3H), 7.32 – 7.22 (m, 6H), 
 51 
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7.16 (d, J = 8.1 Hz, 2H), 7.15 – 7.10 (m, 2H), 7.07 (s, 2H), 6.32 (dd, J = 5.8, 2.0 Hz, 1H), 
4.45 (d, J = 10.9 Hz, 1H), 4.43 (d, J = 10.9 Hz, 1H), 4.22 (ddd, J = 2.3 Hz, 1H), 4.00 (d, J = 
12.6 Hz, 1H), 3.95 (s, 1H), 3.78 (d, J = 12.5 Hz, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 
205.3, 162.3, 144.3, 136.5, 136.2, 134.7, 132.7, 129.6, 129.4, 129.4, 128.5, 128.5, 128.4, 
128.0, 118.8, 111.1, 76.8, 73.1, 61.1, 52.6 ppm; IR (thin film) 3063, 3031, 2919, 2866, 
2227, 1708, 1607, 1454, 1276, 1163, 1028, 972 cm-1; MS (ESI) m/z 417.1573 (417.1579 
calcd for C26H22N2NaO2+ [MNa]+). 
 
+
5 mol % Dy(OTf)3















According to the general procedure, furan-2-yl(4-methoxyphenyl)methanol (23.1 mg, 0.113 
mmol) and N,O-dibenzylhydroxylamine (32) (24.1 mg, 0.113 mmol) were treated with 
Dy(OTf)3 (3.4 mg, 0.0057 mmol) in MeNO2 (1.1 mL). The resulting reaction mixture was 
heated to 80 ºC for 30 min. The reaction was then quenched at 23 ºC with saturated aqueous 
NaHCO3 (5 mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified 
by flash column chromatography to afford cyclopentenone 55 (36.7 mg, 81%) as a yellow 
waxy solid. 1H NMR (600 MHz, CDCl3) δ 7.61 (s, 1H), 7.31 – 7.27 (m, 3H), 7.28 – 7.23 
(m, 3H), 7.15 – 7.09 (m, 4H), 7.02 (d, J = 8.6 Hz, 2H), 6.87 (d, J = 8.6 Hz, 2H), 6.32 (dd, J 
= 5.8, 1.9 Hz, 1H), 4.41 (s, 2H), 4.21 (dd, J = , 4.2, 2.1 Hz, 1H), 4.01 (d, J = 12.6 Hz, 1H), 
3.88 (s, 1H), 3.81 (d, J = 12.6 Hz, 1H), 3.80 (s, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 
207.4, 162.2, 158.8, 136.7, 136.7, 134.9, 130.9, 130.0, 129.5, 129.3, 128.4, 128.4, 128.3, 
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127.7, 114.6, 77.0, 73.9, 61.4, 55.5, 52.0 ppm; IR (thin film)  3030, 2921, 2854, 1883, 1708, 
1611, 1511 cm-1; MS (ESI) m/z 422.1717 (422.1732 calcd for C26H25NNaO3+ [MNa]+). 
 
+
5 mol % Dy(OTf)3














4-(Benzyl(benzyloxy)amino)-5-(thiophen-2-yl)cyclopent-2-en-1-one (56): According 
to the general procedure, furan-2-yl(thiophen-2-yl)methanol (31.1 mg, 0.172 mmol) and 
N,O-dibenzylhydroxylamine (32) (36.8 mg, 0.172 mmol) were treated with Dy(OTf)3 (5.2 
mg, 0.0086 mmol) in MeNO2 (1.8 mL). The resulting reaction mixture was heated to 80 ºC 
for 30 min. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 
mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash 
column chromatography to afford cyclopentenone 56 (59.2 mg, 92%) as a brown oil. 1H 
NMR (500 MHz, CDCl3) δ 7.59 (s, 1H), 7.32 – 7.27 (m, 6H), 7.25 – 7.19 (m, 3H), 7.14 – 
7.10 (m, 2H), 7.00 – 6.96 (m, 1H), 6.90 (d, J = 3.3 Hz, 1H), 6.31 (dd, J = 6.0, 1.8 Hz, 1H), 
4.43 (d, J = 10.6 Hz, 1H), 4.40 (d, J = 10.6 Hz, 1H), 4.34 (ddd, J = 2.4, 2.4, 2.4 Hz, 1H), 
4.20 (s, 1H), 4.06 (d, J = 12.7 Hz, 1H), 3.95 (d, J = 12.7 Hz, 1H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 204.7, 161.4, 140.1, 136.7, 136.5, 134.1, 129.9, 129.2, 128.6, 128.4, 128.3, 127.8, 
127.2, 125.9, 124.7, 77.0, 74.1, 61.4, 47.6 ppm; IR (thin film) 3064, 3030, 2919, 2867, 
1954, 1712, 1454, 1343, 1167, 1028, 972 cm-1; MS (ESI) m/z 398.1188 (398.1191 calcd for 
C23H21NNaO2S+ [MNa]+). 
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+
5 mol % Dy(OTf)3

















one (57): According to the general procedure, furan-2-yl(2,4,6-triisopropylphenyl)methanol 
(32.0 mg, 0.105 mmol) and N,O-dibenzylhydroxylamine (32) (22.5 mg, 0.105 mmol) were 
treated with Dy(OTf)3 (3.2 mg, 0.0053 mmol) in MeNO2 (1.0 mL). The resulting reaction 
mixture was heated to 80 ºC for 40 min. The reaction was then quenched at 23 ºC with 
saturated aqueous NaHCO3 (5 mL) and extracted with ethyl acetate (3 × 5 mL). The 
combined organic layers were dried over MgSO4, filtered and then concentrated in vacuo. 
The residue was purified by flash column chromatography to afford cyclopentenone 57 
(41.7 mg, 80%) as a white solid. 1H NMR (600 MHz, CDCl3) δ 7.39 – 7.30 (m, 4H), 7.28 
(d, J = 7.3 Hz, 2H), 7.17 – 7.13 (m, 1H), 7.11 (t, J = 7.4 Hz, 2H), 7.07 (d, J = 1.9 Hz, 1H), 
6.90 (d, J = 1.9 Hz, 1H), 6.67 (s, 2H), 6.31 (d, J = 4.7 Hz, 1H), 4.66 (d, J = 11.2 Hz, 1H), 
4.63 – 4.53 (m, 2H), 4.03 (s, 1H), 3.99 (d, J = 12.2 Hz, 1H), 3.65 (d, J = 12.2 Hz, 1H), 3.57 
(p, J = 6.8 Hz, 1H), 2.91 (hept, J = 6.9 Hz, 1H), 1.83 (hept, J = 6.7 Hz, 1H), 1.44 (d, J = 6.6 
Hz, 3H), 1.29 (t, J = 7.1 Hz, 6H),z 1.25 (d, J = 6.8 Hz, 3H), 0.94 (d, J = 6.5 Hz, 3H), 0.65 
(d, J = 5.6 Hz, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 207.4, 160.9, 147.9, 147.7, 137.3, 
136.3, 134.4, 130.7, 129.7, 129.2, 128.4, 128.3, 128.2, 127.5, 122.5, 121.4, 76.2, 72.6, 60.1, 
48.3, 34.4, 30.7, 30.3, 29.9, 26.5, 24.4, 24.3, 24.2, 24.1, 22.2 ppm; IR (thin film) 3063, 
3032, 2960, 2926, 2868, 1710, 1607 cm-1; MS (ESI) m/z 518.3011 (518.3035 calcd for 
C34H41NNaO2+ [MNa]+). 
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+
5 mol % Dy(OTf)3















4-(Benzyl(benzyloxy)amino)-5,5-diphenylcyclopent-2-en-1-one (58): According to 
the general procedure, furan-2-yldiphenylmethanol (43.2 mg, 0.173 mmol) and N,O-
dibenzylhydroxylamine (32) (36.8 mg, 0.173 mmol) were treated with Dy(OTf)3 (5.3 mg, 
0.0087 mmol) in MeNO2 (1.7 mL). The resulting reaction mixture was heated to 80 ºC for 4 
h. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) and 
extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 58 (58.4 mg, 76%) as a yellow oil. 1H NMR (500 
MHz, Toluene-d8, 90 °C) δ 7.58 (dd, J = 6.1, 2.8 Hz, 1H), 7.43 – 7.35 (m, 2H), 7.30 – 7.19 
(m, 2H), 7.13 – 7.09 (m, 2H), 7.08 – 6.89 (m, 11H), 6.79 (d, J = 6.7 Hz, 2H), 6.32 (s, 1H), 
6.02 (dd, J = 6.0, 1.4 Hz, 1H), 4.96 (s, 1H), 3.95 (d, J = 11.0 Hz, 1H), 3.76 (d, J = 10.9 Hz, 
1H), 3.49 (dd, J = 20.3, 12.9 Hz, 2H) ppm; 13C NMR (125 MHz, Toluene-d8, 90 °C) δ 
205.0, 143.5, 142.1, 138.3, 135.3, 132.0, 131.8, 130.5, 130.4, 130.4, 128.7, 128.6, 128.5, 
128.1, 128.0, 127.9, 127.3, 127.0, 75.8, 75.5, 63.6, 60.7 ppm; IR (thin film)  3087, 3060, 
3030, 2922, 2858, 1952, 1883, 1808, 1709 cm-1; MS (ESI) m/z 468.1920 (468.1940 calcd 
for C31H27NNaO2+ [MNa]+). 
 
+
5 mol % Dy(OTf)3
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4-((Benzyloxy)(neopentyl)amino)-5,5-diphenylcyclopent-2-en-1-one (59): According 
to the general procedure, furan-2-yldiphenylmethanol (100.0 mg, 0.40 mmol) and O-benzyl-
N-neopentylhydroxylamine (34) (77.2 mg, 0.40 mmol) were treated with Dy(OTf)3 (12.2 
mg, 0.020 mmol) in MeNO2 (4.0 mL). The resulting reaction mixture was heated to 80 ºC 
for 18 h. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) 
and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 59 (142.0 mg, 83%) as a brown/orange solid. 1H 
NMR (500 MHz, toluene-d8, 80 °C) δ 7.58 (dd, J = 6.1, 2.7 Hz, 1H), 7.54 – 7.50 (m, 2H), 
7.18 (d, J = 7.5 Hz, 2H), 7.03 (m, 11H) 6.02 (dd, J = 6.0, 1.4 Hz, 1H), 4.92 (s, 1H), 4.28 (d, 
J = 11.1 Hz, 1H), 3.86 (s, 1H), 2.55 (d, J = 13.9 Hz, 1H), 2.25 (d, J = 13.8 Hz, 1H), 0.71 (s, 
9H) ppm; 13C NMR (125 MHz, toluene-d8, 80 °C) δ 204.5, 158.1, 143.9, 141.3, 138.0, 
135.0, 131.8, 131.6, 128.5, 128.4, 128.2, 127.6, 126.9, 126.7, 77.2, 73.2, 67.7, 62.9, 31.7, 
28.7, 24.2 ppm; IR (thin film) 3059, 2953, 2868, 1707, 1494, 1444, 1265, 1037, 1029, 949 
cm-1; MS (ESI) m/z 448.2231 (448.2252 calcd for C29H31NNaO2+ [MNa]+). 
 
+
10 mol % Dy(OTf)3













4-(Benzyl(benzyloxy)amino)-5-butylcyclopent-2-en-1-one (60): According to the 
general procedure, 1-(furan-2-yl)pentan-1-ol (26.5 mg, 0.172 mmol) and N,O-
dibenzylhydroxylamine (32) (36.7 mg, 0.172 mmol) were treated with Dy(OTf)3 (10.5 mg, 
0.0172 mmol) in MeNO2 (1.8 mL). The resulting reaction mixture was heated to 80 ºC for 
48 h. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) and 
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extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 60 (31.8 mg, 53%) as a dark yellow oil. 1H NMR 
(500 MHz, CDCl3) δ 7.66 (dd, J = 5.9, 2.0 Hz, 1H), 7.42 (d, J = 7.2 Hz, 2H), 7.37 (t, J = 7.2 
Hz, 2H), 7.35 – 7.31 (m, 1H), 7.29 – 7.24 (m, 3H), 7.11 – 7.05 (m, 2H), 6.26 (dd, J = 5.8, 
1.4 Hz, 1H), 4.34 (s, 2H), 3.98 (d, J = 12.9 Hz, 1H), 3.95 (d, J = 13.1 Hz, 1H), 3.91 (s, 1H), 
2.53 (s, 1H), 1.76 – 1.65 (m, 1H), 1.63 – 1.51 (m, 1H), 1.35 – 1.23 (m, 4H), 0.88 (dd, J = 6.9 
Hz, 3H) ppm; 13C NMR (125 MHz, CDCl3) δ 209.9, 160.8, 137.4, 136.7, 135.7, 129.8, 
129.1, 128.5, 128.4, 128.2, 127.8, 76.9, 71.7, 60.7, 47.2, 30.0, 28.9, 23.0, 14.0 ppm; IR (thin 
film) 3063, 3031, 2955, 2928, 2858, 1707, 1454, 1359, 1176, 1028, 976 cm-1; MS (ESI) m/z 
372.1941 (372.1939 calcd for C23H27NNaO2+ [MNa]+). 
 
+
10 mol % Dy(OTf)3












(4-(Benzyl(benzyloxy)amino)-5-isopropylcyclopent-2-en-1-one (61): According to the 
general procedure, 1-(furan-2-yl)-2-methylpropan-1-ol (12.1 mg, 0.086 mmol) and N,O-
dibenzylhydroxylamine (32) (18.4 mg, 0.086 mmol) were treated with Dy(OTf)3 (5.2 mg, 
0.0086 mmol) in MeNO2 (0.9 mL). The resulting reaction mixture was heated to 80 ºC for 
24 h. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 mL) and 
extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 
chromatography to afford cyclopentenone 61 (14.4 mg, 50%) as a light orange oil. 1H NMR 
(500 MHz, CDCl3) δ 7.74 (dd, J = 5.7, 2.1 Hz, 1H), 7.36 (m, 5H), 7.28 – 7.22 (m, 3H), 7.09 
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– 7.01 (m, 2H), 6.26 (dd, J = 5.8, 1.3 Hz, 1H), 4.33 (s, 2H), 4.00 – 3.87 (m, 3H), 2.41 (s, 
1H), 2.19 (dqq, J = 13.9, 6.9, 4.5 Hz, 1H), 0.94 (d, J = 6.9 Hz, 3H), 0.83 (d, J = 6.8 Hz, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 209.7, 160.8, 137.5, 136.7, 136.6, 129.8, 129.1, 128.5, 
128.4, 128.2, 127.8, 77.0, 68.9, 60.5, 52.9, 29.0, 20.2, 18.8 ppm; IR (thin film) 3063, 3031, 
2957, 2928, 2872, 1703, 1454, 1367, 1181, 1028, 963 cm-1; MS (ESI) m/z 358.1787 
(358.1783 calcd for C22H25NNaO2+ [MNa]+). 
 
+











4-((Benzyloxy)(neopentyl)amino)-5-isopropylcyclopent-2-en-1-one (62): According 
to the general procedure, 1-(furan-2-yl)-2-methylpropan-1-ol (20.0 mg, 0.140 mmol) and O-
benzyl-N-neopentylhydroxylamine (34) (27.6 mg, 0.140 mmol) were treated with Dy(OTf)3 
(8.7 mg, 0.014 mmol) in MeNO2 (1.4 mL). The resulting reaction mixture was heated to 80 
ºC for 96 h. The reaction was then quenched at 23 ºC with saturated aqueous NaHCO3 (5 
mL) and extracted with ethyl acetate (3 × 5 mL). The combined organic layers were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash 
column chromatography to afford cyclopentenone 62 (22.6 mg, 51%) as an orange oil. 1H 
NMR (500 MHz, CDCl3) δ 7.80 (dd, J = 5.8, 2.1 Hz, 1H), 7.36 – 7.27 (m, 5H), 6.27 (dd, J = 
5.9, 1.6 Hz, 1H), 4.79 (d, J = 10.6 Hz, 1H), 4.73 (d, J = 10.6 Hz, 1H), 4.15 (s, 1H), 2.55 (d, J 
= 14.3 Hz, 1H), 2.34 (d, J = 14.0 Hz, 1H), 2.27 (dqq, J = 13.8, 6.9, 4.1 Hz, 1H), 2.15 (s, 1H), 
1.04 (d, J = 7.0 Hz, 3H), 0.97 (s, 9H), 0.87 (d, J = 6.8 Hz, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 209.5, 161.9, 137.0, 136.8, 128.6, 128.5, 128.1, 74.6, 69.1, 66.0, 53.4, 31.6, 28.8, 
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28.6, 20.5, 18.6 ppm; IR (thin film) 3065, 3032, 2955, 2870, 1705, 1463, 1362, 1027, 976 
cm-1; MS (ESI) m/z 338.2093 (338.2096 calcd for C20H29NNaO2+ [MNa]+). 
 






















5-(Benzyl(benzyloxy)amino)-3-methyl-4-phenylcyclopent-2-en-1-one (74): Adapted 
from literature procedure.151 In a flame dried round bottom flask with magnetic stirrer under 
N2 atmosphere, 4-(benzyl(benzyloxy)amino)-5-phenylcyclopent-2-en-1-one 38 was 
dissolved in 0.5 mL dry THF followed by the addition of 0.6 M LaCl3(LiCl)2 in THF 
(0.0939 mmol, 157 µL) and stirring at room temperature for 1 hour. The reaction mixture 
was cooled to 0 ºC and 3.0 M methylmagnesium bromide in diethyl ether (0.188 mmol, 63 
µL) was added. Stirring at 0 ºC continued until complete as determined by thin layer 
chromatography. Upon completion, the reaction was quenched with saturated aqueous 
NH4Cl (5 mL) then extracted with EtOAc (3 x 5 mL). The combined organic layers were 
dried over MgSO4, filtered and then concentrated in vacuo. The crude reaction mixture 
contained allylic alcohol 73 in 16:1 dr as determined by 1H NMR spectroscopy. The crude 
reaction mixture was passed through a silica gel plug using 3:1 hexanes : ethyl acetate and 
used as is for the subsequent reaction. 80% Yield of crude material. 
 
Adapted from literature procedure.154 In a 10 mL round bottom flask containing a 
magnetic stir bar under N2 atmosphere, 4Ǻ mol sieves (500 mg) and pyridinium 
chlorochromate (PCC) (27.2 mg, 0.126 mmol) were added to anhydrous CH2Cl2 (1 mL) 
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followed by addition of 4-(benzyl(benzyloxy)amino)-1-methyl-5-phenylcyclopent-2-en-1-ol 
73 (24.3 mg, 0.063 mmol). Reaction was stirred until complete (2 h) as determined by thin 
layer chromatography. Upon completion, 5 mL Et2O was added, and the residual solids were 
decanted off  (3 x). The decanted liquid was transferred to a separatory funnel containing 5 
mL 2M NaOH and extracted with Et2O (3 x 5 mL).  The combined organic layers were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash 
column chromatography  (1% EtOAc in toluene) to afford cyclopentenone  74 (18.4 mg, 
70%) (56% yield over 2 steps) as a colorless oil. 1H NMR (600 MHz, CDCl3) δ 7.36 – 7.30 
(m, 2H), 7.31 – 7.24 (m, 3H), 7.21 – 7.16 (m, 3H), 7.14 – 7.08 (m, 7H), 6.16 (s, 1H), 4.65 
(d, J = 10.3 Hz, 1H), 4.42 (d, J = 10.3 Hz, 1H), 4.33 (s, 1H), 4.10 (d, J = 12.4 Hz, 1H), 3.93 
(d, J = 12.4 Hz, 1H), 3.62 (d, J = 2.7 Hz, 1H), 1.85 (s, 3H) ppm; 13C NMR (150 MHz, 
CDCl3) δ 205.3, 179.1, 141.0, 137.0, 136.5, 130.7, 130.0, 129.3, 129.3, 128.4, 128.2, 128.1, 
128.1, 127.6, 127.4, 76.5, 76.5, 60.8, 51.4, 18.2 ppm; IR (thin film) 3405, 3063, 3030, 2924, 














3-(benzyl(benzyloxy)amino)-2-phenylcyclopentan-1-one (75): A solution of 38 (20.0 
mg, 0.054 mmol) in 5 mL dry THF is cycled between N2 and vacuum (5x) before addition of 
Pd/C (10 wt%) (1.1 mg, 0.0011 mmol). The reaction is then placed under an atmosphere of 
H2 by cycling between vacuum and H2 (5x) and stirred at rt. When no more starting material 
was observed by TLC, the reaction was filtered through Celite, washing with EtOAc. Once 
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the solvent was removed, the residue was purified by flash column chromatography to give 
75 (20.1 mg, quant.).  1H NMR (500 MHz, CDCl3) δ 7.36 – 7.22 (m, 11H), 7.15 (dd, J = 
7.2, 1.7 Hz, 2H), 7.02 (dd, J = 6.3, 3.0 Hz, 2H), 4.40 (d, J = 10.3 Hz, 1H), 3.89 (d, J = 13.0 
Hz, 1H), 3.85 (d, J = 12.9 Hz, 1H), 3.82 – 3.76 (m, 1H), 3.72 (d, J = 9.5 Hz, 1H), 2.63 – 























4-(Benzyl(benzyloxy)amino)-5-phenylcyclopent-2-en-1-ol (71 and 72): 4-
(Benzyl(benzyloxy)amino)-5-phenylcyclopent-2-en-1-one (38) (231 mg, 0.63 mmol) and 
YbCl3·6H2O (387.5 mg, 1.25 mmol) was dissolved in 3 mL THF, then 23 mL MeOH was 
added and the solution stirred while cooling to -78 ºC. NaBH4 (47.3 mg, 1.25 mmol) was 
added in one portion and the reaction was stirred at -78 ºC until complete (1 h) as 
determined by thin layer chromatography (2:1 hexanes:ethyl acetate, stained with 
anisaldehyde). The reaction was then quenched with saturated aqueous NH4Cl (5 mL) and 
extracted with ethyl acetate (3 × 10 mL). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue (20:1 dr as determined by 1H 
NMR of crude mixture) was purified by flash column chromatography to afford 
cyclopentenone  71 (174 mg, 78%) as a colorless oil. Major Diastereomer: 1H NMR (600 
MHz, CDCl3) δ 7.36 – 7.27 (m, 10H), 7.23 (t, J = 7.4 Hz, 1H), 7.17 (d, J = 7.2 Hz, 2H), 7.15 
– 7.09 (m, 2H), 6.24 – 6.19 (m, 1H), 6.19 – 6.14 (m, 1H), 4.48 (s, 1H), 4.43 (d, J = 9.8 Hz, 
1H), 4.29 (d, J = 9.8 Hz, 1H), 4.06 (d, J = 12.7 Hz, 1H), 3.96 (q, J = 2.1 Hz, 1H), 3.85 (d, J 
= 12.7 Hz, 1H), 3.44 (s, 1H), 2.49 (s, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 144.5, 
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137.4, 137.0, 136.1, 134.4, 130.1, 129.5, 128.9, 128.5, 128.4, 128.3, 127.6, 127.0, 126.4, 
83.4, 78.2, 77.3, 61.4, 53.1 ppm; IR (thin film)  3414, 3062, 3030, 2878, 1602, 1495, 1454 
cm-1; MS (ESI) m/z 394.1785 (394.1783 calcd for C25H25NNaO2+ [MNa]+). Minor 
Diastereomer: 1H NMR (600 MHz, Chloroform-d) δ 7.37 – 7.31 (m, 2H), 7.32 – 7.21 (m, 
12H), 7.03 (s, 2H), 6.31 (d, J = 6.4 Hz, 1H), 6.12 (d, J = 5.8 Hz, 1H), 4.96 (d, J = 6.8 Hz, 
1H), 4.49 – 4.40 (m, 1H), 4.40 – 4.24 (m, 2H), 3.89 (d, J = 12.9 Hz, 1H), 3.82 – 3.71 (m, 
2H). ppm; 13C NMR (150 MHz, Chloroform-d) δ 139.0, 137.0, 135.8, 135.4, 130.0, 129.4, 
129.1, 128.8, 128.3, 128.2, 128.0, 127.4, 127.1, 77.7, 77.0, 76.5, 61.6 ppm; IR (thin film) 
3413, 3062, 3003, 2919, 1602, 1495, 1454, 1361 cm-1; MS (ESI) m/z 394.1769 (394.1783 
calcd for C25H25NNaO2+ [MNa]+). 
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3-Amino-2,2-diphenylcyclopentan-1-one (78): In a 20 mL vial, 4-
(benzyl(benzyloxy)amino)-5,5-diphenylcyclopent-2-en-1-one  58 (13.4 mg, 0.0301 mmol) 
was dissolved in MeOH (1.5 mL), followed by addition of Palladium on carbon (10 wt%) 
(1.6 mg, 0.0015 mmol). One drop of 12M HCl from an 18 gauge needle was added prior to 
placing the vial into the pressure vessel. The reaction mixture was placed under H2 gas at 70 
bar for 48h. The reaction mixture was filtered over Celite. The Celite pad was rinsed with 
ethyl acetate (3 x 5mL). The organic layer was then quenched with saturated aqueous 
NaHCO3 (5 mL) and extracted with ethyl acetate (3 x 5 ml). The combined organic layers 
were dried with Na2SO4, filtered and then concentrated in vacuo to afford 78 (7.6 mg, 
 71 
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quantitative yield) as a clear oil. 1H NMR (600 MHz, CDCl3) δ 7.41 (d, J = 7.6 Hz, 2H), 
7.36 – 7.31 (m, 2H), 7.29 – 7.24 (m, 3H), 7.24 – 7.19 (m, 1H), 7.11 (d, J = 8.0 Hz, 2H), 4.37 
(t, J = 4.5 Hz, 1H), 2.75 – 2.60 (m, 1H), 2.46 – 2.29 (m, 2H), 1.83 – 1.74 (m, 1H), 1.69 (bs, 
2H) ppm; 13C NMR (150 MHz, CDCl3) δ 216.3, 140.5, 139.8, 129.7, 128.8, 128.6, 128.2, 
127.3, 127.0, 66.7, 56.4, 36.0, 27.5 ppm; IR (thin film) 3372, 3302, 3086, 3057, 3032, 2925, 















3-(Neopentylamino)-2,2-diphenylcyclopentan-1-one (77): In a 20 mL vial, 4-
((benzyloxy)(neopentyl)amino)-5,5-diphenylcyclopent-2-en-1-one  59 (41.5 mg, 0.098 
mmol) was dissolved in MeOH (1.5 mL), followed by addition of Palladium on carbon (10 
wt%) (5.2 mg, 0.0049 mmol). One drop of 12M HCl from an 18 gauge needle was added 
prior to placing the vial into the pressure vessel. The reaction mixture was placed under H2 
gas at 70 bar for 48h. The reaction mixture was filtered over Celite. The Celite pad was 
rinsed with ethyl acetate (3 x 5mL). The organic layer was then quenched with saturated 
aqueous NaHCO3 (5 mL) and extracted with ethyl acetate (3 x 5 mL). The combined organic 
layers were dried over Na2SO4, filtered and then concentrated in vacuo to afford 77 (31.3 
mg, quantitative yield) as a brown oil. 1H NMR (600 MHz, CDCl3) δ 7.45 (d, J = 7.3 Hz, 
2H), 7.31 (t, J = 7.8 Hz, 2H), 7.28 – 7.21 (m, 3H), 7.20 (d, J = 7.5 Hz, 3H), 3.94 (t, J = 4.3 
Hz, 1H), 2.63 (ddd, J = 18.9, 9.0, 7.2 Hz, 1H), 2.46 (d, J = 11.1 Hz, 1H), 2.28 (ddd, J = 18.8, 
9.1, 4.5 Hz, 1H), 2.22 (d, J = 11.0 Hz, 1H), 2.19 (dddd, J = 11.5, 9.1, 5.9, 3.5 Hz, 1H), 1.89 
(dddd, J = 13.4, 9.1, 4.4, 4.4 Hz, 1H), 1.29 (s, 1H), 0.76 (s, 9H) ppm; 13C NMR (150 MHz, 
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CDCl3) δ 216.6, 140.4, 140.0, 66.3, 63.4, 59.8, 35.5, 31.7, 29.8, 27.7, 23.8 ppm; IR (thin 
film) 3347, 3087, 3058, 3031, 2951, 2864, 1737, 1599 cm-1; MS (EI) m/z 321.2096 
(321.2093 calcd for C22H27NO+ [M]+). 
 























4-((Allyloxy)(benzyl)amino)-5-phenylcyclopent-2-en-1-ol (104): A solution of 46 
(300.0 mg, 0.94 mmol) in MeOH (22 mL) was treated with CeCl3!7H2O (384.9 mg, 1.03 
mmol) and stirred at rt for 20 min. The solution was cooled to –78 °C and subsequently 
treated with NaBH4 (46.2 mg, 1.22 mmol) and stirred at this temperature until the reaction 
was complete by TLC. The reaction was quenched with H2O, and allowed to come to rt 
before removal of the solvent and extracting with EtOAc (3 x 10 mL). The combined 
organic phases were dried over MgSO4, filtered and then concentrated in vacuo. 1H NMR 
analysis of the crude reaction mixture indicated a 5:1 mixture of diastereomers. The residue 
was purified by flash column chromatography to afford the separated allylic alcohols 104 
and 105 (286.8 mg, 95% combined yield) as yellow oils. Major diastereomer: 1H NMR 
(500 MHz, CDCl3) δ 7.32 – 7.27 (m, 2H), 7.27 – 7.24 (m, 5H), 7.25 – 7.18 (m, 1H), 7.18 – 
7.13 (m, 2H), 6.19 (ddd, J = 5.7, 1.9, 1.9 Hz, 1H), 6.11 (dd, J = 5.7, 2.3 Hz, 1H), 5.70 (dddd, 
J = 16.8, 10.3, 6.3, 6.3 Hz, 1H), 5.17 – 5.08 (m, 1H), 5.13–5.11 (m, 1H), 4.48 (d, J = 6.1 Hz, 
1H), 4.04 (d, J = 12.7 Hz, 1H), 3.96 – 3.90 (m, 1H), 3.90 – 3.83 (m, 2H), 3.81 (d, J = 12.8 
Hz, 1H), 3.43 (s, 1H), 2.65 (s, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 144.4, 137.3, 
137.1, 134.4, 133.0, 130.0, 128.9, 128.3, 127.5, 127.0, 126.5, 119.0, 83.3, 78.0, 76.0, 61.4, 
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53.3 ppm; IR (thin film) 3413, 3061, 3029, 2918, 2851, 1601, 1494, 1453, 1344, 1080, 
1027, 995, 925 cm-1; MS (ESI) m/z 344.1605 (344.1626 calcd for C21H23NNaO2 [MNa]+). 
Minor diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.33 (t, J = 7.5 Hz, 2H), 7.29 – 7.18 (m, 
8H), 6.27 (d, J = 4.3 Hz, 1H), 6.11 – 6.05 (m, 1H), 5.63 (dddd, J = 16.7, 10.4, 6.3, 6.3 Hz, 
1H), 5.07 – 5.00 (m, 2H), 4.92 (d, J = 5.9 Hz, 1H), 4.40 – 4.36 (m, 1H), 3.90 – 3.82 (m, 3H), 
3.76 – 3.68 (m, 2H), 1.25 (d, J = 12.8 Hz, 1H) ppm; 13C NMR (125 MHz, CHCl3) δ 139.0, 
137.7, 135.9, 135.2, 133.8, 129.8, 129.4, 128.8, 128.2, 127.4, 127.1, 117.9, 77.6, 76.2, 75.9, 
61.6, 50.8 ppm; IR (thin film) 3425, 3061, 3029, 2917, 2865, 1602, 1494, 1453, 1342, 1069, 



















4-((Benzyloxy)(neopentyl)amino)-5-phenylcyclopent-2-en-1-ol (106 and 107): A 
solution of 47 (52.6 mg, 0.15 mmol) in MeOH (3.6 mL) was treated with CeCl3!7H2O (61.7 
mg, 0.17 mmol) and stirred at rt for 20 min. The solution was cooled to –78 °C and 
subsequently treated with NaBH4 (7.4 mg, 0.20 mmol) and stirred at this temperature until 
the reaction was complete as judged by TLC. The reaction was quenched with H2O and 
allowed to come to rt before extracting with EtOAc (3x 6 mL). The combined organic 
phases were dried over MgSO4, filtered and then concentrated in vacuo. 1H NMR analysis of 
the crude reaction mixture indicated a 2:1 mixture of diastereomers. The residue was 
purified by flash column chromatography to afford the separated allylic alcohols 106 and 
107 (37.1 mg, 70% combined yield) as yellow oils. Major diastereomer: 1H NMR (500 
MHz, CDCl3) δ 7.33 – 7.27 (m, 5H), 7.23 – 7.19 (m, 3H), 7.16 – 7.11 (m, 2H), 6.18 (dd, J = 
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5.7, 2.1 Hz, 1H), 6.15 (ddd, J = 5.7, 1.8, 1.8 Hz, 1H), 4.76 (d, J = 10.0 Hz, 1H), 4.58 (d, J = 
9.9 Hz, 1H), 4.45 (s, 1H), 3.95 (s, 1H), 3.25 (dd, J = 2.6, 2.6 Hz, 1H), 2.82 (d, J = 14.1 Hz, 
1H), 2.60 (d, J = 14.1 Hz, 1H), 2.33 (s, 1H), 0.95 (s, 9H) ppm; 13C NMR (125 MHz, CDCl3) 
δ 144.9, 136.7, 136.2, 134.6, 129.1, 128.9, 128.6, 128.3, 127.0, 126.3, 83.3, 80.9, 75.6, 69.0, 
53.9, 31.7, 28.7 ppm; IR (thin film) 3408, 3086, 3061, 3029, 2951, 2903, 2866, 1945, 1804, 
1602, 1453, 1360, 1209, 1020, 1011, 909 cm-1; MS (ESI) m/z 374.2069 (374.2096 calcd for 
C23H29NNaO2+ [MNa]+). Minor Diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.34 (t, J = 
7.5 Hz, 2H), 7.30 – 7.24 (m, 6H), 7.14 (d, J = 6.0 Hz, 2H), 6.30 (d, J = 5.6 Hz, 1H), 6.13 – 
6.04 (m, 1H), 4.92 (d, J = 6.5 Hz, 1H), 4.66 – 4.60 (m, 2H), 4.56 (s, 1H), 3.53 (dd, J = 6.2 
Hz, 1H), 2.61 (d, J = 14.2 Hz, 1H), 2.48 (d, J = 14.2 Hz, 1H), 1.25 (s, 1H), 0.89 (s, 9H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 139.3, 137.2, 136.1, 135.5, 129.4, 128.8, 128.6, 128.4, 
127.9, 127.0, 78.4, 77.4, 74.8, 67.6, 50.4, 31.6, 28.6 ppm; IR (thin film) 3412, 3086, 3061, 
3030, 2951, 2904, 2865, 1947, 1807, 1602, 1453, 1361, 1208, 1027, 910 cm-1; MS (ESI) m/z 





















4-(Benzyl(benzyloxy)amino)-5-butylcyclopent-2-en-1-ol (108 and 109): A solution of 
60 (145.5 mg, 0.42 mmol) in MeOH (10 mL) was treated with CeCl3!7H2O (170.6 mg, 0.45 
mmol) and stirred at rt for 20 min. The solution was cooled to –30 °C and subsequently 
treated with NaBH4 (20.5 mg, 0.54 mmol) and stirred at this temperature until the reaction 
was complete by TLC. The reaction was quenched with H2O and allowed to come to rt 
before extracting with EtOAc (3x 10 mL). The combined organic phases were dried over 
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MgSO4, filtered and then concentrated in vacuo. 1H NMR analysis of the crude reaction 
mixture indicated a 1.3:1 mixture of diastereomers. The residue was purified by flash 
column chromatography to afford the separated allylic alcohols 108 and 109 (132.6 mg, 
90% combined yield) as a yellow oil (major) and light orange solid (minor). Major 
diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.43 (d, J = 7.2 Hz, 2H), 7.36 (t, J = 7.4 Hz, 
2H), 7.31 (t, J = 7.3 Hz, 1H), 7.25 (d, J = 5.9 Hz, 3H), 7.08 – 7.05 (m, 2H), 6.03 (d, J = 5.3 
Hz, 1H), 5.99 – 5.95 (m, 1H), 4.35 (d, J = 9.7 Hz, 1H), 4.24 – 4.18 (m, 1H), 4.15 (d, J = 8.4 
Hz, 1H), 3.96 (d, J = 12.8 Hz, 1H), 3.86 (d, J = 12.8 Hz, 1H), 3.51 (s, 1H), 2.28 (s, 1H), 2.15 
(s, 1H), 1.42 – 1.27 (m, 6H), 0.90 (dd, J = 7.0, 7.0 Hz, 3H) ppm; 13C NMR (125 MHz, 
CDCl3) δ 137.9, 136.7, 136.1, 133.0, 130.0, 129.5, 128.5, 128.4, 128.3, 127.6, 80.9, 77.2, 
76.1, 61.3, 46.9, 33.6, 30.1, 23.0, 14.2 ppm; IR (thin film) 3422, 3087, 3062, 3031, 2955, 
2926, 2856, 1496, 1454, 1359, 1209, 1028, 1000 cm-1; MS (ESI) m/z 374.2101 (374.2096 
calcd for C23H29NNaO2 [MNa]+). Minor Diastereomer: 1H NMR (600 MHz, CDCl3) δ 7.39 
(d, J = 7.2 Hz, 2H), 7.33 (t, J = 7.3 Hz, 2H), 7.29 (d, J = 7.2 Hz, 1H), 7.28 – 7.21 (m, 3H), 
7.11 – 7.02 (m, 2H), 6.24 (d, J = 5.2 Hz, 1H), 6.06 (ddd, J = 5.8, 2.1, 2.1 Hz, 1H), 4.78 (d, J 
= 5.6 Hz, 1H), 4.34 (s, 2H), 3.93 (d, J = 13.0 Hz, 1H), 3.85 (d, J = 13.0 Hz, 1H), 3.80 (s, 
1H), 2.13 (dddd, J = 12.5, 6.1, 6.1, 6.1 Hz, 1H), 1.64 – 1.54 (m, 1H), 1.52 – 1.45 (m, 1H), 
1.45 – 1.38 (m, 1H), 1.37 – 1.28 (m, 3H), 1.14 (s, 1H), 0.91 (dd, J = 7.1, 7.1 Hz, 3H) ppm; 
13C NMR (125 MHz, CDCl3) δ 138.3, 137.2, 136.0, 134.7, 129.8, 129.1, 128.3, 127.9, 
127.4, 76.7, 76.2, 76.1, 60.3, 44.6, 31.0, 27.5, 23.2, 14.3 ppm; IR (thin film) 3376, 3089, 
3064, 3033, 2956, 2930, 2872, 2859, 1606, 1496, 1454, 1362, 1265, 1210, 1028, 906 cm-1; 
MS (ESI) m/z 374.2087 (374.2096 calcd for C23H29NNaO2 [MNa]+). 
 













1-(Benzyloxy)-6-phenyl-1-azaspiro[4.4]non-8-en-7-ol (110): A solution of 51 (85.0 
mg, 0.27 mmol) in MeOH (3.6 mL) and THF (0.4 mL) was treated with YbCl3!6H2O (206.4 
mg, 0.53 mmol) and stirred at rt for 20 min. The solution was subsequently treated with 
NaBH4 (20.1 mg, 0.53 mmol) and stirred at this temperature until the reaction was complete 
by TLC. The reaction was quenched with saturated NH4Cl and extracted with EtOAc (3 x 10 
mL). The combined organic phases were dried over MgSO4, filtered and then concentrated 
in vacuo. The residue was purified by flash column chromatography to afford allylic alcohol 
110 (66.5 mg, 77%, isolated as an inseparable mixture of diastereomers with 8:1 dr) as a 
light yellow oil. Major: 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.28 (m, 8H), 7.27 – 7.22 (m, 
2H), 6.18 (dd, J = 5.7, 1.9 Hz, 1H), 6.02 (d, J = 5.3 Hz, 1H), 5.19 (dd, J = 6.3, 6.3 Hz, 1H), 
4.80 – 4.67 (m, 2H), 3.68 (d, J = 7.0 Hz, 1H), 3.17 – 2.99 (m, 2H), 1.70 – 1.60 (m, 2H), 1.59 
– 1.49 (m, 1H), 1.49 – 1.38 (m, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ138.2, 137.9, 
137.6, 137.2, 130.6, 128.9, 128.5, 128.4, 127.9, 127.1, 83.0, 78.3, 76.6, 54.7, 53.3, 30.6, 
19.3 ppm; IR (thin film) 3413, 3086, 3059, 3029, 2940, 2866, 1601, 1494, 1453, 1362, 
1208, 1080, 1026, 974 cm-1; MS (ESI) m/z 344.1640 (344.1626 calcd for C21H23NNaO2 
[MNa]+). 
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4-(Benzylamino)-5-phenylcyclopent-2-en-1-ol (81): 4-(Benzyl(benzyloxy)amino)-5-
phenylcyclopent-2-en-1-ol 71 (13.3 mg, 0.036 mmol) was dissolved in 0.5 mL THF, 
followed by addition of 6-9 micron Zn powder (46.8 mg, 0.716 mmol). Next, 2M HCl (1 
mL) in H2O was added and the solution was heated to 70 ºC. Reaction was stirred until 
complete (2 h) as determined by thin layer chromatography.  The reaction was then 
quenched by the addition of 4M NaOH(aq) until pH 14 was reached and extracted with ethyl 
acetate (3 × 5 mL). The combined organic layers were dried over Na2SO4, filtered and then 
concentrated in vacuo. The residue was purified by flash column chromatography  (3% 
MeOH in CH2Cl2) to afford the free amine 81 (9.5 mg, quantitative yield) as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ 7.32 (t, J = 7.5 Hz, 2H), 7.28 – 7.22 (m, 4H), 7.19 (t, J = 7.2 
Hz, 4H), 6.00 (t, J = 7.0 Hz, 2H), 4.64 (d, J = 4.5 Hz, 1H), 3.84 – 3.77 (m, 2H), 3.73 (d, J = 
13.1 Hz, 1H), 3.18 (s, 2H), 3.00 (t, J = 4.9 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 
143.0, 138.9, 135.6, 134.5, 128.9, 128.6, 127.6, 127.4, 126.8, 83.9, 69.6, 62.0, 51.3 ppm; IR 
(thin film) 3294, 3061, 3028, 2922, 2854, 1951, 1877, 1810, 1734, 1602, 1495 cm-1; MS 















4-(Benzylamino)-5-phenylcyclopent-2-en-1-ol (82): A solution of 72 (20.0 mg, 0.062 
mmol) in THF (1.9 mL) was treated with Zn (81.4 mg, 1.2 mmol), followed by slow 
addition of 3.7 mL 2M HCl. The reaction was placed in an oil bath at 70 °C and stirred until 
no starting material was observed by TLC. The reaction was then cooled to rt, quenched 
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with saturated NaHCO3, then the pH was adjusted to 9 using 3 M NaOH before extraction 
with EtOAc (3 x 5 mL). The combined organic phases were dried over Na2SO4, filtered, and 
solvent removed in vacuo. The residue was purified by flash column chromatography to 
afford 82 (11.7 mg, 98%) as a light yellow solid. 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.32 
(m, 2H), 7.31 – 7.27 (m, 3H), 7.27 – 7.24 (m, 2H), 7.24 – 7.18 (m, 3H), 6.21 (dd, J = 5.8, 
1.7 Hz, 1H), 6.04 (ddd, J = 5.8, 2.2, 2.2 Hz, 1H), 4.84 (ddd, J = 6.3, 2.1, 2.1 Hz, 1H), 4.31 
(dddd, J = 6.6, 1.8, 1.8, 1.8 Hz, 1H), 3.77 (s, 2H), 3.23 (dd, J = 6.4, 6.4 Hz, 1H), 1.57 (s, 2H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 140.1, 138.7, 138.2, 133.2, 129.4, 128.8, 128.5, 128.3, 
127.2, 127.2, 77.3, 67.2, 57.8, 52.4 ppm; IR (thin film) 3302, 3059, 3027, 2901, 2851, 1601, 
1553, 1493, 1453, 1319, 1094, 1070, 1028 cm-1; MS (ESI) m/z 288.1354 (288.1364 calcd 














4-(Neopentylamino)-5-phenylcyclopent-2-en-1-ol (83): A solution of 106 (7.6 mg, 
0.022 mmol) in THF (0.7 mL) was treated with Zn (28.3 mg, 0.43 mmol), followed by slow 
addition of 1.3 mL 2M HCl. The reaction was placed in an oil bath at 70 °C and stirred until 
no starting material was observed by TLC. The reaction was then cooled to rt, quenched 
with saturated NaHCO3, then the pH was adjusted to ~10 using 3 M NaOH before extraction 
with EtOAc (3 x 5 mL). The combined organic phases were dried over Na2SO4, filtered, and 
solvent removed in vacuo. The residue was purified by flash column chromatography to 
afford 83 (3.1 mg, 58%) as a yellow oil. 1H NMR (600 MHz, CDCl3) δ 7.32 (t, J = 7.3 Hz, 
2H), 7.27 – 7.20 (m, 3H), 6.08 (d, J = 5.7 Hz, 1H), 6.01 (d, J = 5.2 Hz, 1H), 4.68 (s, 1H), 
  159 
3.80 – 3.75 (m, 1H), 2.99 – 2.94 (m, 1H), 2.39 (s, 2H), 1.28 (s, 1H), 1.25 (s, 1H), 0.89 (s, 
9H) ppm; 13C NMR (125 MHz, CDCl3) δ 143.0, 136.7, 133.9, 129.0, 127.4, 126.9, 84.1, 
71.4, 59.2, 31.4, 29.9, 27.9 ppm; IR (thin film) 3293, 3061, 3028, 2953, 2926, 2855, 1555, 



















4-(Benzylamino)-5-butylcyclopent-2-en-1-ol (84): A solution of 108 (30.2 mg, 0.086 
mmol) in THF (2.6 mL) was treated with Zn (112.4 mg, 1.7 mmol), followed by slow 
addition of 5.2 mL 2M HCl. The reaction was placed in an oil bath at 70 °C and stirred for 
40 min, until no starting material was observed by TLC. The reaction was then cooled to rt, 
quenched with saturated NaHCO3, then the pH was adjusted to ~10 using 3 M NaOH before 
extraction with EtOAc (3 x 5 mL). The combined organic phases were dried over Na2SO4, 
filtered, and solvent removed in vacuo. The residue was purified by flash column 
chromatography to afford 84 (17.3 mg, 82%) as a yellow oil. 1H NMR (500 MHz, CDCl3) δ 
7.37 – 7.30 (m, 4H), 7.28 – 7.23 (m, 1H), 5.97 – 5.91 (m, 1H), 5.89 (ddd, J = 5.7, 1.7, 1.7 
Hz, 1H), 4.32 – 4.27 (m, 1H), 3.84 (d, J = 2.0 Hz, 2H), 3.34 – 3.28 (m, 1H), 2.53 (s, 2H), 
 83 
  161 
1.79 (dddd, J = 10.0, 3.6, 3.6, 3.6 Hz, 1H), 1.56 – 1.28 (m, 6H), 0.91 (dd, J = 7.1, 7.1 Hz, 
3H) ppm; 13C NMR (125 MHz, CDCl3) δ 139.5, 135.7, 134.4, 128.6, 128.5, 127.4, 81.6, 
67.9, 54.7, 51.8, 33.1, 30.1, 23.1, 14.2 ppm; IR (thin film) 3290, 3059, 2039, 2955, 2924, 
2855, 1454, 1354, 1073, 1027, 996 cm-1; MS (ESI) m/z 268.1662 (268.1677 calcd for 













8:1 d.r. 7:1 d.r.  
6-Phenyl-1-azaspiro[4.4]non-8-en-7-ol (85): A solution of (110) (66.5 mg, 0.21 mmol, 
as an 8:1 mixture of diastereomers) in 6.4 mL THF was treated with zinc (274.7 mg, 4.2 
mmol), followed by dropwise addition of 2M HCl (12.7 mL). The reaction was placed in an 
oil bath heated to 70 °C and stirred for 2 hours. The reaction was then cooled to rt, quenched 
with saturated NaHCO3, then the pH was adjusted to ~10 using 3M NaOH before extraction 
with EtOAc (3 x 10 mL). The combined organic phases were dried over Na2SO4, filtered, 
and solvent removed in vacuo. The residue was purified by flash column chromatography to 
afford 85 (34.3 mg, 77%) as a yellow oil and an inseparable 7:1 mixture of diastereomers. 
Major: 1H NMR (500 MHz, CDCl3) δ 7.32 – 7.23 (m, 5H), 6.04 (d, J = 5.8 Hz, 1H), 6.01 
(dd, J = 5.8, 1.9 Hz, 1H), 5.13 (ddd, J = 6.4, 1.6, 1.6 Hz, 1H), 3.37 (d, J = 6.4 Hz, 1H), 2.94 
(ddd, J = 10.4, 7.9, 5.0 Hz, 1H), 2.84 (ddd, J = 10.6, 6.8, 6.8 Hz, 1H), 2.14 (bs, 3H), 1.73 – 
1.46 (m, 5H) ppm; 13C NMR (125 MHz, CDCl3) δ 140.6, 138.0, 134.7, 130.7, 128.4, 127.2, 
77.7, 76.6, 61.0, 45.7, 34.8, 25.7 ppm; IR (thin film) 3363, 3060, 3029, 2922, 2852, 1600, 
1554, 1455, 1387, 1104, 1083, 1033 cm-1; MS (ESI) m/z 216.1393 (216.1388 calcd for 
C14H18NO [MH]+). 
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Bn Bn 8981  
4-(Benzylamino)-5-phenylcyclopent-2-en-1-one (89): A solution of 81 (50.0 mg, 0.19 
mmol) in 1.9 mL dry DMF was treated with pyridinium dichromate (PDC) (354 mg, 0.94 
mmol) and stir ed at rt for 2 h. The reaction was quenched with water (20 mL) and diluted 
with EtOAc (5 mL). The phases were separated, and the aqueous phase extracted with 
EtOAc (3 x 5 mL). Subsequently, the combined organic phases were washed with H2O (5 x 
5 mL) and brine (2 x 5 mL). The organic layer was dried over MgSO4, filtered and solvent 
removed in vacuo to give the crude, desired product 89 (35 mg, 70%) as a yellow oil. 1H 
NMR (600 MHz, CDCl3) δ 7.68 (s, 1H), 7.42 – 7.03 (m, 10H), 6.31 (s, 1H), 4.13 (s, 1H), 
3.91 (d, J = 12.8 Hz, 1H), 3.82 (d, J = 12.3 Hz, 1H), 3.41 (s, 1H), 2.19 (bs, 1H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 207.1, 163.3, 139.4, 138.4, 134.0, 129.0, 128.6, 128.3, 127.4, 
127.3, 67.3, 60.6, 51.9 ppm; IR (thin film) 3085, 3061, 3029, 2925, 2853, 1705, 1494, 1453, 
1265 cm-1; MS (ESI) m/z 264.1376 (264.1388 calcd for C18H18NO [MH]+). 




















4-(Benzylamino)-2-phenylcyclopent-2-en-1-one (90): Upon purification on silica, 
exposure to base, or standing at rt, 89 isomerizes to the more thermodynamically stable 
cyclopentenone 90. 1H NMR (500 MHz, CDCl3) δ 7.71 (d, J = 2.6 Hz, 1H), 7.71 – 7.65 (m, 
2H), 7.41 – 7.32 (m, 7H), 7.32 – 7.27 (m, 1H), 4.08 (ddd, J = 5.9, 2.5, 2.5 Hz, 1H), 3.95 (d, 
J = 13.0 Hz, 1H), 3.91 (d, J = 13.0 Hz, 1H), 2.91 (dd, J = 18.5, 6.2 Hz, 1H), 2.43 (dd, J = 
18.5, 2.4 Hz, 1H), 1.63 (bs, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 205.2, 157.9, 143.9, 
139.7, 131.1, 129.0, 128.8, 128.6, 128.4, 127.5, 55.3, 52.1, 44.3 ppm; IR (thin film) 3086, 
3059, 3029, 2925, 2851, 1704, 1598, 1577, 1494, 1452, 1265 cm-1; MS (ESI) m/z 264.1374 
(264.1388 calcd for C18H18NO [MH]+). 
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Crystallographic Experimental Section  
A colorless crystal of approximate dimensions 0.3*0.1*0.1 mm was mounted on a glass 
fiber and transferred to a Bruker Kappa Apex II diffractometer. The APEX2 program was 
used to determine the unit cell parameters and data collection (15 sec / frame, 0.3 deg. 
/frame). The data were collected at 100K. The raw frame data were processed using APEX2 
program. The absorption correction was applied using program SADABS. Subsequent 
calculations were carried out using SHELXTL program. The structure was solved by direct 
methods and refined on F2 by full-matrix least-squares techniques. Hydrogen atomic 
positions were theoretically calculated. At convergence, wR2= 0.1517 and GOF = 0.957 for 
274 variables refined against 4375 reflections, while R1= 0.0620 for 3625 reflections with 
I>2σ(I). All ORTEP diagrams have been drawn with 50% probability ellipsoids. 
Crystals were prepared by slow vapor diffusion using hexanes and ethyl acetate.  
 90  
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The crystal structure data can be obtained free of charge from the Cambridge 
Crystallographic Data Centre www.ccdc.cam.ac.uk/data_request/cif 
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5. A Mechanistic Investigation of the Aza-Piancatelli Rearrangement 
5.1. Motivation for a Mechanistic Investigation 
The Piancatelli rearrangement was developed in 1976,39 but received limited attention 
from the synthetic community since then.56,155 Despite the intriguing cascade mechanism of 
this transformation, there has been no detailed study on the mechanism of the reaction. 
Analysis has been limited to DeLera and co-workers’ DFT calculations that verified the 4π 
conrotatory electrocyclization, and a similar report by Tantillo and Davis.58,156 The 
challenges we encountered with developing an aza-Pianctelli rearrangement with non-
aniline nucleophiles and a number of observations throughout our studies motivated us to 
investigate the cascade rearrangement from a fundamental mechanistic point of view. Our 
goals were to determine the role of the catalyst in the reaction, analyze the electronic effects 
of the aniline on reaction rates, and hopefully gain a more concrete understanding of the 
limitation to aniline nucleophiles.  
5.2. Initial Observations and Investigations of Reaction Kinetics 
Throughout the development of the aza-Piancatelli rearrangement with anilines, we 
noted that reaction times varied based on the aniline and furylcarbinol involved (see Chapter 
2). However, during Dr. Leoni Palmer’s investigations of the intramolecular aza-Piancatelli 
rearrangement for the formation of aza-spirocycles,138 it became apparent that there was a 
clear dependence of rate on the electronic nature of the para-substituent on the aniline. In 
short, reactions with electron rich anilines were much slower compared to reactions with 
electron poor anilines.  
Initially, we were interested in creating a Hammett plot to clearly map out the electronic 
effect of the substituents on the rate of the reaction. We began our studies by monitoring the 
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reaction of phenylfurylcarbinol (1) and p-iodoaniline (2a) by 1H nuclear magnetic resonance 
(NMR) spectroscopy. The reaction was performed with Sc(OTf)3 since Dy(OTf)3 is 
paramagnetic and can interfere with accurate data collection. After collecting a baseline 1H 
NMR spectrum of the furylcarbinol and aniline in MeCN-d3, the sample was ejected and 
Sc(OTf)3 added. The sample was then re-inserted and spectra obtained every 117 seconds 
until the reaction was complete, as judged by lack of starting material. The NMR spectra 
collected allowed us to accurately map product appearance and starting material 
disappearance (Figure 5.1 A), and examining the first half of the reaction shows that there is 
a linear correlation of starting material disappearance and product appearance (Figure 5.1 
B). 
Following this initial result, we monitored the aza-Piancatelli rearrangement with other 
para-substituted anilines. Unfortunately it immediately became apparent that this method of 
data collection would not be universally applicable to the aza-Piancatelli rearrangement. 
Reactions with electron rich substrates, such as p-methoxyaniline, were extremely slow at 
room temperature (reactions did not go to completion over the course of 9 days) making it 
impractical collect spectra continually. At the same time, reactions with electron poor 
substitutents, such as p-cyanoaniline were so fast at room temperature, that data of the 
important initial phases of the reaction could not be collected. Since it was clear that this 
method would not result in accurate data for a Hammett plot, we ventured toward 
monitoring reaction progress by gas chromatography (GC). Data points were obtained by 
removing aliquots from the reaction mixture. Unfortunately we ran into issues with the 
chromatograph at our campus, and the undergraduate student working under my supervision, 
Jonathan Cook, was unable to get reliable data from this method.  
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In all, there were a multitude of issues with the methods presented above that were not 
ideal for a thorough mechanistic study. With regards to NMR experiments, we were not 
entirely pleased with the necessary switch to Sc(OTf)3 since differences in the reaction 
compared to Dy(OTf)3 might affect the interpretation of the results. Additionally, the 
logistics of running an NMR experiment necessitate removal of the sample from the magnet 
for addition of the catalyst. This results in lack of data over the first minute (or more) before 
data collection starts, and becomes problematic with fast reactions. Limitations in terms of 
the temperatures at which data can be collected made it difficult to collect data in slow 
reactions with electron-rich anilines, and finally the amount of time required for experiments 
on the departmental NMR machines proved to be taxing both financially and logistically.  
With these factors considered, but a positive result with one substrate (Figure 5.1), we 
embarked on a quest to find a collaborator possessing the necessary laboratory facilities to 
obtain quality data, as well as experience with kinetic and mechanistic studies. Enter, 
Professor Jason Hein.  
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Figure 5.1. A) Graph of the reaction of furylcarbinol 1 and aniline 2a monitored by 1H 
NMR, and data collection over the course of 10 hours. B) Depiction of linear transformation 
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5.3. Mechanistic Investigations with the Hein Lab  
In collaboration with the Hein Lab, we set out to investigate the aza-Piancatelli 
rearrangement with anilines to gain a kinetic and mechanistic understanding of the sequence 
of events leading up to the bond-forming electrocyclization.157  
Our first forays into the mechanistic investigations started with kinetic experiments, 
modeled on our NMR studies, monitored by ReactIR with independent verification via 
HPLC/MS sampling throughout the reaction. We monitored the reaction of 1 and 2b under 
Dy(OTf)3 as well as TFA catalysis to ascertain if there were any rate differences. We chose 
TFA as our Brønsted acid because it is easier to handle and gives a cleaner reaction profile 
than triflic acid.  
As discussed earlier in this thesis, it is known that metal triflates may release small 
amounts of triflic acid that can be responsible for catalysis.158 Although we had performed 
control experiments during the development of the aza-Piancatelli rearrangement (Chapter 2, 
Table 2.1), we hoped to further support this finding during these mechanistic investigations 
by directly comparing the Lewis acid (Dy(OTf)3) to the Brønsted acid (TFA) catalysis. The 
reaction progress was monitored as described and is depicted in Figure 5.2. It becomes 
immediately apparent that the reactions with Lewis (Dy(OTf)3) and Brønsted acid (TFA) 
follow different reaction paths. We found that the reaction with Dy(OTf)3 is zero-order in 
substrate and first-order in catalyst ([Dy(OTf)3] = 2.0–12.0 mM) while the reaction with 
TFA is first order in both substrate and acid catalyst ([TFA] = 3.3–30.0 mM). This 
difference in reaction order confirms that in situ generation of triflic acid is not responsible 
for catalysis in the reaction with dysprosium.  
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Figure 5.2. Reaction progress of Dy(OTf)3 and TFA catalyzed rearrangement.  
With the reaction order of the rearrangement established, our focus turned to the effect 
of the p-substituents on the aniline in the aza-Piancatelli rearrangement. In agreement with 
our empirical data, we found that the reaction rate increases when moving from electron 
donating substitutents (i.e. OMe) to electron withdrawing substituents (i.e. CO2Me) (Figure 
5.3). Interestingly, the Hammet ρ value for the Dy(OTf)3 and TFA catalyzed processes are 
+3.36 and +3.30, respectively. This implies that the difference in reaction order is decoupled 




9.6 mol % Dy(OTf)3






















[1] Dy catalyzed 
[3b] Dy catalyzed 
[1] TFA catalyzed 
[3b] TFA catalyzed 
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Figure 5.3. Effect of para-substituents of aniline on the reaction rate under Lewis and 
Brønsted acid catalysis.  
 
Examining the proposed mechanism (Scheme 5.1) of the reaction in light of the 
mechanistic data leads to two possible explanations for the observed trends with both 
dysprosium and TFA. The first explanation is that ring opening of aminal 6 is the rate 
limiting step of the reaction. This aminal has never been observed in the aza-Piancatelli 
rearrangement, but Denisov,75 Wu43,159 and Read de Alaniz139 have described the analogous 
acetal species (11) as isolable and stable (Figure 5.4).  
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Figure 5.4. Formation of observable and isolable acetal structures. 
If ring opening of the aminal is the rate determining step in the reaction, a negative ρ 
value corresponding to stabilization of the positive charge generated would be expected. 
Since this is not the case, an alternative explanation is that preferential binding of Dy(OTf)3 
by the aniline occurs. This binding event may account for both the observed zero order 
reaction profile as well as the positive ρ value. The proposed model for this off-cycle 
binding to dysprosium is pictorially represented in  Scheme 5.2, and a rate equation based on 
a Michaelis-Menten kinetics model with competitive inhibition was also derived.160 The 
steady state equation can be expressed in terms of the dysprosium catalyst, furylcarbinol (1) 
and aniline (2) (Equation 5.1). In this model, the aniline serves the role of both nucleophile 
and inhibitor, and we assume that the aniline and dysprosium bind strongly (12) (k3 >> k1 
and k–3) and that the capture of the oxocarbenium (13) is fast (k2>> k1 and k–1).  

























 Scheme 5.2. Proposed off-cycle binding in the catalytic cycle of the aza-Piancatelli 
rearrangement. 
Equation 5.1. Steady-state rate expression for the aza-Piancatelli rearrangement. 
푑[!]
푑푡 = 푘!푘!!푘! ퟏ [퐃퐲 퐎퐓퐟 ퟑ][!] !!! 
 
The rate expression clearly shows the rate dependence on both the ratio of furylcarbinol 
1 to aniline 2 ([1]/[2]). It also shows the effect of strong binding between the aniline and 
dysprosium (k–3/k3), where the equilibrium lies further toward the formation of complex 12 
in reactions with electron rich anilines than electron poor anilines. Although we did not 
isolate a dysprosium-aniline complex, such aniline-dysprosium complexes have been 
reported in the literature.161,162 We did note the formation of a precipitate during reactions 
with morpholine, which likely corresponds to a morpholine-dysprosium complex (Chapter 
4, Scheme 4.1). Additional experiments to study the formation of this off-cycle complex 
(12) were performed by varying the ratio of furylcarbinol to aniline (Figure 5.5). When an 
excess of furylcarbinol was used, the initial rate was 1.1 mM/min, while the reaction with 
excess aniline was slower at 0.26 mM/min. Subsequent addition of aniline or furylcarbinol 
to create equimolar reaction mixtures resulted in reaction rates of 6.5 mM/min and 5.1 
mM/min, respectively. Although these results indicate that reaction rates may be positively 
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influenced if there is an excess of furylcarbinol, in practice this is not the case due to 
decomposition of 1, as well as increased formation of Friedel–Crafts alkylation products.  
 
Figure 5.5. Effect of excess aniline or furylcarbinol on the aza-Piancatelli rearrangement.  
Finally, we performed a competition experiment with an electron rich and an electron 
poor aniline. The reactions were set up using phenyl furylcarbinol (1) (0.125M) and 
equimolar amounts of p-chloroaniline (2c) (0.0625M) and p-methoxyaniline (2d) (0.0625M) 
with either 5 mol % Dy(OTf)3 or 24 mol % TFA catalyst. To our surprise, we found that the 
electron rich p-methoxyaniline, which forms a stronger complex with dysprosium, 
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Figure 5.6. Competition between anilines. (a) Dy(OTf)3 catalyzed reaction; (b) TFA 
catalyzed reaction. 
Examining our proposed reaction mechanism, we determined that the initial rate of the 
reaction is controlled by the formation of dysprosium-p-methoxyaniline complex 15. 
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outcompetes electron-poor p-chloroaniline. Once p-methoxyaniline is expended, an increase 
in the rate of formation of the 3c is observed (approximately 90 min), corresponding to a 
shift of the equilibrium of the dysprosium complex toward the formation of 16. The reaction 
with TFA proceeds analogously with electron-rich p-methoxyaniline modulating the 
concentration of TFA available to catalyze formation of the oxocarbenium 5. In summary, 
these results indicate that the selectivity determining step and the rate-controlling processes 




























selectivity-controlling process  
Scheme 5.3. Rate and selectivity determining processes in the aza-Piancatelli 
rearrangement. 
In conclusion, our mechanistic studies allowed us to gain a greater understanding of the 
intricacies of the aza-Piancatelli rearrangement. We were able to answer some of the 
questions posed at the beginning of the investigation. First, we determined that the reaction 
with Dy(OTf)3 does not rely on adventitious generation of triflic acid. We also 
experimentally confirmed our empirically observed effects of electronics on the rate of the 
reaction. Finally, we found that the formation of a dysprosium-aniline complex is 
responsible for the observed reaction rates, but that this rate-controlling step is decoupled 
from the chemoselectivity of the reaction.  
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In the future, we hope to continue to use this information to guide the development of 
new reactions with furylcarbinols as well as dysprosium-catalyzed reactions. Ideally, we 
would find reaction conditions where an additional ligand could control the formation of the 
amine-dysprosium complex to allow for the use of more basic alkylamines in the 
rearrangement.  
5.4. Experimental Procedures 
Materials and Methods. Furan-2-yl(phenyl)methanol was prepared according to 
literature precedent of a similar transformation by reacting furfural with phenylmagnesium 
bromide.1 Dysprosium(III) trifluoromethanesulfonate (Dy(OTf)3) was used as received from 
Strem Chemicals, Inc.. All other materials were obtained from conventional suppliers and 
used as received. Flash chromatography was carried out using Sorbtech silica gel 60A 
(230x400 mesh). Thin-layer chromatography (TLC) was performed on Sorbtech precoated 
silica gel plates and was visualized by irradiation with UV light or staining with potassium 
permanganate solution.  
Kinetic studies monitored by in-situ FTIR were conducted with a Mettler-Toledo 
ReactIR iC 10 fitted with a Diamond ATR probe. Reaction temperatures were controlled 
using a Heidolph temperature modulator. 2-Methoxynaphthalene was used as an internal 
standard in some experiments as specified, and had no effect on the reaction, as confirmed 
by monitoring reactions via ReactIR and HPLC-MS both with and in the absence of the 
standard. 
1H NMR spectra were recorded on Varian Spectrometers (at 400, 500 or 600 MHz) 
and are reported relative to deuterated solvent signals. Data for 1H NMR spectra are reported 
as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) and integration. 13C 
NMR spectra were recorded on Varian Spectrometers (125 MHz). Data for 13C NMR 
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spectra are reported as follows: shift (δ ppm), multiplicity and coupling constant (Hz). IR 
spectra were recorded on a Jasco FT/IR 4100 or PerkinElmer Spectrum 100 FT-IR and are 
reported in terms of frequency of absorption (cm-1). High resolution mass spectra were 
obtained from the UC Santa Barbara Mass Spectrometry Facilities.  
NMR experiment set-up. 
NMR experiments were performed on a 600 MHz Varian Spectrometer. The samples 
were prepared in MeCN-d3 with dimethyl terephthalate as an internal standard (1.45 mg, 
0.0075 mmol). An initial spectrum of phenyl furylcarbinol (1) (2.6 mg, 0.015 mmol) and p-
iodoaniline (3.3 mg, 0.015 mmol) in 900 µL MeCN-d3 was obtained. The sample was 
removed from the magnet, treated with a solution of Sc(OTf)3 in MeCN-d3 (100 µL = 0.37 
mg, 0.00075 mmol) and replaced in the magnet after quickly shaking the sample for data 
collection.  
To set up the NMR experiment for continual data collection: 





parameter to be arrayed? pad 
number of steps? xx (each step is one transient, nt=16 takes 1 min 57 sec =117 
sec) 
starting value? 1 
array increment? 0 
da (display array) 
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time (displays how long experiment will take. This number is determined by the 
number of steps in the experiment) 
For the above reaction, nt=16, number of steps = 72 to monitor the reaction over the 










Validation of FTIR for Reaction Analysis. Validation of FTIR as a suitable technique 
for in-situ reaction analysis was performed through reaction sampling and HPLC-MS 
analysis of reaction conversion and product formation as a function of time. The reaction 
was sampled by withdrawal of approximately 5 microliter aliquots of the reaction solution 
and diluted with methanol at room temperature. Samples were analyzed by HPLC-MS 
immediately. HPLC-MS analysis was conducted with an Agilent Eclipse XDB C18, 3.5 µm, 
3.0 x 75 mm column. HPLC-MS analysis was conducted with an Agilent Eclipse XDB C18, 
3.5 µm, 3.0 x 75 mm column (standard column conditions – A = water (0.05% TFA), B = 
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Tandem Reaction Monitoring by ReactIR and HPLC-MS  
 
Analysis of the reaction conversion time course by FTIR and sampling methods were 
in agreement. 
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To a 10 mL vial with PTFE-silicon septum and open screw-cap was added 2 mL of 
acetonitrile. The vial was placed in a pre-heated oil-bath at 80 °C and allowed to equilibrate. 
After taking a background scan in hot solvent, furan-2-yl(phenyl)methanol 1 (44.0 mg, 
0.250 mmol, 0.125 M) and aniline 2b (23.0 mg, 0.250 mmol, 0.125 M) were added to the 
pre-equilibrated acetonitrile. After a stable FTIR signal was observed, Dy(OTf)3 (7.6 mg, 
0.013 mmol, 5 mol %) catalyst was added. Reaction progress was monitored by FTIR using 
two peaks: 1013 cm-1 for the consumption of furylcarbinol 1, and 1715 cm-1 for the 
appearance of cyclopentenone 3b.   
Experiments with Same Excess. As an internal standard, 20 µL of a 0.58 M stock 
solution of 2-methoxynaphthalene was used in each reaction. On the ReactIR, a background 
scan was taken in 65 °C acetonitrile and 2-methoxynaphthalene. Stock solutions of 
furylcarbinol 1 and aniline 2b were injected, followed by subsequent addition of solid 
Dy(OTf)3. All experiments in same excess used the same concentration of Dy(OTf)3 
(0.00625 M) and a total reaction volume of 2 mL. The following table summarizes the 
molarities and excesses of furylcarbinol 1 to aniline 2b. 
Experiment [1]0 / M [2b]0 / M [2b]-[1] / M 
Same excess [1] 0.12 0.10 - 0.02 
Same excess [1] 0.14 0.12 - 0.02 
Same excess [2b] 0.10 0.12 0.02 
Same excess [2b] 0.12 0.14 0.02 
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 The subsequent reaction solutions were analyzed by HPLC to check conversion of 
furylcarbinol 1 to the cyclopentenone 3b. The formation of cyclopentenone 3b, as monitored 




















Order in Trifluoroacetic Acid Catalyst. Stock solutions of 1, 2b, and trifluoroacetic 
acid (TFA) in acetonitrile were prepared and used within two days. Reactions were 0.125 M 
in 1 and 2b and were run at 65 °C. Concentrations of TFA were as follows: 3.125, 6.25, 
12.5, 18.75, 25, and 30 mM. To a pre-heated vial of acetonitrile, the stock solutions of 
furylcarbinol 1 and aniline 2b were added. When a steady signal was reached on the FTIR, 
an appropriate portion of the TFA stock solution was injected. The slope of the initial rate of 
formation of 2b in each reaction was used in finding the order in TFA. The positive and 
linear fit implies that the Piancatelli reaction is first order in TFA. Note: these are not 
absolute rate (k) constants, but relative k values. 
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Order in Dy(OTf)3 Catalyst. Stock solutions of 1 and 2b in acetonitrile were prepared 
and used within two days. Reactions were 0.125 M in 1 and 2b and were run at 65 °C. 
Concentrations of Dy(OTf)3 were as follows: 2, 4, 6.25, 8, 10, and 12 mM.  To a pre-heated 
vial of acetonitrile, the stock solutions of furylcarbinol 1 and aniline 2b were added. When a 
steady signal was reached on the FTIR, the appropriate amount of Dy(OTf)3 was added as a 
solid. The slope of the initial rate of formation of 2b in each reaction was used in finding the 
order in Dy(OTf)3. The positive and linear fit implies that the Piancatelli reaction is first 
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5 mol % Dy(OTf)3












A stock solution of 1 in acetonitrile was prepared and used within two days. 
Reactions were 0.125 M in 1 and the substituted aniline 2a-g and were run at 80 °C on a 2 
mL scale. To a pre-heated vial of acetonitrile, the stock solutions of furylcarbinol 1 and the 
substituted aniline 2a-g were added. When a steady signal was reached on the FTIR, 
Dy(OTf)3 (7.6 mg, 0.013 mmol, 5 mol % relative to furylcarbinol) was added as a solid. For 
the TFA-catalyzed experiments, 0.02 mL of a 0.3 M TFA stock solution was used to provide 
a 2 mL reaction solution that was 30 mM in TFA (24 mol % relative to furylcarbinol 1). The 
slopes of initial rate of formation of 3a-g in individual reactions were used in graphing the 
Hammett Plots. Note: these are not absolute rate (k) constants, but relative k values.  
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Stock solutions of 1 and 2b in acetonitrile were prepared and used within two days. 
Reactions were 0.125 M in 1 and 2b and were run at 65 °C on a 2 mL scale. To a pre-heated 
vial of acetonitrile, the stock solutions of furylcarbinol 1 and aniline 2b were added. When a 
steady signal was reached on the FTIR, 0.02 mL of a 0.3 M TFA stock solution was used to 
provide a 2 mL reaction solution that was 30 mM in TFA (24 mol % relative to aniline 2b). 
The slope of the initial rate of formation of 3b in each reaction was used in finding order in 
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a) 5 mol % Dy(OTf)3
or







Competition experiments were conducted at 80 °C with 4-chloroaniline 2c and 4-
methoxyaniline 2d to make cyclopentenones 3c and 3d, respectively. As a standard, 0.1 mL 
of a 0.101 M stock solution of 2-methoxynaphthalene for every 1 mL reaction solution was 
used. A 3 mL solution of acetonitrile and 2-methoxynaphthalene was preheated to 80 °C.  
Furylcarbinol 1 was added by dissolution from a tared syringe, followed by solid aniline 2c 
or 2d. A sample was taken at this point for analysis of initial conditions. Either Dy(OTf)3 (5 
mol % relative to furylcarbinol 1) or TFA (24 mol % relative to furylcarbinol 1) was added. 
The reactions were sampled by taking approximately 5 µL aliquots and dilution with 
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A Dy(OTf)3 0.125 0.0625 0.0625 0.0063 
B TFA 0.125 0.0625 0.0625 0.030 














































































A calibration curve was created between the two cyclopentenone products 3c and 3d 
and the standard, 2-methoxynaphthalene, to determine the selectivity for either product over 
time. Each cyclopentenone was synthesized by the standard procedure2 and purified by flash 
column chromatography (1:6 to 1:4 EtOAc:hexanes). Relative UV absorptivities at 230 nm 
with 8 µL injections were analyzed by HPLC-MS for the following calibration curves:  
 
 
The column conditions were as follows: 
A= Water, 0.05% TFA 
B= Acetonitrile, 0.05% TFA 
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      Start 10%B 
6.5 min  45%B 
18 min 65%B 
20 min 100%B 
Flow rate 0.400 mL/min 
Agilent Eclipse XDB C18, 3.5 µm, 3.0 x 75 mm column 
Derivation of Steady State Rate Law 







































Mass balance for the catalyst is given by 
1) [cattot] = [cat0] = [cat] + [Int1] + [Int2] 
By using steady state approximations, 




 ≈  0  ≈ - k1 [cat][A] + k-1 [Int1] + k2 [B][Int1] – k3[I][cat] + k-3[Int2] 
 
  2b) 
d [Int1]
dt





 ≈ 0 ≈ k3[cat][I] – k-3[Int2] 
 
Rate of product formation: 
d [P]
dt
 = k2[Int1][B] 
Define [cat] in terms of [Int1] by using 2b): 








Substitute [cat] into 2c) 
0 = k3 [I] ((k-1 + k2![B])[Int1]k1[A] !) – k-3 [Int2]     
     
[Int2] = 
k3!(k!1!+"k2![B])[Int1][I]$k!3!k1[A]    
 




 + [Int1] + k3[Int1][I]!(k!1!+"k2![B])%k!3!k1[A]    
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[cattot] = [Int1] ( (k-1 + k2![B])k1[A] !) + [Int1] + [Int1] (k3![I](k!1!+"k2![B])%k!3!k1[A] )   
[cattot] = [Int1]!k!3!(k!1!+"k2![B])%+%k!3!k1[A]$+!k3""[I](k!1!+"k2![B])%k!3!k1[A]    




Therefore, rate of product formation is: 
d B
dt
 = k2 [B][Int1] = 
k1"k2!k!3![A]$[B]$[cattot]!!!k!3!(k!1!+"k2![B])%+%k!3!k1[A]$+!k3""[I](k!1!+"k2![B]) 
 
If I = B, 
d P
dt
 = k1"k2!k!3![A]$[B]$[cattot]!!!k!3!(k!1!+"k2![B]$+$k1[A])""+!k3""(k!1[B]$+$k2"[B]2!) 
 





















4-((4-Chlorophenyl)amino)-5-phenylcyclopent-2-en-1-one (3c): According to the 
general procedure Dy(OTf)3 (4.4 mg, 0.0072 mmol, 0.05 equiv) was added to furan-2-
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yl(phenyl)methanol 1 (25.0 mg, 0.144 mmol, 1 equiv) and 4-chloroaniline 2c (18.3 mg, 
0.144 mmol, 1 equiv) in 3 mL of acetonitrile. The resulting reaction mixture was heated to 
80 ºC for 10 minutes. The reaction was then quenched with 5 mL of saturated aqueous 
sodium bicarbonate and extracted with ethyl acetate (3 x 5 mL). The combined organic 
layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue was 
purified by column chromatography to afford cyclopentenone 3c (41.2 mg, 90%) as a solid. 
1H NMR (600 MHz, CDCl3) δ 7.74 (dd, J = 5.8, 2.3 Hz, 1H), 7.37 – 7.33 (m, 2H), 7.32 – 
7.28 (m, 1H), 7.14 – 7.10 (m, 2H), 7.08 – 7.04 (m, 2H), 6.44 – 6.40 (m, 3H), 4.70 (q, J = 2.2 
Hz, 1H), 4.13 – 4.02 (m, 1H), 3.36 (d, J = 2.6 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 
206.4, 161.4, 144.8, 138.0, 135.1, 129.4, 129.2, 128.0, 127.6, 123.4, 115.0, 63.5, 60.2 ppm; 
IR (thin film) 3375, 3060, 3029, 2924, 2854, 1870, 1803, 1702, 1597, 1492, 1314, 1248, 
1178, 1090 cm-1; HRMS (ESI) m/z 306.0655 (306.0662 calcd for C17H14ClNNaO+ [M + 
Na]+); MS (ESI) m/z 284.09 (100%), 286.1 (34), 285.10 (20), 287.10 (6) (284.08, 286.08, 
















4-((4-Bromophenyl)amino)-5-phenylcyclopent-2-en-1-one (3e): According to the 
general procedure Dy(OTf)3 (4.4 mg, 0.0072 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 1 (25.0 mg, 0.144 mmol, 1 equiv) and 4-bromoaniline 2e (24.7 mg, 
0.144 mmol, 1 equiv) in 3 mL of acetonitrile. The resulting reaction mixture was heated to 
80 ºC for 15 minutes. The reaction was then quenched with 5 mL of saturated aqueous 
sodium bicarbonate and extracted with ethyl acetate (3 x 5 mL). The combined organic 
  195 
layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue was 
purified by column chromatography to afford cyclopentenone 3e (36.4 mg, 76%) as a solid. 
1H NMR (600 MHz, CDCl3) δ 7.75 (dd, J = 5.8, 2.4 Hz, 1H), 7.38 – 7.32 (m, 2H), 7.33 – 
7.27 (m, 1H), 7.23 – 7.17 (m, 2H), 7.16 – 7.10 (m, 2H), 6.44 (dd, J = 5.8, 1.7 Hz, 1H), 6.40 
– 6.36 (m, 2H), 4.73 – 4.70 (m, 1H), 4.00 (d, J = 8.5 Hz, 1H), 3.36 (d, J = 2.6 Hz, 1H) ppm; 
13C NMR (150 MHz, CDCl3) δ 206.3, 161.2, 145.2, 138.0, 135.2, 132.3, 129.2, 128.0, 
127.7, 115.5, 110.6, 63.5, 60.2 ppm; IR (thin film) 3369, 3061, 3027, 2920, 1700, 1591, 
1487, 1313 cm-1; HRMS (ESI) m/z 350.0145 (350.0156 calcd for C17H14BrNNaO+ [M + 
Na]+); MS (ESI) m/z 352.02 (100%), 350.02 (96), 351.02 (18), 353.02 (15) (352.01, 350.02, 
















4-((4-Fluorophenyl)amino)-5-phenylcyclopent-2-en-1-one (3f): According to the 
general procedure Dy(OTf)3 (8.7 mg, 0.014 mmol, 0.05 equiv) was added to furan-2-
yl(phenyl)methanol 1 (50.0 mg, 0.287 mmol, 1 equiv) and 4-fluoroaniline 2f (27.0 µL, 0.287 
mmol, 1 equiv) in 3 mL of acetonitrile. The resulting reaction mixture was heated to 80 ºC 
for 2.5 hours. The reaction was then quenched with 5 mL of saturated aqueous sodium 
bicarbonate and extracted with ethyl acetate (3 x 5 mL). The combined organic layers were 
dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified by 
column chromatography to afford cyclopentenone 3f (70.5 mg, 92%) as a solid. 1H NMR 
(500 MHz, CDCl3) δ 7.77 (dd, J = 5.7, 2.3 Hz, 1H), 7.38 – 7.27 (m, 3H), 7.15 – 7.08 (m, 
2H), 6.88 – 6.80 (m, 2H), 6.48 – 6.44 (m, 2H), 6.42 (dd, J = 5.8, 1.7 Hz, 1H), 4.69 (s, 1H), 
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3.87 (s, 1H), 3.37 (d, J = 2.6 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 206.5, 161.7, 
156.6 (d, J = 237.0 Hz), 142.5, 138.1, 135.0, 129.2, 128.0, 127.57, 116.0 (d, J = 22.5 Hz), 
115.2 (d, J = 7.5 Hz), 64.2, 60.2; IR (thin film) 3370, 3061, 3029, 2918, 1701, 1505, 1309, 
1213, 1156 cm-1; HRMS (EI+) m/z 267.1053 (267.1059 calcd for C17H14FNO+ [M]•+).  
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6. Development of an Asymmetric Aza-Piancatelli Rearrangement 
6.1. The Importance of an Asymmetric Transformation 
For today’s chemists, the ability to access a single enantiomer of a molecule is of 
paramount importance, and the field of new reaction development is dominated by novel 
asymmetric reactions. Following the development of the aza-Piancatelli rearrangement, we 
sought to further the understanding and utility of this reaction and became interested in 
exploring an asymmetric aza-Piancatelli rearrangement. Developing an asymmetric aza-
Piancatelli is a significant, but important, challenge since no asymmetric variant of the 
Piancatelli rearrangement has been reported despite the reaction being known for over thirty 
years.39  
In 1848, Louis Pasteur discovered that synthetic tartaric acid, when crystallized, is 
composed of two different separable crystals, each of which rotates light in opposite 
directions.163 This discovery of chirality in organic molecules laid the foundation for much 
of the chemistry we know today. Selective synthesis of single enantiomers forms the basis of 
much of the new chemistry that is developed, and is constantly applied in total synthesis. 
More importantly, all of life relies on and is based on chiral molecules, including amino 
acids, DNA, RNA, proteins, and enzymes. Because of the inherent chirality of biological 
molecules, it is often the case that one enantiomer of a target molecule will bind 
preferentially over another. Perhaps the most poignant example of the importance of 
chirality for synthetic chemists is the thalidomide case. Prescribed to scores of pregnant 
women as an antiemetic in the 1950s and 60s, it was soon discovered that thalidomide, 
specifically the (S)-enantiomer (2), is a teratogen (Figure 6.1).164 Thousands of children 
were born with malformed limbs, and many thousands more were never born. It was later 
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learned that the (S)-enantiomer is responsible for the devastating effects. While the (R)-
enantiomer (1) is not itself teratogenic, thalidomide racemizes under physiological 
conditions, making administration of a single enantiomer useless. This tragic and 
unfortunate example truly highlights the importance of asymmetric synthesis, as well as the 




















Figure 6.1. (R)- and (S)-enantiomers of thalidomide. 
An asymmetric aza-Piancatelli rearrangement is desirable for its application to the total 
synthesis of natural products, such as homoharringtonine (3) and stemonamine (4). It would 
also be valuable for the enantioselective synthesis of an hNK1 inhibitor since enantiomer 5 
displays an IC50 of 2.3 nM while the racemic sample (6) and the opposite enantiomer (7) 
display higher IC50 values of 5.7 and 100 nM, respectively (Figure 6.2).  





































IC50 = 100 nM
hNK1 inhibitors
 
Figure 6.2. Natural products and biologically active molecules drive the need for an 
asymmetric aza-Piancatelli rearrangement. 
 
Finally, an asymmetric aza-Piancatelli rearrangement is valuable from a fundamental 
standpoint since nothing is known yet about the interaction of chiral catalysts with these 
substrates or how to effect enantioinduction during the bond-forming 4π conrotatory 
electrocyclization poses. Our efforts to address this formidable challenge are the focus of 
this chapter.   
6.2. The Asymmetric Nazarov Cyclization 
Since there exists no example of an asymmetric Piancatelli rearrangement, we examined 
successful asymmetric rearrangements of its cousin, the Nazarov cyclization. Although there 
are a number of examples of asymmetric Nazarov cyclizations,20,21,165 there are still many 
challenges associated with this transformation, and a general transformation has yet to be 
developed. As Alison Frontier aptly stated at the 2014 Gordon Conference on Heterocyclic 
compounds: “The asymmetric Nazarov cyclization is not a solved problem.” 
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In general, enantioselectivity in 4π conrotatory electrocyclizations is established through 
selective directional conrotation in either a clockwise (cw) (10 to 11) or counter clockwise 
(ccw) (10 to 9) manner (Figure 6.3). This type of preferential conrotation in 
electrocyclizations is known as torquoselectivity, and has been studied in great detail by 
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Figure 6.3. Direction of conrotation in the Nazarov cyclization controls enantioselectivity. 
In the Nazarov cyclization this type of controlled directional electrocyclization to 
preferentially access one enantiomer over the other has been accomplished by several 
methods. Diastereoselective processes where an existing stereocenter guides the direction of 
conrotation have been described. More desirable are approaches that rely on the transfer of 
chirality from a chiral catalyst. To this end, both chiral Lewis acids and chiral 
organocatalysts have been employed. The success of these approaches has often been 
coupled to intelligent substrate design that focuses on designing strong interactions between 
the catalyst and substrate, such as two-point binding (14) (Figure 6.4). Notable progress and 
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Figure 6.4. Two-point binding of a chiral catalyst to a Nazarov substrate. 
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Denmark and co-workers reported the first example of a torquoselective Nazarov 
cyclization during their studies of a silicon directed electrocyclization in 1990.166 They 
found that the presence of a remote stereocenter could influence the direction of conrotation, 






















Scheme 6.1. Retention of stereochemistry in a silicon-directed Nazarov cyclization. 
Tius and co-workers reported another elegant approach toward an asymmetric Nazarov 
cyclization, where axial chirality from an allene is transferred to the tetrahedral chirality of 
the Nazarov product.167 The reaction proceeded in 65% yield with 95% chirality transfer 
(Scheme 6.2). The observed retention of chirality is proposed to come from a steric 
interaction between R2 and R3 that favors rotation in a counter-clockwise manner (22 to 23) 
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Scheme 6.2. Transfer of axial to tetrahedral chirality in the Nazarov cyclization. 
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Despite the value of and interest in an asymmetric Nazarov cyclization, it was not until 
fourteen years after Denmark’s report of silicon-directed chirality transfer in the Nazarov 
cyclization that an asymmetric Lewis acid catalyzed variant was reported. Aggarwal and 
Belfield described the reaction of divinyl ketones bearing α-ester (25) or α-amide (28) 
groups that can coordinate to chiral copper-pyBOX and copper-BOX complexes resulting in 















































Scheme 6.3. First asymmetric Nazarov reaction with chiral Lewis acids. 
Concurrently with Aggarwal’s report, Trauner and co-workers described a single 
example of the first catalytic asymmetric Nazarov cyclization.169 This reaction of divinyl 
ketone derivative (31) was catalyzed by a chiral pyBOX-scandium complex (32) and 
resulted in an impressive 61% ee (Scheme 6.4). The Trauner group followed up on this work 
with another report on enantioselective Nazarov reactions; however, the enantioselectivity in 
these reactions is attributed to asymmetric proton transfer rather than torquoselective 
cyclization (not shown).170 





















Scheme 6.4. The first catalytic asymmetric Nazarov cyclization. 
The first example of an organocatalytic asymmetric Nazarov cyclization was reported by 
Rueping and co-workers in 2007.171 Investigating the use of chiral Brønsted acids, they 
discovered that chiral phosphoric acids and N-triflyl phosphoramides catalyzed the 
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Scheme 6.5. First organocatalyzed enantioselective Nazarov cyclization. 
Best results were achieved with 9-phenanthryl substituted N-triflyl phosphoramide 39 in 
CHCl3 at 0 °C, yielding the desired cyclopentenones 40 and 41 in excellent yield and up to 
98% ee (Scheme 6.6).  
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Scheme 6.6. Results with optimized reaction conditions for the chiral N-triflyl 
phosphoramide catalyzed Nazarov cyclization. 
 
Tius and co-workers developed an elegant strategy for an organocatalytic asymmetric 
Nazarov cyclization with chiral thiourea catalysts.172 The method involved the synthesis of 
strategically designed diketoesters (42) capable of reversibly binding to bifunctional chiral 
catalysts (Scheme 6.7). Two-point binding to the catalyst would yield a polarized 
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Scheme 6.7. Strategy for enantioinduction using a bifunctional chiral thiourea catalyst. 
This method worked well in terms of chirality transfer and was applied to the synthesis 
of a variety of densely functionalized cyclopentenones (48-53) bearing chiral all-carbon 
quaternary centers (Scheme 6.8). However, the strategy is by no means general and 
drawbacks include slow reaction times (up to 21 days) due to product inhibition, and a 
limitation to specially synthesized substrates and catalysts.  













































































Scheme 6.8. Select scope of the chiral thiourea catalyzed Nazarov cyclization. 
The select examples discussed above represent a variety of strategies that have been 
successfully applied towards developing asymmetric Nazarov cyclizations. The strategies 
include chirality transfer, catalytic and stoichiometric reactions with chiral Lewis acid 
catalysts, as well as cyclizations with chiral organocatalysts. A commonality among the 
approaches presented is the presence of the stereodirecting group in close proximity to the 
location of bond formation. Additional examples can be found in a recent review by Tius 
and co-workers.165  
6.3. Toward an Asymmetric Aza-Piancatelli Rearrangement.  
Equipped with a knowledge of successful enantioselective Nazarov cyclizations, we 
began our investigations of an asymmetric aza-Piancatelli rearrangement. We hypothesized 
that the induction of asymmetry needs to come from preferential torquoselective cyclization 
in either a clockwise (cw) (56 to 57) or counter-clockwise (ccw) (56 to 55) direction to 
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provide preferential access to either enantiomer (Scheme 6.9). In addition, we knew that 
success in this area would likely result from the presence of the chiral unit in close 
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Scheme 6.9. Torquoselectivity will enable preferential access to enantiomers. 
Unlike the Nazarov cyclization, where the catalyst is responsible for the formation of the 
carbocation, and thus is automatically either bound to, or in close proximity of the 
pentadienyl cation, little is known about the role of the catalyst after formation of the 
oxocarbenium ion in the aza-Piancatelli rearrangement. As such, we considered four 
different approaches to the asymmetric aza-Piancatelli rearrangement (Figure 6.5). In theory 
the simplest approach would be the use of chiral amines (Figure 6.5, A). Chiral secondary 
amines are abundant, but unfortunately our studies have shown that we are limited to a small 
pKa range of nucleophiles for the rearrangement (see Chapter 4). Chiral anilines can be 
prepared, but the chiral centers are generally far removed from the bond-forming process, 
making chirality transfer unlikely. We also envisioned the design of furylcarbinols bearing a 
chiral auxiliary (Figure 6.1, B), but decided not to pursue that direction since chirality 
transfer from a catalyst is preferable in terms of broad applicability. Finally we envisioned 
the use of either chiral Lewis acids or chiral organocatalysts (Figure 6.5, C and D). These 
two strategies rely on a strong interaction between the catalyst and substrate during the 
bond-forming event for chirality transfer. Despite the lack of information about the fate of 
the catalyst in the aza-Piancatelli rearrangement, we decided to pursue these two strategies, 
confident that we would identify a catalyst that interacts with the pentadienyl intermediate. 
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Ideally, this interaction would proceed through the coordination or tight ion pair of the 
catalyst with the amine substituent or the OH group at the 4-position of the pentadienyl 
cation. 
 
Figure 6.5. Four possible approaches toward inducing enantioselectivity in the aza-
Piancatelli rearrangement. 
 
Before setting up reactions with precious chiral catalysts, we studied the reversibility of 
the reaction to ensure that enantioselectivity established by torquoselective cyclization 
would not be eroded by another process. To accomplish this, we separated the enantiomers 
of 59 using chiral preparatory HPLC, and subjected the single enantiomers to a variety of 
reaction conditions (Table 6.1). We found that there is no change in enantiopurity in the 
presence of dysprosium at rt (entry 1), but that this enantiopurity is eroded under standard 
reaction conditions with Dy(OTf)3 at 80 °C over time (Table 6.1, entries 2 and 3) and 
applies to either enantiomer. Finally, in the absence of Dy(OTf)3, heating at 80 °C does not 
erode the enantiopurity (entry 5). Based on these results, we focused our efforts on reactions 
at room temperature to avoid loss of the established enantioselectivity over the course of the 
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Entry Enantiomer Catalyst (5 mol %) Temp [°C] Time 60:61[b] 
1 60 Dy(OTf)3 23 17 h 100:0 
2 60 Dy(OTf)3 80 30 min 73:27 
3 60 Dy(OTf)3 80 4 h 49:51 
4 61 Dy(OTf)3 80 4 h 49:51 
5 61 -- 80 4 h 0:100 
[a] The absolute configuration of the isomers has not been determined. The depicted configuration 
was arbitrarily assigned. [b] Ratios were determined by analytical HPLC.  
 
 
6.3.1. Chiral Lewis Acid Catalysis 
Our first attempts at an asymmetric aza-Piancatelli rearrangement were based on 
reactions catalyzed by RE(OTf)3 in combination with chiral ligands, including reactions 
inspired by Trauner’s success with pyBOX-scandium complexes.169,170 We chose to perform 
all reactions at room temperature based on the results in Table 6.1. One general drawback of 
the aza-Piancatelli rearrangement that we were aware of from the start is that the reaction 
proceeds quickly and cleanly in polar solvents, but is sluggish and results in formation of 
substitution products in nonpolar solvents. This is unfortunate for an asymmetric reaction 
where chemists often rely on nonpolar solvents to encourage strong interactions between 
polar substrates and catalysts.  
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To our disappointment, reactions with scandium-pyBOX complexes resulted in no 
enantioselectivity (Scheme 6.10). The use of bis-phenylfurylcarbinol 65 and chiral 
scandium-pyBOX were performed at elevated temperatures since the stereocenter cannot be 
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Scheme 6.10. Aza-Piancatelli rearrangements with scandium pyBOX complexes. 
Interestingly, a recent result showed that the addition of 5 mol % sodium tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate (NaBArF, 70) to the scandium-pyBOX reaction of 
phenylfurylcarbinol 62 and p-iodoaniline in toluene results in 10% ee (Figure 6.6).173 
Although this is an incremental advance, it does show that there is potential for a chiral 
Lewis-acid catalyzed aza-Piancatelli rearrangement.   
















17 mol % 68
10 mol % Sc(OTf)3










Figure 6.6. Reaction with NaBArF additive. 
We examined a number of other RE(OTf)3 based chiral catalyst systems with no success 
(Scheme 6.11).  Commercially available europium shift reagent 71, which could potentially 
act as a Lewis acid, did not catalyze the aza-Piancatelli rearrangement. Reactions with a (R)-
BINOL and Dy(OTf)3 did result in product formation, but unfortunately no enantioinduction 
was observed. Enantioinduction was also absent when using Kobayashi’s conditions with 
BINOL, Yb(OTf)3 and Hünig’s base (not pictured).174 The same goes for a reaction 
catalyzed by a lanthanum-N, N’-dioxide complex 72,175,176 as well as a europium complex 
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48 mol % 73
20 mol % Eu(OTf)3
0% ee  
Scheme 6.11. Aza-Piancatelli rearrangement with a variety of chiral RE(OTf)3 complexes.  
  211 
 
6.3.2. Chiral Organocatalysis 
With little success using chiral Lewis acid complexes for the asymmetric aza-Piancatelli, 
we turned to organocatalysts inspired by Tius and co-worker’s work.172 We chose to 
examine both chiral thiourea, as well as chiral cinchona alkaloid catalysts, which could 
potentially transfer chirality to the electrocyclization through hydrogen-bonding interactions 
or through a tight ion pair.   
As with the chiral Lewis acid complexes, reactions with chiral thiorueas 74 and 75 did 
not result in an asymmetric transformation (Scheme 6.12). In fact, addition of 75 did not 
result in any reaction. Addition of 20 mol % Dy(OTf)3 did result in product formation, but 






































Scheme 6.12. Chiral thiourea catalyzed aza-Piancatelli rearrangements. 
Speculating that a second binding site might be necessary for successful transfer of 
chirality from the catalyst to the substrate,172 we synthesized furylcarbinol 76 with a 
phenolic alcohol that could serve as a secondary binding site. To our disappointment, no 
reaction was observed when using either thiourea catalyst (Scheme 6.13), despite the 
success of the transformation utilizing standard Dy(OTf)3 reaction conditions.  











HOx20 mol % 74 or 75MeCN, rt
 
Scheme 6.13. A second binding site shuts down the aza-Piancatelli rearrangement with 
chiral thiourea catalysts. 
 
Chiral cinchona alkaloids 78 and 79 were also tested, but resulted in either no reaction or 






78 79  
Figure 6.7. Cinchona alkaloids are ineffective chiral catalysts for the aza-Piancatelli 
rearrangement. 
 
6.3.3. Chiral Phosphoric Acid Catalysis 
Disappointed with the lack of success thus far, we finally turned to chiral Brønsted acid 
catalysis as a means for torquoselective cyclization in the aza-Piancatelli rearrangement. 
Although (–)-camphorsulfonic acid (pKA 1.2) readily catalyzes the aza-Piancatelli 
rearrangement, no enantioselectivity was observed. With Rueping’s organocatalytic 
asymmetric Nazarov cyclization in mind,171 we became interested in exploring chiral 
phosphoric acids. The pKas of chiral phosphoric acids and derivatives vary depending on 
substituents and the choice of solvent, but generally range from 6 to -4,178,179 leading us to 
believe that the more acidic cases could catalyze the aza-Piancatelli rearrangement.  
  213 
Summarized in Table 6.2 are the results of the reaction with a variety of chiral 
phosphoric acids in MeCN and PhMe. While (R)-VAPOL was quite ineffective as a catalyst, 
we did detect 4% ee (Table 6.2, entry 1). We were delighted to find that Benjamin List’s 
bulky (R)-TRIP would not only catalyze the rearrangement,180,181 but also resulted in an 
impressive and unprecedented 46% ee in MeCN and 49% ee in MeNO2 at rt (Table 6.2, 
entries 2 and 3). These results represent the very first examples of an asymmetric aza-
Piancatelli rearrangement with reasonable selectivity. HPLC traces of the racemic 
dysprosium catalyzed reaction and the reaction with 20 mol % (R)-TRIP resulting in 46% ee 
(27:73 enantiomeric ratio) are shown in Figure 6.8.  
 
Figure 6.8. HPLC traces of the A) racemic and B) enantioselective aza-Piancatelli 
rearrangement.  
 
Increasing the amount of chiral phosphoric acid to a full equivalent did not increase the 
enantioselectivity or rate of the reaction. It should be noted that reactions with (R)-TRIP and 






A) 5 mol % Dy(OTf)3
MeCN, 80 °C
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decided to initially focus mainly on enantioselectivity rather than rate enhancement, and 
therefore do not report yields of reactions. 













































































       [a] Catalyst donated by Sigma-Aldrich. [b] Catalyst prepared in the Read de Alaniz lab. 
        [c] Catalyst donated by the Antilla group.  
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Entry Catalyst Solvent % ee 
1 (R)-VAPOL MeCN 4 
2 (R)-TRIP MeCN 46 
3 (R)-TRIP MeNO2 49 
4 (R)-TRIP PhMe 29 
5 (R)-TRIP CH2Cl2 19 
6 80 MeCN 5 
7 80 PhMe 34 
8 81 MeCN 9 
9 81 PhMe 12 
10 (R)-STRIP MeCN 12 
11 82 MeCN 5 
12 83 MeCN no reaction 
13 84 MeCN 36 
 
Although there is some precedent for successful enantioinduction with chiral phosphoric 
acids in MeCN,182 best results are usually achieved in nonpolar solvents such as toluene. We 
found that the asymmetric aza-Piancatelli is fairly unusual in that reactions with (R)-TRIP in 
toluene or CH2Cl2 result in lower selectivity compared to polar MeCN and MeNO2 (Table 
6.2, entries 4 and 5 vs entries 2 and 3).182 Interestingly however, trifluoromethyl-substituted 
chiral phosphoric acid 80 followed a more traditional path, resulting in increased reaction 
times with low enantioselectivity in MeCN but good selectivity in toluene (Table 6.2, entries 
6 and 7). The increased reaction rates can be attributed to a lower pKa value of 80 (pKa = 
2.63) compared to that of (R)-TRIP (pKa = 3.18).179 Use of chiral phosphoric acid 81 
resulted in only 9 and 12% ee in MeCN and toluene, respectively (Table 6.2, entries 8 and 
9), and was not further pursued.  
Thanks to a generous donation by Professor Jon Antilla at the University of South 
Florida, we were also able to test reactions with chiral phosphoric acids based on the 1,1’-
spirobiindane backbone, including (R)-STRIP and 82.183 We hoped that the more rigid chiral 
pocket might generate an increase in enantioselectivity, but unfortunately the chiral pocket 
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must be too small for the aza-Piancatelli rearrangement, and a decrease in enantioselectivity 
was observed for both (R)-STRIP and 82 (Table 6.2, entries 10 and 11). Along the same 
lines, List reported the synthesis of the dimeric imidophosphoric acid 83,184 which we 
synthesized, but found that it did not catalyze the reaction (Table 6.2, entry 12). One 
challenge we faced with the use of chiral phosphoric acids was solubility. Often heterogenic 
mixtures formed and it was difficult to determine if this affected our enantioselectivity. To 
probe this question, we sought to use more lipophilic variants of the catalyst. Lipophilic (R)-
TRIP derivative 84 was prepared by undergraduate researcher Aurora Ginzburg,185 but 
despite the alkyl chains increasing the solubility of the catalyst in MeCN, the 
enantioselectivity was not positively affected (Table 6.2, entry 13).  
We hypothesized that the source of the observed enantioselectivity comes from an 
interaction between the chiral phosphoric acid and the pentadienyl cation in one of two ways 
(Figure 6.9). The chiral phosphoric acid could serve as a chiral counterion that interacts 
either with the amine (85) or, alternatively, interacts with the alcohol on the other side (86). 
Alternatively, one could imagine the presence of π-stacking interactions between the chiral 





















Figure 6.9. Proposed points of catalyst-substrate interactions. 
We hoped to hone in on the catalyst-substrate interaction, and perhaps positively 
influence enantioselectivity, by examining the scope of the rearrangement with our best 
catalyst, (R)-TRIP. If successful, this would allow us to rationally design new catalysts. The 
results of this investigation are summarized in Table 6.3.  
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The (R)-TRIP catalyzed aza-Piancatelli rearrangement with p-cyanoaniline (90) resulted 
in similar enantioselectivity as p-iodoaniline (64) while sterically bulky 2,4,6-
trimethylaniline results in cyclopentenone 91 with an impressive 52% ee. However, the 
formation of 91 is extremely sluggish and the reaction did not go to completion over the 
course of a month. Switching from furylcarbinol 62 to its more activated acylated equivalent 
did speed the reaction up a bit, but resulted in only 45% ee (not depicted). Employing more 
activated p-methoxy substituted furylcarbinol, the reaction was significantly faster, but 
resulted in a small drop in enantioselectivity (92). The use of an alkyl substituent or 
sterically bulky triisopropylphenyl furylcarbinol resulted in a marked drop in 
enantioselectivity down to 27% and 16%, respectively (93 and 94).  
In an attempt to further our understanding of where the chiral catalyst sits during the 
stereodetermining event (Figure 6.9), we examined a number of substrates. Use of secondary 
N-methyl aniline resulted in nearly complete erosion of selectivity (95). The presence of a 
potential secondary binding point on the R1 substituent had no effect on the 
enantioselectivity compared to a simple aryl group (96 compared to 91). In an effort to trap 
the stereochemical configuration after the reaction, we performed the reaction with 2-
aminophenol, where a Michael addition into the enone follows the rearrangement.186 
Unfortunately, the reaction with 2-aminophenol resulted in greatly reduced 
enantioselectivity (97). It should be noted that this reaction does proceed through an aza-
Piancatelli first, since phenols do not participate in the Piancatelli rearrangement.  
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42% ee  
 [a] The reaction was performed in MeNO2.  
N-Phenylhydroxylamine (98) and N,O-dibenzylhydroxylamine (100) performed 
similarly to anilines, showing no improvement due to the presence of potential binding 
points. Finally, we proposed that the presence of an R1 group capable of π-stacking, such as 
naphthalene, may improve the interaction with (R)-TRIP and result in greater 
enantioselectivity based on a report by Jacobsen with chiral thiourea catalysts,187 but again 
we observed no such effect (99). Reactions with donor-acceptor cyclopropane substituted 
furans were not catalyzed by chiral phosphoric acids.140  
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Proposing that a tethered nucleophile may simplify the reaction and thus lead to an 
increase in enantioselectivity, we tested the (R)-TRIP catalyzed intramolecular aza-
Piancatelli rearrangement. Although the reactions were catalyzed, enantioselectivities in the 
intramolecular aza-Piancatelli rearrangement were lower than those with an external 
nucleophile (Table 6.4, 103-105).  
































At this point, we had examined a variety of chiral phosphoric acids and identified (R)-
TRIP as the best contender and had also studied the scope of the aza-Piancatelli 
rearrangement and determined that (R)-TRIP is an excellent catalyst effecting up to 52% ee. 
However, our attempts at influencing the enantioselectivity of the reaction via substrate 
control did not further our understanding of the binding mode of the catalyst and the origin 
of torquoselectivity that leads to the observed enantiomeric excess. Since the synthesis of 
chiral phosphoric acids is fairly involved and modification of the BINOL backbone occurs 
early on in the synthesis, we decided to focus on examining additives for the (R)-TRIP 
catalyzed aza-Piancatelli rearrangement.  
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6.3.4. Additives in the Chiral Phosphoric Acid Catalyzed Aza-Piancatelli 
Rearrangement  
The literature on chiral phosphoric acids is full of examples of increased reactivity and 
enantioselectivity in the presence of a wide range of additives, and we decided to explore 
some of these options in the search for increased reactivity and enantioselectivity. Reactions 
with (R)-TRIP in MeCN often take weeks to go to completion, but proceed faster in MeNO2 
(8 days; Table 6.2, entry 3). Obviously faster reaction times are desired, and we hoped that 
additives might provide the necessary increased activation as well as enantioselectivity. Our 
first forays into additives started with the addition of metal catalysts.  
Reactions that pair chiral phosphoric acid catalysts and rare earth triflates have been 
reported by Inanaga and co-workers for enantioselective HDA reactions,188 leading us to 
evaluate a combination of (R)-TRIP and Dy(OTf)3. Our hope was that dysprosium would 
give the added activation boost while allowing the chiral phosphoric acid to direct the 
stereodetermining event. Although it was pleasing to find that the reaction proceeded much 






20 mol % (R)-TRIP
10 mol % Dy(OTf)3
MeCN, rt






28% ee  
Scheme 6.14. (R)-TRIP catalyzed reaction with dysprosium additive. 
Other chiral phosphoric acid-metal catalyst systems have been reported, and we chose to 
test the aza-Piancatelli reaction with some additives that have been shown to increase 
enantioselectivity, including: MgF2,189 CuCl2,190 Cu(OTf)2, (PPh3)AuCl191,192 and ZnBr2. 
While MgF2 had no effect on the enantioselectivity or rate of the reaction (Table 6.5, entry 
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1), reactions with copper, gold and zinc additives resulted in much lower selectivity but 
increased reaction rates (Table 6.5, entries 2-4).  






20 mol % additive









Entry Additive Time[a] Yield (%) % ee 
1 MgF2 22 d -- 44 
2 CuCl2 1 d 40 39 
3 Cu(OTf)2 10+ d 82 27 
4[b] (PPh3)AuCl 4 d 21 16 
5 ZnBr2 1 d 91 27 
[a] The reaction with (R)-TRIP without additives does not go to completion in 20 days. [b] Reaction 
performed in toluene. 
With no observed enhanced enantioselectivity using metal additives, we next turned to 
the addition of acid or base to the reaction as summarized in Table 6.6.  As may be expected 
based on our earlier control experiments with triflic acid (Chapter 2, Table 2.1), addition of 
KOtBu shuts down the reaction completely (Table 6.6, entry 1). Surprisingly, some product 
formed in the presence of NaHCO3, albeit with 5% ee (Table 6.6, entry 2). Basic alumina, 
on the other hand had no effect on the (R)-TRIP catalyzed reaction in terms of selectivity 
(Table 6.6, entry 3). Addition of acetic acid, which does not catalyze the reaction itself 
(Chapter 2, Table 2.1), had no effect on the reaction, resulting in the usual 45% ee (Table 
6.6, entry 4). Addition of 20 mol % hexafluoroisopropanol (HFIP), which might increase the 
ability of the pentadienyl cation and chiral phosphoric acid to interact through strong 
hydrogen bonds, also did not affect the enantioselectivity of the reaction (Table 6.6, entry 5).  
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x mol % additive









Entry Additive x % ee 
1 KOt-Bu 100 no reaction 
2 NaHCO3 100 5 
3[a] basic alumina 600 44 
4 AcOH 15 45 
5 HFIP 20 47 
    [a] One small scoop, equal to approximately 10 mg Al2O3 was added. 
Steering away from these basic additives, we entered the arena of chiral additives. 
Combinations of chiral phosphoric acids with chiral cinchona alkaloids have resulted in 
excellent selectivity in double Michael addition reactions.193 Reactions of (R)-TRIP with 79 
and 78 led to 34 and 44% ee, respectively (Table 6.7). Further pursuing this concept, we 
examined reactions with (R)-TRIP and chiral thiourea catalysts 75 and 76, which also had 
no effect on the enantioselectivity of the rearrangement. Addition of pyBOX ligands, which 
resulted in no enantioselectivity in reactions with scandium triflate, resulted in a slight 
increase in enantioselectivity in MeNO2 (Table 6.7, 69 and 68).  
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20 mol % additive

























































Pursuing reactions with additives further, we examined the addition of other chiral and 
achiral amines. List and co-workers have reported successful asymmetric epoxidation 
reactions in the presence of amine additives.194,195 Addition of NEt3 shuts down the aza-
Piancatelli rearrangement completely, as was expected from the difficulties encountered in 
developing an aza-Piancatelli rearrangement with non-aniline amines (Chapter 4). 
Interestingly, the addition of chiral Koga bases (106-108),196 generously provided by the 
Zakarian group, did not completely shut down the reaction (Scheme 6.15). Unfortunately, 
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however, the products recovered from reactions in the presence of Koga bases exhibited 






20 mol % Koga base


























Scheme 6.15. Asymmetric aza-Piancatelli rearrangement with Koga base additives. 
To our delight, addition of 4-(dimethylamino)pyridine (DMAP) or 2,6-di-tert-butyl-4-
methylpyridine (DTBMP) to the reaction resulted in 49% and 50% ee, respectively (Table 
6.8, entry 1 and 2). A solvent switch to MeNO2 with the addition of DTBMP resulted in an 
unprecedented 59% ee (Table 6.8, entry 3); the highest enantioselectivity observed for an 
aza-Piancatelli rearrangement to date. Varying the amount of DTBMP had little effect on the 
enantioselectivity (Table 6.8, entry 4 and 5), but the balance between reactivity and 
enantioselectivity was achieved with equimolar ratios of (R)-TRIP and DTBMP (Table 6.8, 
entry 3). Attempting to further increase the selectivity, we tested Gregory Fu’s chiral DMAP 
catalysts 109 and 110,197,198 but found that selectivities were not affected (Table 6.8, entry 6 
and 7).  
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109 110  
Entry Additive x Solvent % ee 
1 DMAP 20 MeCN 49 
2 DTBMP 20 MeCN 50 
3 DTBMP 20 MeNO2 59 
4 DTBMP 10 MeNO2 57 
5[a] DTBMP 40 MeNO2 61 
6 109 15 MeCN 40 
7 110 15 MeCN 41 
[a] Although this is the highest observed enantioselectivity, the reaction was inhibited by 
the presence of additional DTBMP. 
Currently, the best results for the asymmetric aza-Piancatelli rearrangement are achieved 
when using a combination of 20 mol % (R)-TRIP and 20 mol % DTBMP in MeNO2, 
resulting in up to 59% ee. Although there is still much room for improvement in the 
asymmetric aza-Piancatelli, the current progress is impressive in its own right and further 
studies will certainly result in the desired >90% enantiomeric excess. 
6.4. Future Directions 
Much work has been done in the area of the asymmetric aza-Piancatelli, but there are 
still paths that have been largely unexplored. Considering the amount of avenues explored 
with limited success certainly indicate that this reaction might benefit from MacMillan’s 
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accelerated serendipity approach.199 In the meantime, further investigations into other chiral 
phosphoric acids and derivatives could lead to greater enantioselectivity. Although the 
synthesis of chiral phosphoric acids is cumbersome, there clearly is a fine line between 
reactivity and selectivity in the aza-Piancatelli, and synthesis of the “right” catalyst could 
strike the necessary balance. Additionally, the current success with additives suggests that 
there may be a perfectly suitable additive that can generate the desired cyclopentenones in 
good yield and enantioselectivity. For example, the addition of chiral boronic acids, which 
was recently reported by Toste and co-workers,200 may be a new avenue to explore. 
Reactions with other chiral metals such as chiral bismuth complexes,201,202 derivatives of 
Shibasaki’s REMB rare earth complexes,203 or chiral zinc or iron complexes might also be 
investigated.204,205  
 Some recent forays into NaBArF (70) as an additive have shown that the aza-Piancatelli 
rearrangement proceeds at lower temperatures and, more importantly, in nonpolar solvents 
such as toluene. The ability to perform the aza-Piancatelli rearrangement in nonpolar 
solvents opens up new windows of opportunity in terms of influencing tight binding 
between catalyst and substrate. It may be worth pursuing the reaction in toluene with chiral 
phosphoric acids and NaBArF and other additives.  
Another avenue that might be considered is the use of ionic liquids for the reaction. Dr. 
Donald Wenz successfully performed some aza-Piancatelli rearrangements in ionic liquids. 
If using a chiral ionic liquid, it is possible that the chiral medium itself could induce 
enantioselectivity.206 
Finally, theoretical studies as well as kinetic and mechanistic analyses along the lines of 
our recent collaboration with the Hein lab might lead to insights regarding the binding mode 
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of the catalyst and substrate that leads to torquoselective cyclization. Such a basic 
understanding could guide reaction development.  
6.5. Experimental Procedures 
General Information. Unless stated otherwise, reactions were conducted in flame-dried 
glassware under an atmosphere of air using reagent grade solvents. All commercially 
obtained reagents were used as received. Reaction temperatures were controlled using an 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates, (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with anisaldehyde and potassium permanganate. 
Flash column chromatography was performed using normal phase silica gel (60 Å, 0.040 – 
0.063 mm, Geduran). Chiral HPLC data was obtained on a Shimadzu instrument equipped 
with LC-6AD pumps and a diode array detector using HPLC grade hexanes and isopropyl 
alcohol (IPA) as eluents. The chiral columns employed were Chiralpak IA (4.6 mm diameter 
x 250 mmL with 5 µm particle size) and Chiralpak IB (4.6 mm diameter x 250 mmL with 5 
µm particle size). HPLC spectra were examined at 254 nm wavelength. Enantiomeric excess 
(ee) is determined from the ratio of one enantiomer (R) to the other enantiomer (S) using the 




















Reversibility Studies. To determine the reversibility of the rearrangement, the 
enantiomers of cyclopentenone 59 were separated via preparatory chiral HPLC using an OJ-
H preparatory column eluting with 5% IPA in hexanes on the Zakarian group’s instrument. 
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The purity of the single enantiomer was confirmed by analytical HPLC on a Chiralpak IA 
column eluting with 10% IPA in hexanes (retention times: 7.24 min, 9.16 min), before 
submitting it to test reactions. Reversibility studies were all performed using solutions of 
cyclopentenone 60 or 61 in MeCN with conditions as summarized in Table 6.1.  
6.5.1. Reactions with Chiral Lewis Acid Complexes.  
General Procedure. Unless otherwise stated, reactions were set up as follows. A 
solution of RE(OTf)3 and chiral ligand in MeCN was stirred at rt for thirty minutes prior to 
addition of a solution of furylcarbinol 62 and p-iodoaniline (63) in MeCN. The reaction was 
monitored by TLC and, upon completion or after a sufficient amount of product had formed 
by TLC, was quenched with saturated NaHCO3 and extracted (3x EtOAc). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 














17 mol % pyBOX








68 69  
 Reaction with 68:169,170 Furylcarbinol 62 (5.0 mg, 0.029 mmol), p-iodoaniline (6.4 mg, 
0.029 mmol), pyBOX 68 (1.9 mg, 0.0049 mmol), Sc(OTf)3 (1.4 mg, 0.0029 mmol), 1 mL 
MeCN. 0% ee (Chiralpak IA, 1.0 mL/min, 10% IPA; retention times: 19.91, 29.47).  
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Reaction with 69:169,170 Furylcarbinol 62 (5.0 mg, 0.029 mmol), p-iodoaniline (6.4 mg, 
0.029 mmol), pyBOX 69 (1.8 mg, 0.0049 mmol), Sc(OTf)3 (1.4 mg, 0.0029 mmol), 1 mL 
MeCN. 0% ee (Chiralpak IA, 1.0 mL/min, 10% IPA; retention times: 19.47, 28.9). 
 
17 mol % pyBOX


















Reaction with 68:169,170 Furylcarbinol 65 (50.1 mg, 0.20 mmol), p-iodoaniline (43.8 mg, 
0.20 mmol), pyBOX 68 (13.4 mg, 0.034 mmol), Sc(OTf)3 (9.84 mg, 0.020 mmol), 5 mL 
MeCN. 0% ee (Chiralpak IA, 1.0 mL/min, 10% IPA retention times: 9.27 min, 9.92 min).  
Reaction with 69:169,170 Furylcarbinol 65 (50.1 mg, 0.20 mmol), p-iodoaniline (43.8 mg, 
0.20 mmol), pyBOX 69 (12.6 mg, 0.034 mmol), Sc(OTf)3 (9.84 mg, 0.020 mmol), 5 mL 

















17 mol % 68
10 mol % Sc(OTf)3








Reaction with 68 and NaBArF: Furylcarbinol 62 (10.0 mg, 0.057 mmol), p-iodoaniline 
(12.6 mg, 0.20 mmol), 68 (3.8 mg, 0.0098 mmol), Sc(OTf)3 (2.8 mg, 0.0057 mmol), 
NaBArF (70) (2.5 mg, 0.0029 mmol), 2 mL PhMe. 10% ee (Chiralpak IB, 1.0 mL/min, 10% 
IPA; retention times: 19.26 min minor, 24.73 min major). 
 

















20 mol % (R)-BINOL









10 mol % 72









48 mol % 73
20 mol % Eu(OTf)3  
Reaction with (R)-BINOL: Furylcarbinol 62 (13.1 mg, 0.075 mmol), p-iodoaniline 
(16.4 mg, 0.075 mmol), (R)-BINOL (6.6 mg, 0.026 mmol), Dy(OTf)3 (9.1 mg, 0.015 mmol), 
2.5 mL MeCN. 0% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.89 min, 
26.22 min). 
Reaction with 72:175,176 Furylcarbinol 62 (20.0 mg, 0.11 mmol), p-iodoaniline (24.1 mg, 
0.11 mmol), 72 (12.9 mg, 0.022 mmol), La(OTf)3 (5.6 mg, 0.011 mmol), 3 mL MeCN. 0% 
ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.83 min, 25.74 min). 
Reaction with 73:177 Furylcarbinol 62 (2.0 mg, 0.011 mmol), p-iodoaniline (2.5 mg, 
0.011 mmol), 73 (2.2 mg, 0.0055 mmol), Eu(OTf)3 (1.4 mg, 0.0023 mmol), 1 mL MeCN. 
0% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.57 min, 25.81 min). 
 
6.5.2. Reactions with Chiral Organocatalysts  
General Procedure. A solution of furylcarbinol 62 and p-iodoaniline (63) in MeCN was 
treated with the organocatalyst and stirred at rt. The reaction was monitored by TLC and, 
upon completion or after a sufficient amount of product had formed by TLC, was quenched 
with saturated NaHCO3 and extracted (3x EtOAc). The combined organic layers were dried 
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over MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 




























Reaction with 74: Furylcarbinol 62 (10.0 mg, 0.057 mmol), p-iodoaniline (13.1 mg, 
0.057 mmol), 74 (6.1 mg, 0.012 mmol), 1 mL MeCN. 0% ee (Chiralpak IA, 1.0 mL/min, 
10% IPA; retention times: 13.93 min, 20.07 min). 
 
6.5.3. Reactions with Chiral Phosphoric Acids  
General Procedure. A solution of furylcarbinol 62 and p-iodoaniline (63) in the desired 
solvent was treated with the chiral phosphoric acid and stirred at rt. The reaction was 
monitored by TLC and, upon completion or after a sufficient amount of product had formed 
by TLC, was quenched with saturated NaHCO3 and extracted (3x EtOAc). The combined 
organic layers were dried over MgSO4, filtered and then concentrated in vacuo. The residue 
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Reaction with (R)-VAPOL: Furylcarbinol 62 (6.3 mg, 0.036 mmol), p-iodoaniline (7.9 
mg, 0.036 mmol), (R)-VAPOL (4.0 mg, 0.0067 mmol), 1 mL MeCN. 0% ee (Chiralpak IB, 











Reaction with (R)-TRIP: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 
mg, 0.015 mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), 0.5 mL solvent. MeCN: 46% ee 
(Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.40 min minor, 25.28 min major). 
MeNO2: 49% ee (Chiralpak IA, 1.0 mL/min, 10% IPA; retention times: 13.85 min minor, 
19.99 min major). PhMe: 29% ee (Chiralpak IA, 1.0 mL/min, 10% IPA; retention times: 
13.66 min minor, 19.62 min major). CH2Cl2: 19 % ee (Chiralpak IA, 1.0 mL/min, 10% IPA; 
retention times: 14.20 min minor, 20.44 min major). 









Reaction with 80: Furylcarbinol 62 (5.0 mg, 0.029 mmol), p-iodoaniline (6.4 mg, 0.029 
mmol), 80 (4.5 mg, 0.0058 mmol), 1 mL solvent. MeCN: 5% ee (Chiralpak IA, retention 
times: 14.13 min minor, 20.50 min major). PhMe: 34% ee (Chiralpak IB, 1.0 mL/min, 10% 








Reaction with 81: Furylcarbinol 62 (5.0 mg, 0.029 mmol), p-iodoaniline (6.4 mg, 0.029 
mmol), 81 (4.1 mg, 0.0058 mmol), 1 mL solvent. MeCN: 9% ee (Chiralpak IB, retention 
times: 19.77 min minor, 25.96 min major). PhMe: 12% ee (Chiralpak IB, 1.0 mL/min, 10% 
IPA; retention times: 19.53 min minor, 25.76 min major). 









Reaction with (R)-STRIP: Furylcarbinol 62 (2.0 mg, 0.011 mmol), p-iodoaniline (2.4 
mg, 0.011 mmol), (R)-STRIP (1.6 mg, 0.0022 mmol), 0.5 mL MeCN. 12% ee (Chiralpak 





Reaction with 82: Furylcarbinol 62 (2.0 mg, 0.011 mmol), p-iodoaniline (2.4 mg, 0.011 
mmol), 82 (1.2 mg, 0.0022 mmol), 0.5 mL MeCN. 5% ee (Chiralpak IB, 1.0 mL/min, 10% 
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Reaction with 84: Furylcarbinol 62 (2.0 mg, 0.011 mmol), p-iodoaniline (2.4 mg, 0.011 
mmol), 84 (2.2 mg, 0.0022 mmol), 0.5 mL MeCN. 36% ee (Chiralpak IB, 1.0 mL/min, 10% 
IPA; retention times: 19.16 min minor, 23.97 min major). 
 
6.5.4. Reaction Scope with (R)-TRIP 
General Procedure. A solution of furylcarbinol and aniline in the desired solvent was 
treated with (R)-TRIP and stirred at rt. The reaction was monitored by TLC and, upon 
completion or after a sufficient amount of product had formed by TLC, was quenched with 
saturated NaHCO3 and extracted (3x EtOAc). The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by column 












+ 20 mol % (R)-TRIP
MeCN, rt
 
90: Furylcarbinol 62 (2.6 mg, 0.015 mmol), 4-aminobenzonitrile (111) (1.8 mg, 0.015 
mmol), (R)-TRIP (2.3 mg, 0.0030 mmol) in 1 mL MeCN. 43% ee (Chiralpak IB, 1.0 

















+ 20 mol % (R)-TRIP
MeCN, rt
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91: Furylcarbinol 62 (5.0 mg, 0.029 mmol), 2,4,6-trimethylaniline (112) (3.9 mg, 0.029 
mmol), (R)-TRIP (4.4 mg, 0.0058 mmol) in 1 mL MeCN. 52% ee (Chiralpak IA, 1.0 
















+ 20 mol % (R)-TRIP
MeCN, rt
 
92: Furylcarbinol 113 (2.9 mg, 0.014 mmol), 2,4,6-trimethylaniline (112) (1.9 mg, 0.014 
mmol), (R)-TRIP (2.1 mg, 0.0028 mmol) in 0.5 mL MeCN. 47% ee (Chiralpak IA, 1.0 















+ 20 mol % (R)-TRIP
MeCN, rt
 
93: Furylcarbinol 114 (4.2 mg, 0.030 mmol), p-iodoaniline (6.4 mg, 0.030 mmol), (R)-
TRIP (4.5 mg, 0.006 mmol) in 0.5 mL MeCN. 27% ee (Chiralpak IA, 1.0 mL/min, 10% 















+ 20 mol % (R)-TRIP
MeCN, rt iPr
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94: Furylcarbinol 115 (4.2 mg, 0.014 mmol), p-iodoaniline (3.1 mg, 0.014 mmol), (R)-
TRIP (2.1 mg, 0.0028 mmol) in 0.5 mL MeCN. 16% ee (Chiralpak IB, 1.0 mL/min, 10% 













Me+ 20 mol % (R)-TRIP
MeCN, rt
 
95: Furylcarbinol 62 (5.0 mg, 0.029 mmol), N-methylaniline (116) (3.1 mg, 0.029 
mmol), (R)-TRIP (4.4 mg, 0.0058 mmol) in 1 mL MeCN. 4% ee (Chiralpak IB, 1.0 mL/min, 

















+ 20 mol % (R)-TRIP
MeCN, rt
 
96: Furylcarbinol 117 (5.0 mg, 0.018 mmol), 2,4,6-trimethylaniline (112) (2.4 mg, 0.018 
mmol), (R)-TRIP (2.7 mg, 0.0036 mmol) in 1 mL MeCN. 49% ee (Chiralpak IB, 1.0 












+ 20 mol % (R)-TRIP
MeCN, rt
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97: Furylcarbinol 62 (5.0 mg, 0.029 mmol), 2-aminophenol (118) (3.2 mg, 0.029 mmol), 
(R)-TRIP (4.4 mg, 0.0058 mmol) in 1 mL MeCN. 7% ee (Chiralpak IB, 1.0 mL/min, 10% 













HO+ 20 mol % (R)-TRIP
MeCN, rt
 
98: Furylcarbinol 62 (2.6 mg, 0.015 mmol), N-phenylhydroxlamine (119) (1.6 mg, 0.015 
mmol), (R)-TRIP (2.5 mg, 0.0030 mmol) in 0.5 mL MeCN. 41% ee (Chiralpak IB, 1.0 












20 mol % (R)-TRIP
MeCN, rt
 
99: Furylcarbinol 120 (3.3 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 mmol), (R)-
TRIP (2.3 mg, 0.0030 mmol) in 0.5 mL MeCN. 41% ee (Chiralpak IB, 1.0 mL/min, 10% 















OBn 20 mol % (R)-TRIP
MeNO2, rt
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100: Furylcarbinol 62 (2.0 mg, 0.012 mmol), N,O-dibenzylhydroxylamine (121) (2.5 
mg, 0.012 mmol), (R)-TRIP (1.7 mg, 0.0023 mmol) in 0.5 mL MeNO2. 42% ee (Chiralpak 

















103: Furylcarbinol 122 (2.3 mg, 0.0066 mmol), (R)-TRIP (1.0 mg, 0.0013 mmol) in 0.5 
mL MeCN. 36% ee (Chiralpak IA, 1.0 mL/min, 10% IPA; retention times: 5.94 min minor, 









20 mol % (R)-TRIP
MeCN, rt
123  
104: Furylcarbinol 123 (5.0 mg, 0.017 mmol), (R)-TRIP (2.6 mg, 0.0034 mmol) in 0.5 
mL MeCN. 32% ee (Chiralpak IA, 1.0 mL/min, 10% IPA; retention times: 4.90 min minor, 
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105: Furylcarbinol 124 (2.0 mg, 0.077 mmol), (R)-TRIP (1.1 mg, 0.0015 mmol) in 0.5 
mL MeCN at 80 °C. 8% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 9.71 min, 
10.79 min). 
 






x mol % additive









General Procedure. A solution of furylcarbinol 62 and aniline 63 in the desired solvent 
was treated with the additive and (R)-TRIP and stirred at rt. The reaction was monitored by 
TLC and, upon completion or after a sufficient amount of product had formed by TLC, was 
quenched with saturated NaHCO3 and extracted (3x EtOAc). The combined organic layers 
were dried over MgSO4, filtered and then concentrated in vacuo. The residue was purified 
by column chromatography to afford cyclopentenone 64.  
Dy(OTf)3 additive: Furylcarbinol 62 (5.0 mg, 0.029 mmol), p-iodoaniline (6.4 mg, 
0.029 mmol), (R)-TRIP (4.4 mg, 0.0058 mmol), Dy(OTf)3 (1.8 mg, 0.0029 mmol) in 0.5 mL 
MeCN. 28% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.31 min minor, 
28.52 min major). 
MgF2 additive:189 Furylcarbinol 62 (2.5 mg, 0.014 mmol), p-iodoaniline (3.1 mg, 0.014 
mmol), (R)-TRIP (2.1 mg, 0.0028 mmol), MgF2 (0.2 mg, 0.003 mmol) in 1 mL MeCN. 44% 
ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 21.02 min minor, 27.65 min 
major). 
CuCl2 additive:190 Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), CuCl2 (0.4 mg, 0.0030 mmol) in 0.5 mL MeCN. 
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39% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.35 min minor, 25.15 min 
major). 
Cu(OTf)2 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 
0.015 mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), Cu(OTf)2 (1.1 mg, 0.0030 mmol) in 0.5 mL 
MeCN. 27% ee (Chiralpak IB, 1.0 mL/min, 3% IPA; retention times: 44.09 min minor, 
57.20 min major). 
(Ph3P)AuCl additive:191,192 Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 
mg, 0.015 mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), (Ph3P)AuCl (1.5 mg, 0.0030 mmol) in 
0.5 mL PhMe. 16% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.71 min 
minor, 25.83 min major). 
ZnBr2 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), ZnBr2 (0.7 mg, 0.0030 mmol) in 0.5 mL MeCN. 
27% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.51 min minor, 25.54 min 
major). 
NaHCO3 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 
0.015 mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), NaHCO3 (1.6 mg, 0.015 mmol) in 0.5 mL 
MeCN. 5% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.78 min minor, 
25.98 min major). 
Basic alumina additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 
0.015 mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), basic alumina (small scoop, ~10 mg, 0.1 
mmol) in 0.5 mL MeCN. 44% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 
20.48 min minor, 27.09 min major). 
AcOH additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), AcOH (0.14 mg, 0.0023 mmol) in 0.5 mL MeCN. 
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45% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.76 min minor, 25.98 min 
major). 
HFIP additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), HFIP (0.3 µL, 0.0030 mmol) in 0.5 mL MeCN. 





79 additive:193 Furylcarbinol 62 (5.0 mg, 0.029 mmol), p-iodoaniline (6.6 mg, 0.029 
mmol),  (R)-TRIP (4.5 mg, 0.0060 mmol), 79 (2.5 mg, 0.0060 mmol) in 1 mL MeCN. 34% 






79 additive: 193 Furylcarbinol 62 (5.0 mg, 0.029 mmol), p-iodoaniline (6.6 mg, 0.029 
mmol),  (R)-TRIP (4.5 mg, 0.0060 mmol), 79 (3.6 mg, 0.0060 mmol) in 1 mL MeCN. 44% 
ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.83 min minor, 26.16 min 
major). 
 












75 additive: Furylcarbinol 62 (5.0 mg, 0.029 mmol), p-iodoaniline (6.6 mg, 0.029 
mmol),  (R)-TRIP (4.5 mg, 0.0060 mmol), 75 (3.6 mg, 0.0060 mmol) in 1 mL MeCN. 42% 














74 additive: Furylcarbinol 62 (5.0 mg, 0.029 mmol), p-iodoaniline (6.6 mg, 0.029 
mmol),  (R)-TRIP (4.5 mg, 0.0060 mmol), 74 (3.0 mg, 0.0060 mmol) in 1 mL MeCN. 45% 






PhPh 69  
69 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), 69 (1.1 mg, 0.0030 mmol) in 0.5 mL MeNO2. 
53% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.66 min minor, 25.49 min 
major). 
 






68 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), 68 (1.2 mg, 0.0030 mmol) in 0.5 mL MeNO2. 









106 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), 106 (1.3 mg, 0.0030 mmol) in 0.5 mL MeCN. 6% 





107 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), 107 (0.8 mg, 0.0030 mmol) in 0.5 mL MeCN. 7% 
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108 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), 108 (1.8 mg, 0.0030 mmol) in 0.5 mL MeCN. 





DMAP additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), DMAP (0.3 mg, 0.0030 mmol) in 0.5 mL MeCN. 






DTBMP additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.3 mg, 0.0030 mmol), DTBMP (0.5 mg, 0.0030 mmol) in 0.5 mL 
solvent. MeCN: 50% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 20.17 min 
minor, 26.59 min major). MeNO2: 59% ee ((Chiralpak IB, 1.0 mL/min, 10% IPA; retention 
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109 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), 109 (1.5 mg, 0.0030 mmol) in 0.5 mL MeCN. 










110 additive: Furylcarbinol 62 (2.6 mg, 0.015 mmol), p-iodoaniline (3.3 mg, 0.015 
mmol), (R)-TRIP (2.2 mg, 0.0030 mmol), 110 (0.8 mg, 0.0030 mmol) in 0.5 mL MeCN. 
41% ee (Chiralpak IB, 1.0 mL/min, 10% IPA; retention times: 19.74 min minor, 25.91 min 
major). 
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7. The (Aza-)Piancatelli Rearrangement in Total Synthesis 
7.1. Natural Products Accessible via an (Aza-)Piancatelli Rearrangement 
The Piancatelli and aza-Piancatelli rearrangements are exceptional methods for 
expedient synthesis of densely functionalized cyclopentenones from cheap, sustainable 
starting materials. Piancatelli originally investigated the transformation of furylcarbinols 
because of an interest in the synthesis of prostaglandins.39 The rearrangement has since been 
successfully applied to the synthesis of prostaglandin E1 (Figure 7.1, 1),54 as well as a 
number of other approaches to natural products.207–209 Coralloidolide F210 (2) and 
jogyamycin (3)211 are two natural products whose synthesis has not been accomplished that 
could also be accesses via a Piancatelli rearrangement. Due to the novelty of the aza-
Piancatelli rearrangement, its potential in terms of natural product synthesis has not yet been 
realized. In our first communication detailing the aza-Piancatelli rearrangement we 
demonstrated the value of the reaction with the synthesis of an hNK1 inhibitor (4).78 
Following the development of an intramolecular aza-Piancatelli rearrangement to access 
azaspirocycles,138 we have had a continued interest in the synthesis of homoharringtonine212 
and stemonamine.213  




























































Figure 7.1. Natural products containing the substituted cyclopentenone motif. 
7.2.  Efforts Toward the Total Synthesis of Cephalotaxine and Homoharringtonine  
Early on in the development of an intramolecular aza-Piancatelli rearrangement, we 
recognized the potential of this rearrangement in terms of its application to the total 
synthesis of homoharringtonine. The presence of the azaspirocyclic cyclopentenone makes it 
an ideal target for the intramolecular aza-Piancatelli rearrangement.  
Homoharringtonine is a plant alkaloid member of the cephalotaxus group of natural 
products isolated from coniferous Cephalotaxus evergreen trees found in China.214 Many 
studies have shown homoharringtonine to have exceptional antitumor properties and in 2012 
it was approved by the U.S. Food and Drug Administration (FDA) for treatment of chronic 
myeloid leukemia (CML) with resistance to treatment with tyrosine kinase inhibitors.215 
Homoharringtonine differs from the parent alkaloid cephalotaxine (11) only by the presence 
of an ester side chain. Although cephalotaxine possesses no relevant biological activity, 
many synthetic efforts have focused on its synthesis,216–221 since subsequent esterification is 
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a known process.212,222 Interestingly, several syntheses make use of a Nazarov cyclization to 

























Scheme 7.1. Approach to cephalotaxine via a Nazarov-type reaction. 
Our efforts have been focused on synthesizing the core of cephalotaxine via an aza-
Piancatelli rearrangement. The first approach to cephalotaxine by our group was based on 
the intramolecular aza-Piancatelli rearrangement with tethered aniline nucleophiles.225 The 
precursor furylcarbinol (14) was synthesized in just five steps from 12 and 13, and readily 
underwent the dysprosium catalyzed rearrangement affording cyclopentenone 15 in 86% 
yield (Scheme 7.2). To our disappointment and despite previous success with removing the 
PMP group to access the hNK1 inhibitor (Chapter 2, Scheme 2.11), all efforts to access the 
free amine were unsuccessful, resulting in decomposition of the azaspirocycle. It became 
clear that we had to re-evaluate our approach to the cephalotaxine core.  





























Scheme 7.2. First approach to the total synthesis of cephalotaxine. 
Following the development of the hydroxylamine aza-Piancatelli rearrangement, we 
devised a new approach to cephalotaxine that involves an intramolecular hydroxylamine 
aza-Piancatelli rearrangement (Scheme 7.3). Access to the free amine (5) would rely on our 
previously described three-step reduction-cleavage-oxidation protocol (Chapter 4). 






















Scheme 7.3. Second generation approach to cephalotaxine. 
The synthesis of furylcarbinol 24 was accomplished in seven steps as depicted in 
Scheme 7.4. Starting from commercially available ester 12, alcohol 19 was prepared. 
Subsequent Swern oxidation to the volatile, unstable aldehyde was immediately followed by 
condensation with O-benzylhydroxylamine hydrochloride to form imine 20. Reduction with 
NaBH3CN gave 21 in 93% yield. Initially amine 21 was protected with di-tert-butyl 
dicarbonate (Boc), but we later discovered that removal of the protecting group was 
difficult. Instead, we settled on using fluorenylmethyloxycarbonyl chloride (Fmoc-Cl), and 
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subsequently were able to synthesize aldehyde 23 via Vilsmeier-Haack formylation. One-pot 
aldehyde reduction and Fmoc-deprotection with NaBH4 and 3M NaOH, respectively, 
resulted in the desired unsubstituted furylcarbinol 24. Using this route, we were able to 
access gram quantities of Fmoc-protected aldehyde 23.  
LiAlH4





0 °C to rt
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Scheme 7.4. Synthesis of unsubstituted furylcarbinol 24. 
At this stage, we were ready to test our key hydroxylamine aza-Piancatelli 
rearrangement. Exposing the furylcarbinol 24 to Dy(OTf)3 in MeCN or MeNO2 resulted in 
complete decomposition of the starting material (Table 7.1, entry 1 and 2). From our 
previous studies, we knew that primary furylcarbinols do not participate in the 
intermolecular aza-Piancatelli rearrangement. In the intramolecular aza-Piancatelli 
rearrangement, primary furylcarbinols will rearrange, but the reaction is not as robust as 
those with substituted secondary furylcarbinols.138 In our experience, although less 
sustainable, zinc facilitated reactions tend to be milder than dysprosium catalyzed reactions, 
leading us to examine this finicky rearrangement with zinc bromide. To our delight, 
furylcarbinol 24 rearranged to the desired cyclopentenone 25 in 26% yield when treated with 
ZnBr2 in MeCN (Table 7.1, entry 3). However, we also observed the formation of 26, 
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presumably resulting from a subsequent molecular rearrangement. A simple solvent switch 
to MeNO2, which we had already identified as a superior solvent for reactions with 
hydroxylamines, resulted in formation of cyclopentenone 25 in 39% yield without the 
formation of the side product (Table 7.1, entry 4). Knowing that the desired cyclopentenone 
can be formed and is isolable, we then examined a few more dysprosium catalyzed 
reactions. Similar to entry 1, the reaction of furylcarbinol 24 with Dy(OTf)3 in toluene with 
addition of NaBArF resulted in decomposition (Table 7.1, entry 6). Pleasingly, using 
anhydrous Dy(OTf)3 (dried for 48 hours under vacuum at 200 °C)102 under highly dilute 
conditions resulted in formation of 25 in an excellent 56% yield.  
















Entry Catalyst (mol %) Solvent Yield 25 (%) 
Yield 26 
(%) 
1[a] Dy(OTf)3 (5) MeCN -- -- 
2 Dy(OTf)3 (5) MeNO2 -- -- 
3 ZnBr2 (100) MeCN 26 14 
4 ZnBr2 (100) MeNO2 39 -- 
5[b] ZnBr2 (100) MeCN 39 -- 
6[c] Dy(OTf)3 (10) PhMe -- -- 
7 anhyd. Dy(OTf)3 MeCN 56 -- 
[a] The reaction resulted in complete decomposition of the starting material. [b] The reaction was 
performed with acylated 24.226 [c] The reaction was performed with addition of 10 mol % NaBArF at 
rt. 
With our key cyclopentenone in hand, we were ready to examine N–O bond clipping 
reactions to access the free amine required to complete the synthesis of cephalotaxine. 
Again, cleaving the N–O bond proved to be a challenge. Use of Zn/HCl,147 SmI2144 or 
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hydrogenation over Pd/C145 did not result in the formation of the desired free amine (5). 
Reduction of the cyclopentenone to the allylic alcohol (27) proceeded nicely in 18:1 dr 
(Scheme 7.5). To our disappointment, our previously successful Zn/HCl protocol for 
cleaving the N–O bond of allylic alcohols did not work for the synthesis of the requisite free 

















Scheme 7.5. Reduction to the allylic alcohol, and unsuccessful attempts at N–O bond 
cleavage. 
 
Taking the challenges we have encountered with unsubstituted cyclopentenone 25 into 
consideration, we are currently investigating installation of the requisite aryl group prior to 
the aza-Piancatelli rearrangement, similar to the approach described in our first efforts to 
synthesize cephalotaxine (Scheme 7.2). Access to 29 would be followed by N–O bond 
cleavage to give 30. Preliminary calculations at the B3LYP 6-31G* level of density 
functional theory suggest that there is only a small difference in strain between the trans and 
cis substituted cyclopentenones. This leads us to believe that N-alkylation to form the seven-
membered macrocycle from the trans-substituted cyclopentenone should be possible. 
Following formation of the macrocycle, epimerization to the cis-substituted cyclopentenone 
and reduction of the ketone would furnish des-methoxy cephalotaxine (31) (Scheme 7.6).  






















Scheme 7.6. Proposed alternative pathway to des-methoxy cephalotaxine. 
Although the synthesis of cephalotaxine is not yet complete, we are confident that our 
toolbox of synthetic transformations and knowledge of the behavior of cyclopentenones will 
allow us to synthesize the natural product using our strategy. The total synthesis of 
cephalotaxine would certainly highlight the value of the intramolecular aza-Piancatelli 
rearrangement as a means for building azaspirocycles. One of the most valuable lessons 
learned from the synthesis thus far is that the specific substitution patterns and oxidation 
states of cyclopentenones, in particular those with amine substituents, greatly influence the 
stability of these compounds to subsequent transformations.  
7.3. Efforts Toward the Total Synthesis of Coralloidolide F 
We became interested in the total synthesis of coralloidolide F following a report by 
Trauner and co-workers on the total synthesis of coralloidolides A, B, C and E (Scheme 
7.7).227 The coralloidolides belong to the furanocembranoid family of natural products that 
has received much interest from the synthetic community.228–231 Coralloidolides A-F are 
proposed to be naturally derived from rubifolide (33), which the Trauner group had 
previously accessed from bipinnatin J (32) (Scheme 7.7),232 through a series of oxidations 
and rearrangements.  
















































Scheme 7.7. Synthesis of rubifolide and coralloidolide A,B,C and E from bipinnatin J. 
It was proposed that coralloidolide E (35) is the precursor to coralloidolide F (2), which 
could be accessed from a transannular aldol addition of enolate 38 (Scheme 7.8). Despite 
great efforts, the Trauner group was unable to access coralloidolide F via their proposed 
pathway, and had to accept defeat.  





















Scheme 7.8. Trauner’s proposed biosynthetic pathway to coralloidolide F. 
Coralloidolide F was first isolated in 1990 by Pietra and co-workers,210 but thus far, no 
successful total synthesis has been reported. Noting the presence of the 4-
hydroxycyclopentenone motif in coralloidolide F, our group proposed an alternative 
pathway to this natural product. We hypothesized that coralloidolide F (2) could be accessed 
via a Piancatelli rearrangement of bipinnatin J (32) to cyclopentenone 39, which would yield 
the desired natural product upon epoxidation (Scheme 7.9). We approached Professor 
Trauner with this proposal and struck up a collaboration to achieve the synthesis of this 
elusive natural product. Thanks to a generous travel grant through UCSB’s Materials 
Research Laboratory’s International Center for Materials Research (ICMR) program, I was 
able to travel to the Ludwig-Maximilians Universität in Munich to conduct the proposed 


























Scheme 7.9. Our proposed synthesis of coralloidolide F via a Piancatelli rearrangement. 
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We commenced our studies with the synthesis of a model macrocyclic substrate. The 
model macrocycle was easily obtained via a four step protocol directly from furan (Scheme 
7.10). Alkylation of furan (40) with 6-bromohex-1-ene233 was followed by formylation with 
DMF and Grignard addition of the second alkyl chain to the other side of the furan. Finally, 
ring-closing metathesis (RCM) using Grubbs’ first generation catalyst provided macrocyclic 
furylcarbinol 44 in 51% yield.234 
i. n-BuLi, THF, -20 °C
ii.
           83%
Br
i. n-BuLi, THF, -20 °C
 
ii. DMF 


















Scheme 7.10. Synthesis of a macrocyclic model substrate. 
With macrocyclic furylcarbinol 44 in hand, we studied its rearrangement to 4-
hydroxycyclopentenone 45. To our disappointment, all efforts to effect the Piancatelli 
rearrangement of this macrocycle were unsuccessful (Table 7.2). Reactions using our 
standard aza-Piancatelli78 rearrangement conditions or Piancatelli52 and the Read Lab’s 57 
conditions did not result in formation of the desired product (Table 7.2, entries 1-4). Wu’s 
conditions using CuSO4•5H2O (Table 7.2, entry 5),235 rearrangement in 1,4-dioxane at reflux 
with MgCl2 (Table 7.2, entry 7),236 or reaction in a buffered NaOAc/AcOH (Table 7.2, entry 
6) system all resulted in recovery of starting material. In some cases unidentified products 
possessing aldehyde protons were observed, but no desired product was formed. Speculating 
that ring-strain was the source of our difficulties, we also attempted the rearrangement of 
furylcarbinol 43, but with no success.  
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Entry Catalyst (mol %) Solvent Temp (°C) Yield (%) 
1 Dy(OTf)3 (30) MeCN 80 -- 
2 Dy(OTf)3 (10) TFA (5) 
tBuOH/H2O 
(5:1) 80 -- 
3 ZnCl2 (100) MeCN 60 -- 
4 ZnCl2 (100) Acetone 56 -- 
5 CuSO4•5H2O (100) PhMe 60 -- 
6 NaOAc, AcOH pH ~ 5 H2O µw -- 
7 MgCl2 (400) H2O/dioxane reflux -- 
 
While working in the Trauner laboratory, I also completed the total synthesis of 
bipinnatin J (32). The published synthesis protocol was successfully followed (Scheme 
7.11).232,237 The synthesis started from a zirconium mediated carboalumination of 3-butynol 
to afford (Z)-vinyl iodide 47 in 20% yield. Dess-Martin oxidation to the aldehyde followed 
by alkynilation provided 48 in 29% yield over two steps. Trost enyne reaction forming 
aldehyde 49 was followed by a Wittig reaction to form 50. Reduction of aldehyde 50 was 
followed by Stille coupling to 52 to form allylic alcohol 53. Appel reaction of the allylic 
alcohol furnished cyclization precursor 54 in 33% yield. Finally, the key Nozaki-Hiyama-
Kishi cyclization was performed to give bipinnatin J (32) in 22% yield.  
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Scheme 7.11. Total synthesis of bipinnatin J. 
Unfortunately we never had a chance to test the rearrangement of bipinnatin J to 
coralloidolide F. I am confident that further investigations on the Piancatelli rearrangement 
of the macrocyclic model substrate will be successful. Once optimal conditions have been 
determined, the rearrangement could be applied to bipinnatin J to give macrocyclic 
cyclopentenone 39 which, upon epoxidation, would result in the formation of coralloidolide 
F (2). Additionally, success of the rearrangement would open up the door to exploring a 
variety of rearrangements of furylcarbinols embedded in macrocycles.      
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7.4. Experimental Procedures 
Materials and Methods.  Unless stated otherwise, reactions were conducted in flame-
dried glassware under an atmosphere of air using reagent grade solvents. All commercially 
obtained reagents were used as received. Reaction temperatures were controlled using a 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with anisaldehyde and potassium permanganate.  
Flash column chromatography was performed using normal phase silica gel (60 Å, 230-240 
mesh, Merck KGA). 1H NMR spectra were recorded on Varian spectrometers (at 400, 500 
or 600 MHz) and are reported relative to deuterated solvent signals. Data for 1H NMR 
spectra are reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) 
and integration. 13C NMR spectra were recorded on Varian Spectrometers (125 MHz). Data 
for 13C NMR spectra are reported as follows: shift (δ ppm), multiplicity and coupling 
constant (Hz). IR spectra were recorded on a Jasco FT/IR 4100 or a Perkin Elmer Spectrum 
100 FT/IR spectrometer and are reported in terms of frequency of absorption (cm-1). High 
resolution mass spectra were obtained from the UC Santa Barbara Mass Spectrometry 
facility.  
 





12 19  
3-(Furan-2-yl)propan-1-ol (19): A solution of ethyl 3-(furan-2-yl)propanoate (12) (6.01 
g, 35.7 mmol) in dry THF (180 mL) was treated with LiAlH4 (1.36 g, 35.7 mmol) in several 
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small portions and stirred at rt for 1 h when so starting material was visible by TLC. The 
reaction was quenched via slow, dropwise addition of 1.36 mL H2O, followed by 1.36 mL 
3M NaOH, and finally 13.6 mL H2O. After stirring at room temperature for 20 min, the 
suspension was filtered through Celite, washing with EtOAc (100 mL). The solvent was 
removed via rotary evaporation, and the product purified by flash column chromatography 
to afford alcohol 19 (3.47 mg, 77%) as a clear oil. 1H NMR (500 MHz, CDCl3) δ 7.30 (dd, J 
= 1.8, 0.7 Hz, 1H), 6.28 (dd, J = 3.1, 1.9 Hz, 1H), 6.01-5.99 (m, 1H), 3.69 (t, J = 6.3 Hz, 
1H), 2.74 (t, J = 7.4 Hz, 1H), 1.94 – 1.88 (m, 1H), 1.53 – 1.34 (m, 1H) ppm; 13C NMR (125 
MHz, CDCl3) δ 155.7, 141.1, 110.3, 105.2, 62.2, 31.1, 24.4 ppm; IR (thin film) 3336, 2943, 
2878, 1596, 1507, 1145, 1054, 1039, 1004 cm-1; MS (EI+) m/z 126. 0678 (126. 0681 calcd 










































































































   
  CH2Cl2, –78 °C
19 55  
3-(Furan-2-yl)propanal (55): The Swern reagent was prepared by treating (COCl)2 
(3.45 mL, 40.7 mmol) in 250 mL dry CH2Cl2 at -78 °C with DMSO (3.86 mL, 54.3 mmol) 
via dropwise addition over 15 min. After 15 min, 19 (4.28 g, 33.9 mmol) was added 
dropwise as a solution in 20 mL dry CH2Cl2. The reaction was stirred at -78 °C for 45 min 
before it was quenched with NEt3 (16.6 mL, 118.8 mmol) and allowed to come to rt. The 
resulting suspension was filtered through a pad of MgSO4, washing with copious amounts of 
Et2O. Due to the instability and volatility of the resulting aldehyde, the solvent was carefully 
removed via rotary evaporation, and the crude product 55 (3.01 g, 72%, clear oil) 
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1H), 7.31 (dd, J = 1.7, 0.9 Hz, 1H), 6.28 (dd, J = 3.2, 1.9 Hz, 1H), 6.02 (ddd, J = 3.4, 1.0, 





    pyridine, rt
55 20
+ Bn O N H
H •HCl
56  
3-(Furan-2-yl)propanal O-benzyl oxime (20): A solution of 55 (3.01 g, 24.3 mmol) in 
12 mL dry pyridine was treated with O-benzylhydroxylamine hydrochloride (56) (4.26 g, 
26.7 mmol) and stirred at rt for 3 d. When the reaction was complete by TLC, it was diluted 
with Et2O and H2O, washed 3 x H2O, 1 x brine. The combined organic layers were dried 
over MgSO4, filtered, and the solvent removed via rotary evaporation. The product was 
purified by flash column chromatography to afford oxime 20 (4.79 g, 86%). 1H NMR (600 
MHz, CDCl3) δ 7.49 (dd, J = 5.8, 5.8 Hz, 0.6H), 7.38 – 7.34 (m, 4H), 7.33 – 7.29 (m, 2H), 
6.74 (tdd J = 5.2, 5.2 Hz, 0.4H), 6.28 (ddd, J = 3.2, 3.2, 1.9 Hz, 1H), 6.04 – 5.99 (m, 3H), 
5.13 (s, 1H), 5.07 (s, 1H), 2.83 (ddd, J = 10.9, 7.4, 7.4 Hz, 2H), 2.74 – 2.70 (m, 1H), 2.57 – 
2.53 (m, 1H) ppm; 13C NMR (125 MHz, CDCl3) δ 154.5, 154.4, 151.0, 150.2, 141.4, 141.3, 
138.1, 137.8, 128.5, 128.4, 128.1, 128.0, 127.9, 110.3, 110.3, 105.6, 105.6, 76.0, 75.8, 28.3, 
25.4, 24.8, 24.5 ppm; IR (thin film) 3032, 2919, 2856, 1597, 1507, 1454, 1367, 1145, 1009 












O-Benzyl-N-(3-(furan-2-yl)propyl)hydroxylamine (21): A solution of 20 (412.5 mg, 
1.80 mmol) in 13 mL MeOH was treated with NaBH3CN (181.3 mg, 2.89 mmol), followed 
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by dropwise addition of 2.7 M methanolic HCl  (2.7 mL). The reaction was stirred at rt until 
complete by TLC (18 h). The reaction was quenched with 3M NaOH until a pH of 9 was 
reached, then diluted with CH2Cl2 and extracted (3 x CH2Cl2). The combined organic layers 
were dried over MgSO4, filtered, and the solvent removed via rotary evaporation. The 
product was purified by flash column chromatography to afford hydroxylamine 21 (389.0 
mg, 93%) as a clear oil. 1H NMR (500 MHz, CDCl3) δ 7.38 – 7.28 (m, 6H), 6.28 (dd, J = 
3.1, 1.9 Hz, 1H), 5.99 – 5.98 (m, 1H), 5.58 (s, 1H), 4.71 (s, 2H), 2.98 (t, J = 7.0 Hz, 2H), 
2.69 (t, J = 7.5 Hz, 2H), 1.88 (dt, J = 14.8, 7.3 Hz, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 
155.8, 141.0, 138.1, 128.5, 128.5, 127.9, 110.2, 105.1, 76.4, 51.5, 26.0, 25.7 ppm; IR (thin 
film) 2913, 2856, 1596, 1507, 1454, 1362, 1145, 1005, 915 cm-1; MS (ESI) m/z 254.1147 













21 22  
(9H-Fluoren-9-yl)methyl (benzyloxy)(3-(furan-2-yl)propyl)carbamate (22): A 
solution of 21 (2.64 g, 11.4 mmol) in H2O/dioxane (2:1) (31 mL) was treated with NaHCO3 
(1.02 g, 22.8 mmol) and cooled to 0 °C for 10 min. Then, a solution of Fmoc-Cl (2.96 g, 
11.4 mmol) in 30 mL dioxane was added via dropwise addition over 10 min. The reaction 
was allowed to come to rt for 2.5 h, then diluted with H2O and EtOAc. Extracted with 
EtOAc (3 x 20 mL), the combined organic layers were dried over MgSO4, filtered and the 
solvent removed via rotary evaporation. The product was purified via flash column 
chromatography to afford 22 (4.58 g, 89%). 1H NMR (500 MHz, CDCl3) δ 7.71 (d, J = 7.6 
Hz, 2H), 7.59 (d, J = 7.5 Hz, 2H), 7.35 (dd, J = 7.5, 7.5 Hz, 2H), 7.30 – 7.27 (m, 4H), 7.27 – 
7.21 (m, 4H), 6.23 – 6.21 (m, 1H), 5.92 (ddd, J = 3.4, 1.0, 1.0 Hz, 1H), 4.67 (s, 2H), 4.57 (d, 
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J = 1.0 Hz, 1H), 4.56 (d, J = 1.0 Hz, 1H), 4.22 (t, J = 6.3 Hz, 1H), 3.39 (dd, J = 7.2, 7.2 Hz, 
2H), 2.54 (dd, J = 7.5, 7.5 Hz, 2H), 1.84 (dddd, J = 7.4, 7.4, 7.4, 7.4 Hz, 2H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 157.3, 155.2, 143.9, 141.5, 141.1, 135.4, 129.4, 128.7, 128.6, 
127.9, 127.3, 125.1, 120.1, 110.3, 105.2, 77.2, 67.4, 49.4, 47.5, 25.5, 25.4 ppm; IR (thin 
film) 3083, 2947, 2879, 1701, 1450, 1402, 1283, 1168, 1098, 1005 cm-1; MS (ESI) m/z 






POCl3, DMF   





(9H-Fluoren-9-yl)methyl (benzyloxy)(3-(5-formylfuran-2-yl)propyl)carbamate (23): 
To prepare the Vilsmeier-Haack reagent, phosphorous oxychloride (2.16 mL, 23.1 mmol) 
was slowly added to DMF (2.1 mL, 27.2 mmol) at 0 °C via dropwise addition. After 
complete addition, the mixture was heated at 85 °C for 1 h to ensure complete formation of 
the reagent. The flask was cooled to 0 °C for the addition of a solution of 22 (4.56 g, 10.1 
mmol) in 3 mL dry CH2Cl2. The reaction was allowed to come to rt, and stirred for 3 h. The 
reaction was transferred to an Erlenmeyer flask, quenching with water, then NaHCO3 until 
the evolution of bubbles ceased. The mixture was diluted with EtOAc and extracted (3 x 20 
mL). The combined organic layers were dried over MgSO4, filtered and the solvent 
removed. The product was purified via flash column chromatography to give 23 (4.21 g, 
87%) as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 9.51 (s, 1H), 7.74 (d, J = 7.5 Hz, 2H), 
7.62 (d, J = 7.5 Hz, 2H), 7.39 (dd, J = 7.5, 7.5 Hz, 2H), 7.35 – 7.28 (m, 5H), 7.27 – 7.22 (m, 
2H), 7.14 (d, J = 3.5 Hz, 1H), 6.18 (d, J = 3.5 Hz, 1H), 4.67 (s, 2H), 4.65 (s, 1H), 4.64 (s, 
1H), 4.26 (t, J = 6.0 Hz, 1H), 3.39 (dd, J = 6.9, 6.9 Hz, 2H), 2.62 (dd, J = 7.6, 7.6 Hz, 2H), 
1.87 (dddd, J = 7.3, 7.3, 7.3, 7.3 Hz, 2H) ppm; 13C NMR (125 MHz, CDCl3) δ 177.1, 162.7, 
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157.2, 152.1, 143.8, 141.6, 135.3, 129.4, 128.8, 128.6, 127.9, 127.3, 125.0, 120.2, 109.1, 
77.1, 67.3, 49.1, 47.5, 25.7, 24.9 ppm; IR (thin film) 3084, 2948, 2880, 2820, 1699, 1672, 
1516, 1450, 1398, 1279, 1167, 1097, 1021, 961 cm-1; MS (ESI) m/z 504.1764(504.1787 












23 24  
(5-(3-((Benzyloxy)amino)propyl)furan-2-yl)methanol (24): A solution of 23 (1071 
mg, 2.22 mmol) in 64 mL MeOH was treated with NaBH4 (134.6 mg, 3.56 mmol) and 
stirred at rt. The reaction was complete after 10 min as determined by TLC. The reaction 
was quenched with H2O, followed by addition of 3 M NaOH. After 40 min, the reaction was 
complete by TLC and was extracted 3 x EtOAc (30 mL). The combined organic layers were 
dried over MgSO4, filtered, and the solvent removed via rotary evaporation. The product 
was purified by flash column chromatography to give 24 (563.3 mg, 97%) as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 4.4 Hz, 4H), 7.34 – 7.27 (m, 1H), 6.17 (d, J = 3.1 
Hz, 1H), 5.93 (d, J = 3.1 Hz, 1H), 5.57 (bs, 1H), 4.70 (s, 2H), 4.54 (s, 2H), 2.97 (dd, J = 7.0, 
7.0 Hz, 2H), 2.66 (dd, J = 7.5, 7.5 Hz, 2H), 1.87 (dddd, J = 7.3, 7.3, 7.3, 7.3 Hz, 2H) ppm; 
13C NMR (125 MHz, CDCl3) δ 156.0, 152.5, 138.0, 128.5, 128.5, 128.0, 108.6, 105.9, 76.4, 
57.7, 51.4, 25.8, 25.8 ppm; IR (thin film) 3348, 3257, 3031, 2918, 2862, 1560, 1454, 1362, 
1208, 1009 cm-1; MS (ESI) m/z 284.1253 (284.1263 calcd for C15H19NNaO3 [MNa]+). 

















































































































































































































































































































































































































































10 mol % Dy(OTf)3 anhyd.
MeCN, 80 °C
 
1-(Benzyloxy)-1-azaspiro[4.4]non-8-en-7-one (25): A solution of 24 (50.0 mg, 0.19 
mmol) in 20 mL dry MeCN was treated with anhydrous Dy(OTf)3 (11.7 mg, 0.019 mmol) 
and heated in a preheated oil bath at 80 °C. The reaction was complete by TLC after 
approximately 6 h, although reaction times varied, and in some cases, an additional 10 mol 
% Dy(OTf)3 was added to push the reaction to completion. The flask was removed from the 
oil bath and the reaction quenched with saturated NaHCO3 (20 mL) and diluted with EtOAc. 
The mixture was extracted 3x EtOAc (20 mL) and the combined organic phases were dried 
over MgSO4, filtered and the solvent removed via rotary evaporation. The product was 
purified by flash column chromatography to give 25 (20.0 mg, 43%) as a light yellow oil. 1H 
NMR (400 MHz, CDCl3) δ 7.39 – 7.33 (m, 1H), 7.33 – 7.20 (m, 5H), 6.12 (d, J = 5.6 Hz, 
1H), 4.61 (d, J = 11.4 Hz, 1H), 4.57 (d, J = 11.4 Hz, 1H), 3.29 (ddd, J = 10.3, 8.4, 4.2 Hz, 
1H), 2.88 (ddd, J = 10.1, 9.7, 9.7 1H), 2.75 (d, J = 18.0 Hz, 1H), 2.06 (d, J = 18.0 Hz, 1H), 
2.01 – 1.94 (m, 1H), 1.94 – 1.76 (m, 2H), 1.71 (ddd, J = 12.5, 9.0, 3.7 Hz, 1H) ppm; 13C 
NMR (125 MHz, CDCl3) δ 207.7, 165.8, 137.6, 134.9, 128.8, 128.4, 128.0, 76.5, 65.5, 54.0, 
42.0, 33.6, 19.7 ppm; IR (thin film) 3063, 3031, 2933, 2865, 1713, 1454, 1186, 1041, 993 
cm-1; MS (ESI) m/z 266.1145 (266.1157 calcd for C15H17NNaO2 [MNa]+). 


































































































































































































































































































































































































































































































1-(Benzyloxy)-1-azaspiro[4.4]non-8-en-7-ol (27): A solution of 25 (17.6 mg, 0.072 
mmol) in MeOH (1.8 mL) and THF (0.2 mL) was treated with YbCl3!6H2O (56.1 mg, 0.14 
mmol) and stirred at rt for 20 min. The solution was cooled to –78 °C and subsequently 
treated with NaBH4 (5.4 mg, 0.14 mmol) and stirred at this temperature until the reaction 
was complete by TLC. The reaction was quenched with saturated NH4Cl, allowed to come 
to rt and then extracted with EtOAc (3 x 10 mL). The combined organic phases were dried 
over MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash 
column chromatography to afford allylic alcohol 27 (16.5 mg, 95%, 18:1 dr) as a brown 
yellow oil. Major: 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.29 (m, 5H), 6.03 (dd, J = 5.6, 2.4 
Hz, 1H), 5.78 (d, J = 5.5 Hz, 1H), 4.69 (d, J = 10.7 Hz, 1H), 4.63 (d, J = 10.7 Hz, 1H), 4.57 
(dd, J = 8.2, 8.2 Hz, 1H), 3.26 (ddd, J = 9.8, 6.5 Hz, 1H), 2.88 (ddd, J = 9.1, 9.1, 9.1 Hz, 
1H), 2.32 (d, J = 11.9 Hz, 1H), 2.06 (d, J = 14.4 Hz, 1H), 2.01 – 1.74 (m, 4H), 1.62 (ddd, J = 
12.9, 6.7, 6.7 Hz, 1H) ppm. 
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7.4.2. Efforts Toward the Total Synthesis of Coralloidolide F 
i. n-BuLi, THF, -20 °C
ii. BrO O
40 41  
 2-(Hex-5-en-1-yl)furan (41): A solution of furan (195 µL, 2.69 mmoL) in 12 mL 
dry THF was treated with n-BuLi (2.5 M in hexanes) (1.08 mL, 2.69 mmol) at -20 °C. After 
1h below 0 °C, 6-bromo-1-hexene (300 µL, 2.24 mmol) was added to the solution at -20 °C, 
and the reaction allowed to come to rt over 2 h. The reaction was quenched with saturated 
NH4Cl solution (10 mL) and extracted with Et2O (3 x 10 mL). The combined organic layers 
were dried over MgSO4, filtered and solvent removed via rotary evaporation. The product 
was purified by flash column chromatography to give 41, which is inseparable from 
unreacted 6-bromo-1-hexene (277.7 mg, 83%) as a clear oil. 1H NMR (500 MHz, CDCl3) δ 
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5.81 (dddd, J = 16.9, 10.2, 6.7, 6.7 Hz, 1H), 5.01 (dddd, J = 17.1, 1.7, 1.7 Hz, 1H), 4.95 
(dddd, J = 10.3, 2.3, 1.2, 1.2 Hz, 1H), 2.63 (dd, J = 7.6, 7.6 Hz, 2H), 2.13 – 2.03 (m, 2H), 
1.66 (dddd, J = 7.6, 7.6, 7.6, 7.6 Hz, 2H), 1.45 (dddd, J = 7.6, 7.6, 7.6, 7.6 Hz, 2H) ppm.  
 
 
i. n-BuLi, THF, -20 °C
 
ii. DMFO O O41 42  
5-(Hex-5-en-1-yl)furan-2-carbaldehyde (42): A solution of 41 (729.3 mg, 4.86 mmoL) 
in 170 mL dry THF was treated with n-BuLi (2.2 M in hexanes) (4.41 mL, 9.72 mmol) at -
20 °C. After 1h below 0 °C, DMF (720 µL, 9.72 mmol) was added to the solution at -20 °C, 
and the reaction allowed to come to rt over 2 h. The reaction was quenched with saturated 
NH4Cl solution (100 mL) and extracted with Et2O (3 x 100 mL). The combined organic 
layers were dried over MgSO4, filtered and solvent removed via rotary evaporation. The 
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oil. 1H NMR (500 MHz, CDCl3) δ 9.52 (s, 1H), 7.17 (d, J = 3.5 Hz, 1H), 6.23 (d, J = 3.5 
Hz, 1H), 5.79 (dddd, J = 16.9, 10.2, 6.7, 6.7 Hz, 1H), 5.01 (dddd, J = 17.1, 1.7, 1.7, 1.7 Hz, 
1H), 4.96 (dddd, J = 10.1, 2.1, 1.2, 1.2 Hz, 1H), 2.73 (dd, J = 7.6, 7.6 Hz, 2H), 2.13 – 2.04 






64% O OH43  
1-(5-(Hex-5-en-1-yl)furan-2-yl)hept-6-en-1-ol (43): The Grignard reagent was 
prepared by combining iodine-activated Mg (79.5 mg, 3.27 mmol) with 6-bromo-1-hexene 
(380 µL, 2.84 mmol) in 10 mL dry THF and stirring at rt for 4 h. The Grignard reagent was 
then added to a solution of 42 (358.1 mg, 2.18 mmol) in 10 mL dry THF and the reaction 
stirred for 4 h until no starting material was visible by TLC. The reaction was quenched with 
saturated NH4Cl, extracted 3 x Et2O (20 mL), and the combined organic layers were dried 
over MgSO4 before filtering and removing the solvent via rotary evaporation. The product 
was purified via flash column chromatography to give 43 (358.4 mg, 63%) as a clear oil. 1H 
NMR (600 MHz, CDCl3) δ 6.10 (d, J = 3.0 Hz, 1H), 5.90 (d, J = 3.0 Hz, 1H), 5.84 – 5.76 
(m, 2H), 5.03 – 4.97 (m, 2H), 4.96 – 4.91 (m, 2H), 4.61 (ddd, J = 6.8, 6.8, 5.0 Hz, 1H), 2.60 
(dd, J = 7.6, 7.6 Hz, 2H), 2.11 – 2.03 (m, 4H), 1.84 (dddd, J = 11.1, 5.6, 3.2, 3.2 Hz, 2H), 
1.78 – 1.74 (m, 1H), 1.64 (dddd, J = 7.6, 7.6, 7.6, 7.6 Hz, 2H), 1.50 – 1.39 (m, 4H), 1.36 – 
1.23 (m, 2H) ppm. 13C NMR (150 MHz, CDCl3) δ  156.0, 155.0, 139.0, 138.8, 114.6, 114.5, 
106.5, 105.3, 68.0, 35.4, 33.8, 33.6, 28.8, 28.5, 28.0, 27.6, 25.3 ppm. 






























































































































































































































































OH43 44  
(E)-1(2,5)-Furanacyclododecaphan-7-en-2-ol (44): A solution of 43 (100.0 mg, 0.38 
mmol) in 130 mL dry, degassed CH2Cl2 was treated with Grubbs 1 (47.0 mg, 0.057 mmol) 
and heated at reflux for 16 h. The reaction was monitored by removing aliquots and 
examining them by 1H NMR to determine completion of the reaction. If the reaction had not 
gone to completion, additional catalyst was added. Once the reaction was complete, the 
solvent was removed and the product was purified by flash column chromatography to give 
44 (45.4 mg, 51%, 8:1 E/Z) as a light brown solid. 1H NMR (600 MHz, CDCl3) δ6.06 (d, J 
= 3.0 Hz, 1H), 5.88 (d, J = 2.9 Hz, 1H), 5.46 (dtt, J = 15.0, 7.7, 1.3 Hz, 1H), 5.12 (ddd, J = 
15.2, 7.7, 6.3 Hz, 1H), 4.60 (ddd, J = 9.3, 4.3, 4.3 Hz, 1H), 2.68 (ddd, J = 15.0, 6.8, 3.1 Hz, 
1H), 2.46 (ddd, J = 14.5, 11.1, 3.0 Hz, 1H), 2.07 – 1.99 (m, 1H), 1.98 – 1.88 (m, 3H), 1.87 – 
1.78 (m, 3H), 1.71 (tt, J = 12.7, 4.4 Hz, 1H), 1.60 (dddq, J = 15.7, 9.4, 6.3, 3.1 Hz, 1H), 1.47 
– 1.40 (m, 1H), 1.38 – 1.29 (m, 2H), 1.09 – 0.96 (m, 3H) ppm. 
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8. A Molecular Rearrangement of Oxaspirocycles to Fused Bicycles 
8.1. The Intramolecular Oxa-Piancatelli Rearrangement  
With the widespread presence of the aminocyclopentenone motif in natural products and 
pharmaceutically active compounds, much of my research focus has centered on the 
development of the aza-Piancatelli rearrangement. Throughout the course of our studies, 
however, we also developed an interest in expanding on the original Piancatelli 
rearrangement.57 Having already developed the aza-Piancatelli rearrangement with anilines78 
as well as the intramolecular aza-Piancatelli rearrangement to access azaspirocycles,138 we 
became intrigued by the possibility of accessing oxaspirocycles 1. Oxaspirocycles are well 
represented in natural products, such as sieboldine A (2)238,239 and heliespirone C (3),240 and 















Figure 8.1. Oxaspirocycles in natural products. 
Despite the obvious value of such an intramolecular Piancatelli rearrangement, it was not 
until Dr. Leoni Palmer’s efforts that an intramolecular oxa-Piancatelli rearrangement was 
realized.139 The rearrangement furylcarbinols 4 was catalyzed by Dy(OTf)3 in toluene at 80 
°C and was utilized for the synthesis of a variety of oxaspirocyclic cyclopentenones 5 
(Scheme 8.1). Prior to the development of this protocol, access to the spirocyclic 
cyclopentenones had been elusive. Wu and co-workers have studied reactions of enol ether 
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spiroketals 11 extensively, but only observed formation of the ring-opened furan derivatives 








HO 5 mol % Dy(OTf)3




















9   R  = H      0%
10 R  = Me  25%  
















Scheme 8.2. Previous work with oxaspirocycle precursors. 
Having established that the intramolecular oxa-Piancatelli rearrangement to access 
oxaspirocyclic cyclopentenones is a possibility, we were interested in examining whether 
spirocycles 5 could be isomerized to oxabicycles 13. Several groups have studied the 
migration of the hydroxyl group to the more highly substituted cyclopentenone. Piancatelli 
and co-workers described an intramolecular process facilitated by Al2O3 for the synthesis of 
prostaglandin alkaloids,244 while Stork and West described a two-step hydration-dehydration 
process with strong base (Figure 8.2).242,245 The ZnCl2 catalyzed rearrangement of 17 to 13 
described by Wu is proposed to proceed via addition of the tethered alcohol followed by 
elimination of the hydroxyl group of 18 (Scheme 8.3).242,243  











































Scheme 8.3. Wu’s method to access to fused oxabicycles via 4-hydroxycyclopentenones. 
8.2. Molecular Rearrangement of Oxaspirocycles to Fused Oxabicycles 
We commenced our studies with the proposed molecular rearrangement of spirocycle 6 
to oxabicycle 19 (Table 8.1). Initially, we attempted the conversion between the two 
bicycles using reaction conditions previously described by Wu et al., (ZnCl2 in refluxing 
aqueous 1,2-dimethoxyethane (DME)).242,243 No change to the spirocycle was observed and 
6 was recovered from the reaction conditions in good yield and with little to no 
decomposition. Treatment of the spirocycle with basic alumina resulted in complete erosion 
of the trans selectivity through epimerization; however, no desired rearrangement was 
observed. Interestingly, other bases, such as DMAP, Hünigs base, cesium carbonate, sodium 
carbonate and sodium phosphates resulted in only recovered starting material. Based on 
these experiments, we further examined the use of other acids (Table 8.1, entries 3 – 7), 
which also resulted in epimerization of the trans-substituted spirocycle to a mixture of trans 
and cis substitution to varying degrees along with other unidentified minor reaction 
components. Treatment of spirocycle 6 with sulfuric acid resulted in its decomposition 
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within minutes. A notable exception was p-TSA, which showed the fused cyclopentenone 
19 in roughly 50% conversion after 24 hours. We were pleased to find that the acidic ion-
exchange resin Amberlyst®15 could be used to carry out the same transformation in a 
cleaner and more efficient manner; treatment of 6 with acidic Amberlyst®15 provided the 
fused bicycle 19 in excellent yield (Table 8.1, entry 8). 













6 19±6  
Entry Reagent (mol %)[a] Yield (%) trans-6/cis-6/19[b] 
1 Basic alumina (na)[c] 45:45:0 
2 ZnCl2 (20) 89:5:0 
3 HCl (20) 57:3:0 
4 H2SO4 decomposition 
5 CSA (20) 66:9:0 
6 p-TSA (20) 41:3:36 
7 PMA (20) 45:45:0 
8 Amberlyst® 15 (na)[c] 0:0:91 
[a] CSA= camphorsulfonic acid, p-TSA = p-toluenesulfonic acid, PMA =poly-
phosphomolybdic acid. [b] Determined by analysis of the reaction mixture by 1H NMR 
spectroscopy. [c] na = not applicable. 
Importantly, this skeletal rearrangement is general and can be used to efficiently prepare 
the fused oxabicycles directly from their spirocyclic precursors in high yield (Table 8.2). All 
substrates subjected to the reaction conditions behaved accordingly. The rearrangement was 
extremely clean for electron rich, poor and bulky substituted cyclopentenones (22, 23, 24–
26), but slower and slightly lower yielding when the ether oxygen was substituted with a 
gem-dimethyl group (29 and 30). We were thrilled to discover that treatment of a mixture of 
diastereomers at the γ position of the spirocyclic ether to the reaction conditions resulted in 
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the formation of a single diastereomer of the bicyclic ether (31 and 32). An anti relationship, 
corresponding to the more thermodynamically stable product, was confirmed by NOE 
experiments. 






































































29  R  = nBu; 60%




[a] Yield of isolated product. [b] The product was isolated as a single diastereomer. [c] A 7:1 
ratio of diastereomers was obtained.  
Interestingly, for the isopropyl substrate 33, only a 7:1 ratio was achieved. The 
molecular rearrangement allowed efficient access to chrycorin (27), a natural product with 
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plant growth inhibitor properties, isolated from Chrysanthemum coranarium by Tada and 
Chiba.242,243,246 Moreover, the skeletal rearrangement demonstrated that spirocyclic ethers 
are a viable intermediate in the synthesis of oxabicyclic cyclopentenones from an acid 
catalyzed cascade rearrangement of α-furylcarbinols. 
From a mechanistic and synthetic point of view, it is interesting that only a single 
diastereomer is isolated in the case of substituted products 31 and 32 from a 2:1 
diastereomeric mixture of the starting materials. It could be considered that the skeletal 
rearrangement follows a stepwise pathway (Figure 8.3), that allows for the interconversion 
of intermediates to the thermodynamically favored cyclopentenone framework 19. In acidic 
media, protonation of spirocylic ether 34 in combination with the acidity of the (here, 
benzylic) proton in 35 and the proximity of the carbonyl group leads to cleavage of the ether 
to give alcohol 36. This extremely reactive species would close rapidly through attack of the 
primary alcohol to give intermediate 37, which upon tautomerization yields the 





































Figure 8.3. Possible mechanism of the skeletal rearrangement and proposed source of 
selectivity. 
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If a secondary alcohol is used, as in the case of products 31 to 32, having the secondary 
alcohol-substituent in an equatorial position during ring closure minimizes unfavorable 
steric interactions (Figure 8.3). The possibility of introducing 1,3-diaxial interactions is 
illustrated clearly in the obtained crystal structure of product 31 (Figure 8.4). 
 
Figure 8.4. ORTEP drawing of oxabicycle 31. Ellipsoids draws at 30% probability. CCDC 
931233. 
 
It is also noteworthy that we can access the desired fused cyclopentenone framework 
directly from furfural-derived starting materials (Table 8.3).242,243 Treatment of furylcarbinol 
38 with Amberlyst®15 and heating in toluene at 60 °C gave the desired product (19) in 39% 
yield (Table 8.3, entry 1). Heating the furylcarbinol at 100 °C followed by treatment with 
Amberlyst®15 at 60 °C produced the product in only 16% yield. We were surprised to 
discover that the treatment of furylcarbinol 38 with Dy(OTf)3 and Amberlyst®15 
concurrently (Table 8.3, entry 3) gave the fused cyclopentenone 19 in only 34% yield. Based 
on Wu’s one-pot protocol where water was found to be critical for obtaining good yields, 
242,243 we tested if water would have a similar effect on the one-pot reaction in Table 8.3. 
Unfortunately, the addition of water as a co-solvent (1:1, H2O:PhMe) gave similar results. 
During the course of these reactions, spirocyclic ether 6 was observed, along with a number 
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formation of 6, which is presumably low yielding. This is not entirely surprising because in 
previous studies for the formation of 6 from the corresponding furylcarbinol 38, extensive 
optimization of the reaction conditions was required to achieve good yields.139 Although our 
protocol allows for direct access to the fused cyclopentenone 19 directly from furylcarbinol 
38, the described two-step protocol is superior for the conversion of spirocycle 6 to 
cyclopentenone 19. 








38 19  
Entry Catalyst Yield (%) 
1 Amberlyst® 15 39 
2 100 °C, then Amberlyst® 15 16 
3 Dy(OTf)3 (5 mol %) + Amberlyst® 15 34 
 
In conclusion, we discovered an operationally simple conversion of spirocyclic ethers to 
fused bicyclic ethers through an acid catalyzed isomerization. This transformation provides 
direct access to fused oxabicycles, which are important intermediates in the total synthesis 
of numerous biologically active molecules. This approach to fused oxabicycles is attractive 
because it demonstrates the versatile nature of using renewable resources to build molecular 
diversity and as such, current efforts are focused on extending the methodology to include 
industrially important transformations and utilizing our products as substrates for further 
synthetic manipulations. 
8.3. Experimental Procedures 
Materials and Methods. Unless stated otherwise, reactions were conducted in flame-
dried glassware under an atmosphere of air using reagent grade solvents. All commercially 
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obtained reagents were used as received. Reaction temperatures were controlled using an 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates, (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with anisaldehyde and potassium permanganate. 
Flash column chromatography was performed using normal phase silica gel (60 Å, 230-240 
mesh, Merck KGA). 1H NMR spectra were recorded on Varian spectrometers (at 500 or 600 
MHz) and are reported relative to deuterated solvent signals. Data for 1H NMR spectra are 
reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) and 
integration. 13C NMR spectra were recorded on Varian Spectrometers (125 or 150 MHz). 
Data for 13C NMR spectra are reported in terms of chemical shift (δ ppm), multiplicity, 
coupling constant (Hz). IR spectra were recorded on a Perkin Elmer Spectrum Two FT/IR 
spectrometer and are reported in terms of frequency of absorption (cm-1). Mass spectra were 
obtained from the UC Santa Barbara Mass Spectrometry Facility on a (Waters Corp.) 
Micromass QTOF2 with an electrospray ionization source. X-ray data were obtained from 
the UC Santa Barbara X-ray Facility.  
4,5-Substituted oxa-spirocycles 20 were prepared from readily available commercial 
starting materials and following procedures previously disclosed.139 The crystal structure 
data for oxa-bicycle 31 can be obtained free of charge from the Cambridge Crystallographic 
Data Centre via www.ccdc.cam.ac.uk/data_request/cif. CCDC 931233. 
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The Preparation of Oxaspirocycles: 5-Substituted furylcarbinols (39) were stirred as a 
solution in toluene at 23 ºC in base-washed glassware (KOH base bath, rinsed once with DI 
water and acetone) or a new scintillation vial. 5 mol % of Dy(OTf)3 was added and the 
reaction flask immediately placed in an oil bath pre-heated to 80 ºC. The reaction was 
monitored by TLC. Upon completion, the reaction was quenched with saturated aqueous 
NaHCO3 and extracted with ethyl acetate. The combined organic layers were dried over 
MgSO4, filtered and then concentrated in vacuo. The residue was purified by flash column 






6-Phenyl-1-oxaspiro[4.4]non-8-en-7-one (6): Colorless, crystalline solid. 1H NMR 
(600 MHz, CDCl3) δ 7.46 (d, J = 5.8 Hz, 1H), 7.34 (dd, J = 7.5, 7.2 Hz, 2H), 7.29 (t, J = 7.5 
Hz, 1H), 7.10 (d, J = 7.2 Hz, 2H), 6.30 (d, J = 5.8 Hz, 1H), 3.96 (ddd, J = 7.8, 7.8, 5.4 Hz, 
1H), 3.89 (dd, J = 15.0, 7.8 Hz, 1H), 3.84 (s, 1H), 1.81 (dddd, J = 12.2, 12.2, 6.8, 5.4 Hz, 
1H), 1.72 (ddd, J = 13.0, 7.8, 7.8 Hz, 1H), 1.68 (ddd, J = 13.0, 7.8, 5.4 Hz, 1H), 1.44 
(ddddd, J = 12.0, 7.7, 7.7, 7.7, 7.7 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 206.4, 
163.9, 136.1, 132.9, 130.2, 128.8, 127.5, 91.1, 69.0, 63.7, 33.1, 26.2 ppm; IR (thin film) 
3030, 2926, 1713, 1602, 1497, 1453, 1341, 1251, 1176, 1050 cm-1; MS (ESI) m/z 237.09 
(237.09 calcd for C14H14NaO2+ [MNa]+). 


















6-(4-Methoxyphenyl)-1-oxaspiro[4.4]non-8-en-7-one (40): Pale yellow oil. 1H NMR 
(600 MHz, CDCl3) δ 7.45 (d, J = 6.0 Hz, 1H), 7.02 (d, J = 9.0 Hz, 2H), 6.88 (d, J = 9.0 Hz, 
2H), 6.28 (d, J = 6.0 Hz, 1H), 3.95 (ddd, J = 7.8, 7.8, 5.0 Hz, 1H), 3.88 (ddd, J = 7.6, 7.6, 
7.6 Hz, 1H), 3.80 (s, 4H), 1.82 (ddddd, J = 12.0, 6.6, 6.6, 6.6, 5.0 Hz, 1H), 1.73 – 1.68 (m, 
2H), 1.45 (ddddd, J = 12.0, 7.8, 7.8, 7.8, 7.8 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 
206.6, 163.8, 159.0, 132.9, 131.3, 128.0, 114.3, 91.1, 69.0, 63.1, 55.5, 33.2, 26.3 ppm; IR 
(thin film) 3079, 2924, 2874, 1717, 1593, 1437, 1341, 1216, 1121, 1051 cm-1; MS (ESI) m/z 





6-Mesityl-1-oxaspiro[4.4]non-8-en-7-one (8): Colorless, crystalline solid. 1H NMR 
(600 MHz, CDCl3) δ 7.45 (d, J = 5.7 Hz, 1H), 6.88 (s, 1H), 6.83 (s, 1H), 6.25 (d, J = 5.7 Hz, 
1H), 4.23 (s, 1H), 3.88 (ddd, J = 7.8, 7.8, 6.6 Hz, 1H), 3.86 (ddd, J = 15.0, 7.8, 5.4 Hz, 1H), 
2.34 (s, 3H), 2.25 (s, 3H), 1.93 (ddddd, J = 13.2, 6.6, 6.6, 6.6, 6.6 Hz, 1H), 1.89 (s, 3H), 1.84 
(ddd, J = 13.2, 6.6, 6.6 Hz, 1H), 1.73 (ddd, J = 13.2, 7.2, 7.2 Hz, 1H), 1.65 (ddddd, J = 12.6, 
6.6, 6.6, 6.6, 6.6 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 207.0, 163.2, 139.4, 137.1, 
137.0, 132.0, 130.5, 130.3, 129.4, 91.5, 68.2, 58.9, 31.2, 27.1, 22.4, 21.4, 21.1 ppm; IR (thin 
film) 2924, 2863, 1717, 1613, 1484, 1459, 1379, 1338, 1273, 1124, 1073, 1048 cm-1; MS 
(ESI) m/z 279.14 (279.14 calcd for C17H20NaO2+ [MNa]+). 





6-(4-Bromophenyl)-1-oxaspiro[4.4]non-8-en-7-one (41): Yellow oil. 1H NMR (600 
MHz, CDCl3) δ 7.48 (d, J = 8.4 Hz, 2H), 7.46 (d, J = 5.7 Hz, 1H), 6.99 (d, J = 8.4 Hz, 2H), 
6.28 (d, J = 5.7 Hz, 1H), 3.95 (ddd, J = 7.8, 7.8, 5.0 Hz, 1H), 3.89 (ddd, J = 7.6, 7.6, 7.6 Hz, 
1H), 3.82 (s, 1H), 1.84 (ddddd, J = 12.0, 6.6, 6.6, 6.6, 5.0 Hz, 1H), 1.74 (ddd, J = 13.0, 8.1, 
8.1 Hz, 1H), 1.64 (ddd, J = 13.0, 7.8, 5.4 Hz, 1H), 1.45 (ddddd, J = 12.0, 7.8, 7.8, 7.8, 7.8 
Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 205.6, 163.9, 135.0, 132.8, 132.0, 131.9, 
121.7, 90.9, 69.0, 63.1, 33.2, 26.3 ppm; IR (thin film) 3063, 2926, 2875, 1715, 1589, 1489, 
1444, 1406, 1341, 1220, 1172, 1073, 1051, 1012 cm-1; MS (ESI) m/z 315.01 (100%), 317.01 






6-(4-(Trifluoromethyl)phenyl)-1-oxaspiro[4.4]non-8-en-7-one (42): Colorless, 
crystalline solid. 1H NMR (600 MHz, CDCl3) δ 7.61 (d, J = 8.1 Hz, 2H), 7.49 (d, J = 5.7 
Hz, 1H), 7.24 (d, J = 8.1 Hz, 2H), 6.31 (d, J = 5.7 Hz, 1H), 3.96 (ddd, J = 7.8, 7.8, 5.0 Hz, 
1H), 3.93 (s, 1H), 3.90 (ddd, J = 7.6, 7.6, 7.6 Hz, 1H), 1.85 (ddddd, J = 12.0, 6.7, 6.7, 6.7, 
5.1 Hz, 1H), 1.76 (ddd, J = 13.0, 7.8, 7.8 Hz, 1H), 1.61 (ddd, J = 13.0, 7.8, 5.4 Hz, 1H), 1.43 
(ddddd, J = 12.0, 7.8, 7.8, 7.8, 7.8 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 205.3, 
164.0, 140.1, 132.7, 130.6, 124.3 (q, J = 270 Hz), 125.7 (q, J = 4 Hz), 129.9 (q, J = 33 Hz), 
91.0, 69.0, 63.4, 33.2, 26.3 ppm; IR (thin film) 2928, 1717, 1620, 1420, 1327, 1165, 1124, 
1112, 1068, 1020 cm-1; MS (ESI) m/z 305.09 (305.08 calcd for C15H13F3NaO2+ [MNa]+). 





6-(4-Nitrophenyl)-1-oxaspiro[4.4]non-8-en-7-one (43): Pale solid and inseperable 
from the epimerized cis product in a 9:1 ratio. 1H NMR (600 MHz, CDCl3) δ 8.23 (d, J = 
8.7 Hz, 2H), 7.51 (d, J = 5.7 Hz, 1H), 7.31 (d, J = 8.7 Hz, 2H), 6.32 (d, J = 5.7 Hz, 1H), 4.00 
(s, 1H), 3.98 (ddd, J = 7.8, 7.8, 5.4 Hz, 1H), 3.91 (ddd, J = 7.6, 7.6, 7.6 Hz, 1H), 1.87 
(ddddd, J = 12.0, 6.6, 6.6, 6.6, 5.4 Hz, 1H), 1.78 (ddd, J = 13.0, 7.8, 7.8 Hz, 1H), 1.58 (ddd, 
J = 13.0, 7.8, 5.4 Hz, 1H), 1.48 (ddddd, J = 12.0, 7.8, 7.8, 7.8, 7.8 Hz, 1H) ppm; 13C NMR 
(150 MHz, CDCl3) δ 204.4, 164.0, 143.6, 134.1, 132.6, 131.2, 124.0, 91.0, 69.1, 63.3, 33.2, 
26.3 ppm; IR (thin film) 3080, 2924, 1715, 1604, 1519, 1346, 1174, 1110, 1053, 1020, cm-1; 






6-(Thiophen-2-yl)-1-oxaspiro[4.4]non-8-en-7-one (7): Pale orange solid. 1H NMR 
(600 MHz, CDCl3) δ 7.44 (d, J = 5.7 Hz, 1H), 7.28 (d, J = 4.8 Hz, 1H), 7.03 (dd, J = 4.8, 3.0 
Hz, 1H), 6.89 (d, J = 3.0 Hz, 1H), 6.27 (d, J = 5.7 Hz, 1H), 4.16 (s, 1H), 4.03 (ddd, J = 7.6, 
7.6, 4.8 Hz, 1H), 3.92 (ddd, J = 14.8, 7.6, 7.6 Hz, 1H), 1.91 – 1.85 (m, 1H), 1.83 (ddd, J = 
13.0, 7.8, 5.4 Hz, 1H), 1.75 (ddd, J = 13.0, 7.8, 7.8 Hz, 1H), 1.61 (ddddd, J = 10.2, 7.8, 7.8, 
7.8, 7.8 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 203.9, 163.3, 136.6, 132.1, 127.8, 
127.2, 125.4, 90.9, 69.3, 58.8, 33.2, 26.5 ppm; IR (thin film) 2919, 2851, 1717, 1592, 1437, 
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6-(Naphthalen-2-yl)-1-oxaspiro[4.4]non-8-en-7-one (44): Pale yellow solid. 1H NMR 
(600 MHz, CDCl3) δ 7.86 – 7.78 (m, 3H), 7.62 (s, 1H), 7.51 (d, J = 5.7 Hz, 1H), 7.50 – 7.46 
(m, 2H), 7.17 (dd, J = 8.4, 1.8 Hz, 1H), 6.35 (d, J = 5.7 Hz, 1H), 4.03 (s, 1H), 3.98 (ddd, J = 
7.8, 7.8, 4.8 Hz, 1H), 3.91 (ddd, J = 7.6, 7.6, 7.6 Hz, 1H), 1.79 (ddddd, J = 9.6, 7.2, 7.2, 7.2, 
5.4 Hz, 1H), 1.78 – 1.70 (m, 2H), 1.44 (ddddd, J = 9.6, 7.6, 7.6, 7.6, 7.6 Hz, 1H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 206.5, 164.0, 133.7, 133.6, 133.0, 132.8, 129.5, 128.5, 128.0, 
127.8, 127.7, 126.4, 126.2, 91.2, 69.0, 63.8, 33.2, 26.4 ppm; IR (thin film) 3056, 2924, 
1712, 1631, 1600, 1508, 1441, 1341, 1273, 1171, 1125, 1049 cm-1; MS (ESI) m/z 287.11 






6-Butyl-2,2-dimethyl-1-oxaspiro[4.4]non-8-en-7-one (45): Yellow oil. 1H NMR (600 
MHz, CDCl3) δ 7.35 (d, J = 5.7 Hz, 1H), 6.04 (d, J = 5.7 Hz, 1H), 2.45 (t, J = 6.3 Hz, 1H), 
2.17 (ddd, J = 7.2, 7.2, 5.4 Hz, 1H), 1.99 – 1.86 (m, 3H), 1.73 – 1.67 (m, 1H), 1.62 – 1.55 
(m, 1H), 1.49 – 1.42 (m, 2H), 1.39 – 1.33 (m, 2H), 1.34 (s, 3H), 1.30 (s, 3H), 0.92 (t, J = 7.2 
Hz, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 208.2, 164.7, 131.2, 90.5, 81.9, 55.9, 39.1, 
32.0, 30.3, 29.7, 29.3, 25.7, 23.1, 14.1 ppm; IR (thin film) 2963, 2932, 2873, 1717, 1459, 
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2,2-Dimethyl-6-phenyl-1-oxaspiro[4.4]non-8-en-7-one (46): Pale, crystalline solid. 1H 
NMR (600 MHz, CDCl3) δ 7.44 (d, J = 5.4 Hz, 1H), 7.35 (dd, J = 7.5, 7.2 Hz, 2H), 7.29 (t, J 
= 7.5 Hz, 1H), 7.10 (d, J = 7.2 Hz, 2H), 6.25 (d, J = 5.4 Hz, 1H), 3.82 (s, 1H), 1.87 (ddd, J = 
13.2, 7.8, 7.8 Hz, 1H), 1.76 (ddd, J = 13.2, 6.6, 6.6 Hz, 1H), 1.66 (ddd, J = 13.0, 6.6, 6.6 Hz, 
1H), 1.35 – 1.29 (m 1H), 1.30 (s, 3H), 1.24 (s, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 
206.4, 165.2, 135.9, 132.3, 130.4, 128.7, 127.5, 91.4, 82.7, 64.3, 38.4, 33.4, 29.1, 28.9 ppm; 
IR (thin film) 3063, 3031, 2971, 2931, 2873, 1717, 1594, 1498, 1454, 1382, 1368, 1339, 







2-Methyl-6-phenyl-1-oxaspiro[4.4]non-8-en-7-one (47): Pale, crystalline solid, 2:1 
mixture of diastereomers. 1H NMR (600 MHz, CDCl3) δ 7.48 (d, J = 6.0 Hz, 1H(MAJ)), 7.48 
(d, J = 6.0 Hz, 1H(min)), 7.36 – 7.28 (m, 3H), 7.12 (d, J = 7.8 Hz, 2H(MAJ)), 7.08 (d, J = 7.8 
Hz, 2H(min)), 6.29 (d, J =6.0 Hz, 1H(min)), 6.27 (d, J =6.0 Hz, 1H(MAJ)), 4.23 – 4.12 (m, 1H), 
3.85 (s, 3H(MAJ)), 3.84 (s, 3H(min)), 1.82 – 1.65 (m, 3H), 1.52 - 1.46 (m, 1H(min)) 1.26 (d, J = 
6.6 Hz, 3H(min)), 1.25 (d, J = 6.6 Hz, 3H(MAJ)), 0.97 – 0.91 (m, 1H(MAJ)) ppm; 13C NMR (150 
MHz, CDCl3) δ [MAJOR]: 206.1, 164.3, 135.4, 132.4, 130.4, 128.7, 127.6, 91.1, 76.4, 64.2, 
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33.7, 33.6, 21.2, [minor]: 206.7, 164.9, 136.7, 132.8, 130.1, 128.9, 127.5, 91.3, 76.8, 64.0, 
33.6, 33.2, 22.2 ppm; IR (thin film) 3031, 2971, 2929, 1715, 1601, 1498, 1453, 1382, 1340, 







2,6-Diphenyl-1-oxaspiro[4.4]non-8-en-7-one (48): Pale oil, 2:1 mixture of 
diastereomers. 1H NMR (600 MHz, CDCl3) δ 7.61 (d, J = 6.0 Hz, 1H(MAJ)), 7.59 (d, J = 6.0 
Hz, 1H(min)), 7.39 – 7.27 (m, 8H), 7.15 (d, J = 7.8 Hz, 2H(min)), 7.12 (d, J = 7.2 Hz, 2H(MAJ)), 
6.35 (d, J = 6.0 Hz, 1H(min)), 6.34 (d, J = 6.0 Hz, 1H(MAJ)), 5.10 (t, J = 6.6 Hz, 1H(min)), 5.04 
(dd, J = 9.3, 5.7 Hz, 1H(MAJ)), 4.03 (s, 1H(MAJ)), 4.01 (s, 1H(min)), 2.16 – 2.11 (m, 1H(MAJ)), 
2.06 – 2.00 (m, 1H(min)), 1.96 – 1.79 (m, 2H(MAJ)3H(min)) 1.43 – 1.36 (m, 1H(MAJ)) ppm; 13C 
NMR (150 MHz, CDCl3) δ [MAJOR]: 206.2, 164.0, 141.5, 135.5, 132.9, 130.5, 128.8, 
128.7, 127.9, 127.7, 126.0, 91.5, 81.5, 63.8, 34.7, 33.5 [minor]: 206.5, 164.0, 142.7, 136.6, 
133.1, 130.2, 129.0, 128.7, 127.7, 125.6, 91.9, 82.0, 63.9, 35.0, 33.4 ppm; IR (thin film) 
3062, 3031, 2926, 1714, 1602, 1497, 1452, 1342, 1267, 1217, 1158, 1078, 1043 cm-1; MS 







2-isoPropyl-6-phenyl-1-oxaspiro[4.4]non-8-en-7-one (49): Yellow oil, 2:1 mixture of 
diastereomers. 1H NMR (600 MHz, CDCl3) δ 7.49 (d, J = 5.7 Hz, 1H(MAJ)), 7.42 (d, J = 5.7 
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Hz, 1H(min)), 7.35 – 7.27 (m, 3H), 7.09 (d, J = 7.2 Hz, 2H), 6.28 (d, J = 5.7 Hz, 1H(min)), 6.27 
(d, J = 5.7 Hz, 1H(MAJ)), 3.86 (s, 1H(min)), 3.84 (s, 1H(MAJ)), 3.76 (ddd, J = 7.0, 7.0, 7.0 Hz, 
1H(min)), 3.68 (ddd, J = 7.8, 7.8, 5.0 Hz, 1H(MAJ)), 1.76 – 1.50 (m, 4H), 1.10 – 1.02 (m, 1H), 
1.00 (d, J = 6.6 Hz, 3H(MAJ)), 0.96 (d, J = 6.6 Hz, 3H(min)), 0.86 (d, J = 6.6 Hz, 3H(min)), 0.84 
(d, J = 6.6 Hz, 3H(MAJ)) ppm; 13C NMR (150 MHz, CDCl3) δ [MAJOR]: 206.5, 164.5, 
135.7, 132.5, 130.4, 128.7, 127.5, 90.9, 85.8, 64.0, 33.4, 33.3, 29.4, 19.8, 18.7 [minor]: 
206.9, 164.7, 136.9, 132.8, 130.1, 128.8, 127.5, 91.1, 86.2, 64.0, 33.5, 33.3, 29.0, 19.3, 18.4 
ppm; IR (thin film) 3031, 2960, 2873, 1717, 1594, 1498, 1454, 1388, 1339, 1224, 1164, 















General Procedure for the Rearrangement of Spirocycles to Bicycles: 
Oxaspirocycles (20) were stirred as a solution in toluene at 23 ºC and treated with 
Amberlyst®15 (20 mg). The reaction flask was immediately placed in an oil bath pre-heated 
to 60 ºC. The reaction was monitored by TLC. Upon completion, the reaction was cooled to 
room temperature and filtered through cotton, eluted with ethyl acetate. The combined 










5-Phenyl-3,4,7,7a-tetrahydrocyclopenta[b]pyran-6(2H)-one (19): According to the 
general procedure Amberlyst®15 (20 mg) was added to 6-phenyl-1-oxaspiro[4.4]non-8-en-
7-one 6 (10 mg, 0.047 mmol, 1 equiv) in toluene (1.2 mL). The resulting reaction mixture 
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was heated to 60 ºC for 24 h then cooled to room temperature and filtered through cotton, 
eluted with ethyl acetate (10 mL). The combined organic layers were concentrated in vacuo 
to afford oxabicycle 19 (9.1 mg, 91%) as a pale yellow oil. 1H NMR (600 MHz, CDCl3) δ 
7.42 (t, J = 8.9 Hz, 2H), 7.37 – 7.33 (m, 1H), 7.31 (d, J = 10.0 Hz, 2H), 4.55 (dd, J = 7.8, 2.8 
Hz, 1H), 4.12 – 4.17 (m, 1H), 3.81 – 3.76 (m, 1H), 3.13 – 3.06 (m, 1H), 2.88 (dd, J = 22.0, 
7.8 Hz, 1H), 2.60 – 2.52 (m, 1H), 2.54 (dd, J = 22.0, 2.8 Hz, 1H), 1.90 – 1.83 (m, 2H) ppm; 
13C NMR (150 MHz, CDCl3) δ 203.0, 169.0, 138.5, 130.4, 129.3, 128.6, 128.4, 75.9, 67.7, 
42.3, 27.1, 26.8 ppm; IR (thin film) 3398, 3058, 2956, 2925, 2850, 1706, 1647, 1496, 1445, 
1326, 1295, 1137, 1090, 1049 cm-1; MS (ESI) m/z 237.09 (237.09 calcd for C14H14NaO2+ 

















According to the general procedure Amberlyst®15 (20 mg) was added to 6-(4-
methoxyphenyl)-1-oxaspiro[4.4]non-8-en-7-one 40 (7.6 mg, 0.031 mmol, 1 equiv) in 
toluene (1.2 mL). The resulting reaction mixture was heated to 60 ºC for 24 h then cooled to 
room temperature and filtered through cotton, eluted with ethyl acetate (10 mL). The 
combined organic layers were concentrated in vacuo to afford oxabicycle 22 (5.7 mg, 75%) 
as a colorless oil. 1H NMR (600 MHz, CDCl3) δ 7.27 (d, J = 8.6 Hz, 2H), 6.95 (d, J = 8.6 
Hz, 2H), 4.53 (dd, J = 6.5, 2.2 Hz, 1H), 4.11 – 4.07 (m, 1H), 3.83 (s, 3H), 3.78 (td, J = 11.0, 
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1H), 2.48 (dd, J = 18.3, 2.2 Hz, 1H), 1.88 – 1.82 (m, 2H) ppm; 13C NMR (150 MHz, 
CDCl3) δ 203.3, 167.8, 159.7, 138.0, 130.6, 122.7, 114.1, 75.8, 67.7, 55.5, 42.3, 27.0, 26.8 
ppm; IR (thin film) 3470, 2956, 2925, 2851, 1705, 1608, 1513, 1327, 1289, 1250, 1175, 
1090, 1032 cm-1; MS (ESI) m/z 267.11 (267.10 calcd for C15H16NaO3+ [MNa]+). Data was 










5-Mesityl-3,4,7,7a-tetrahydrocyclopenta[b]pyran-6(2H)-one (23): According to the 
general procedure Amberlyst®15 (20 mg) was added to 6-mesityl-1-oxaspiro[4.4]non-8-en-
7-one 8 (7.0 mg, 0.027 mmol, 1 equiv) in toluene (1.2 mL). The resulting reaction mixture 
was heated to 60 ºC for 24 h then cooled to room temperature and filtered through cotton, 
eluted with ethyl acetate (10 mL). The combined organic layers were concentrated in vacuo 
to afford oxabicycle 23 (7.0 mg, 98%) as a colorless oil. 1H NMR (600 MHz, CDCl3) δ 6.90 
(s, 1H), 6.88 (s, 1H), 4.59 (dd, J = 6.4, 2.3 Hz, 1H), 4.12 – 4.08 (m, 1H), 3.78 – 3.73 (m, 
1H), 2.88 (dd, J = 18.4, 6.4 Hz, 1H), 2.56 – 2.51 (m, 1H), 2.52 (dd, J = 18.4, 2.3 Hz, 1H), 
2.37 – 2.30 (m, 1H), 2.28 (s, 3H), 2.08 (s, 3H), 1.99 (s, 3H), 1.88 – 1.82 (m, 2H) ppm; 13C 
NMR (150 MHz, CDCl3) δ 203.3, 170.6, 139.3, 138.0, 136.7, 136.5, 128.5, 128.4, 126.9, 
76.1, 67.7, 42.3, 27.1, 26.7, 21.3, 20.3, 20.1 ppm; IR (thin film) 3407, 2923, 2852, 1711, 
1654, 1612, 1443, 1376, 1324, 1289, 1161, 1121, 1088, 1049, 1035 cm-1; MS (ESI) m/z 
279.14 (279.14 calcd for C17H20NaO2+ [MNa]+).  
 










According to the general procedure Amberlyst®15 (20 mg) was added to 6-(4-
bromophenyl)-1-oxaspiro[4.4]non-8-en-7-one 41 (25 mg, 0.085 mmol, 1 equiv) in toluene 
(1.2 mL). The resulting reaction mixture was heated to 60 ºC for 24 h then cooled to room 
temperature and filtered through cotton, eluted with ethyl acetate (10 mL). The combined 
organic layers were concentrated in vacuo to afford oxabicycle 24 (21 mg, 84%) as a pale 
yellow oil. 1H NMR (600 MHz, CDCl3) δ 7.54 (d, J = 8.4 Hz, 2H), 7.19 (d, J = 8.4 Hz, 2H), 
4.53 (dd, J = 6.5, 2.5 Hz, 1H), 4.11 – 4.07 (m, 1H), 3.78 (td, J = 11.8, 3.0 Hz, 1H), 3.06 – 
3.01 (m, 1H), 2.87 (dd, J = 18.4, 6.5 Hz, 1H), 2.55 (td, J = 13.5, 6.6 Hz, 1H), 2.48 (dd, J = 
18.4, 2.5 Hz, 1H), 1.91 – 1.81 (m, 2H) ppm; 13C NMR (150 MHz, CDCl3) δ 202.6, 169.4, 
137.4, 131.8, 130.9, 129.3, 122.7, 75.8, 67.6, 42.2, 27.0, 26.8 ppm; IR (thin film) 3397, 
2956, 2925, 2851, 1708, 1648, 1588, 1489, 1462, 1441, 1398, 1364, 1326, 1304, 1292, 
1264, 1176, 1138, 1089, 1073, 1050, 1012 cm-1; MS (ESI) m/z 315.01 (100%), 317.01 











(25): According to the general procedure Amberlyst®15 (20 mg) was added to 6-(4-
(trifluoromethyl)phenyl)-1-oxaspiro[4.4]non-8-en-7-one 42 (10 mg, 0.035 mmol, 1 equiv) in 
toluene (1.2 mL). The resulting reaction mixture was heated to 60 ºC for 24 h then cooled to 
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room temperature and filtered through cotton, eluted with ethyl acetate (10 mL). The 
combined organic layers were concentrated in vacuo to afford oxabicycle 25 (8.1 mg, 81%) 
as a pale yellow oil. 1H NMR (600 MHz, CDCl3) δ 7.68 (d, J = 8.1 Hz, 2H), 7.43 (d, J = 8.1 
Hz, 2H), 4.62 (dd, J = 6.5, 2.4 Hz, 1H), 4.13 – 4.19 (m, 1H), 3.79 (td, J = 11.9, 2.6 Hz, 1H), 
3.08 – 3.03 (m, 1H), 2.90 (dd, J = 18.5, 6.5 Hz, 1H), 2.60 (td, J = 13.5, 6.5 Hz, 1H), 2.52 
(dd, J = 18.5, 2.4 Hz, 1H), 1.94 – 1.83 (m, 2H) ppm; 13C NMR (150 MHz, CDCl3) δ 202.4, 
170.4, 137.4, 134.1, 130.4 (q, J = 31 Hz), 129.7, 127.6 (q, J = 271 Hz), 126.1 (q, J = 4 Hz), 
75.9, 67.6, 42.3, 27.1, 26.8 ppm; IR (thin film) 3406, 2958, 2927, 2852, 1709, 1650, 1616, 
1411, 1365, 1327, 1299, 1166, 1125, 1091, 1067, 1050, 1020 cm-1; MS (ESI) m/z 305.09 










5-(4-Nitrophenyl)-3,4,7,7a-tetrahydrocyclopenta[b]pyran-6(2H)-one (26): According 
to the general procedure Amberlyst®15 (20 mg) was added to 6-(4-nitrophenyl)-1-
oxaspiro[4.4]non-8-en-7-one 43 (8.5 mg, 0.033 mmol, 1 equiv) in toluene (1.2 mL). The 
resulting reaction mixture was heated to 60 ºC for 24 h then cooled to room temperature and 
filtered through cotton, eluted with ethyl acetate (10 mL). The combined organic layers were 
concentrated in vacuo to afford oxabicycle 26 (7 mg, 82%) as a pale orange oil. 1H NMR 
(600 MHz, CDCl3) δ 8.28 (d, J = 8.7 Hz, 2H), 7.50 (d, J = 8.7 Hz, 2H), 4.58 (dd, J = 6.5, 2.3 
Hz, 1H), 4.14 – 4.10 (m, 1H), 3.80 (td, J = 12.0, 2.3 Hz, 1H), 3.07 – 3.03 (m, 1H), 2.92 (dd, 
J = 18.5, 6.5 Hz, 1H), 2.63 (td, J = 13.6, 6.3 Hz, 1H), 2.53 (dd, J = 18.5, 2.3 Hz, 1H), 1.96 – 
1.84 (m, 2H) ppm; 13C NMR (150 MHz, CDCl3) δ 201.9, 171.4, 147.7, 137.2, 136.7, 130.3, 
123.8, 75.9, 67.6, 42.3, 27.1, 27.0 ppm; IR (thin film) 3405, 2925, 2852, 1709, 1599, 1519, 
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1347, 1326, 1300, 1138, 1090, 1049 cm-1; MS (ESI) m/z 282.08 (282.07 calcd for 











5-(Thiophen-2-yl)-3,4,7,7a-tetrahydrocyclopenta[b]pyran-6(2H)-one (27): According 
to the general procedure Amberlyst®15 (20 mg) was added to 6-(thiophen-2-yl)-1-
oxaspiro[4.4]non-8-en-7-one 7 (12.6 mg, 0.057 mmol, 1 equiv) in toluene (1.2 mL). The 
resulting reaction mixture was heated to 60 ºC for 24 h then cooled to room temperature and 
filtered through cotton, eluted with ethyl acetate (10 mL). The combined organic layers were 
concentrated in vacuo to afford oxabicycle 27 (10 mg, 80%) as a yellow oil. 1H NMR (600 
MHz, CDCl3) δ 7.50 (d, J = 3.7 Hz, 1H), 7.41 (d, J = 5.1 Hz, 1H), 7.12 (dd, J = 5.1, 3.7 Hz, 
1H), 4.53 (dd, J = 6.5, 2.7 Hz, 1H), 4.12 – 4.08 (m, 1H), 3.79 (td, J = 11.5, 3.5 Hz, 1H), 3.48 
– 3.43 (m, 1H), 2.88 (dd, J = 18.4, 6.5 Hz, 1H), 2.62 (dt, J = 14.8, 10.0 Hz, 1H), 2.49 (dd, J 
= 18.4, 2.7 Hz, 1H), 1.94 – 1.89 (m, 2H) ppm; 13C NMR (150 MHz, CDCl3) δ 201.8, 166.6, 
131.4, 128.2, 127.3, 126.9, 120.7, 75.7, 67.6, 42.0, 27.1, 26.7 ppm; IR (thin film) 3102, 
2923, 2851, 1702, 1630, 1428, 1323, 1292, 1219, 1162, 1122, 1090, 1048 cm-1; MS (ESI) 
m/z 243.05 (243.05 calcd for C12H12NaO2S+ [MNa]+). Data was consistent with those found 
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5-(Naphthalen-2-yl)-3,4,7,7a-tetrahydrocyclopenta[b]pyran-6(2H)-one (28): 
According to the general procedure Amberlyst®15 (20 mg) was added to 6-(naphthalen-2-
yl)-1-oxaspiro[4.4]non-8-en-7-one 44 (10 mg, 0.038 mmol, 1 equiv) in toluene (1.2 mL). 
The resulting reaction mixture was heated to 60 ºC for 24 h then cooled to room temperature 
and filtered through cotton, eluted with ethyl acetate (10 mL). The combined organic layers 
were concentrated in vacuo to afford oxabicycle 28 (7.5 mg, 75%) as a pale yellow oil. 1H 
NMR (600 MHz, CDCl3) δ 7.88 (d, J = 8.5 Hz, 1H), 7.87 – 7.83 (m, 2H), 7.81 (s, 1H), 7.51 
– 7.48 (m, 2H), 7.42 (dd, J = 8.4, 1.5 Hz, 1H), 4.66 (dd, J = 6.5, 2.5 Hz, 1H), 4.14 – 4.10 (m, 
1H), 3.84 – 3.79 (m, 1H), 3.18 – 3.13 (m, 1H), 2.93 (dd, J = 18.3, 6.5 Hz, 1H), 2.63 (dt, J = 
14.5, 9.8 Hz, 1H), 2.55 (dd, J = 18.3, 2.5 Hz, 1H), 1.91 – 1.85 (m, 2H) ppm; 13C NMR (150 
MHz, CDCl3) δ 203.1, 169.3, 138.5, 133.4, 133.2, 128.8, 128.4, 128.2, 127.9, 127.9, 126.8, 
126.6, 126.4, 75.9, 67.7, 42.4, 27.1, 26.9 ppm; IR (thin film) 3398, 3057, 2957, 2925, 2852, 
1708, 1646, 1596, 1506, 1461, 1441, 1374, 1323, 1310, 1294, 1271, 1261, 1139, 1118, 













According to the general procedure Amberlyst®15 (20 mg) was added to 6-butyl-2,2-
dimethyl-1-oxaspiro[4.4]non-8-en-7-one 45 (9.0 mg, 0.045 mmol, 1 equiv) in toluene (1.2 
mL). The resulting reaction mixture was heated to 60 ºC for 24 h then cooled to room 
temperature and filtered through cotton, eluted with ethyl acetate (10 mL). The combined 
organic layers were concentrated in vacuo to afford oxabicycle 29 (6.0 mg, 60%) as a very 
pale oil. 1H NMR (600 MHz, CDCl3) δ 4.64 (dd, J = 6.2, 2.4 Hz, 1H), 2.77 – 2.72 (m, 1H), 
  305 
2.67 (dd, J = 18.1, 6.2 Hz, 1H), 2.53 (td, J = 14.0, 5.5 Hz, 1H), 2.26 (dd, J = 18.1, 2.4 Hz, 
1H), 2.16 (t, J = 7.6 Hz, 2H), 1.80 (ddd, J = 13.3, 5.7, 2.4 Hz, 1H), 1.63 (td, J = 13.3, 4.8 
Hz, 1H), 1.41 – 1.40 (m, 2H), 1.39 – 1.34 (m 1H), 1.31 – 1.28 (m, 1H), 1.25 (s, 6H), 0.89 (t, 
J = 7.3 Hz, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 205.3, 168.4, 139.1, 120.7, 72.9, 69.7, 
42.6, 36.9, 31.0, 23.0, 22.8, 22.4, 21.9, 14.1 ppm; IR (thin film) 3410, 2958, 2928, 2857, 
1710, 1659, 1465, 1366, 1288, 1125, 1075, 1029 cm-1; MS (ESI) m/z 245.16 (245.15 calcd 













According to the general procedure Amberlyst®15 (20 mg) was added to 2,2-dimethyl-6-
phenyl-1-oxaspiro[4.4]non-8-en-7-one 46 (10 mg, 0.041 mmol, 1 equiv) in toluene (1.2 
mL). The resulting reaction mixture was heated to 60 ºC for 24 h then cooled to room 
temperature and filtered through cotton, eluted with ethyl acetate (10 mL). The combined 
organic layers were concentrated in vacuo and the residue purified by flash column 
chromatography to afford oxabicycle 30 (9 mg, 90%) as a colorless oil. 1H NMR (600 MHz, 
CDCl3) δ 7.42 (t, J = 7.6 Hz, 2H), 7.36 – 7.32 (m, 3H), 4.82 (dd, J = 6.4, 2.6 Hz, 1H), 2.97 – 
2.93 (m, 1H), 2.86 (dd, J = 18.2, 6.4 Hz, 1H), 2.73 (td, J = 14.1, 5.9 Hz, 1H), 2.49 (dd, J = 
18.2, 2.6 Hz, 1H), 1.78 (ddd, J = 13.4, 5.9, 2.2 Hz, 1H), 1.68 (td, J = 13.3, 4.9 Hz, 1H), 1.47 
(s, 3H), 1.28 (s, 3H) ppm; 13C NMR (150 MHz, CDCl3) δ 203.2, 169.6, 130.6, 129.4, 128.6, 
128.4, 120.7, 73.0, 69.6, 43.2, 36.8, 30.9, 23.8, 21.9 ppm; IR (thin film) 3401, 2924, 2852, 
1706, 1627, 1446, 1363, 1328, 1298, 1262, 1145, 1116, 1077, 1043, 1019 cm-1; MS (ESI) 
m/z 265.13 (265.12 calcd for C16H18NaO2+ [MNa]+). 















According to the general procedure Amberlyst®15 (20 mg) was added to 2-methyl-6-
phenyl-1-oxaspiro[4.4]non-8-en-7-one 47 (10 mg, 0.044 mmol, 1 equiv) in toluene (1.2 
mL). The resulting reaction mixture was heated to 60 ºC for 24 h then cooled to room 
temperature and filtered through cotton, eluted with ethyl acetate (10 mL). The combined 
organic layers were concentrated in vacuo to afford oxabicycle 31 (9.3 mg, 93%) as a 
colorless oil. Single diastereomer: relative stereochemistry determined by cycle nOe. 1H 
NMR (600 MHz, CDCl3) δ 7.41 (t, J = 7.5 Hz, 2H), 7.35 (t, J = 7.4 Hz, 1H), 7.31 (d, J = 7.8 
Hz, 2H), 4.62 (dd, J = 6.5, 2.5 Hz, 1H), 3.89 – 3.84 (m, 1H), 3.09 - 3.05 (m, 1H), 2.89 (dd, J 
= 18.3, 6.5 Hz, 1H), 2.59 (td, J = 13.9, 6.1 Hz, 1H), 2.52 (dd, J = 18.3, 2.5 Hz, 1H), 1.91 
(ddt, J = 13.4, 6.1, 1.9 Hz, 1H), 1.50 (qd, J = 13.3, 4.7 Hz, 1H), 1.26 (d, J = 6.0 Hz, 3H) 
ppm; 13C NMR (150 MHz, CDCl3) δ 203.2, 168.8, 138.4, 130.5, 129.4, 128.6, 128.4, 75.6, 
73.4, 42.5, 33.9, 26.7, 21.6 ppm; IR (thin film) 3405, 2971, 2932, 2851, 1707, 1646, 1601, 
1495, 1445, 1385, 1364, 1347, 1315, 1293, 1173, 1135, 1077, 1029 cm-1; MS (ESI) m/z 
251.11 (251.10 calcd for C15H16NaO2+ [MNa]+).  




























2,5-Diphenyl-3,4,7,7a-tetrahydrocyclopenta[b]pyran-6(2H)-one (32): According to 
the general procedure Amberlyst®15 (20 mg) was added to 2,6-diphenyl-1-
oxaspiro[4.4]non-8-en-7-one 48 (10 mg, 0.034 mmol, 1 equiv) in toluene (1.2 mL). The 
resulting reaction mixture was heated to 60 ºC for 24 h then cooled to room temperature and 
filtered through cotton, eluted with ethyl acetate (10 mL). The combined organic layers were 
concentrated in vacuo and the residue purified by flash column chromatography to afford 
oxabicycle 32 (7.4 mg, 74%) as a yellow oil. Single diastereomer. 1H NMR (600 MHz, 
CDCl3) δ 7.46 – 7.41 (m, 2H), 7.40 – 7.35 (m, 6H), 7.32 – 7.22 (m, 2H), 4.82 (dd, J = 6.5, 
2.6 Hz, 1H), 4.80 (dd, J = 11.7, 1.8, Hz, 1H), 3.20 (ddd, J = 14.6, 4.3, 1.6 Hz, 1H), 2.95 (dd, 
J = 18.4, 6.5 Hz, 1H), 2.78 (td, J = 13.9, 5.9 Hz, 1H), 2.66 (dd, J = 18.4, 2.6 Hz, 1H), 2.17 – 
2.13 (m, 1H), 1.85 (qd, J = 13.2, 4.6 Hz, 1H) ppm; 13C NMR (150 MHz, CDCl3) δ 203.1, 
168.0, 141.4, 130.4, 129.4, 128.7 (2), 128.5, 128.1, 126.1, 120.7, 79.5, 76.2, 42.5, 34.3, 27.1 
ppm; IR (thin film) 3398, 3061, 3031, 2923, 2851, 1706, 1646, 1601, 1496, 1447, 1312, 
















According to the general procedure Amberlyst®15 (20 mg) was added to 2-isopropyl-6-
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phenyl-1-oxaspiro[4.4]non-8-en-7-one 49 (30 mg, 0.117 mmol, 1 equiv) in toluene (3.6 
mL). The resulting reaction mixture was heated to 60 ºC for 24 h then cooled to room 
temperature and filtered through cotton, eluted with ethyl acetate (15 mL). The combined 
organic layers were concentrated in vacuo and the residue purified by flash column 
chromatography to afford oxabicycle 33 (22 mg, 73%) as a colorless oil. 7:1 mixture of 
diastereomers. 1H NMR (600 MHz, CDCl3) δ 7.41 (t, J = 7.5 Hz, 2H), 7.34 (t, J = 7.5 Hz, 
1H), 7.33 (d, J = 7.5 Hz, 2H), 4.80 (dd, J = 6.5, 2.5 Hz, 1H(min)), 4.57 (dd, J = 6.5, 2.5 Hz, 
1H(MAJ)), 3.49 – 3.46 (m, 1H(min)), 3.43 – 3.40 (m, 1H(MAJ)), 3.12 – 3.07 (m, 1H), 2.88 (dd, J 
= 18.3, 6.5 Hz, 1H), 2.55 (td, J = 13.8, 6.1 Hz, 1H), 2.52 (dd, J = 18.3, 2.5 Hz, 1H(MAJ)), 
2.48 (dd, J = 18.3, 2.5 Hz, 1H(min)), 1.94 – 1.89 (m, 1H), 1.74 (dq, J = 13.4, 6.7 Hz, 1H), 
1.49 (qd, J = 13.0, 4.6 Hz, 1H), 1.08 (d, J = 6.5 Hz, 3H(min)), 0.98 (d, J = 6.9 Hz, 3H(MAJ)), 
0.95 (d, J = 6.5 Hz, 3H(min)), 0.94 (d, J = 6.9 Hz, 3H(MAJ)) ppm; 13C NMR (150 MHz, 
CDCl3) δ (MAJOR) 203.4, 169.6, 138.0, 130.6, 129.4, 128.6, 128.3, 82.3, 75.8, 42.5, 33.1, 
28.9, 26.8, 18.8, 18.7 ppm; IR (thin film) 3405, 2959, 2922, 2851, 1709, 1464, 1446, 1324, 







i) nBuLi (2.5), THF, -20 ∞C
ii) PhCHO to rt
OHO
50  
3-(5-(Hydroxy(phenyl)methyl)furan-2-yl)propan-1-ol (38): 2-Substituted furan 50 
(519 mg, 4.12 mmol) was stirred as a solution in anh. THF (35 mL) at -20 ºC. nButyllithium 
(3.93 mL, 10.3 mmol, 2.5 equiv.) was added dropwise and the reaction mixture stirred for 1 
h at this temperature before the addition of benzaldehyde (1.05 mL, 10.3 mmol). The 
reaction flask was allowed to warm to room temperature over 2.5 h. The reaction was 
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quenched with saturated aqueous NH4Cl (25 mL) and extracted with ethyl acetate (4 x 50 
mL). The combined organic layers were dried over MgSO4, filtered and then concentrated in 
vacuo. The residue was purified by column chromatography to afford 5-substituted 
furylcarbinol 38 (669 mg, 70%) as a pale crystalline solid; 1H NMR (600 MHz, CDCl3) δ 
7.41 (d, J = 7.3 Hz, 2H), 7.34 (dd, J = 7.6, 7.3 Hz, 2H), 7.29 (dd, J = 7.3, 7.3 Hz, 1H), 5.92 
(d, J = 3.1 Hz, 1H), 5.90 (d, J = 3.1 Hz, 1H), 5.72 (s, 1H), 3.59 (t, J = 6.4 Hz, 2H), 2.65 (t, J 
= 7.5 Hz, 2H), 1.82 (dddd, J = 7.5, 7.5, 6.4, 6.4 Hz, 2H) ppm; 13C NMR (150 MHz, CDCl3) 
δ 155.9, 154.5, 141.2, 128.5, 128.0, 126.8, 108.4, 105.8, 70.1, 61.9, 30.9, 24.5 ppm; IR (thin 
film) 3352(br), 2946, 2881, 1650, 1603, 1558, 1494, 1191, 1051, 1013, 966, 920 cm-1; MS 
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9. Miscellaneous Projects 
9.1. Introduction 
In this chapter, work and projects that could result in interesting new directions and 
research projects are discussed. Some of these areas were investigated out of curiosity 
during my Ph.D. studies, but never developed into complete projects.   
9.2. Dysprosium Catalyzed [4+3] Cycloaddition 
Our interest in cycloaddition reactions with furylcarbinols was sparked by a report by 
Johan Winne and co-workers in 2011. In their publication, the group described the 
development of a [4+3] cycloaddition of furylcarbinols 1 and dienes 2,247 inspired by the 
observation of an unexpected [4+3] cycloaddition during Pattenden and Winne’s studies 
toward the total synthesis of rameswaralide.248  
The cycloaddition worked well with a variety of furylcarbinols where the 5-position was 
blocked, and could be performed with a number of dienes. The reaction was facilitated by 
1.5 equiv TiCl4 at –78 °C in CH2Cl2 (Table 9.1). If the 5-position of furan was not blocked, 
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Because superstoichiometric amounts of a strong Lewis acid and cryogenic conditions 
were used, we wondered if dysprosium could serve as the catalyst in the [4+3] 
cycloaddition. We were confident that we could perform the reaction under milder 
conditions with much lower catalyst loadings based on our success with the dysprosium 
triflate catalyzed aza-Piancatelli rearrangement.78 Additionally, we wondered if the mild 
nature of dysprosium might allow us to perform the reaction with furylcarbinols lacking the 
substituent at the 5-position.  
To our delight, we found that 5 mol % Dy(OTf)3 in MeNO2 at rt effectively catalyzed 
the cycloaddition of furylcarbinol 8 and cyclohexadiene (9) to give 10 in 85% yield (Scheme 
9.1). The reaction proceeded cleanly, and the yield is comparable to that achieved by Winne 
and co-workers (6, Table 9.1). Moreover, the experimental setup is extremely user friendly 
and requires no special skills or equipment. The reaction with furylcarbinol 11 gave 12 in 
only 7% yield with 3:1 dr. We presume that the secondary carbocation with only one methyl 
substituent is less stable and therefore may have resulted in increased decomposition.  


























Scheme 9.1. Dysprosium triflate catalyzed [4+3] cycloaddition of 5-substituted 
furylcarbinols and cyclohexadiene. 
 
We chose to focus our attention on the reaction with furylcarbinols lacking a substituent 
at the 5-position. Pleasingly, reaction of phenyl furylcarbinol 13 with cyclohexadiene 
resulted in the formation of 14 in 19% yield in 5:1 dr using 5 mol % Dy(OTf)3 in MeCN at 
rt (Scheme 9.2). Although the yield is quite low, this represents a huge improvement over 














Scheme 9.2. Successful dysprosium catalyzed reaction. 
Unfortunately, subsequent studies showed no improvement in yield of the reaction. We 
screened all RE(OTf)3 catalysts on hand (12), in addition to a number of solvents (MeNO2, 
CH2Cl2, hexanes, Et2O, THF, PhMe, EtOH, methyl tert-butyl ether) and different 
temperatures. We surmised that although activation does occur, decomposition of the 
furylcation occurs at a faster rate than cycloaddition. It may be possible to circumvent 
decomposition with a more reactive diene, but this has not yet been tested.  
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Despite the limited success in using Dy(OTf)3 for the reaction with furylcarbinols 
lacking a substituent at the 5-position, the initial success reported opens up a novel area of 
research for our group. The reaction with benzofurans could be extended to other 
cycloaddition reactions, such as [3+2] cycloadditions,249 and we could even envision 
departure from furan to other heterocycles, such as thiophene or indole. In fact, Wu and co-
workers recently described a gallium(III)- catalyzed [4+3] cycloaddition reaction of dienes 
with indole.250 Winne and co-workers subsequently utilized a gallium triflate catalyzed 
[4+3] cycloaddition in their efforts toward synthesizing the core ring system of 
guaianolides.251   
Thinking about the potential of furylcations outside of the scope of the aza-Piancatelli 
rearrangement opens up a whole new area of research, and it is exciting to think about 
harnessing the potential of these carbocations using our mild dysprosium catalyzed 
conditions. 
9.3. Alternative Activation of Furylcarbinols for the Aza-Piancatelli 
Rearrangement with Non-Aniline Amines 
During the synthesis of some intramolecular aza-Piancatelli cyclization precursors, we 
discovered some interesting behavior under Swern oxidation conditions. During the planned 
synthesis of aldehyde 16 from furylcarbinol 15 via Swern oxidation, we observed only a 
small amount of the desired aldehyde, and found the main component of the reaction to be 
cyclopentenone 17 (Scheme 9.3), the product of an aza-Piancatelli rearrangement. This was 
quite a surprise to us, especially considering that synthesis of cyclopentenone 16 using our 
Dy(OTf)3 catalyzed conditions had been quite challenging.   























Scheme 9.3. Unexpected aza-Piancatelli rearrangement under Swern oxidation 
conditions. 
 
Curious as to the generality of this surprising reaction, we set up the aza-Piancatelli 
rearrangement of phenyl furylcarbinol (13) and p-iodoaniline under Swern conditions, but 

















Scheme 9.4. Swern-mediated aza-Piancatelli rearrangement. 
Undeterred, we set up a reaction of phenyl furylcarbinol (13) with morpholine (20). To 
our delight, the desired cyclopentenone 21 formed in 23% yield, in addition to 18% of the 
substitution product 22 (Scheme 9.5). Switching to 1-phenylethan-1-amine (23), we were 
able to isolate 12% of the cyclopentenone 24 (Scheme 9.5). A few other experiments were 
completed, including the use of trifluoroacetic anhydride (TFAA) in the place of oxalyl 
chloride, changing the order of addition, and quenching with other bases, but thus far have 
not resulted in yields greater above 30%.  

























































Scheme 9.5. Swern-mediated aza-Piancatelli rearrangements with non-aniline amines. 
Although the Swern-mediated reaction does not perform as well as the dysprosium 
catalyzed rearrangement in the aniline case, it is much superior when using other amines. 
The reaction is especially intriguing from a mechanistic standpoint. We currently have two 
hypotheses as to the mode of activation. Our first hypothesis is that formation of 26 
facilitates the formation of oxocarbenium 27, which can be intercepted by the amine 
nucleophile and participate in the product-forming cascade (Figure 9.1). Alternatively, we 
have speculated that the chloride ion generated during the formation of the Swern reagent 
could displace the alcohol of the furylcarbinol, resulting in highly reactive alkyl chloride 29, 
which can result in the formation of oxocarbenium 27 and rearrange upon attack of the 
amine nucleophile (Figure 9.1). Importantly, the amine nucleophile is not inhibited from 
reacting, unlike the dysprosium-catalyzed reaction, opening this transformation up to a 
whole host of other nucleophiles. 










































Figure 9.1. Proposed mechanisms for the Swern-mediated aza-Piancatelli rearrangement. 
A thorough investigation of the Swern mediated aza-Piancatelli rearrangement could 
lead to a better understanding of the events that result in the product forming cascade, and 
could then be used to optimize reaction conditions for the aza-Piancatelli rearrangement 
with non-aniline amines – an exciting prospect. 
9.4. Experimental Procedures 
Materials and Methods. Unless stated otherwise, reactions were conducted in flame-
dried glassware under an atmosphere of air using reagent grade solvents. All commercially 
obtained reagents were used as received. Reaction temperatures were controlled using an 
Heidolph temperature modulator, and unless stated otherwise, reactions were performed at 
room temperature (rt, approximately 23 ºC). Thin-layer chromatography (TLC) was 
conducted with E. Merck silica gel 60 F254 pre-coated plates, (0.25 mm) and visualized by 
exposure to UV light (254 nm) or stained with anisaldehyde and potassium permanganate. 
Flash column chromatography was performed using normal phase silica gel (60 Å, 0.040 – 
0.063 mm, Geduran). 1H NMR spectra were recorded on Varian spectrometers (at 500 or 
600 MHz) and are reported relative to deuterated solvent signals. Data for 1H NMR spectra 
are reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) and 
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integration. 13C NMR spectra were recorded on Varian Spectrometers (125 or 150 MHz). 
Data for 13C NMR spectra are reported in terms of chemical shift (δ ppm), multiplicity, 















6,6-Dimethyl-7,10-dihydro-6H-7,10-ethanocyclohepta[b]benzofuran (10): A solution 
of furylcarbinol 8 (10.0 mg, 0.057 mmol) and cyclohexadiene 9 (11 µL, 0.11 mmol) in 0.6 
mL MeNO2 was treated with Dy(OTf)3 (1.7 mg, 0.0028 mmol) and stirred at rt. After 18 h, 
no starting material was observable by TLC, and the reaction was quenched with saturated 
NaHCO3 (5 mL), and extracted with EtOAc (3 x 5 mL). The combined organic layers were 
dried over MgSO4, filtered and the solvent removed via rotary evaporation. The product was 
purified by flash column chromatography to give 10 (11.6 mg, 85%). 1H NMR (400 MHz, 
CDCl3) δ 7.46 – 7.42 (m, 1H), 7.39 – 7.35 (m, 1H), 7.21 – 7.14 (m, 2H), 6.59 (dd, J = 8.8, 
7.2 Hz, 1H), 6.15 (dd, J = 8.3, 7.8 Hz, 1H), 3.50 (ddd, J = 6.4, 4.1, 2.0 Hz, 1H), 2.38 (t, J = 
7.2 Hz, 1H), 2.15 (ddd, J = 13.9, 9.6, 5.5 Hz, 1H), 2.01 (dddd, J = 9.6, 9.6, 2.6, 2.6 Hz, 1H), 
1.85 (dddd, J = 11.9, 11.9, 5.5, 4.1 Hz, 1H), 1.69 (dddd, J = 14.0, 11.2, 7.1, 2.9 Hz, 1H), 
1.46 (s, 3H), 1.29 (s, 3H) ppm. 














2 equiv  
6-Methyl-7,10-dihydro-6H-7,10-ethanocyclohepta[b]benzofuran (12): A solution of 
furylcarbinol 11 (10.0 mg, 0.062 mmol) and cyclohexadiene 9 (12 µL, 0.11 mmol) in 0.6 
mL MeNO2 was treated with Dy(OTf)3 (1.9 mg, 0.0030 mmol) and stirred at rt. After 18 h, 
no starting material was observable by TLC, and the reaction was quenched with saturated 
NaHCO3 (5 mL), and extracted with EtOAc (3 x 5 mL). The combined organic layers were 
dried over MgSO4, filtered and the solvent removed via rotary evaporation. The product was 
purified by flash column chromatography to give 12 (1.0 mg, 7%). 1H NMR (400 MHz, 
CDCl3) δ 7.48 – 7.41 (m, 1H), 7.40 – 7.34 (m, 1H), 7.22 – 7.13 (m, 2H), 6.70 – 6.64 (m, 
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0.3H), 3.50 (dddd, J = 6.0, 4.9, 2.2, 1.1 Hz, 1H), 3.17 (dddd, J = 9.9, 8.2, 6.6, 2.5 Hz, 1H), 
3.09 (dddd, J = 7.1, 7.1, 7.1, 4.2 Hz, 0.3H), 2.76 (td, J = 7.3, 4.2 Hz, 0.3H), 2.51 (td, J = 7.3, 
2.8 Hz, 1H), 2.12 – 2.00 (m, 2H), 2.00 – 1.74 (m, 2H), 1.70 – 1.59 (m, 1H), 1.45 (d, J = 7.1 













2 equiv  
8-Phenyl-7,8-dihydro-4H-4,7-ethanocyclohepta[b]furan (14): A solution of 
furylcarbinol 13 (50.5 mg, 0.29 mmol) and cyclohexadiene 9 (55 µL, 0.58 mmol) in 1.5 mL 
MeCN was treated with Dy(OTf)3 (9.1 mg, 0.015 mmol) and stirred at rt. After 24 h, no 
starting material was observable by TLC, and the reaction was quenched with saturated 
NaHCO3 (5 mL), and extracted with EtOAc (3 x 5 mL). The combined organic layers were 
dried over MgSO4, filtered and the solvent removed via rotary evaporation. The product was 
purified by flash column chromatography to give 14 (13 mg, 19%). 1H NMR (600 MHz, 
CDCl3) δ 7.34 – 7.17 (m, 4H), 7.14 – 7.05 (m, 1H), 6.58 (ddd, J = 9.0, 7.0, 2.2 Hz, 1H), 6.27 
(dd, J = 3.3, 1.7 Hz, 1H), 6.25 – 6.18 (m, 1H), 6.01 – 5.97 (m, 1H), 4.30 (dd, J = 3.2, 3.2 Hz, 
1H), 3.15 – 3.09 (m, 1H), 2.65 (ddd, J = 7.2, 7.2, 3.2 Hz, 1H), 2.13 – 2.07 (m, 1H), 1.85 – 
1.76 (m, 2H), 1.33 – 1.24 (m, 1H) ppm. 


















4-((4-Iodophenyl)amino)-5-phenylcyclopent-2-en-1-one (19): The Swern reagent was 
prepared by treating (COCl)2 (58 µL, 0.69 mmol) in 3 mL dry CH2Cl2 at -78 °C with DMSO 
(65 µL, 0.92 mmol) via dropwise addition over 15 min. After 15 min, a solution of 
furylcarbinol 13 (100 mg, 0.57 mmol) and p-iodoaniline (125.7 mg, 0.57 mmol) in 1 mL dry 
CH2Cl2 was added via dropwise addition. The reaction was stirred at -78 °C for 45 min 
before it was quenched with NEt3 (297 µL, 2.01 mmol) and allowed to come to rt. The 
resulting suspension was filtered through a pad of MgSO4, washing with copious amounts of 
Et2O. The solvent was removed via rotary evaporation and the product purified via flash 






















































































































































































































































































































































































































































































4-Morpholino-5-phenylcyclopent-2-en-1-one (21): The Swern reagent was prepared 
by treating (COCl)2 (58 µL, 0.57 mmol) in 3 mL dry CH2Cl2 at -78 °C with DMSO (65 µL, 
0.92 mmol) via dropwise addition over 15 min.  After 15 min, a solution of furylcarbinol 13 
(100 mg, 0.57 mmol) and morpholine (20) (50 µL, 0.57 mmol) in 1 mL dry CH2Cl2 was 
added via dropwise addition. The reaction was stirred at -78 °C for 45 min before it was 
quenched with NEt3 (297 µL, 2.01 mmol) and allowed to come to rt. The resulting 
suspension was filtered through a pad of MgSO4, washing with copious amounts of Et2O. 
The solvent was removed via rotary evaporation and the product purified via flash column 
chromatography to give cyclopentenone 21 (31.9 mg, 23%) as a light brown oil. 1H NMR 
(600 MHz, CDCl3) δ 7.73 (dd, J = 5.9, 2.3 Hz, 1H), 7.31 (t, J = 7.6 Hz, 2H), 7.27 – 7.21 (m, 
1H), 7.11 (dd, J = 7.3, 1.5 Hz, 2H), 6.37 (dd, J = 5.9, 1.9 Hz, 1H), 4.08 (ddd, J = 2.3, 2.3, 
2.3 Hz, 1H), 3.69 (ddd, J = 4.2, 4.2, 2.0 Hz, 4H), 3.59 (d, J = 2.7 Hz, 1H), 2.55 (dd, J = 4.6, 
4.6 Hz, 4H) ppm. 



















5-Phenyl-4-((1-phenylethyl)amino)cyclopent-2-en-1-one (24): The Swern reagent was 
prepared by treating (COCl)2 (58 µL, 0.57 mmol) in 3 mL dry CH2Cl2 at -78 °C with DMSO 
(65 µL, 0.92 mmol) via dropwise addition over 15 min.  After 15 min, a solution of 
furylcarbinol 13 (100 mg, 0.57 mmol) and 1-phenylethan-1-amine (23) (50 µL, 0.57 mmol) 
in 1 mL dry CH2Cl2 was added via dropwise addition. The reaction was stirred at -78 °C for 
45 min before it was quenched with NEt3 (297 µL, 2.01 mmol) and allowed to come to rt. 
The resulting suspension was filtered through a pad of MgSO4, washing with copious 
amounts of Et2O. The solvent was removed via rotary evaporation and the product purified 
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brown oil. 1H NMR (500 MHz, CDCl3) δ 7.40 (dd, J = 5.9, 2.4 Hz, 1H), 7.24 – 7.17 (m, 
4H), 7.12 – 7.09 (m, 2H), 6.97 – 6.93 (m, 2H), 6.90 (dd, J = 6.7, 3.0 Hz, 2H), 6.15 (dd, J = 
5.7, 1.9 Hz, 1H), 3.85 – 3.78 (m, 2H), 3.25 (d, J = 2.7 Hz, 1H), 1.72 (bs, 1H), 1.27 (d, J = 
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